
<html lang="en"     class="pb-page"  data-request-id="7925672e-9281-45a3-9b21-d8cc2054e977"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-24;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.0c01072;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Novel Targeted Photosensitizer as an Immunomodulator for Highly Efficient Therapy of T-Cell Acute Lymphoblastic Leukemia" /></meta><meta name="dc.Creator" content="Gankun  Yuan" /></meta><meta name="dc.Creator" content="Mengyu  Yao" /></meta><meta name="dc.Creator" content="Huihui  Lv" /></meta><meta name="dc.Creator" content="Xiao  Jia" /></meta><meta name="dc.Creator" content="Juanjuan  Chen" /></meta><meta name="dc.Creator" content="Jinping  Xue" /></meta><meta name="dc.Description" content="Dasatinib is a kinase-targeted drug used in the treatment of leukemia. Regrettably, it remains far from optimal medicine due to insurmountable drug resistance and side effects. Photodynamic therapy..." /></meta><meta name="Description" content="Dasatinib is a kinase-targeted drug used in the treatment of leukemia. Regrettably, it remains far from optimal medicine due to insurmountable drug resistance and side effects. Photodynamic therapy..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 10, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01072" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01072" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01072" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01072" /></link>
        
    
    

<title>Novel Targeted Photosensitizer as an Immunomodulator for Highly Efficient Therapy of T-Cell Acute Lymphoblastic Leukemia | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01072" /></meta><meta property="og:title" content="Novel Targeted Photosensitizer as an Immunomodulator for Highly Efficient Therapy of T-Cell Acute Lymphoblastic Leukemia" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0011.jpeg" /></meta><meta property="og:description" content="Dasatinib is a kinase-targeted drug used in the treatment of leukemia. Regrettably, it remains far from optimal medicine due to insurmountable drug resistance and side effects. Photodynamic therapy (PDT) has proven that it can induce systemic immune responses. However, conventional photosensitizers as immunomodulators produce anticancer immunities, which are inadequate to eliminate residual cancer cells. Herein, a novel compound 4 was synthesized and investigated, which introduces dasatinib and zinc(II) phthalocyanine as the targeting and photodynamic moiety, respectively. Compound 4 exhibits a high affinity to CCRF-CEM cells/tumor tissues, which overexpress lymphocyte-specific protein tyrosine kinase (LCK), and preferential elimination from the body. Meanwhile, compound 4 shows excellent photocytotoxicity and tumor regression. Significantly, compound 4-induced PDT can obviously enhance immune responses, resulting in the production of more immune cells. We believe that the proposed manner is a potential strategy for the treatment of T-cell acute lymphoblastic leukemia." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01072"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01072">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01072&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01072&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01072&amp;href=/doi/10.1021/acs.jmedchem.0c01072" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 15655-15667</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00894" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01150" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Targeted Photosensitizer as an Immunomodulator for Highly Efficient Therapy of T-Cell Acute Lymphoblastic Leukemia</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Gankun Yuan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gankun Yuan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National & Local Joint Biomedical Engineering Research Center on Photodynamic Technologies, State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fuzhou University, 2 Xueyuan Road, University Town, Fuzhou 350116, Fujian, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gankun++Yuan">Gankun Yuan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mengyu Yao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mengyu Yao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National & Local Joint Biomedical Engineering Research Center on Photodynamic Technologies, State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fuzhou University, 2 Xueyuan Road, University Town, Fuzhou 350116, Fujian, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mengyu++Yao">Mengyu Yao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Huihui Lv</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Huihui Lv</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National & Local Joint Biomedical Engineering Research Center on Photodynamic Technologies, State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fuzhou University, 2 Xueyuan Road, University Town, Fuzhou 350116, Fujian, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Huihui++Lv">Huihui Lv</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiao Jia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiao Jia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National & Local Joint Biomedical Engineering Research Center on Photodynamic Technologies, State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fuzhou University, 2 Xueyuan Road, University Town, Fuzhou 350116, Fujian, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiao++Jia">Xiao Jia</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Juanjuan Chen</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Juanjuan Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National & Local Joint Biomedical Engineering Research Center on Photodynamic Technologies, State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fuzhou University, 2 Xueyuan Road, University Town, Fuzhou 350116, Fujian, P. R. China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#86e5eee3e8ecf3e7e8ecf3e7e8c6e0fcf3a8e3e2f3a8e5e8"><span class="__cf_email__" data-cfemail="ed8e85888387988c8387988c83ad8b9798c3888998c38e83">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Juanjuan++Chen">Juanjuan Chen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9148-2206" title="Orcid link">http://orcid.org/0000-0002-9148-2206</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jinping Xue</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jinping Xue</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National & Local Joint Biomedical Engineering Research Center on Photodynamic Technologies, State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fuzhou University, 2 Xueyuan Road, University Town, Fuzhou 350116, Fujian, P. R. China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#225a5747484b4c524b4c451414624458570c4746570c414c"><span class="__cf_email__" data-cfemail="621a1707080b0c120b0c055454220418174c0706174c010c">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jinping++Xue">Jinping Xue</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6952-0475" title="Orcid link">http://orcid.org/0000-0001-6952-0475</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01072&amp;href=/doi/10.1021%2Facs.jmedchem.0c01072" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 15655–15667</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 10, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 July 2020</li><li><span class="item_label"><b>Published</b> online</span>10 December 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 December 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01072" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01072</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D15655%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGankun%2BYuan%252C%2BMengyu%2BYao%252C%2BHuihui%2BLv%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D24%26contentID%3Dacs.jmedchem.0c01072%26title%3DNovel%2BTargeted%2BPhotosensitizer%2Bas%2Ban%2BImmunomodulator%2Bfor%2BHighly%2BEfficient%2BTherapy%2Bof%2BT-Cell%2BAcute%2BLymphoblastic%2BLeukemia%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D15667%26publicationDate%3DDecember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01072"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">776</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01072" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Targeted Photosensitizer as an Immunomodulator for Highly Efficient Therapy of T-Cell Acute Lymphoblastic Leukemia&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Gankun&quot;,&quot;last_name&quot;:&quot;Yuan&quot;},{&quot;first_name&quot;:&quot;Mengyu&quot;,&quot;last_name&quot;:&quot;Yao&quot;},{&quot;first_name&quot;:&quot;Huihui&quot;,&quot;last_name&quot;:&quot;Lv&quot;},{&quot;first_name&quot;:&quot;Xiao&quot;,&quot;last_name&quot;:&quot;Jia&quot;},{&quot;first_name&quot;:&quot;Juanjuan&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Jinping&quot;,&quot;last_name&quot;:&quot;Xue&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;15655-15667&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01072&quot;},&quot;abstract&quot;:&quot;Dasatinib is a kinase-targeted drug used in the treatment of leukemia. Regrettably, it remains far from optimal medicine due to insurmountable drug resistance and side effects. Photodynamic therapy (PDT) has proven that it can induce systemic immune responses. However, conventional photosensitizers as immunomodulators produce anticancer immunities, which are inadequate to eliminate residual cancer cells. Herein, a novel compound 4 was synthesized and investigated, which introduces dasatinib and zinc(II) phthalocyanine as the targeting and photodynamic moiety, respectively. Compound 4 exhibits a high affinity to CCRF-CEM cells/tumor tissues, which overexpress lymphocyte-specific protein tyrosine kinase (LCK), and preferential elimination from the body. Meanwhile, compound 4 shows excellent photocytotoxicity and tumor regression. Significantly, compound 4-induced PDT can obviously enhance immune responses, resulting in the production of more immune cells. We believe that the proposed manner is a potential strat&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01072&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01072" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01072&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01072" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01072&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01072" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01072&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01072&amp;href=/doi/10.1021/acs.jmedchem.0c01072" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01072" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01072" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (11 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01072%26sid%3Dliteratum%253Aachs%26pmid%3D33300796%26genre%3Darticle%26aulast%3DYuan%26date%3D2020%26atitle%3DNovel%2BTargeted%2BPhotosensitizer%2Bas%2Ban%2BImmunomodulator%2Bfor%2BHighly%2BEfficient%2BTherapy%2Bof%2BT-Cell%2BAcute%2BLymphoblastic%2BLeukemia%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D24%26spage%3D15655%26epage%3D15667%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291650" title="Alcohols">Alcohols</a>,</li><li><a href="/action/doSearch?ConceptID=291912" title="Fluorescence">Fluorescence</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/jmcmar.2020.63.issue-24/20201224/jmcmar.2020.63.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Dasatinib is a kinase-targeted drug used in the treatment of leukemia. Regrettably, it remains far from optimal medicine due to insurmountable drug resistance and side effects. Photodynamic therapy (PDT) has proven that it can induce systemic immune responses. However, conventional photosensitizers as immunomodulators produce anticancer immunities, which are inadequate to eliminate residual cancer cells. Herein, a novel compound <b>4</b> was synthesized and investigated, which introduces dasatinib and zinc(II) phthalocyanine as the targeting and photodynamic moiety, respectively. Compound <b>4</b> exhibits a high affinity to CCRF-CEM cells/tumor tissues, which overexpress lymphocyte-specific protein tyrosine kinase (LCK), and preferential elimination from the body. Meanwhile, compound <b>4</b> shows excellent photocytotoxicity and tumor regression. Significantly, compound <b>4</b>-induced PDT can obviously enhance immune responses, resulting in the production of more immune cells. We believe that the proposed manner is a potential strategy for the treatment of T-cell acute lymphoblastic leukemia.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31833" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31833" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Acute lymphoblastic leukemia (ALL) is a malignant tumor disease in which B-line or T-line cells derived from lymphocytes abnormally proliferate in the bone marrow.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> Abnormally proliferating primitive cells can aggregate in the bone marrow, inhibit normal hematopoietic function, and spread to the whole body through the blood circulation. T-cell acute lymphoblastic leukemia (T-ALL) is a common type of ALL, which seriously endangers the physical and mental health of human beings.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> Currently, chemotherapy, radiation therapy, and bone marrow transplantation are the main clinical treatment methods. Specifically, tyrosine kinase inhibitors are the most used and direct chemotherapeutic drugs.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9">(6−9)</a> Dasatinib, a second-generation small-molecule-targeted tyrosine kinase inhibitor, exhibits a wide range of targets, such as BCR-ABL kinase, SRC family kinases (SRC, LCK, YES, FYN), etc.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10−12)</a> Lymphocyte-specific protein tyrosine kinase (LCK), a member of SRC family kinases, shows abnormally high expression in T-ALL cells, surpassing that in other leukemia or normal T cells. It has been reported that dasatinib can accurately target and reduce the activity of LCK kinase, which results in cell proliferation inhibition.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17 ref18">(13−18)</a> However, it is still far from an optimal drug due to insurmountable drug resistance and significant side effects (such as nausea, vomiting, diarrhea, rashes, and liver toxicity) after long-term usage.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19−21)</a> Therefore, it is urgent to develop a new and effective strategy for the treatment of T-ALL.</div><div class="NLM_p">Photodynamic therapy (PDT) is an emerging and promising treatment option for cancers and some noncancerous diseases. It utilizes photosensitizers (PSs) and the special wavelength of light and oxygen to generate reactive oxygen species (ROS) to ablate cancer cells.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25">(22−25)</a> In comparison with traditional treatment methods, PDT exhibits some unique and desirable properties, such as fewer side effects, no drug resistance, and minimal trauma.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> Over the past few decades, it has been reported that PDT can promote anticancer immune responses through cancer-associated antigens produced from cancer cell residues.<a onclick="showRef(event, 'ref28 ref29 ref30 ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31 ref32 ref33 ref34">(28−34)</a> In particular, under the stimulation of PDT, activated dendritic cells (DCs) can induce acute inflammation and migrate to lymph nodes, which can activate T cells and B cells and cause adaptive immune responses.<a onclick="showRef(event, 'ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38">(35−38)</a> Thus, during the PDT process, the photosensitizers can be regarded as immunomodulators due to their effect on the immune responses.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> However, the degree of immune responses produced by conventional photosensitizers is usually insufficient and needs to be further improved to eradicate residual tumor cells.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In addition, most photosensitizers used in PDT still face many challenges, such as poor tumor targeting, low singlet oxygen yield, and low efficacy in metastatic tumors,<a onclick="showRef(event, 'ref40 ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42 ref43">(40−43)</a> hampering their application in clinical practice. Meanwhile, the photosensitizers have a long retention time in the body, which causes significant skin photosensitivity and damage to normal tissues.<a onclick="showRef(event, 'ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46">(44−46)</a> Recently, photosensitizers have been demonstrated to be able to improve cancer targeting in PDT by combining biotargeting macromolecules<a onclick="showRef(event, 'ref47 ref48 ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49 ref50 ref51">(47−51)</a> and nanomaterials.<a onclick="showRef(event, 'ref52 ref53 ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54 ref55 ref56">(52−56)</a> However, their biological activity optimization and efficiency of biomolecules were limited due to their complex structure, variable inactivation, complex aggregation state, etc.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Additionally, the obstacles to their development for clinical trials are the toxicity of nanomaterials toward normal tissues/organs<a onclick="showRef(event, 'ref58 ref59 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref58 ref59 ref60 ref61">(58−61)</a> and the metabolic block of some large-sized nanoparticles in the body.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Thus, it is necessary to formulate a novel photosensitizer with cancer-specificity, nontoxicity, high singlet oxygen generation, and easy elimination as an effective immunomodulator.</div><div class="NLM_p last">In recent years, some trials of PDT have been applied in the treatment of leukemia.<a onclick="showRef(event, 'ref63 ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref63 ref64 ref65">(63−65)</a> However, the strategy of small-molecule-targeted drug-mediated PDT for T-ALL has not been reported to the best of our knowledge. In this work, a novel anticancer conjugate that combined the efficient photosensitizer zinc(II) phthalocyanine with dasatinib was designed and synthesized to attack T-ALL. Dasatinib and zinc(II) phthalocyanine were used as the targeting and photodynamic moiety, respectively. Compound <b>4</b> was obtained by covalent linkage of the tetraethylene glycol chain. Then, its photophysical and photochemical properties and <i>in vitro</i> and <i>in vivo</i> tumor targeting and anticancer efficacy were investigated. Furthermore, the anticancer immune responses induced by <b>4</b> were examined by immunofluorescent staining. All results showed that <b>4</b> exhibits high singlet oxygen generation and cancer targeting, a remarkable anticancer effect, and strong immune responses. Moreover, preferential elimination from the body and negligible systemic toxicity of <b>4</b> were also found. Overall, our study provides a promising strategy to achieve targeting and highly efficient therapy of T-ALL.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis</h3><div class="NLM_p">The synthetic route of compound <b>4</b> is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Briefly, based on the functional and modifiable regions of dasatinib (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A),<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> zinc(II) phthalocyanine was attached to its hydroxyl group by the tetraethylene glycol chain to maintain the targeting ability of dasatinib and improve biocompatibility. First, compound <b>1</b> was obtained by ring-opening succinic anhydride and esterifying dasatinib under alkaline conditions. Under the catalysis of K<sub>2</sub>CO<sub>3</sub>, one terminal hydroxyl group of triethylene glycol was electrophilically substituted with 3-nitrophthalonitrile to obtain compound <b>2</b>. Next, compound <b>2</b>, phthalonitrile, Zn(OAc)<sub>2</sub>, and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) were reacted in anhydrous n-pentanol. Finally, using compounds <b>3</b> and <b>1</b> as reactants, compound <b>4</b> was obtained by catalyzed esterification under 4-dimethylaminopyridine (DMAP) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) in anhydrous <i>N</i>,<i>N</i>-dimethylformamide (DMF). The reference compound <b>5</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B) was synthesized according to a previous report.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> All new compounds were characterized by <sup>1</sup>H NMR, <sup>13</sup>C NMR, and high-resolution mass spectrometry (HRMS), and the purity of compounds <b>3</b>, <b>4</b>, and <b>5</b> was verified using high-performance liquid chromatography (HPLC).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Binding site of dasatinib to kinases (pink) and the modifiable functional group (green). (B) Chemical structure of the reference compound <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1</b>–<b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) dasatinib, succinic anhydride, triethylamine, DMF, room temperature (rt), 48 h, and 90%; (b) (i) K<sub>2</sub>CO<sub>3</sub>, 3-nitrophthalphthalonitrile, acetonitrile, and 70 °C and (ii) triethylene glycol, 90 °C, 7 h, and 65%; (c) phthalonitrile, n-pentanol, and 100 °C and (ii) Zn(OAc)<sub>2</sub>, diazabicyclo[5.4.0]undec-7-ene, 130 °C, 7 h, and 12%; (d) <b>1</b>, EDCI, DMAP, DMF, rt, 24 h, and 7%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Photophysical and Photochemical Characterization</h3><div class="NLM_p">Photophysical and photochemical properties of <b>4</b> and <b>5</b> were investigated. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, the Q bands in UV/vis absorption spectra of both compounds in DMF are sharp and intense with no observable new band (∼710 nm for J-aggregation)<a onclick="showRef(event, 'ref68 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref68 ref69 ref70">(68−70)</a> and exhibit typical electronic spectra of monomer zinc(II) phthalocyanine. Meanwhile, the absorption spectra of both compounds in phosphate-buffered saline (PBS) or Roswell Park Memorial Institute 1640 (RPMI-1640) medium are similar to those in DMF (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01072/suppl_file/jm0c01072_si_001.pdf" class="ext-link">Figures S1 and S2</a>). Therefore, <b>4</b> and <b>5</b> are essentially free from aggregation not only in DMF but also in PBS and RPMI-1640 medium. Upon excitation at 610 nm, <b>4</b> and <b>5</b> showed a fluorescence emission band at 693 and 684 nm, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01072/suppl_file/jm0c01072_si_001.pdf" class="ext-link">Figure S3</a>). All of the emission and absorption data are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The fluorescence quantum yields (Φ<sub>F</sub>) of <b>4</b> (0.28) and <b>5</b> (0.26) were approximately equal to that of standard unsubstituted zinc(II) phthalocyanine (0.28). Using 1,3-diphenylisobenzofuran (DPBF) as a capture agent for <sup>1</sup>O<sub>2</sub>, <b>4</b> and <b>5</b> have high singlet oxygen yields (0.57 and 0.63, respectively; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01072/suppl_file/jm0c01072_si_001.pdf" class="ext-link">Figure S4</a>). These results showed that <b>4</b> still maintains the excellent photophysical and photochemical properties of zinc(II) phthalocyanine after introduction of the dasatinib moiety.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. UV/vis absorption spectra of (A) <b>4</b> and (B) <b>5</b> at different concentrations in DMF. The inset shows the linear relationship of absorbance (Q band at 677 and 678 nm, respectively) and concentration (0.5–3.0 and 1.0–6.0 μM, respectively).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Photophysical/Photochemical Data of Compounds <b>4</b> and <b>5</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">λ<sub>max</sub><sup>abs</sup> (nm/log ε)</th><th class="colsep0 rowsep0" align="center" char=".">λ<sub>max</sub><sup>em</sup> (nm)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">Φ<sub>F</sub><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">Φ<sub><b>Δ</b></sub><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">678/5.52</td><td class="colsep0 rowsep0" align="char" char=".">693</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="char" char=".">0.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">677/5.41</td><td class="colsep0 rowsep0" align="char" char=".">684</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">0.63</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Excited at 610 nm.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Using ZnPc as the standard in DMF (Φ<sub>F</sub> = 0.28).</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Using ZnPc as the standard in DMF (Φ<sub>Δ</sub> = 0.56).<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Cellular Uptake</h3><div class="NLM_p">To demonstrate the targeting ability of <b>4</b> at the cellular level, the CEM cells (human T-cell acute lymphoblastic leukemia cells CCRF-CEM; LCK is highly expressed) and HELF cells (human embryo lung fibroblast; LCK is lowly expressed) with different expression levels of LCK were selected. According to the dependence of uptake on time<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72,73)</a> and the data at different time points in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01072/suppl_file/jm0c01072_si_001.pdf" class="ext-link">Figure S5</a>, 1 h was selected as a suitable time point for studying targeted uptake. First, the CEM cells were incubated with <b>4</b> and <b>5</b> (both at 1 μM) for 1 h, and then the intracellular fluorescence intensity of <b>4</b> and <b>5</b> under different conditions was measured by flow cytometry. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, the fluorescence intensity of <b>4</b> was significantly higher (about five-fold) than that of <b>5</b>, which indicates the role of the dasatinib moiety in enhancing the cellular uptake of <b>4</b>. To further reveal whether the uptake of <b>4</b> in CEM cells is the LCK-mediated entry process, a competition test was conducted using dasatinib, which has an inhibitory effect on LCK and reduces the expression of LCK.<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(74,75)</a> The CEM cells were pretreated with increasing concentrations of free dasatinib (0, 10, 20, 30, and 50 μM) for 1 h, followed by incubation with <b>4</b> (1 μM) for a further 1 h. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B, upon dasatinib pretreatment, the intracellular fluorescence intensity of <b>4</b> in CEM cells decreased with increasing concentrations of free dasatinib, implying that the uptake of <b>4</b> is suppressed. This result indicated that the LCK-mediated uptake pathway is the principal cellular entry pathway for <b>4</b>. Meanwhile, to reflect the selectivity of <b>4</b>, HELF cells were chosen as the control cell lines to co-incubate with CEM cells in the same cell dishes. Then, <b>4</b> and <b>5</b> (both at 1 μM) were added to the co-incubated cell culture dishes for 1 h. Their fluorescence intensity in CEM cells and HELF cells can be measured separately. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C, the fluorescence intensity of <b>4</b> in CEM cells was significantly higher (about five-fold) than that in HELF cells. In contrast, no significant difference in the fluorescence intensity of <b>5</b> was observed between the two kinds of cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D). These results indicated that the introduction of the dasatinib moiety can efficiently enhance the targeting and selection capabilities of zinc(II) phthalocyanine to T-ALL cells.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <i>In vitro</i> cellular uptake study. The fluorescence intensity profiles and the mean intracellular fluorescence intensities of (A) CEM cells incubated with <b>4</b> and <b>5</b> (both at 1 μM) for 1 h, (B) CEM cells pretreated with free dasatinib (0, 10, 20, 30, and 50 μM) for 1 h, followed by incubation with <b>4</b> (1 μM) for a further 1 h, (C) CEM and HELF cells co-incubated with <b>4</b> (1 μM) in the same cell culture dishes for 1 h, and (D) CEM and HELF cells co-incubated with <b>5</b> (1 μM) in the same cell culture dishes for 1 h. All of the experimental under the same conditions determined by flow cytometry. The compounds were in a culture medium with 0.78% <i>N</i>,<i>N</i>-dimethylacetamide (DMAC), 0.20% 1,2-propylene glycol, and 0.02% Cremophor EL (CEL) (v/v) prior to addition to the cells. Data are expressed as mean values ± standard error of mean (SEM) value of three independent experiments (*<i>p</i> < 0.05, <sup>**</sup><i>p</i> < 0.01, <sup>***</sup><i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> <i>In Vitro</i> Photodynamic Cytotoxic Activities</h3><div class="NLM_p">To evaluate the <i>in vitro</i> photodynamic cytostatic activities, the Cell Counting Kit-8 (CCK-8) was used. Compounds <b>4</b> and <b>5</b> and dasatinib were incubated with CEM cells at the same concentration gradient (1–100 nM) for 1 h, separately. Then, the cells were irradiated under a light-emitting diode (LED) light source (λ = 670 nm, 4 mW·cm<sup>–2</sup>, 0.48 J·cm<sup>–2</sup>). The survival curves are shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A. It can be seen that <b>4</b> exhibits remarkable photocytotoxicity toward CEM cells than <b>5</b>, which may be caused by the higher uptake of <b>4</b>. The IC<sub>50</sub> values of <b>4</b> and <b>5</b> (21.38 ± 0.83 and 63.04 ± 0.78 nM, respectively) are listed in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. However, dasatinib did not exhibit cytotoxicity at the same concentration gradient (1–100 nM), and a much higher concentration (≥50 μM) was required for cytotoxicity to occur (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01072/suppl_file/jm0c01072_si_001.pdf" class="ext-link">Figure S6</a>). At the same time, dark cytotoxicity experiments were performed under the same incubation conditions. The essential cytotoxicity of all compounds was not observed in the absence of irradiation (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). Meanwhile, the photodynamic activities of all compounds toward HELF cells were also investigated. It was found that the photocytotoxicities of <b>4</b> and <b>5</b> toward HELF cells are low under light illumination (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01072/suppl_file/jm0c01072_si_001.pdf" class="ext-link">Figure S7</a>), which was consistent with their low uptake in HELF cells. These results proved that <b>4</b> exhibits remarkable photocytotoxicity toward CEM cells and maintains the low dark cytotoxicity of zinc(II) phthalocyanine.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <i>In vitro</i> photodynamic activities. (A) Cytotoxicity toward CEM cells by incubation with <b>4</b>, <b>5</b>, dasatinib, and the control for 1 h under light illumination (λ = 670 nm, 4 mW·cm<sup>–2</sup>, 0.48 J·cm<sup>–2</sup>). (B) Cytotoxicity toward CEM cells by incubation with <b>4</b>, <b>5</b>, dasatinib, and the control for 1 h in the absence of irradiation. The compounds were in a culture medium with 0.1% or less mixed organic solvents (78% DMAC, 20% 1,2-propylene glycol, and 2% Cremophor EL) (v/v) prior to addition to the cells. Data are expressed as mean values ± standard error of mean (SEM) value of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Values for Compounds <b>4</b> and <b>5</b> and Dasatinib against CEM Cells</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center"><b>4</b></th><th class="colsep0 rowsep0" align="center"><b>5</b></th><th class="colsep0 rowsep0" align="center">dasatinib</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">21.38 ± 0.84</td><td class="colsep0 rowsep0" align="left">63.04 ± 0.81</td><td class="colsep0 rowsep0" align="left">335100.00 ± 0.76</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Under light illumination (λ = 670 nm, 4 mW·cm<sup>–2</sup>, 0.48 J·cm<sup>–2</sup>). Data are expressed as mean values ± standard error of mean (SEM) value of three independent experiments.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Subcellular Localization</h3><div class="NLM_p">ROS is the key and final agent to destruct tumor cells and tissues in the PDT process; however, it has a short lifetime and a limited diffusion radius.<a onclick="showRef(event, 'ref76 ref77 ref78 ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref76 ref77 ref78 ref79 ref80">(76−80)</a> Thus, the subcellular localization of photosensitizers is closely related to their cytotoxicity. Hoechst 33258 (excited at 405 nm, monitored at 425–475 nm), Lyso-Tracker DND-26, and Mito-Tracker Green FM (both excited at 488 nm, monitored at 510–570 nm) dyes were used as specific probes for the nucleus, lysosomes, and mitochondria, respectively, to study the intracellular distribution of <b>4</b> and <b>5</b> (both excited at 633 nm, monitored at 650–750 nm). As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, the colocalization overlap of <b>4</b> with Lyso-Tracker DND-26 (0.74) or Mito-Tracker Green FM (0.82) was superior to that with Hoechst 33258 (0.37). These results demonstrated that <b>4</b> is mainly concentrated in the lysosomes and mitochondria but hardly found in the nucleus. Meanwhile, the intracellular distribution of <b>5</b> was observed to be almost similar to that of <b>4</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01072/suppl_file/jm0c01072_si_001.pdf" class="ext-link">Figure S8</a>).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Confocal fluorescence images of CEM cells treated with Hoechst 33258, Lyso-Tracker DND-26, and Mito-Tracker Green FM (column 2) and <b>4</b> (column 3); the merged images (column 4) and the fluorescence colocalization of <b>4</b> with trackers traced along the green lines in the merged images (column 5, <i>r</i> = overlap ratio). The scale bar is 10 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> <i>In Vivo</i> Tumor Tissue Targeting</h3><div class="NLM_p"><i>In vivo</i> tumor-targeting ability of <b>4</b> was validated by <i>in vivo</i> fluorescence molecular tomography (FMT). Compound <b>4</b> and <b>5</b> were injected into nude mice bearing CCRF-CEM tumors via the tail vein. The fluorescence intensity of both compounds was detected (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B, at 0–6 h post injection, both compounds showed an increasing trend of fluorescence intensity and reached their peak at 6 h. Compared to <b>5</b>, compound <b>4</b> exhibited a markedly faster increase rate. At 6 h, the tumor tissue content of <b>4</b> was approximately 75 pmol·mm<sup>–3</sup>, which is about four-fold higher than that of <b>5</b> (19 pmol·mm<sup>–3</sup>). Interestingly, at 6–8 h post injection, the content of <b>4</b> in the tumor tissues was quickly decreased to about 32 pmol·mm<sup>–3</sup>, while <b>5</b> was only slightly reduced. At 8–24 h post injection, the fluorescence intensities of both compounds gradually decreased, and <b>4</b> was reduced at a faster speed. Additionally, at 24 h post injection, the residual fluorescence intensity of <b>4</b> was significantly lower than that of <b>5</b>. These results prove that <b>4</b> is superior to <b>5</b> in terms of tumor-targeting ability and elimination speed.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <i>In vivo</i> specificity study using nude mice bearing CEM tumors. (A) Three-dimensional fluorescence images based on FMT at 0, 2, 6, and 12 h after administration of <b>4</b> and <b>5</b>. (B) Changes in the mean tumor content of <b>4</b> and <b>5</b> over time were compared. Compounds <b>4</b> and <b>5</b> were present in PBS with 0.78% DMAC, 0.20% 1,2-propylene glycol, and 0.02% Cremophor EL (v/v) prior to injection in the mice. Data are presented as mean ± standard deviation (SD) (<i>n</i> = 3) (*<i>p</i> < 0.05, <sup>**</sup><i>p</i> < 0.01, <sup>***</sup><i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> <i>In Vivo</i> Photodynamic Activities</h3><div class="NLM_p">The anticancer efficacy of <b>4</b> was explored using nude mice bearing CCRF-CEM tumors. Mice were randomized into four groups: <b>4</b>, <b>5</b>, dasatinib, and the control. A 670 nm laser (50 mW·cm<sup>–2</sup>, 10 min) was employed at 6 h post injection. The tumor sizes in the four groups were closely monitored every other day. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A,C, a gradual decrease of the tumor sizes in the <b>4</b> group was observed post treatment and the tumor almost completely disappeared after 16 days. However, for the <b>5</b> group, a certain tumor sluggish growth was displayed within the first 6 days post treatment but then accelerated after 6 days, which is due to an inhibitory effect induced by PDT in the early stage. The dasatinib group showed a feeble effect on tumor suppression, and the tumor size was slightly smaller than that of the control group, which is due to the low tumor suppression effect of dasatinib. Notably, in terms of the tumor size, the <b>4</b> group is remarkably smaller than that of the dasatinib group, which also indicates that <b>4</b> is superior to the chemotherapeutic drug alone under light illumination. Moreover, unlike multiple times of administration of chemotherapy, <b>4</b>-induced PDT only requires administration and irradiation once, and its anticancer effect can last for several days, which may be due to the continuous effect of ROS produced and the related immune response induced by PDT. The same results were confirmed by the stripped tumor volume and weight in the four groups after 16 days (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B,D). Meanwhile, histological analysis of tumor tissues in the four groups was conducted (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>F). Evident necrosis was observed in the <b>4</b> group, which includes joint interspace widening, nuclei contraction, and the destruction of membrane integrity, indicating that the tumor tissues had been successfully destroyed. However, only a small extent of necrosis and vacuoles could be observed in <b>5</b> and dasatinib groups. All results suggested that the <b>4</b> group exhibits a significant anticancer effect than the other three groups.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <i>In vivo</i> PDT study of nude mice bearing CEM tumors. (A) Photos of mice at 0, 1, 7, and 16 days post treatment. (B) Pictures of tumors stripped from mice at 16 days after treatment. (C) Tumor volume change curves after PDT treatment. (D) Average tumor weight after PDT treatment. (E) Body weight change curves of mice during 16 days. (F) Hematoxylin and eosin (H&E) staining of tumor tissues. The compounds were in PBS with 0.78% DMAC, 0.20% 1,2-propylene glycol, and 0.02% Cremophor EL (v/v) prior to injection in the mice. Data are presented as mean ± SD (<i>n</i> = 5) (*<i>p</i> < 0.05, <sup>**</sup><i>p</i> < 0.01, <sup>***</sup><i>p</i> < 0.001). The scale bar is 50 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To further verify the <i>in vivo</i> biosafety of <b>4</b>, the weight of the mice was measured during treatment. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>E, a slight increase in weight in all groups was seen post treatment. Subsequently, the H&E staining results of other normal organ sections (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01072/suppl_file/jm0c01072_si_001.pdf" class="ext-link">Figure S9</a>) showed that the <b>4</b> group has neither obvious signs of organ damage nor inflammation, which is the same as that of other groups. These results indicated that <b>4</b> shows no notable systemic toxicity <i>in vivo</i> with a high biosafety index.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Immunity Response Study</h3><div class="NLM_p">The anticancer immunity responses were further explored by immunohistochemical staining. The B cells are important immune cells in the immune system, whose main function is to mediate humoral immunity. In addition, it has been reported that natural killer (NK) cells and macrophages play key roles in immune responses.<a onclick="showRef(event, 'ref81 ref82 ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref81 ref82 ref83 ref84">(81−84)</a> NK cells are inherently capable of recognizing tumor cells without being contacted or activated in advance to exert their tumor-killing ability. Macrophages in different tissues are polarized to form different macrophage subtypes according to the environment, such as M1 macrophages and M2 macrophages. M1 macrophages can produce proinflammatory cytokine macrophages, which can promote immune function to inhibit tumor growth. In contrast, M2 macrophages are known as alternatively activated macrophages, which can inhibit immune function to promote angiogenesis and tumor growth.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><div class="NLM_p">Therefore, 4′-6′-diamidino-2-phenylindole (DAPI) (for cell nucleus) and five different antibodies (NK1.1 for NK cells, CD19 for B cells, F4–80 for macrophages, CD163 for M2 macrophages, and Ki67 for tumor proliferation) were used to investigate the anticancer immunity responses of <b>4</b>. The images of immunohistochemical staining are shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01072/suppl_file/jm0c01072_si_001.pdf" class="ext-link">S10–S12</a>. The expression level of antibodies was quantified by their fluorescence intensity. First, for the expression level of NK1.1 and CD19 (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B-a,B-b), compared with the <b>5</b> group, the <b>4</b> group shows a significant increase. Meanwhile, the <b>5</b> group exhibits a slightly higher level compared to dasatinib and control groups, which confirms that no targeted photosensitizer-induced PDT can promote immune responses to a certain extent, but the effect is very faint. However, no obvious difference between the control and dasatinib groups were found. As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B-c, the expression level of F4–80 antibody in all groups was basically the same, which indicates that the four groups have no significant effect on the expression of macrophages. Nevertheless, the expression levels of CD163 in <b>4</b> and <b>5</b> groups were obviously lower than those in the other two groups (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B-d), which implies that both the compounds induced less polarization to M2 macrophages. We speculated that PDT can inhibit the polarization to M2 macrophages to a certain extent, thereby indirectly inhibiting tumor growth. Furthermore, as shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B-e, the expression level of Ki67 in the <b>4</b> group was visibly lower than those in the other three groups, which further indicates that <b>4</b>-induced PDT results in stronger anticancer immune responses and significantly inhibits tumor proliferation. These results are also consistent with the <i>in vivo</i> photodynamic activity.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Immunohistochemical staining of tumor tissues sections. (A) Staining of different antibodies in the <b>4</b> group: (a) DAPI (blue), (b) NK1.1 (red), (c) CD19 (cyan), (d) F4–80 (yellow), (e) CD163 (pink), and (f) Ki67 (green). (B) Five antibodies’ expression levels in the four groups: (a) NK1.1, (b) CD19, (c) F4–80, (d) CD163, and (e) Ki67. Data are presented as mean ± SD (<i>n</i> = 3) (*<i>p</i> < 0.05, <sup>**</sup><i>p</i> < 0.01, <sup>***</sup><i>p</i> < 0.001). The scale bar is 100 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77112" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77112" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, a novel anticancer target photosensitizer that combined zinc(II) phthalocyanine with the small-molecule-targeted drug dasatinib was designed and synthesized as an immunomodulator for the treatment of T-ALL. As expected, the results showed that <b>4</b> still maintained excellent photophysical and photochemical properties of ZnPc and the targeting ability of dasatinib. Due to the introduction of dasatinib, <b>4</b> can efficiently enhance the targeting and selection capabilities of zinc(II) phthalocyanine to T-ALL cells. The fast elimination rate of <b>4</b> from the body was demonstrated in nude mice bearing CCRF-CEM tumors. Meanwhile, compared with <b>5</b> and dasatinib, excellent photocytotoxicity in nanomolar concentrations and remarkable tumor regression of <b>4</b> were confirmed. Especially, <b>4</b> exhibited predominantly strong immune responses as an immunomodulator after administration, which may result in secondary destruction of cancer cells and produce systemic anticancer immunity. We believe that our study offers a promising therapeutic strategy for T-ALL. In the future, we will perform animal cardiopulmonary bypass model experiments for further research and promote the clinical application of <b>4</b>.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48785" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48785" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Methods</h3><div class="NLM_p">The reaction in the synthesis process was carried out under the protection of nitrogen. All solvents were of reagent grade and dehydrated using a purification system EX-SPS5–800 (EMINEX, Co., LTD). All new compounds were dissolved in DMSO-<i>d</i><sub>6</sub> and tested for <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra on an AVANCE III 400 MHz spectrometer. The chemical shift (δ) relative to TMS was expressed in parts per million (ppm). HRMS analysis was performed on an MSD X Series 2 ion trap mass spectrometer from Agilent Technologies Germany. The purity of compounds <b>3</b>, <b>4</b>, and <b>5</b> was measured using HPLC on an E2695 system (Waters). <i>In vitro</i> toxicity was tested using a Spectra Max i3x microplate reader. The UV/vis absorption spectra were obtained on a PerkinElmer UV spectrometer. Fluorescence spectra were measured using a Varian Kali Eclipse spectrometer. Intracellular localization was recorded on an Olympus FV1000 laser confocal microscope. Fluorescence imaging was obtained on a PerkinElmer fluorescence molecular tomography instrument (FMTTM 2500 LX).</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 4-(2-(4-(6-((5-((2-Chloro-6-methylphenyl)carbamoyl)thiazol-2-yl)amino)-2-methylpyrimidin-4-yl)piperazin-1-yl)ethoxy)-4-oxobutanoic Acid (<b>1</b>)</h4><div class="NLM_p last">Compound dasatinib (1.60 g, 3.27 mmol) and succinic anhydride (0.37 g, 3.70 mmol) were dissolved in 15 mL of DMF and stirred at room temperature (rt), and then triethylamine (0.70 g, 6.90 mmol) was added dropwise under nitrogen. The reaction was carried out for 48 h; the mixture was evaporated under vacuum, redissolved in CH<sub>2</sub>Cl<sub>2</sub> (10 mL), and washed with CH<sub>2</sub>Cl<sub>2</sub> (3 × 10 mL) and CH<sub>3</sub>OH (3 × 40 mL). The product was evaporated to obtain a white solid compound <b>1</b> (1.73 g, 90%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 11.45 (s, 1H), 9.89 (s, 1H), 8.23 (s, 1H), 7.38 (d, <i>J</i> = 7.4 Hz, 1H), 7.27 (dd, <i>J</i> = 10.6, 7.5 Hz, 2H), 6.06 (s, 1H), 4.15 (t, <i>J</i> = 5.7 Hz, 2H), 3.50 (s, 4H), 2.58 (t, <i>J</i> = 5.7 Hz, 2H), 2.49 (s, 8H), 2.40 (s, 3H), 2.23 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 172.60, 165.63, 162.93, 160.41, 157.43, 141.34, 139.30, 134.03, 132.93, 129.48, 128.62, 127.47, 126.18, 83.12, 61.97, 58.95, 56.42, 53.18, 52.86, 44.04, 29.29, 26.05, 18.79. HRMS (ESI): <i>m</i>/<i>z</i> calculated for C<sub>26</sub>H<sub>30</sub>ClN<sub>7</sub>O<sub>5</sub>S [M + H]<sup>+</sup>, 588.1790; found, 588.1781.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 3-(2-(2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy)ethoxy)phthalonitrile (<b>2</b>)</h4><div class="NLM_p last">Compound potassium carbonate (27.50 g, 200 mmol) and 3-nitrophthalphthalonitrile (8.70 g, 50 mmol) were dissolved in 15 mL of acetonitrile and heated to 70 °C. Triethylene glycol was then added and further heated to 90 °C for 7 h. The mixture was dried under reduced pressure, extracted with CH<sub>2</sub>Cl<sub>2</sub> and brine, and purified using column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 30:1 v/v) to obtain a pale yellow solid compound <b>2</b> (10.45 g, 65%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.86 (t, <i>J</i> = 8.0 Hz, 1H), 7.68 (t, <i>J</i> = 7.9 Hz, 2H), 4.56 (s, 1H), 4.38 (s, 2H), 3.82 (s, 2H), 3.63 (s, 2H), 3.51 (q, <i>J</i> = 15.2, 7.7 Hz, 8H), 3.41 (s, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 161.47, 136.22, 126.28, 119.33, 116.27, 115.86, 114.12, 103.46, 72.8, 70.58, 70.3, 70.28, 70.23, 69.94, 68.98, 60.69. HRMS (ESI): <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>20</sub>N<sub>2</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 321.1445; found, 321.1442.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 2-(2-(2-(2-(Zinc(II)phthalocyanine-1-yloxy)ethoxy)ethoxy)ethoxy)ethan-1-ol (<b>3</b>)</h4><div class="NLM_p last">Compound <b>2</b> (2.20 g, 6.80 mmol) and phthalonitrile (7.80 g, 61 mmol) were dissolved in 10 mL of anhydrous n-pentanol. The solution was stirred and heated to 100 °C until it became clear. Anhydrous Zn(OAc)<sub>2</sub> was then added, and the temperature was increased to 130 °C. Finally, 0.80 mL of DBU was added after the mixture turned green, and the reaction was continued for 7 h. The mixture was evaporated and purified using column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 20:1 v/v) to obtain a blue-black solid compound <b>3</b> (0.63 g, 12%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 9.25 (dd, <i>J</i> = 9.8, 6.6 Hz, 4H), 9.20 (d, <i>J</i> = 6.1 Hz, 1H), 9.11 (d, <i>J</i> = 7.2 Hz, 1H), 8.75 (d, <i>J</i> = 7.4 Hz, 1H), 8.16 (t, <i>J</i> = 16.8, 5.8 Hz, 6H), 7.97 (t, <i>J</i> = 7.6 Hz, 1H), 7.58 (d, <i>J</i> = 7.9 Hz, 1H), 4.82 (m, 2H), 4.53 (t, <i>J</i> = 5.5 Hz, 1H), 4.37 (m, 2H), 4.07 (t, <i>J</i> = 5.0 Hz, 2H), 3.76 (t, <i>J</i> = 5.0 Hz, 2H), 3.59(m, 2H), 3.49 (dd, <i>J</i> = 5.6, 4.1 Hz, 2H), 3.42 (m, 2H), 3.38 (s, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 174.96, 169.25, 167.95, 156.11, 153.38, 153.28, 153.20, 153.14, 140.93, 138.91, 138.61, 138.56, 138.51, 138.48, 136.87, 131.01, 129.61, 129.56, 129.46, 125.57, 122.66, 120.05, 115.45, 114.15, 72.79, 70.99, 70.57, 70.40, 70.22, 69.38, 69.16, 60.65, 34.17, 31.73, 29.42, 29.13, 24.98, 22.53, 14.39. HRMS (ESI): <i>m</i>/<i>z</i> calculated for C<sub>40</sub>H<sub>32</sub>N<sub>8</sub>O<sub>5</sub>Zn [M + H]<sup>+</sup>, 769.1867; found, 769.1855. The purity was examined using HPLC (<i>R</i><sub>t</sub> = 6.52 min) and found to be >95%.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 2-(4-(6-((5-((2-Chloro-6-methylphenyl)carbamoyl)thiazol-2-yl)amino)-2-methylpyrimidin-4-yl)piperazin-1-yl)ethyl (2-(2-(2-(2-(zinc(II)phthalocyanine-1-yloxy)ethoxy)ethoxy)ethoxy)ethyl) Succinate (<b>4</b>)</h4><div class="NLM_p">Compound <b>1</b> (0.64 g, 1.00 mmol) and EDCI (0.21 g, 1.09 mmol) were dissolved in 10 mL of DMF and stirred for 10 min; DMAP (0.052 g, 0.16 mmol) and compound <b>3</b> (1.00 g, 1.30 mmol) were then added, and the reaction was carried out for 24 h at rt. The mixture was evaporated under vacuum and purified using column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 20:1 v/v) to obtain a blue-green solid compound <b>4</b> (0.01 g, 7%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 11.47 (s, 1H), 9.91 (s, 1H), 9.25<b>–</b>8.92 (m, 6H), 8.61 (d, <i>J</i> = 7.4 Hz, 1H), 8.25 (s, 1H), 8.18<b>–</b>8.05 (m, 6H), 7.87 (t, <i>J</i> = 7.6 Hz, 1H), 7.44 (dd, <i>J</i> = 23.6, 4.9 Hz, 2H), 7.29 (dd, <i>J</i> = 7.7, 4.7 Hz, 2H), 6.00 (s, 1H), 4.79<b>–</b>4.71 (m, 2H), 4.38<b>–</b>4.30 (m, 2H), 4.05 (dd, <i>J</i> = 10.6, 6.1 Hz, 6H), 3.74 (dd, <i>J</i> = 5.8, 3.9 Hz, 2H), 3.68<b>–</b>3.46 (m, 8H), 3.41 (d, <i>J</i> = 19.6 Hz, 4H), 2.48 (s, 4H), 2.41 (d, <i>J</i> = 7.5 Hz, 4H), 2.39 (s, 3H), 2.26 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub> with a trace amount of pyridine-<i>d</i><sub>5</sub>): δ = 174.41, 171.73, 171.61, 165.03, 162.49, 162.21, 159.87, 156.84, 155.75, 154.09, 153.12, 153.09, 153.02, 153.00, 152.93, 152.89, 152.87, 146.71, 140.80, 140.59, 138.75, 138.49, 138.17, 138.12, 138.07, 138.04, 133.50, 132.39, 130.64, 128.91, 128.04, 126.90, 125.63, 125.24, 122.20, 115.07, 113.81, 106.42, 82.53, 70.44, 70.03, 69.85, 69.74, 69.68, 68.95, 68.07, 63.31, 61.36, 52.18, 43.41, 38.45, 33.62, 31.17, 28.88, 28.78, 28.63, 28.58, 28.45, 28.39, 25.46, 24.42, 21.97, 18.23,13.83. HRMS (ESI): <i>m</i>/<i>z</i> calculated for C<sub>66</sub>H<sub>60</sub>N<sub>15</sub>O<sub>9</sub>SZnCl [M + H]<sup>+</sup>, 1338.3472; found, 1338.3441. The purity was examined using HPLC (<i>R</i><sub>t</sub> = 9.15 min) and found to be >95%.</div><div class="NLM_p last">Compound <b>5</b> was prepared according to the literature procedure.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> The purity was examined using HPLC (<i>R</i><sub>t</sub> = 11.04 min) and found to be >95%.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Photophysical and Photochemical Characterization</h3><div class="NLM_p">The UV/vis spectra of <b>4</b> and <b>5</b> with different concentration gradients in DMF were measured in the range of 300–800 nm. To prevent aggregation and retain the stability of phthalocyanines, compounds <b>4</b> and <b>5</b> were dissolved in the mixed organic solvents of 78% DMAC (<i>N</i>,<i>N</i>-dimethylacetamide), 20% 1,2-propylene glycol, and 2% Cremophor EL (CEL) to form 1 mM stock solutions and then diluted with the same organic solvents to various concentrations. Meanwhile, the UV/vis spectra of <b>4</b> and <b>5</b> (both at 2.5 μM) in PBS or RPMI-1640 medium (containing 0.78% DMAC, 0.2% 1,2-propylene glycol, and 0.02% CEL) were also measured in the range of 300–800 nm. The fluorescence quantum yields (Φ<sub>F</sub>) of both compounds were determined according to the formula<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_m001.gif" alt="" id="_i23" /></img></span>where <i>F</i>, <i>A</i>, and η are the maximum emission peak integral area, the absorbance at a specific wavelength (610 nm), and the refractive index of the selected solvent, respectively. Unsubstituted zinc(II) phthalocyanine (ZnPc) was selected as the standard (Φ<sub>std F</sub> = 0.28 in DMF).</div><div class="NLM_p last">The singlet oxygen quantum yield (Φ<sub>Δ</sub>) was obtained using 1,3-diphenylisobenzofuran (DPBF) as a scavenger. Light (670 nm, 100 mW·cm<sup>–2</sup>) was employed, and the absorbance of DPBF at 415 nm was measured every 10 s. The singlet oxygen quantum yields (Φ<sub>Δ</sub>) of the two compounds were determined according to the formula<span class="NLM_disp-formula" id="ueq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_m002.gif" alt="" id="_i24" /></img></span>where <i>K</i> and <i>I</i> are the DPBF degradation rate constant and the light absorption rate, respectively. Unsubstituted zinc(II) phthalocyanine was used as the standard (Φ<sub>Δ</sub> = 0.56 in DMF).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> HPLC Analysis</h3><div class="NLM_p last">Analytical HPLC experiments were performed using an E2695 (Waters) binary HPLC pump with a Waters 2998 photodiode array detector. The solvents used for HPLC analysis were of HPLC grade. The conditions of HPLC were set as follows: solvent A = tetrahydrofuran (THF), solvent B = deionized water, and elution mode = isocratic: [50% A] and [50% B]. The total elution time was 30 min. The flow rate was fixed at 1.0 mL·min<sup>–1</sup>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Cellular Uptake</h3><div class="NLM_p last">Approximately 2 × 10<sup>5</sup> CEM cells were inoculated in cell culture dishes for 24 h at 37 °C under 5% CO<sub>2</sub>. Compounds <b>4</b> and <b>5</b> were dissolved in the mixed organic solvents of 78% DMAC, 20% 1,2-propylene glycol, and 2% CEL to form 1 mM stock solutions. Then, these stock solutions were diluted with the same organic solvents to 100 μM and further diluted with RPMI-1640 medium (HyClone) to 1 μM (containing 0.78% DMAC, 0.2% 1,2-propylene glycol, and 0.02% CEL). The medium was then exchanged with a fresh medium containing <b>4</b> and <b>5</b> (both at 1 μM). After 1 h of incubation, the medium was centrifuged to remove drugs that were not ingested, and then CEM cells were collected. For the dasatinib inhibition assay, the CEM cells were pretreated with or without dasatinib (10 μM) for 1 h, followed by incubation with <b>4</b> (1 μM) for a further 1 h. After 1 h of incubation, the medium was centrifuged to remove drugs that were not ingested, and then the CEM cells were collected. For the selectivity assay of <b>4</b>, the HELF and CEM cells were inoculated in the same cell culture dish, which contains approximately 1 × 10<sup>5</sup> cells of each kind, and incubated for 24 h at 37 °C under 5% CO<sub>2</sub>. All cell culture dishes were randomly divided into two groups, <b>4</b> and <b>5</b> (both at 1 μM). After 1 h of incubation, the medium was centrifuged to remove drugs that were not ingested, and then CEM cells were collected. At the same time, HELF cells were washed, digested, and collected. The fluorescence intensities of all groups were detected by cell flow cytometry. All control groups were treated with a fresh medium (containing 0.78% DMAC, 0.2% 1,2-propylene glycol, and 0.02% CEL).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>In Vitro</i> Photodynamic Cytostatic Activities</h3><div class="NLM_p last">Approximately 1 × 10<sup>4</sup> CEM cells in RPMI-1640 medium and HELF cells in Dulbecco’s modified Eagle’s medium (DMEM) were seeded per well in different 96-well cell plates and incubated for 24 h at 37 °C under 5% CO<sub>2</sub>. All compounds were prepared as mentioned above to form 1 μM solutions (containing 0.78% DMAC, 0.2% 1,2-propylene glycol, and 0.02% CEL) and then diluted with RPMI-1640 medium to various concentrations. The control group was treated with a fresh medium (containing 0.78% DMAC, 0.2% 1,2-propylene glycol, and 0.02% CEL). The compounds were diluted to the required concentration and added to the corresponding wells. After 1 h of incubation, for the CEM cells, the medium was centrifuged at 1000 rpm for 4 min to remove the supernatant, and then the cells were resuspended and transferred to a new 96-well plate. The HELF cells were washed three times with PBS and transferred to the new DMEM medium. All plates for photocytotoxicity were irradiated with a LED light source (λ = 670 nm, 4 mW·cm<sup>–2</sup>, 0.48 J·cm<sup>–2</sup>) for 2 min and incubated for 24 h. Then, 20 μL of CCK-8 solution (Dojindo. Japan) was added to each well and incubated for 4 h. The absorbance at 450 nm was detected on the microplate reader. The steps of the dark cytotoxic experiments were consistent with those of the photocytotoxicity experiments but without irradiation. The data and the concentration IC<sub>50</sub> were analyzed and calculated using the GraphPad Prism 6.0 software.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Subcellular Localization</h3><div class="NLM_p last">Approximately 1 × 10<sup>4</sup> CEM cells were seeded in a cell culture dish containing 1 μM <b>4</b> and <b>5</b> (containing 0.78% DMAC, 0.2% 1,2-propylene glycol, and 0.02% CEL). After 24 h of incubation, the mixture was centrifuged at 1000 rpm for 4 min to remove the supernatant. After centrifugation, the cells were resuspended in a fresh medium and stained with Mito-Tracker Green FM (Beijing Dingguo Biotechnology Co., Ltd., 2 μM in a culture medium stained for 20 min), Lyso-Tracker DND-26 (Beijing Dingguo Biotechnology Co., Ltd., 2 μM in a culture medium stained for 25 min), and Hoechst 33258 (Beijing Dingguo Biotechnology Co., Ltd., 1 μM in a culture medium stained for 30 min), respectively. Then, the cells were centrifuged to remove the supernatant. Finally, the cells were resuspended by a small amount of PBS and then placed in a cell culture dish prior to photographing. The cells were then viewed with an Olympus FV1000 laser confocal microscope equipped with a 405 nm or 488 nm multiargon laser and a 633 nm diode laser. All of the trackers were excited at 405 nm and monitored at 425–475 nm (Hoechst 33258) or excited at 488 nm and monitored at 510–570 nm (Mito-Tracker Green FM, Lyso-Tracker DND-26), while <b>4</b> and <b>5</b> were both excited at 633 nm and monitored at 650–750 nm. The images were digitized and analyzed using the FV10-ASW software.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>In Vivo</i> Tumor Tissue Targeting</h3><div class="NLM_p last">The experiment used female nude mice of 4–5 weeks (17–20 g, purchased from Shanghai SLAC Laboratory Animal Co., Ltd, China). All mice were maintained and handled in accordance with the recommendations of the Animal Care and Use Committee (IACUC). All mice were randomly divided into two groups (<i>n</i> = 3), and all laboratory supplies and procedures were sterile. Briefly, 200 μL of CEM cells (1 x 10<sup>7</sup>cells) were subcutaneously inoculated into the right forelimbs of mice for 14 days. Compounds <b>4</b> and <b>5</b> were dissolved in 78% DMAC, 20% 1,2-propylene glycol, and 2% CEL to obtain 2.5 mM stock solutions. Then, these stock solutions were diluted with PBS to 25 μM (containing 0.78% DMAC, 0.2% 1,2-propylene glycol, and 0.02% CEL). Once the tumor grew to 50–100 mm<sup>3</sup>, 200 μL of <b>4</b> and <b>5</b> (0.25 μmol·kg<sup>–1</sup>) were injected into the mice by tail vein injection. All mice were observed using a fluorescence molecular tomography FMT 2500FM. LX. instrument. The accumulation of drugs in tumors at different time points (0, 2, 6, 12, 24 h) was detected by three-dimensional fluorescence imaging. The images and the average drug concentrations were obtained using software TrueQuant version 3.0 (PerkinElmer).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>In Vivo</i> Photodynamic Activities</h3><div class="NLM_p last">All mice with tumor were randomly divided into four groups (<i>n</i> = 5): (a) <b>4</b>, (b) <b>5</b>, (c) dasatinib, and (d) control. All compounds were dissolved in 78% DMAC, 20% 1,2-propylene glycol, and 2% CEL, respectively, to obtain 7.5 mM stock solutions and diluted with PBS to 75 μM (containing 0.78% DMAC, 0.2% 1,2-propylene glycol, and 0.02% CEL). Then, 200 μL of <b>4</b>, <b>5</b>, and dasatinib (0.75 μmol·kg<sup>–1</sup>) were injected into the mice by tail vein injection. The control group was treated with 200 μL of PBS (containing 0.78% DMAC, 0.2% 1,2-propylene glycol, and 0.02% CEL). The tumor site of the mice was irradiated by a laser (λ = 670 nm, 50 mW·cm<sup>–2</sup>, 10 min) at 6 h post injection. After treatment, the weight of the mice was measured. The length (<i>a</i>) and width (<i>b</i>) of the tumor were measured using vernier caliper every other day. The tumor volume was calculated using the formula <i>ab</i><sup>2</sup>/2. At 16 days post treatment, all mice were sacrificed, and major organs and tumors were removed and weighed.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Histological Analysis</h3><div class="NLM_p last">All representative tumors and major organs in each group were collected at 16 days after treatment and fixed in 10% formalin. The paraffin sections were stained with hematoxylin and eosin (H&E).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Immunity Response Study</h3><div class="NLM_p last">The tissue sections of the four groups (<i>n</i> = 3) were first dehydrated and then rehydrated, immersed in an antigen repair working solution, and repaired by microwave. Then, the tissue sections were incubated with the primary antibody at room temperature for the corresponding durations. After incubation, the goat antirabbit or goat antimouse rabbit antibody diluted in proportion was used for secondary incubation. Multiplex immunofluorescence staining was obtained by PPD650 fluorescence staining, and antigen retrieval was performed again. Sequentially, the different primary antibodies were applied, the secondary antibody which horseradish peroxidase-conjugated were incubated and tyramide signal amplification. Finally, the remaining washing solution in the sections was removed, and the nuclei were incubated with 4′-6′-diamidino-2-phenylindole (DAPI) at room temperature for 10 min. The sections were dipped in TBST buffer for 3 min at room temperature and washed for 2 min with sterile water. A strong antiquenching sealer and nail polish were added when the sections were slightly dry. The stained tissue slides were observed under a fluorescence microscope.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01072" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18481" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18481" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01072?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01072</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Electronic absorption spectra of <b>4</b> and <b>5</b> in PBS or RPMI-1640 medium; fluorescence spectra of <b>4</b> and <b>5</b> in DMF; absorbance spectra of DPBF at 415 nm; cytotoxicity of dasatinib toward CEM cells at high concentrations; cytotoxicity of compounds toward HELF cells with/without light illumination; subcellular localization of <b>5</b>; H&E staining of different organs in the four groups; staining of different antibodies in <b>5</b>, dasatinib, and control groups; and <sup>1</sup>H NMR, <sup>13</sup>C NMR, and HRMS of all new compounds and HPLC of compounds <b>3</b>, <b>4</b>, and <b>5</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01072/suppl_file/jm0c01072_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01072/suppl_file/jm0c01072_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01072/suppl_file/jm0c01072_si_001.pdf">jm0c01072_si_001.pdf (2.35 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01072/suppl_file/jm0c01072_si_003.csv">jm0c01072_si_003.csv (0.96 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01072" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40844" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40844" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juanjuan Chen</span> - <span class="hlFld-Affiliation affiliation">National & Local Joint
Biomedical Engineering Research Center on Photodynamic Technologies,
State Key Laboratory of Photocatalysis on Energy and Environment,
College of Chemistry, Fuzhou University, 2 Xueyuan Road, University Town, Fuzhou 350116, Fujian, P. R. China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9148-2206" title="Orcid link">http://orcid.org/0000-0002-9148-2206</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#43202b262d2936222d2936222d032539366d2627366d202d"><span class="__cf_email__" data-cfemail="e6858e83888c9387888c938788a6809c93c8838293c88588">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinping Xue</span> - <span class="hlFld-Affiliation affiliation">National & Local Joint
Biomedical Engineering Research Center on Photodynamic Technologies,
State Key Laboratory of Photocatalysis on Energy and Environment,
College of Chemistry, Fuzhou University, 2 Xueyuan Road, University Town, Fuzhou 350116, Fujian, P. R. China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6952-0475" title="Orcid link">http://orcid.org/0000-0001-6952-0475</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#09717c6c6360677960676e3f3f496f737c276c6d7c276a67"><span class="__cf_email__" data-cfemail="dba3aebeb1b2b5abb2b5bceded9bbda1aef5bebfaef5b8b5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gankun Yuan</span> - <span class="hlFld-Affiliation affiliation">National & Local Joint
Biomedical Engineering Research Center on Photodynamic Technologies,
State Key Laboratory of Photocatalysis on Energy and Environment,
College of Chemistry, Fuzhou University, 2 Xueyuan Road, University Town, Fuzhou 350116, Fujian, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mengyu Yao</span> - <span class="hlFld-Affiliation affiliation">National & Local Joint
Biomedical Engineering Research Center on Photodynamic Technologies,
State Key Laboratory of Photocatalysis on Energy and Environment,
College of Chemistry, Fuzhou University, 2 Xueyuan Road, University Town, Fuzhou 350116, Fujian, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huihui Lv</span> - <span class="hlFld-Affiliation affiliation">National & Local Joint
Biomedical Engineering Research Center on Photodynamic Technologies,
State Key Laboratory of Photocatalysis on Energy and Environment,
College of Chemistry, Fuzhou University, 2 Xueyuan Road, University Town, Fuzhou 350116, Fujian, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiao Jia</span> - <span class="hlFld-Affiliation affiliation">National & Local Joint
Biomedical Engineering Research Center on Photodynamic Technologies,
State Key Laboratory of Photocatalysis on Energy and Environment,
College of Chemistry, Fuzhou University, 2 Xueyuan Road, University Town, Fuzhou 350116, Fujian, P. R. China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through the contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>The National Natural Science Foundation of China (Project No. 81703345) and the National Health and Family Planning Commission jointly established a scientific research fund (Project No. WKJ2016-2-14).</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e2149-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76638" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76638" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank WuXi AppTec Co., Ltd (WuXi, China) for mice care and operation during <i>in vivo</i> experiments. We thank Panovue Biotechnology (Beijing) Co. Ltd for technical support with immunofluorescent staining.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">PDT</td><td class="NLM_def"><p class="first last">photodynamic therapy</p></td></tr><tr><td class="NLM_term">LCK</td><td class="NLM_def"><p class="first last">lymphocyte-specific protein tyrosine kinase</p></td></tr><tr><td class="NLM_term">ALL</td><td class="NLM_def"><p class="first last">acute lymphoblastic leukemia</p></td></tr><tr><td class="NLM_term">T-ALL</td><td class="NLM_def"><p class="first last">T-cell acute lymphoblastic leukemia</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">PS</td><td class="NLM_def"><p class="first last">photosensitizer</p></td></tr><tr><td class="NLM_term">DCs</td><td class="NLM_def"><p class="first last">dendritic cells</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">diazabicyclo[5.4.0]undec-7-ene</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">ZnPc</td><td class="NLM_def"><p class="first last">zinc phthalocyanine</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">Φ<sub>F</sub></td><td class="NLM_def"><p class="first last">fluorescence quantum yield</p></td></tr><tr><td class="NLM_term">Φ<sub>Δ</sub></td><td class="NLM_def"><p class="first last">singlet oxygen quantum yield</p></td></tr><tr><td class="NLM_term">DPBF</td><td class="NLM_def"><p class="first last">1,3-diphenylisobenzofuran</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">CCK-8</td><td class="NLM_def"><p class="first last">cell counting kit-8</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">dye concentration required to kill 50% of the cells</p></td></tr><tr><td class="NLM_term">DMAC</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylacetamide</p></td></tr><tr><td class="NLM_term">FMT</td><td class="NLM_def"><p class="first last">fluorescence molecular tomography</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate-buffered saline</p></td></tr><tr><td class="NLM_term">NK</td><td class="NLM_def"><p class="first last">natural killer</p></td></tr><tr><td class="NLM_term">DAPI</td><td class="NLM_def"><p class="first last">4′,6-diamidino-2-phenylindole</p></td></tr><tr><td class="NLM_term">RPMI-1640</td><td class="NLM_def"><p class="first last">Roswell Park Memorial Institute 1640</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle’s medium</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">CEL</td><td class="NLM_def"><p class="first last">Cremophor EL</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18820" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18820" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 85 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantarjian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabbour, E. J.</span></span> <span> </span><span class="NLM_article-title">Adult acute lymphoblastic leukemia</span>. <i>Mayo Clin. Proc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">1645</span>– <span class="NLM_lpage">1666</span>, <span class="refDoi"> DOI: 10.1016/j.mayocp.2016.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.mayocp.2016.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=27814839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BC2snjtFCksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2016&pages=1645-1666&author=S.+Paulauthor=H.+Kantarjianauthor=E.+J.+Jabbour&title=Adult+acute+lymphoblastic+leukemia&doi=10.1016%2Fj.mayocp.2016.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Adult Acute Lymphoblastic Leukemia</span></div><div class="casAuthors">Paul Shilpa; Kantarjian Hagop; Jabbour Elias J</div><div class="citationInfo"><span class="NLM_cas:title">Mayo Clinic proceedings</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1645-1666</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Conventional cytotoxic chemotherapy used to treat acute lymphoblastic leukemia (ALL) results in high cure rates in pediatric patients but is suboptimal in the treatment of adult patients.  The 5-year overall survival is approximately 90% in children and 30% to 40% in adults and elderly patients.  Adults with ALL tend to have higher risk factors at diagnosis, more comorbidities, and increasing age that often requires dose reductions.  Major advancements have been made in redefining the pathologic classification of ALL, identifying new cytogenetic-molecular abnormalities, and developing novel targeted agents in order to improve survival.  The addition of new monoclonal antibodies and tyrosine kinase inhibitors to conventional chemotherapy in the frontline setting has resulted in increased rates of complete remission and overall survival.  These new developments are changing the treatment of adult ALL from a "one therapy fits all" approach to individualized treatment based on patient's cytogenetic and molecular profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXUmUA9vzNdb5XHngOXiV_fW6udTcc2ea1YkTZd9z5_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snjtFCksw%253D%253D&md5=a98b4dd3e8a8a3f0fb8f4b6bfb9e4d1d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.mayocp.2016.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mayocp.2016.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DS.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DJabbour%26aufirst%3DE.%2BJ.%26atitle%3DAdult%2520acute%2520lymphoblastic%2520leukemia%26jtitle%3DMayo%2520Clin.%2520Proc.%26date%3D2016%26volume%3D91%26spage%3D1645%26epage%3D1666%26doi%3D10.1016%2Fj.mayocp.2016.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Styczynski, J.</span></span> <span> </span><span class="NLM_article-title">A step forward in acute lymphoblastic leukemia</span>. <i>Transl. Pediatr.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=26835266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BC28nmvVegtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2012&pages=68-69&author=J.+Styczynski&title=A+step+forward+in+acute+lymphoblastic+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A step forward in acute lymphoblastic leukemia</span></div><div class="casAuthors">Styczynski Jan</div><div class="citationInfo"><span class="NLM_cas:title">Translational pediatrics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">68-9</span>
        ISSN:<span class="NLM_cas:issn">2224-4344</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAM8q032c8iEPI-fCgwosgfW6udTcc2ea1YkTZd9z5_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28nmvVegtw%253D%253D&md5=a6a39e181b33eae4d56d5b1ff55c8231</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStyczynski%26aufirst%3DJ.%26atitle%3DA%2520step%2520forward%2520in%2520acute%2520lymphoblastic%2520leukemia%26jtitle%3DTransl.%2520Pediatr.%26date%3D2012%26volume%3D1%26spage%3D68%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdul-Hay, M.</span></span> <span> </span><span class="NLM_article-title">Acute lymphoblastic leukemia: a comprehensive review and 2017 update</span>. <i>Blood Cancer J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e577</span> <span class="refDoi"> DOI: 10.1038/bcj.2017.53</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fbcj.2017.53" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=28665419" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&author=T.+Terwilligerauthor=M.+Abdul-Hay&title=Acute+lymphoblastic+leukemia%3A+a+comprehensive+review+and+2017+update&doi=10.1038%2Fbcj.2017.53"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fbcj.2017.53&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbcj.2017.53%26sid%3Dliteratum%253Aachs%26aulast%3DTerwilliger%26aufirst%3DT.%26aulast%3DAbdul-Hay%26aufirst%3DM.%26atitle%3DAcute%2520lymphoblastic%2520leukemia%253A%2520a%2520comprehensive%2520review%2520and%25202017%2520update%26jtitle%3DBlood%2520Cancer%2520J.%26date%3D2017%26volume%3D7%26doi%3D10.1038%2Fbcj.2017.53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, D.</span></span> <span> </span><span class="NLM_article-title">Sgc8 aptamer targeted glutathione-responsive nanoassemblies containing Ara-C prodrug for the treatment of acute lymphoblastic leukemia</span>. <i>Nanoscale</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">23000</span>– <span class="NLM_lpage">23012</span>, <span class="refDoi"> DOI: 10.1039/C9NR07391D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2FC9NR07391D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31769777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFamtr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=23000-23012&author=Z.+Fangauthor=X.+Wangauthor=Y.+Sunauthor=R.+Fanauthor=Z.+Liuauthor=R.+Guoauthor=D.+Xie&title=Sgc8+aptamer+targeted+glutathione-responsive+nanoassemblies+containing+Ara-C+prodrug+for+the+treatment+of+acute+lymphoblastic+leukemia&doi=10.1039%2FC9NR07391D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Sgc8 aptamer targeted glutathione-responsive nanoassemblies containing Ara-C prodrug for the treatment of acute lymphoblastic leukemia</span></div><div class="casAuthors">Fang, Zhigang; Wang, Xiaozhen; Sun, Yanling; Fan, Ruifang; Liu, Zhong; Guo, Rui; Xie, Deming</div><div class="citationInfo"><span class="NLM_cas:title">Nanoscale</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">23000-23012</span>CODEN:
                <span class="NLM_cas:coden">NANOHL</span>;
        ISSN:<span class="NLM_cas:issn">2040-3372</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cytarabine (Ara-C) is an essential medicine used in the clin. treatment of acute lymphoblastic leukemia.  However, Ara-C suffers from high hydrophilicity, rapid plasma degrdn. and significant side effects.  Thus, herein, to eliminate the limitations of Ara-C in the treatment of leukemia, Sgc8 aptamer targeting and glutathione (GSH)-responsive polymeric micelles (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="84d4c7c8a9f7f7a9c5f6e5c4d7e3e7bca9c6d7c5">[email protected]</a>) were prepd.  The prodrug was synthesized via covalent bond formation between acryloyl chloride-terminal PCL-ss-PCL and Ara-C, and surface decoration with Sgc8-bovine serum albumin (Sgc8-BSA).  The obtained <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="1e4e5d52336d6d335f6c7f5e4d797d26335c4d5f">[email protected]</a> exhibited good GSH-responsive drug release behavior, obvious targetability and sufficient antitumor effect to acute lymphoblastic leukemia (ALL) cells (CCRF-CEM).  A hemolysis test was further carried out to demonstrate that these polymeric micelles are safe to be administrated i.v.  Compared with free Ara-C, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="5404171879272779152635140733376c79160715">[email protected]</a> significantly enhanced tumor growth inhibition in mice bearing CCRF-CEM xenograft tumors, while causing little side effects, and improved the survival rate of CCRF-CEM tumor-bearing mice in vivo.  Therefore, this new self-assembling small mol. prodrug equipped with Sgc8 targeting function is a potential treatment for the targeted therapy of acute lymphoblastic leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyVcF9FDjaabVg90H21EOLACvtfcHk0ljmFOqOb-h0jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFamtr%252FF&md5=b5b83859897b9ab949c36c5a5eb3ddfb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1039%2FC9NR07391D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9NR07391D%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DXie%26aufirst%3DD.%26atitle%3DSgc8%2520aptamer%2520targeted%2520glutathione-responsive%2520nanoassemblies%2520containing%2520Ara-C%2520prodrug%2520for%2520the%2520treatment%2520of%2520acute%2520lymphoblastic%2520leukemia%26jtitle%3DNanoscale%26date%3D2019%26volume%3D11%26spage%3D23000%26epage%3D23012%26doi%3D10.1039%2FC9NR07391D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogueira, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariotto, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabroff, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfano, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span> <span> </span><span class="NLM_article-title">Cancer treatment and survivorship statistics, 2019</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.3322/caac.21565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.3322%2Fcaac.21565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31184787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BB3M3ltlemug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2019&pages=363-385&author=K.+D.+Millerauthor=L.+Nogueiraauthor=A.+B.+Mariottoauthor=J.+H.+Rowlandauthor=K.+R.+Yabroffauthor=C.+M.+Alfanoauthor=A.+Jemalauthor=J.+L.+Kramerauthor=R.+L.+Siegel&title=Cancer+treatment+and+survivorship+statistics%2C+2019&doi=10.3322%2Fcaac.21565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer treatment and survivorship statistics, 2019</span></div><div class="casAuthors">Miller Kimberly D; Jemal Ahmedin; Siegel Rebecca L; Nogueira Leticia; Yabroff K Robin; Jemal Ahmedin; Mariotto Angela B; Rowland Julia H; Alfano Catherine M; Kramer Joan L</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">363-385</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The number of cancer survivors continues to increase in the United States because of the growth and aging of the population as well as advances in early detection and treatment.  To assist the public health community in better serving these individuals, the American Cancer Society and the National Cancer Institute collaborate every 3 years to estimate cancer prevalence in the United States using incidence and survival data from the Surveillance, Epidemiology, and End Results cancer registries; vital statistics from the Centers for Disease Control and Prevention's National Center for Health Statistics; and population projections from the US Census Bureau.  Current treatment patterns based on information in the National Cancer Data Base are presented for the most prevalent cancer types.  Cancer-related and treatment-related short-term, long-term, and late health effects are also briefly described.  More than 16.9 million Americans (8.1 million males and 8.8 million females) with a history of cancer were alive on January 1, 2019; this number is projected to reach more than 22.1 million by January 1, 2030 based on the growth and aging of the population alone.  The 3 most prevalent cancers in 2019 are prostate (3,650,030), colon and rectum (776,120), and melanoma of the skin (684,470) among males, and breast (3,861,520), uterine corpus (807,860), and colon and rectum (768,650) among females.  More than one-half (56%) of survivors were diagnosed within the past 10 years, and almost two-thirds (64%) are aged 65 years or older.  People with a history of cancer have unique medical and psychosocial needs that require proactive assessment and management by follow-up care providers.  Although there are growing numbers of tools that can assist patients, caregivers, and clinicians in navigating the various phases of cancer survivorship, further evidence-based resources are needed to optimize care.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTqS-tR1uHDx5ggzHGM8X5CfW6udTcc2eYx0nF2NzeF1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3ltlemug%253D%253D&md5=3bcced5db38c65d9d98364c3884a21d9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21565%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DNogueira%26aufirst%3DL.%26aulast%3DMariotto%26aufirst%3DA.%2BB.%26aulast%3DRowland%26aufirst%3DJ.%2BH.%26aulast%3DYabroff%26aufirst%3DK.%2BR.%26aulast%3DAlfano%26aufirst%3DC.%2BM.%26aulast%3DJemal%26aufirst%3DA.%26aulast%3DKramer%26aufirst%3DJ.%2BL.%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26atitle%3DCancer%2520treatment%2520and%2520survivorship%2520statistics%252C%25202019%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2019%26volume%3D69%26spage%3D363%26epage%3D385%26doi%3D10.3322%2Fcaac.21565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Portell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Advani, A.</span></span> <span> </span><span class="NLM_article-title">Antibody therapy for acute lymphoblastic leukemia</span>. <i>Curr. Hematol. Malig. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1007/s11899-012-0120-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1007%2Fs11899-012-0120-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=22422550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BC38vntVelsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=153-159&author=C.+Portellauthor=A.+Advani&title=Antibody+therapy+for+acute+lymphoblastic+leukemia&doi=10.1007%2Fs11899-012-0120-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody therapy for acute lymphoblastic leukemia</span></div><div class="casAuthors">Portell Craig A; Advani Anjali S</div><div class="citationInfo"><span class="NLM_cas:title">Current hematologic malignancy reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Advances in chemotherapy administration have made acute lymphoblastic leukemia (ALL) a curable disease; however, most patients will relapse, despite readily attaining a complete remission.  Treatment of relapse has shown dismal results with little advances made in the recent decades.  Antigenic-directed therapy of ALL can complement cytotoxic chemotherapy and has shown encouraging results.  This review will evaluate four antigens in ALL (CD20, CD22, CD52, and CD19) and therapeutic strategies to target them.  We will review the clinical and preclinical data surrounding rituximab, epratuzumab, inotuzumab ozogamicin, alemtuzumab, blinatumomab, and chimeric antigen receptor-modified T-cell therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSTtGK2GWcaaCSm0e6ZOaemfW6udTcc2eaiiWI7Dhczorntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vntVelsw%253D%253D&md5=ba20fff753568fe09cea2595c487e75f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs11899-012-0120-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11899-012-0120-7%26sid%3Dliteratum%253Aachs%26aulast%3DPortell%26aufirst%3DC.%26aulast%3DAdvani%26aufirst%3DA.%26atitle%3DAntibody%2520therapy%2520for%2520acute%2520lymphoblastic%2520leukemia%26jtitle%3DCurr.%2520Hematol.%2520Malig.%2520Rep.%26date%3D2012%26volume%3D7%26spage%3D153%26epage%3D159%26doi%3D10.1007%2Fs11899-012-0120-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bassan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelzer, D.</span></span> <span> </span><span class="NLM_article-title">Modern therapy of acute lymphoblastic leukemia</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">543</span>, <span class="refDoi"> DOI: 10.1200/JCO.2010.30.1382</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1200%2FJCO.2010.30.1382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=21220592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BC3M7ns1yjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=532-543&author=R.+Bassanauthor=D.+Hoelzer&title=Modern+therapy+of+acute+lymphoblastic+leukemia&doi=10.1200%2FJCO.2010.30.1382"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Modern therapy of acute lymphoblastic leukemia</span></div><div class="casAuthors">Bassan Renato; Hoelzer Dieter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">532-43</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although acute lymphoblastic leukemia is curable in one third of adult patients, results vary greatly on account of different clinical, immunologic, and cytogenetic/genetic characteristics.  These data, along with the kinetics of response to early treatment, help establish the individual risk class with considerable accuracy, and support risk-specific treatments that should warrant optimal results with as little as possible nonrelapse mortality.  Modern first-line therapy consists of standard- and high-dose chemotherapy (increasingly inspired to pediatric principles), hematopoietic stem-cell transplantation, and new targeted therapy, all integrated with the analysis of prognostic factors and the study of subclinical residual disease for key therapeutic decisions.  These changes are improving long-term outcome, which in ongoing studies is expected close to 50% or greater.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQfM1v72oaeokh5eUSa2oe_fW6udTcc2eaiiWI7Dhczorntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7ns1yjtw%253D%253D&md5=bd8d0b0bb14736761fce9dff233bc53b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1200%2FJCO.2010.30.1382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2010.30.1382%26sid%3Dliteratum%253Aachs%26aulast%3DBassan%26aufirst%3DR.%26aulast%3DHoelzer%26aufirst%3DD.%26atitle%3DModern%2520therapy%2520of%2520acute%2520lymphoblastic%2520leukemia%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26spage%3D532%26epage%3D543%26doi%3D10.1200%2FJCO.2010.30.1382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moisoiu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodorescu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tranca, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pop, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iluta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blag, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Man, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constantinescu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rus, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buse, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fetica, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selicean, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berindan-Neagoe, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrushev, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bumbea, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanase, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zdrenghea, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomuleasa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanian Soc Bone Marrow, T.</span></span> <span> </span><span class="NLM_article-title">Approach to the adult acute lymphoblastic leukemia patient</span>. <i>J. Clin. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1175</span>, <span class="refDoi"> DOI: 10.3390/jcm8081175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.3390%2Fjcm8081175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslWktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=1175&author=V.+Sasauthor=V.+Moisoiuauthor=P.+Teodorescuauthor=S.+Trancaauthor=L.+Popauthor=S.+Ilutaauthor=S.+Pascaauthor=C.+Blagauthor=S.+Manauthor=A.+Romanauthor=C.+Constantinescuauthor=I.+Rusauthor=M.+Buseauthor=B.+Feticaauthor=M.+Marianauthor=C.+Seliceanauthor=I.+Berindan-Neagoeauthor=B.+Petrushevauthor=H.+Bumbeaauthor=A.+Tanaseauthor=M.+Zdrengheaauthor=S.+Fujiauthor=S.+Kitanoauthor=C.+Tomuleasaauthor=T.+Romanian+Soc+Bone+Marrow&title=Approach+to+the+adult+acute+lymphoblastic+leukemia+patient&doi=10.3390%2Fjcm8081175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Approach to the adult acute lymphoblastic leukemia patient</span></div><div class="casAuthors">Sas, Valentina; Moisoiu, Vlad; Teodorescu, Patric; Tranca, Sebastian; Pop, Laura; Iluta, Sabina; Pasca, Sergiu; Blag, Cristina; Man, Sorin; Roman, Andrei; Constantinescu, Catalin; Rus, Ioana; Buse, Mihail; Fetica, Bogdan; Marian, Mirela; Selicean, Cristina; Berindan-Neagoe, Ioana; Petrushev, Bobe; Bumbea, Horia; Tanase, Alina; Zdrenghea, Mihnea; Fuji, Shigeo; Kitano, Shigehisa; Tomuleasa, Ciprian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1175</span>CODEN:
                <span class="NLM_cas:coden">JCMOHK</span>;
        ISSN:<span class="NLM_cas:issn">2077-0383</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">During recent decades, understanding of the mol. mechanisms of acute lymphoblastic leukemia (ALL) has improved considerably, resulting in better risk stratification of patients and increased survival rates.  Age, white blood cell count (WBC), and specific genetic abnormalities are the most important factors that define risk groups for ALL.  State-of-the-art diagnosis of ALL requires cytol. and cytogenetical analyses, as well as flow cytometry and high-throughput sequencing assays.  An important aspect in the diagnostic characterization of patients with ALL is the identification of the Philadelphia (Ph) chromosome, which warrants the addn. of tyrosine kinase inhibitors (TKI) to the chemotherapy backbone.  Data that support the benefit of hematopoietic stem cell transplantation (HSCT) in high risk patient subsets or in late relapse patients are still questioned and have yet to be detd. conclusive.  This article presents the newly published data in ALL workup and treatment, putting it into perspective for the attending physician in hematol. and oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCcEc_msdOsrVg90H21EOLACvtfcHk0li-ysWSr8zfaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslWktrc%253D&md5=d98a8643ee472bf667c5e53994aef82c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3390%2Fjcm8081175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcm8081175%26sid%3Dliteratum%253Aachs%26aulast%3DSas%26aufirst%3DV.%26aulast%3DMoisoiu%26aufirst%3DV.%26aulast%3DTeodorescu%26aufirst%3DP.%26aulast%3DTranca%26aufirst%3DS.%26aulast%3DPop%26aufirst%3DL.%26aulast%3DIluta%26aufirst%3DS.%26aulast%3DPasca%26aufirst%3DS.%26aulast%3DBlag%26aufirst%3DC.%26aulast%3DMan%26aufirst%3DS.%26aulast%3DRoman%26aufirst%3DA.%26aulast%3DConstantinescu%26aufirst%3DC.%26aulast%3DRus%26aufirst%3DI.%26aulast%3DBuse%26aufirst%3DM.%26aulast%3DFetica%26aufirst%3DB.%26aulast%3DMarian%26aufirst%3DM.%26aulast%3DSelicean%26aufirst%3DC.%26aulast%3DBerindan-Neagoe%26aufirst%3DI.%26aulast%3DPetrushev%26aufirst%3DB.%26aulast%3DBumbea%26aufirst%3DH.%26aulast%3DTanase%26aufirst%3DA.%26aulast%3DZdrenghea%26aufirst%3DM.%26aulast%3DFuji%26aufirst%3DS.%26aulast%3DKitano%26aufirst%3DS.%26aulast%3DTomuleasa%26aufirst%3DC.%26aulast%3DRomanian%2BSoc%2BBone%2BMarrow%26aufirst%3DT.%26atitle%3DApproach%2520to%2520the%2520adult%2520acute%2520lymphoblastic%2520leukemia%2520patient%26jtitle%3DJ.%2520Clin.%2520Med.%26date%3D2019%26volume%3D8%26spage%3D1175%26doi%3D10.3390%2Fjcm8081175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldoss, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, A. S.</span></span> <span> </span><span class="NLM_article-title">Advances in adult acute lymphoblastic leukemia therapy</span>. <i>Leuk. Lymphoma</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1050</span>, <span class="refDoi"> DOI: 10.1080/10428194.2017.1354372</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1080%2F10428194.2017.1354372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=28745565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BC1cfhtlarsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2018&pages=1033-1050&author=I.+Aldossauthor=A.+S.+Stein&title=Advances+in+adult+acute+lymphoblastic+leukemia+therapy&doi=10.1080%2F10428194.2017.1354372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in adult acute lymphoblastic leukemia therapy</span></div><div class="casAuthors">Aldoss Ibrahim; Stein Anthony S</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & lymphoma</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1033-1050</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Progress in adult acute lymphoblastic leukemia (ALL) treatment has been met with challenge until recently.  A steady improvement in outcomes is being witnessed among adults with ALL, and it will be enhanced further with early referral of newly diagnosed ALL patients to specialized centers, enrolling more ALL adults in clinical trials, adopting pediatric-inspired ALL regimens in younger adults, tailoring treatments according to minimal residual disease response and disease genetics, incorporating novel therapies and tyrosine kinase inhibitors in frontline regimens, early referral to transplant when indicated, expanding the donor pool, and developing more effective salvage therapies for relapsed/refractory ALL.  In this review, we will discuss the most significant advances in treating adult ALL observed in the last five years that have the potential to enhance adult ALL treatment and outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQwlCI9LSUG9acY7HFp97qMfW6udTcc2eZlTVUdtBaiDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfhtlarsw%253D%253D&md5=2ea6b5c9cd6a23361de30459af3c01ce</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1080%2F10428194.2017.1354372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10428194.2017.1354372%26sid%3Dliteratum%253Aachs%26aulast%3DAldoss%26aufirst%3DI.%26aulast%3DStein%26aufirst%3DA.%2BS.%26atitle%3DAdvances%2520in%2520adult%2520acute%2520lymphoblastic%2520leukemia%2520therapy%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2018%26volume%3D59%26spage%3D1033%26epage%3D1050%26doi%3D10.1080%2F10428194.2017.1354372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Araujo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logothetis, C.</span></span> <span> </span><span class="NLM_article-title">Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumors</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">500</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2010.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.ctrv.2010.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=20226597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWqsrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2010&pages=492-500&author=J.+Araujoauthor=C.+Logothetis&title=Dasatinib%3A+a+potent+SRC+inhibitor+in+clinical+development+for+the+treatment+of+solid+tumors&doi=10.1016%2Fj.ctrv.2010.02.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors</span></div><div class="casAuthors">Araujo, John; Logothetis, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">492-500</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  SRC is a tyrosine kinase that plays a role in oncogenic, invasive and bone-metastatic processes.  It has therefore been prioritized as a candidate therapeutic target in patients with solid tumors.  Several SRC inhibitors are now in development, of which dasatinib has been most explored.  Preclin. studies in a wide variety of solid tumor cell lines, including prostate, breast and glioma, have shown that that dasatinib acts as a cytostatic agent, inhibiting the processes of cell proliferation, invasion and metastasis.  Dasatinib also inhibits the activity of osteoclasts, which have a major role in the development of metastatic bone lesions.  Dasatinib has additive or synergistic activity in combination with a no. of other agents, including cytotoxic agents and targeted therapies, providing a rationale for combination treatment in a clin. setting.  Emerging clin. data with dasatinib support exptl. observations, with preliminary phase 1 and 2 data demonstrating activity, both as a single agent and as combination therapy, in a range of solid tumors.  Future clin. trials will further assess the clin. value of SRC inhibition with dasatinib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDmKVikY4klbVg90H21EOLACvtfcHk0lhqOB8BKWZ3bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWqsrrK&md5=b3ab6c318777b619d8b8ba72d0817ac6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2010.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2010.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DAraujo%26aufirst%3DJ.%26aulast%3DLogothetis%26aufirst%3DC.%26atitle%3DDasatinib%253A%2520a%2520potent%2520SRC%2520inhibitor%2520in%2520clinical%2520development%2520for%2520the%2520treatment%2520of%2520solid%2520tumors%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2010%26volume%3D36%26spage%3D492%26epage%3D500%26doi%3D10.1016%2Fj.ctrv.2010.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malkan, U. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etgul, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aydin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haznedaroglu, I. C.</span></span> <span> </span><span class="NLM_article-title">Reply: management of De Novo CML and imatinib-induced acute rhabdomyolysis with the second-generation TKI, dasatinib</span>. <i>Ann. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">336</span>, <span class="refDoi"> DOI: 10.1177/1060028016629981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1177%2F1060028016629981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=26861992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ajsbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2016&pages=336&author=U.+Y.+Malkanauthor=G.+Gunesauthor=S.+Etgulauthor=T.+Aslanauthor=S.+Aydinauthor=I.+C.+Haznedaroglu&title=Reply%3A+management+of+De+Novo+CML+and+imatinib-induced+acute+rhabdomyolysis+with+the+second-generation+TKI%2C+dasatinib&doi=10.1177%2F1060028016629981"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Reply: management of de novo CML and imatinib-induced acute rhabdomyolysis with the second-generation TKI, dasatinib</span></div><div class="casAuthors">Malkan, Umit Y.; Gunes, Gursel; Etgul, Sezgin; Aslan, Tuncay; Aydin, Seda; Haznedaroglu, Ibrahim C.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Pharmacotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">336</span>CODEN:
                <span class="NLM_cas:coden">APHRER</span>;
        ISSN:<span class="NLM_cas:issn">1542-6270</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A polemic in response to Torres et al is given.  In this article the author discusses about the management of de novo CML and imatinib-induced acute rhabdomyolysis with the second-generation TKI, dasatinib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1T4q8KroUr7Vg90H21EOLACvtfcHk0lhqOB8BKWZ3bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ajsbzL&md5=3f2cc0e16cbad7f174f2437822caa985</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1177%2F1060028016629981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1060028016629981%26sid%3Dliteratum%253Aachs%26aulast%3DMalkan%26aufirst%3DU.%2BY.%26aulast%3DGunes%26aufirst%3DG.%26aulast%3DEtgul%26aufirst%3DS.%26aulast%3DAslan%26aufirst%3DT.%26aulast%3DAydin%26aufirst%3DS.%26aulast%3DHaznedaroglu%26aufirst%3DI.%2BC.%26atitle%3DReply%253A%2520management%2520of%2520De%2520Novo%2520CML%2520and%2520imatinib-induced%2520acute%2520rhabdomyolysis%2520with%2520the%2520second-generation%2520TKI%252C%2520dasatinib%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2016%26volume%3D50%26spage%3D336%26doi%3D10.1177%2F1060028016629981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kostos, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burbury, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prince, H. M.</span></span> <span> </span><span class="NLM_article-title">Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: case report</span>. <i>Platelets</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">811</span>, <span class="refDoi"> DOI: 10.3109/09537104.2015.1049138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.3109%2F09537104.2015.1049138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=26029798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCqtbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=809-811&author=L.+Kostosauthor=K.+Burburyauthor=G.+Srivastavaauthor=H.+M.+Prince&title=Gastrointestinal+bleeding+in+a+chronic+myeloid+leukaemia+patient+precipitated+by+dasatinib-induced+platelet+dysfunction%3A+case+report&doi=10.3109%2F09537104.2015.1049138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case report</span></div><div class="casAuthors">Kostos, Louise; Burbury, Kate; Srivastava, Gaurav; Prince, H. Miles</div><div class="citationInfo"><span class="NLM_cas:title">Platelets</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">809-811</span>CODEN:
                <span class="NLM_cas:coden">PLTEEF</span>;
        ISSN:<span class="NLM_cas:issn">0953-7104</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Bleeding in patients with chronic myeloid leukemia (CML) receiving the second-line tyrosine kinase inhibitor (TKI) dasatinib is a well-documented side effect, occurring in up to 24% of patients.  In most cases, it is attributed directly to a secondary grade 3 or 4 thrombocytopaenia.  Platelet dysfunction pptd. by dasatinib has been demonstrated in multiple in vitro and in vivo studies; however, there is currently no correlative data that definitively assocs. this with clin. significant bleeding.  In this case, we report a patient with chronic-phase CML receiving dasatinib who developed significant gastrointestinal bleeding secondary to angiodysplasia in the absence of a severe thrombocytopaenia or coagulopathy.  Platelet function testing on the PFA-100 assay and formal platelet aggregometry demonstrated impaired platelet aggregation, however, upon cessation of dasatinib, platelet function normalized and the bleeding resolved without further intervention.  This case demonstrates that dasatinib-induced platelet dysfunction can cause clin. significant bleeding and highlights the need for physicians to be aware of this adverse effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU_gh5qaGv87Vg90H21EOLACvtfcHk0lhqOB8BKWZ3bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCqtbrN&md5=ad86acef8c9ea09db1ccc6eee13f1747</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3109%2F09537104.2015.1049138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F09537104.2015.1049138%26sid%3Dliteratum%253Aachs%26aulast%3DKostos%26aufirst%3DL.%26aulast%3DBurbury%26aufirst%3DK.%26aulast%3DSrivastava%26aufirst%3DG.%26aulast%3DPrince%26aufirst%3DH.%2BM.%26atitle%3DGastrointestinal%2520bleeding%2520in%2520a%2520chronic%2520myeloid%2520leukaemia%2520patient%2520precipitated%2520by%2520dasatinib-induced%2520platelet%2520dysfunction%253A%2520case%2520report%26jtitle%3DPlatelets%26date%3D2015%26volume%3D26%26spage%3D809%26epage%3D811%26doi%3D10.3109%2F09537104.2015.1049138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aleshin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, R. S.</span></span> <span> </span><span class="NLM_article-title">SRC: a century of science brought to the clinic</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1593/neo.10328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1593%2Fneo.10328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=20689754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVClsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=599-607&author=A.+Aleshinauthor=R.+S.+Finn&title=SRC%3A+a+century+of+science+brought+to+the+clinic&doi=10.1593%2Fneo.10328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">SRC: a century of science brought to the clinic</span></div><div class="casAuthors">Aleshin, Alexey; Finn, Richard S.</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (Ann Arbor, MI, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">599-607</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Neoplasia Press Inc.</span>)
        </div><div class="casAbstract">A review.  The SRC family kinases are the largest family of nonreceptor tyrosine kinases and one of the best-studied targets for cancer therapy.  SRC, arguably the oldest oncogene, has been implicated in pathways regulating proliferation, angiogenesis, invasion and metastasis, and bone metab.  More recently, researchers have proposed that the transforming ability of SRC is linked to its ability to activate key signaling mols. in these pathways, rather than through direct activity.  It has been hypothesized that blocking SRC activation may inhibit these pathways, resulting in antitumor activity.  However, successfully targeting SRC in a clin. setting remains a challenge, and SRC inhibitors have only recently begun to move through clin. development.  Preclin. studies have identified specific mol. "subgroups" and histologies that may be more sensitive to SRC inhibition.  In addn., other studies have demonstrated synergistic interactions between SRC inhibitors and other targeted therapies and cytotoxics.  In this review, we summarize SRC biol. and how it has been applied to the clin. development of SRC inhibitors.  The status of SRC inhibitors, including dasatinib, saracatinib, and bosutinib, which are in phase 1, 2, and 3 trials, is highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_g3wyg6sIcLVg90H21EOLACvtfcHk0lhtx2g5gBtgeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVClsrs%253D&md5=4eaa783194fb3abb0a8234f4e16d5af4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1593%2Fneo.10328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.10328%26sid%3Dliteratum%253Aachs%26aulast%3DAleshin%26aufirst%3DA.%26aulast%3DFinn%26aufirst%3DR.%2BS.%26atitle%3DSRC%253A%2520a%2520century%2520of%2520science%2520brought%2520to%2520the%2520clinic%26jtitle%3DNeoplasia%26date%3D2010%26volume%3D12%26spage%3D599%26epage%3D607%26doi%3D10.1593%2Fneo.10328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakadiya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanjiv, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. C.</span></span> <span> </span><span class="NLM_article-title">Multidrug-resistant cells overexpressing P-glycoprotein are susceptible to DNA crosslinking agents due to attenuated Src/nuclear EGFR cascade-activated DNA repair activity</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1144</span>– <span class="NLM_lpage">1154</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fonc.2012.133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=22525278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFajsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=1144-1154&author=P.+C.+Leeauthor=H.+J.+Leeauthor=R.+Kakadiyaauthor=K.+Sanjivauthor=T.+L.+Suauthor=T.+C.+Lee&title=Multidrug-resistant+cells+overexpressing+P-glycoprotein+are+susceptible+to+DNA+crosslinking+agents+due+to+attenuated+Src%2Fnuclear+EGFR+cascade-activated+DNA+repair+activity&doi=10.1038%2Fonc.2012.133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug-resistant cells overexpressing P-glycoprotein are susceptible to DNA crosslinking agents due to attenuated Src/nuclear EGFR cascade-activated DNA repair activity</span></div><div class="casAuthors">Lee, P.-C.; Lee, H.-J.; Kakadiya, R.; Sanjiv, K.; Su, T.-L.; Lee, T.-C.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1144-1154</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We synthesized several novel bifunctional alkylating derivs. of 3a-aza-cyclopenta[a]indene (BO-1012, BO-1005, BO-1099 and BO-1101) that are potent DNA interstrand crosslinking agents.  In in vitro cytotoxicity assay, these compds. were more cytotoxic to multidrug-resistant (MDR) cells, such as KBvin10, KBtax50 and CEM/VBL, than their parental cells.  Using a xenograft model, BO-1012, at a dose of 5 mg/kg, partially suppressed the growth of parental KB cells but completely suppressed the growth of KBvin10 cells in nude mice.  In exploring the possible mechanism, we found that DNA double-strand break (DSB) repair activity in MDR cells, KBvin10 and CEM/VBL, was significantly reduced compared with their parental cells, KB and CEM.  Reduced DSB repair activity in KBvin10 cells was likely due to a defect in nuclear translocation of DNA-dependent protein kinase (DNA-PK), a component of the non-homologous end-joining repair machinery.  Furthermore, BO-1012-induced DNA-PK translocation from the cytosol into the nucleus in KB cells is assocd. with the activation of the Src/nuclear epidermal growth factor receptor (EGFR) cascade, which is defective in MDR cells.  As knockdown of P-glycoprotein (P-gp) by siRNA reactivated the Src/nuclear EGFR cascade, DNA-PK translocation and DNA repair activity in MDR cells, overexpression of P-gp attenuates the activity of DNA DSB repair through suppression of Src/nuclear EGFR cascade.  Therefore, DNA interstrand crosslinking agents may have potential therapeutic use against P-gp-overexpressing MDR cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYHDTx6Q_Eq7Vg90H21EOLACvtfcHk0lhtx2g5gBtgeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFajsbc%253D&md5=428754f87994cad5091302c41436604c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.133%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DP.%2BC.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DKakadiya%26aufirst%3DR.%26aulast%3DSanjiv%26aufirst%3DK.%26aulast%3DSu%26aufirst%3DT.%2BL.%26aulast%3DLee%26aufirst%3DT.%2BC.%26atitle%3DMultidrug-resistant%2520cells%2520overexpressing%2520P-glycoprotein%2520are%2520susceptible%2520to%2520DNA%2520crosslinking%2520agents%2520due%2520to%2520attenuated%2520Src%252Fnuclear%2520EGFR%2520cascade-activated%2520DNA%2520repair%2520activity%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D1144%26epage%3D1154%26doi%3D10.1038%2Fonc.2012.133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yeatman, T. J.</span></span> <span> </span><span class="NLM_article-title">A renaissance for SRC</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">470</span>– <span class="NLM_lpage">480</span>, <span class="refDoi"> DOI: 10.1038/nrc1366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fnrc1366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=15170449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVaisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=470-480&author=T.+J.+Yeatman&title=A+renaissance+for+SRC&doi=10.1038%2Fnrc1366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A renaissance for SRC</span></div><div class="casAuthors">Yeatman, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">470-480</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  The c-SRC non-receptor tyrosine kinase is overexpressed and activated in a large no. of human malignancies and has been linked to the development of cancer and progression to distant metastases.  These observations have led to the recent targeting of c-SRC for the development of anticancer therapeutics, which show promise as a new avenue for cancer treatment.  Despite this, however, the precise functions of c-SRC in cancer remain unclear.  In addn. to increasing cell proliferation, a key role of c-SRC in cancer seems to be to promote invasion and motility, functions that might contribute to tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCGFL31NDP4LVg90H21EOLACvtfcHk0ljgexT5bD3_4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVaisbo%253D&md5=e14e862826b2881721d0f6bb14356650</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrc1366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1366%26sid%3Dliteratum%253Aachs%26aulast%3DYeatman%26aufirst%3DT.%2BJ.%26atitle%3DA%2520renaissance%2520for%2520SRC%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D470%26epage%3D480%26doi%3D10.1038%2Fnrc1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serafin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuzzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minuzzo, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinazza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolozzi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bresolin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porcu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frasson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Indraccolo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Accordi, B.</span></span> <span> </span><span class="NLM_article-title">Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">2750</span>– <span class="NLM_lpage">2761</span>, <span class="refDoi"> DOI: 10.1182/blood-2017-05-784603</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1182%2Fblood-2017-05-784603" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=29101238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Cjur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2017&pages=2750-2761&author=V.+Serafinauthor=G.+Capuzzoauthor=G.+Milaniauthor=S.+A.+Minuzzoauthor=M.+Pinazzaauthor=R.+Bortolozziauthor=S.+Bresolinauthor=E.+Porcuauthor=C.+Frassonauthor=S.+Indraccoloauthor=G.+Bassoauthor=B.+Accordi&title=Glucocorticoid+resistance+is+reverted+by+LCK+inhibition+in+pediatric+T-cell+acute+lymphoblastic+leukemia&doi=10.1182%2Fblood-2017-05-784603"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia</span></div><div class="casAuthors">Serafin, Valentina; Capuzzo, Giorgia; Milani, Gloria; Minuzzo, Sonia Anna; Pinazza, Marica; Bortolozzi, Roberta; Bresolin, Silvia; Porcu, Elena; Frasson, Chiara; Indraccolo, Stefano; Basso, Giuseppe; Accordi, Benedetta</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2750-2761</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">1528-0020</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Pediatric T-acute lymphoblastic leukemia (T-ALL) patients often display resistance to glucocorticoid (GC) treatment.  These patients, classified as prednisone poor responders (PPR), have poorer outcome than do the other pediatric T-ALL patients receiving a high-risk adapted therapy.  Because glucocorticoids are administered to ALL patients during all the different phases of therapy, GC resistance represents an important challenge to improving the outcome for these patients.  Mechanisms underlying resistance are not yet fully unraveled; thus our research focused on the identification of deregulated signaling pathways to point out new targeted approaches.  We first identified, by reverse-phase protein arrays, the lymphocyte cell-specific protein-tyrosine kinase (LCK) as aberrantly activated in PPR patients.  We showed that LCK inhibitors, such as dasatinib, bosutinib, nintedanib, and WH-4-023, are able to induce cell death in GC-resistant T-ALL cells, and remarkably, cotreatment with dexamethasone is able to reverse GC resistance, even at therapeutic drug concns.  This was confirmed by specific LCK gene silencing and ex vivo combined treatment of cells from PPR patient-derived xenografts.  Moreover, we obsd. that LCK hyperactivation in PPR patients upregulates the calcineurin/nuclear factor of activated T cells signaling triggering to interleukin-4 (IL-4) overexpression.  GC-sensitive cells cultured with IL-4 display an increased resistance to dexamethasone, whereas the inhibition of IL-4 signaling could increase GC-induced apoptosis in resistant cells.  Treatment with dexamethasone and dasatinib also impaired engraftment of leukemia cells in vivo.  Our results suggest a quickly actionable approach to supporting conventional therapies and overcoming GC resistance in pediatric T-ALL patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQm_rduInbzLVg90H21EOLACvtfcHk0ljgexT5bD3_4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Cjur%252FL&md5=9103800c495bccdd2bac3a7f4496babb</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1182%2Fblood-2017-05-784603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2017-05-784603%26sid%3Dliteratum%253Aachs%26aulast%3DSerafin%26aufirst%3DV.%26aulast%3DCapuzzo%26aufirst%3DG.%26aulast%3DMilani%26aufirst%3DG.%26aulast%3DMinuzzo%26aufirst%3DS.%2BA.%26aulast%3DPinazza%26aufirst%3DM.%26aulast%3DBortolozzi%26aufirst%3DR.%26aulast%3DBresolin%26aufirst%3DS.%26aulast%3DPorcu%26aufirst%3DE.%26aulast%3DFrasson%26aufirst%3DC.%26aulast%3DIndraccolo%26aufirst%3DS.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DAccordi%26aufirst%3DB.%26atitle%3DGlucocorticoid%2520resistance%2520is%2520reverted%2520by%2520LCK%2520inhibition%2520in%2520pediatric%2520T-cell%2520acute%2520lymphoblastic%2520leukemia%26jtitle%3DBlood%26date%3D2017%26volume%3D130%26spage%3D2750%26epage%3D2761%26doi%3D10.1182%2Fblood-2017-05-784603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joosten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seitz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sommerfeld, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenze, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hummel, M.</span></span> <span> </span><span class="NLM_article-title">Histone acetylation and DNA demethylation of T cells result in an anaplastic large cell lymphoma-like phenotype</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.3324/haematol.2011.054619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.3324%2Fhaematol.2011.054619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=22899583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFalurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2013&pages=247-254&author=M.+Joostenauthor=V.+Seitzauthor=K.+Zimmermannauthor=A.+Sommerfeldauthor=E.+Bergauthor=D.+Lenzeauthor=U.+Leserauthor=H.+Steinauthor=M.+Hummel&title=Histone+acetylation+and+DNA+demethylation+of+T+cells+result+in+an+anaplastic+large+cell+lymphoma-like+phenotype&doi=10.3324%2Fhaematol.2011.054619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Histone acetylation and DNA demethylation of T cells result in an anaplastic large cell lymphoma-like phenotype</span></div><div class="casAuthors">Joosten, Maria; Seitz, Volkhard; Zimmermann, Karin; Sommerfeld, Anke; Berg, Erika; Lenze, Dido; Leser, Ulf; Stein, Harald; Hummel, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Haematologica</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-254</span>CODEN:
                <span class="NLM_cas:coden">HAEMAX</span>;
        ISSN:<span class="NLM_cas:issn">0390-6078</span>.
    
            (<span class="NLM_cas:orgname">Ferrata Storti Foundation</span>)
        </div><div class="casAbstract">A characteristic feature of anaplastic large cell lymphoma is the significant repression of the T-cell expression program despite its T-cell origin.  The reasons for this down-regulation of T-cell phenotype are still unknown.  To elucidate whether epigenetic mechanisms are responsible for the loss of the T-cell phenotype, we treated anaplastic large cell lymphoma and T-cell lymphoma/leukemia cell lines (n=4, each) with epigenetic modifiers to evoke DNA demethylation and histone acetylation.  Global gene expression data from treated and untreated cell lines were generated and selected, and differentially expressed genes were evaluated by real-time reverse transcriptase polymerase chain reaction and western blot anal.  Addnl., histone H3 lysine 27 trimethylation was analyzed by chromatin immunopptn.  Combined DNA demethylation and histone acetylation of anaplastic large cell lymphoma cells was not able to reconstitute their T-cell phenotype.  Instead, the same treatment induced in T cells: (i) an up-regulation of anaplastic large cell lymphoma-characteristic genes (e.g. ID2, LGALS1, c-JUN), and (ii) an almost complete extinction of their T-cell phenotype including CD3, LCK and ZAP70.  In addn., suppressive trimethylation of histone H3 lysine 27 of important T-cell transcription factor genes (GATA3, LEF1, TCF1) was present in anaplastic large cell lymphoma cells, which is in line with their absence in primary tumor specimens as demonstrated by immunohistochem.  Our data suggest that epigenetically activated suppressors (e.g. ID2) contribute to the down-regulation of the T-cell expression program in anaplastic large cell lymphoma, which is maintained by trimethylation of histone H3 lysine 27.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppnc9xmdJRt7Vg90H21EOLACvtfcHk0ljgexT5bD3_4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFalurjO&md5=7c7245e4c005d3797afb6528fe3da541</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2011.054619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2011.054619%26sid%3Dliteratum%253Aachs%26aulast%3DJoosten%26aufirst%3DM.%26aulast%3DSeitz%26aufirst%3DV.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DSommerfeld%26aufirst%3DA.%26aulast%3DBerg%26aufirst%3DE.%26aulast%3DLenze%26aufirst%3DD.%26aulast%3DLeser%26aufirst%3DU.%26aulast%3DStein%26aufirst%3DH.%26aulast%3DHummel%26aufirst%3DM.%26atitle%3DHistone%2520acetylation%2520and%2520DNA%2520demethylation%2520of%2520T%2520cells%2520result%2520in%2520an%2520anaplastic%2520large%2520cell%2520lymphoma-like%2520phenotype%26jtitle%3DHaematologica%26date%3D2013%26volume%3D98%26spage%3D247%26epage%3D254%26doi%3D10.3324%2Fhaematol.2011.054619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laukkanen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gronroos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polonen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuusanmaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehtonen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ossenkoppele, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gjertsen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oystein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinaniemi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohi, O.</span></span> <span> </span><span class="NLM_article-title">In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL</span>. <i>Blood Cancer J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e604</span> <span class="refDoi"> DOI: 10.1038/bcj.2017.87</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fbcj.2017.87" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=28885610" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&author=S.+Laukkanenauthor=T.+Gronroosauthor=P.+Polonenauthor=H.+Kuusanmakiauthor=J.+Mehtonenauthor=J.+Cloosauthor=G.+Ossenkoppeleauthor=B.+Gjertsenauthor=B.+Oysteinauthor=C.+Heckmanauthor=M.+Heinaniemiauthor=M.+Kontroauthor=O.+Lohi&title=In+silico+and+preclinical+drug+screening+identifies+dasatinib+as+a+targeted+therapy+for+T-ALL&doi=10.1038%2Fbcj.2017.87"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fbcj.2017.87&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbcj.2017.87%26sid%3Dliteratum%253Aachs%26aulast%3DLaukkanen%26aufirst%3DS.%26aulast%3DGronroos%26aufirst%3DT.%26aulast%3DPolonen%26aufirst%3DP.%26aulast%3DKuusanmaki%26aufirst%3DH.%26aulast%3DMehtonen%26aufirst%3DJ.%26aulast%3DCloos%26aufirst%3DJ.%26aulast%3DOssenkoppele%26aufirst%3DG.%26aulast%3DGjertsen%26aufirst%3DB.%26aulast%3DOystein%26aufirst%3DB.%26aulast%3DHeckman%26aufirst%3DC.%26aulast%3DHeinaniemi%26aufirst%3DM.%26aulast%3DKontro%26aufirst%3DM.%26aulast%3DLohi%26aufirst%3DO.%26atitle%3DIn%2520silico%2520and%2520preclinical%2520drug%2520screening%2520identifies%2520dasatinib%2520as%2520a%2520targeted%2520therapy%2520for%2520T-ALL%26jtitle%3DBlood%2520Cancer%2520J.%26date%3D2017%26volume%3D7%26doi%3D10.1038%2Fbcj.2017.87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.-l.</span></span> <span> </span><span class="NLM_article-title">Transferrin-conjugated polymeric nanomedicine to enhance the anticancer efficacy of edelfosine in acute myeloid leukemia</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2016.05.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.biopha.2016.05.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=27470549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFWhs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2016&pages=51-57&author=Y.+Sunauthor=Z.-l.+Sun&title=Transferrin-conjugated+polymeric+nanomedicine+to+enhance+the+anticancer+efficacy+of+edelfosine+in+acute+myeloid+leukemia&doi=10.1016%2Fj.biopha.2016.05.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Transferrin-conjugated polymeric nanomedicine to enhance the anticancer efficacy of edelfosine in acute myeloid leukemia</span></div><div class="casAuthors">Sun, Yu; Sun, Zhong-liang</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51-57</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In this study, transferrin (Tf)-conjugated polyethylene glycol (PEG)-poly-L-lysine (PLL)-poly(lactic-co-glycolic acid) (PLGA) (PEG-PLL-PLGA)-based micellar formulations were successfully prepd. for the delivery of edelfosine (EDS) in leukemia treatment.  The micelles were nanosized and presented spherical shaped particles.  Our in vitro data suggest that the nanoformulations maintain the biol. activity of drugs for longer periods and lead to a continuous release of active drug.  The enhanced cellular uptake of EDS-TM resulted in significantly higher cytotoxic effect in K562 leukemia cells.  Cell cycle anal. further demonstrated the significantly higher G2/M phase arrest of cancer cells.  Immunoblot anal. clearly revealed the potential of EDS-TM in inducing apoptosis of cancer cells which could improve the anticancer efficacy in leukemia.  Importantly, EDS-M and EDS-TM significantly prolonged the circulation profile of EDS throughout until 24 h, indicating the potential of targeted nanoparticulate delivery system.  The prolonged blood circulation potential of micellar formulations might improve the therapeutic potential of drug by increasing its bioavailability in the serum.  It would be worthwhile evaluating the effects of the EDS-loaded micelles on cancer cells in vivo for clin. application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw1fDFGnJBdLVg90H21EOLACvtfcHk0lguLJoRJLQIcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFWhs7bF&md5=76bbe948d59d94198eb6436273290c7a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2016.05.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2016.05.046%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DZ.-l.%26atitle%3DTransferrin-conjugated%2520polymeric%2520nanomedicine%2520to%2520enhance%2520the%2520anticancer%2520efficacy%2520of%2520edelfosine%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2016%26volume%3D83%26spage%3D51%26epage%3D57%26doi%3D10.1016%2Fj.biopha.2016.05.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hareedy, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Desoky, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woillard, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thabet, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picard, N.</span></span> <span> </span><span class="NLM_article-title">Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients</span>. <i>Pharmacogenomics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1119</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.2217/PGS.15.62</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.2217%2FPGS.15.62" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=26237184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVyktLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=1119-1133&author=M.+S.+Hareedyauthor=E.+S.+El+Desokyauthor=J.-B.+Woillardauthor=R.+H.+Thabetauthor=A.+M.+Aliauthor=P.+Marquetauthor=N.+Picard&title=Genetic+variants+in+6-mercaptopurine+pathway+as+potential+factors+of+hematological+toxicity+in+acute+lymphoblastic+leukemia+patients&doi=10.2217%2FPGS.15.62"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients</span></div><div class="casAuthors">Hareedy, Mohammad Salem; El Desoky, Ehab S.; Woillard, Jean-Baptiste; Thabet, Romany Helmy; Ali, Amany Mohamad; Marquet, Pierre; Picard, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacogenomics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1119-1134</span>CODEN:
                <span class="NLM_cas:coden">PARMFL</span>;
        ISSN:<span class="NLM_cas:issn">1462-2416</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">Aim: We investigated the assocns. between variants in genes coding for enzymes and transporters related to the 6-mercaptopurine pathway and clin. outcomes in pediatric patients with acute lymphoblastic leukemia.  Materials & methods: Statistical assocn. between gender, age and genotypes of selected SNPs, and the risks of hematol. toxicity and relapse were investigated using a Cox proportional hazard model in 70 acute lymphoblastic leukemia patients from upper Egypt.  Results: We found significant assocns. between ITPA, IMPDH1, SLC29A1, SLC28A2, SLC28A3 and ABCC4 SNPs and one or more of the hematol. toxicity manifestations (neutropenia, agranulocytosis and leukopenia); age was significantly related to relapse.  Conclusion: Genetic polymorphisms in enzymes and transporters involved in the 6-mercaptopurine pathway should be considered during its use to avoid hematol. toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobHqyGQGUh57Vg90H21EOLACvtfcHk0lixnT7x7ZLMew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVyktLfK&md5=8b50f25467fdde6ab239e58e04042dc4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2217%2FPGS.15.62&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252FPGS.15.62%26sid%3Dliteratum%253Aachs%26aulast%3DHareedy%26aufirst%3DM.%2BS.%26aulast%3DEl%2BDesoky%26aufirst%3DE.%2BS.%26aulast%3DWoillard%26aufirst%3DJ.-B.%26aulast%3DThabet%26aufirst%3DR.%2BH.%26aulast%3DAli%26aufirst%3DA.%2BM.%26aulast%3DMarquet%26aufirst%3DP.%26aulast%3DPicard%26aufirst%3DN.%26atitle%3DGenetic%2520variants%2520in%25206-mercaptopurine%2520pathway%2520as%2520potential%2520factors%2520of%2520hematological%2520toxicity%2520in%2520acute%2520lymphoblastic%2520leukemia%2520patients%26jtitle%3DPharmacogenomics%26date%3D2015%26volume%3D16%26spage%3D1119%26epage%3D1133%26doi%3D10.2217%2FPGS.15.62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span> <span> </span><span class="NLM_article-title">Glutathione-sensitive hyaluronic acid-mercaptopurine prodrug linked via carbonyl vinyl sulfide: a robust and CD44-targeted nanomedicine for leukemia</span>. <i>Biomacromolecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3207</span>– <span class="NLM_lpage">3214</span>, <span class="refDoi"> DOI: 10.1021/acs.biomac.7b00846</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biomac.7b00846" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKqtrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=3207-3214&author=J.+Qiuauthor=R.+Chengauthor=J.+Zhangauthor=H.+Sunauthor=C.+Dengauthor=F.+Mengauthor=Z.+Zhong&title=Glutathione-sensitive+hyaluronic+acid-mercaptopurine+prodrug+linked+via+carbonyl+vinyl+sulfide%3A+a+robust+and+CD44-targeted+nanomedicine+for+leukemia&doi=10.1021%2Facs.biomac.7b00846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Glutathione-Sensitive Hyaluronic Acid-Mercaptopurine Prodrug Linked via Carbonyl Vinyl Sulfide: A Robust and CD44-Targeted Nanomedicine for Leukemia</span></div><div class="casAuthors">Qiu, Jie; Cheng, Ru; Zhang, Jian; Sun, Huanli; Deng, Chao; Meng, Fenghua; Zhong, Zhiyuan</div><div class="citationInfo"><span class="NLM_cas:title">Biomacromolecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3207-3214</span>CODEN:
                <span class="NLM_cas:coden">BOMAF6</span>;
        ISSN:<span class="NLM_cas:issn">1525-7797</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">6-Mercaptopurine (6-MP) is an essential medicine used for treating leukemia in the clinics. 6-MP suffers, however, from poor water soly., low bioavailability and significant side effects.  Here, we designed CD44-targeted glutathione-sensitive hyaluronic acid-mercaptopurine prodrug (HA-GS-MP) linked via carbonyl vinyl sulfide for safer and enhanced treatment of acute myeloid leukemia (AML).  HA-GS-MP obtained with 50 kDa HA and 6-MP conjugation content of 6.9 wt.% showed excellent water soly. with a hydrodynamic size of ca. 15 nm.  Intriguingly, HA-GS-MP was extremely stable, without any drug leakage, under physiol. environment while rapidly released 6-MP in response to 10 mM glutathione.  HA-GS-MP exhibited obvious targetability and markedly enhanced antitumor effect to OCI/AML-2 human acute myeloid leukemia cells (IC50 = 16.9 μg 6-MP equiv./mL).  The pharmacokinetic studies displayed that Cy5-labeled HA-GS-MP had a long circulation time in mice (elimination half-life = 4.37 h).  The in vivo fluorescence images demonstrated strong and persistent accumulation of Cy5-labeled HA-GS-MP from 4 to 48 h post injection in the s.c. OCI/AML-2 tumor in nude mice.  Notably, HA-GS-MP while causing little side effects induced significantly enhanced growth inhibition of OCI/AML-2 tumor and better survival rate of OCI/AML-2 tumor-bearing mice as compared to free 6-MP.  Carbonyl vinyl sulfide-linked hyaluronic acid-mercaptopurine prodrug has appeared to be a simple and smart nanomedicine for targeted treatment of acute myeloid leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr56vga8jmGMbVg90H21EOLACvtfcHk0lixnT7x7ZLMew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKqtrrE&md5=7071ab8485a4099be3bc670516c65679</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.biomac.7b00846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biomac.7b00846%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DC.%26aulast%3DMeng%26aufirst%3DF.%26aulast%3DZhong%26aufirst%3DZ.%26atitle%3DGlutathione-sensitive%2520hyaluronic%2520acid-mercaptopurine%2520prodrug%2520linked%2520via%2520carbonyl%2520vinyl%2520sulfide%253A%2520a%2520robust%2520and%2520CD44-targeted%2520nanomedicine%2520for%2520leukemia%26jtitle%3DBiomacromolecules%26date%3D2017%26volume%3D18%26spage%3D3207%26epage%3D3214%26doi%3D10.1021%2Facs.biomac.7b00846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Celli, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, B. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizvi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samkoe, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogue, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, T.</span></span> <span> </span><span class="NLM_article-title">Imaging and photodynamic therapy: mechanisms, monitoring, and optimization</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">2795</span>– <span class="NLM_lpage">2838</span>, <span class="refDoi"> DOI: 10.1021/cr900300p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr900300p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVeqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2010&pages=2795-2838&author=J.+P.+Celliauthor=B.+Q.+Springauthor=I.+Rizviauthor=C.+L.+Evansauthor=K.+S.+Samkoeauthor=S.+Vermaauthor=B.+W.+Pogueauthor=T.+Hasan&title=Imaging+and+photodynamic+therapy%3A+mechanisms%2C+monitoring%2C+and+optimization&doi=10.1021%2Fcr900300p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization</span></div><div class="casAuthors">Celli, Jonathan P.; Spring, Bryan Q.; Rizvi, Imran; Evans, Conor L.; Samkoe, Kimberley S.; Verma, Sarika; Pogue, Brian W.; Hasan, Tayyaba</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2795-2838</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI9HITC5FGibVg90H21EOLACvtfcHk0lgp12Zgyfx2WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVeqt7o%253D&md5=43f42186964bfb1227739a8acaf82077</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcr900300p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900300p%26sid%3Dliteratum%253Aachs%26aulast%3DCelli%26aufirst%3DJ.%2BP.%26aulast%3DSpring%26aufirst%3DB.%2BQ.%26aulast%3DRizvi%26aufirst%3DI.%26aulast%3DEvans%26aufirst%3DC.%2BL.%26aulast%3DSamkoe%26aufirst%3DK.%2BS.%26aulast%3DVerma%26aufirst%3DS.%26aulast%3DPogue%26aufirst%3DB.%2BW.%26aulast%3DHasan%26aufirst%3DT.%26atitle%3DImaging%2520and%2520photodynamic%2520therapy%253A%2520mechanisms%252C%2520monitoring%252C%2520and%2520optimization%26jtitle%3DChem.%2520Rev.%26date%3D2010%26volume%3D110%26spage%3D2795%26epage%3D2838%26doi%3D10.1021%2Fcr900300p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovell, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T. W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, G.</span></span> <span> </span><span class="NLM_article-title">Activatable photosensitizers for imaging and therapy</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">2839</span>– <span class="NLM_lpage">2857</span>, <span class="refDoi"> DOI: 10.1021/cr900236h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr900236h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Sgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2010&pages=2839-2857&author=J.+F.+Lovellauthor=T.+W.+B.+Liuauthor=J.+Chenauthor=G.+Zheng&title=Activatable+photosensitizers+for+imaging+and+therapy&doi=10.1021%2Fcr900236h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Activatable Photosensitizers for Imaging and Therapy</span></div><div class="casAuthors">Lovell, Jonathan F.; Liu, Tracy W. B.; Chen, Juan; Zheng, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2839-2857</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG5g8oYD9QXLVg90H21EOLACvtfcHk0lgp12Zgyfx2WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Sgu7k%253D&md5=c6bd3c7a45733ed230b04715a9477d39</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcr900236h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900236h%26sid%3Dliteratum%253Aachs%26aulast%3DLovell%26aufirst%3DJ.%2BF.%26aulast%3DLiu%26aufirst%3DT.%2BW.%2BB.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DG.%26atitle%3DActivatable%2520photosensitizers%2520for%2520imaging%2520and%2520therapy%26jtitle%3DChem.%2520Rev.%26date%3D2010%26volume%3D110%26spage%3D2839%26epage%3D2857%26doi%3D10.1021%2Fcr900236h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Acetal-linked hyperbranched polyphosphoester nanocarriers loaded with chlorin e6 for pH-activatable photodynamic therapy</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">21198</span>– <span class="NLM_lpage">21205</span>, <span class="refDoi"> DOI: 10.1021/acsami.8b06758</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.8b06758" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFeht7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=21198-21205&author=F.+Liauthor=C.+Chenauthor=X.+Yangauthor=X.+Heauthor=Z.+Zhaoauthor=J.+Liauthor=Y.+Yuauthor=X.+Yangauthor=J.+Wang&title=Acetal-linked+hyperbranched+polyphosphoester+nanocarriers+loaded+with+chlorin+e6+for+pH-activatable+photodynamic+therapy&doi=10.1021%2Facsami.8b06758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Acetal-Linked Hyperbranched Polyphosphoester Nanocarriers Loaded with Chlorin e6 for pH-Activatable Photodynamic Therapy</span></div><div class="casAuthors">Li, Feng; Chen, Chao; Yang, Xixi; He, Xinyu; Zhao, Zhangyan; Li, Jie; Yu, Yue; Yang, Xianzhu; Wang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">21198-21205</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nanocarrier-mediated photodynamic therapy (PDT), which involves the systemic delivery of photosensitizers (PSs) into tumor tissue and tumor cells, has emerged as an attractive treatment for cancer.  However, insufficient PS release limits intracellular cytotoxic reactive oxygen species (ROS) generation, which has become a major obstacle to improving the PDT therapeutic efficacy.  Herein, a novel hyperbranched polyphosphoester (hbPPE) contg. numerous acetal bonds (S-hbPPE/Ce6) was explored as a chlorin e6 (Ce6) nanocarrier for PDT.  S-hbPPE/Ce6 with a branched topol. structure efficiently encapsulated Ce6 and then significantly enhanced its internalization by tumor cells.  Subsequently, the endo-/lysosomal acid microenvironment rapidly cleaved the acetal linkage of S-hbPPE and destroyed the nanostructure of S-hbPPE/Ce6, resulting in increased Ce6 release and obviously elevated the intracellular ROS generation under illumination.  Therefore, treatment with S-hbPPE/Ce6 noticeably enhanced the PDT therapeutic efficacy, indicating that such a pH-sensitive hbPPE nanocarrier has great potential to improve the PDT therapeutic efficacy for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYhWUzofBaALVg90H21EOLACvtfcHk0lgp12Zgyfx2WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFeht7vN&md5=1cfd6a4f36e821adc13b3837453fd86a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facsami.8b06758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.8b06758%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DAcetal-linked%2520hyperbranched%2520polyphosphoester%2520nanocarriers%2520loaded%2520with%2520chlorin%2520e6%2520for%2520pH-activatable%2520photodynamic%2520therapy%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2018%26volume%3D10%26spage%3D21198%26epage%3D21205%26doi%3D10.1021%2Facsami.8b06758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">6597</span>– <span class="NLM_lpage">6626</span>, <span class="refDoi"> DOI: 10.1039/C6CS00271D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2FC6CS00271D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=27722328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1ajsb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=6597-6626&author=Z.+Zhouauthor=J.+Songauthor=L.+Nieauthor=X.+Chen&title=Reactive+oxygen+species+generating+systems+meeting+challenges+of+photodynamic+cancer+therapy&doi=10.1039%2FC6CS00271D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy</span></div><div class="casAuthors">Zhou, Zijian; Song, Jibin; Nie, Liming; Chen, Xiaoyuan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6597-6626</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The reactive oxygen species (ROS)-mediated mechanism is the major cause underlying the efficacy of photodynamic therapy (PDT).  The PDT procedure is based on the cascade of synergistic effects between light, a photosensitizer (PS) and oxygen, which greatly favors the spatiotemporal control of the treatment.  This procedure has also evoked several unresolved challenges at different levels including (i) the limited penetration depth of light, which restricts traditional PDT to superficial tumors; (ii) oxygen reliance does not allow PDT treatment of hypoxic tumors; (iii) light can complicate the phototherapeutic outcomes because of the concurrent heat generation; (iv) specific delivery of PSs to sub-cellular organelles for exerting effective toxicity remains an issue; and (v) side effects from undesirable white-light activation and self-catalyzation of traditional PSs.  Recent advances in nanotechnol. and nanomedicine have provided new opportunities to develop ROS-generating systems through photodynamic or non-photodynamic procedures while tackling the challenges of the current PDT approaches.  In this review, we summarize the current status and discuss the possible opportunities for ROS generation for cancer therapy.  We hope this review will spur pre-clin. research and clin. practice for ROS-mediated tumor treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1GpQ6JDijQLVg90H21EOLACvtfcHk0lj2yQLXaKVhWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1ajsb7J&md5=f20c76915d97a39cd9630934701291bb</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2FC6CS00271D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6CS00271D%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DNie%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DReactive%2520oxygen%2520species%2520generating%2520systems%2520meeting%2520challenges%2520of%2520photodynamic%2520cancer%2520therapy%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2016%26volume%3D45%26spage%3D6597%26epage%3D6626%26doi%3D10.1039%2FC6CS00271D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Glutathione-induced amino-activatable micellar photosensitization platform for synergistic redox modulation and photodynamic therapy</span>. <i>Biomater. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1238</span>– <span class="NLM_lpage">1249</span>, <span class="refDoi"> DOI: 10.1039/C8BM00094H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2FC8BM00094H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=29589866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltFWrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=1238-1249&author=R.+Guoauthor=G.+Yangauthor=Z.+Fengauthor=Y.+Zhuauthor=P.+Yangauthor=H.+Songauthor=W.+Wangauthor=P.+Huangauthor=J.+Zhang&title=Glutathione-induced+amino-activatable+micellar+photosensitization+platform+for+synergistic+redox+modulation+and+photodynamic+therapy&doi=10.1039%2FC8BM00094H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Glutathione-induced amino-activatable micellar photosensitization platform for synergistic redox modulation and photodynamic therapy</span></div><div class="casAuthors">Guo, Ruiwei; Yang, Guang; Feng, Zujian; Zhu, Yujie; Yang, Pengxiang; Song, Huijuan; Wang, Weiwei; Huang, Pingsheng; Zhang, Jianhua</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1238-1249</span>CODEN:
                <span class="NLM_cas:coden">BSICCH</span>;
        ISSN:<span class="NLM_cas:issn">2047-4849</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In recent years, photodynamic therapy (PDT) was considered to be a promising cancer treatment modality, however, the therapeutic efficiency was often attenuated by the intrinsic antioxidant defense systems.  Herein, a kind of novel glutathione-induced amino-activatable micelle was designed, which was expected to weaken the antioxidant capacity and in the meantime release the photosensitizer by the exhaustion of intracellular glutathione (GSH).  The amphiphilic poly(ethylene glycol)-(2-((2,4-dinitro-N-(ethyl) phenyl)sulfonamido) Et methacrylate) copolymers were synthesized and assembled into a core-shell nano structure in aq. media.  The nano structure demonstrated high sensitivity and selectivity to bio-thiols in vitro and in vivo.  Subsequently, pheophorbide a (PhA) was encapsulated as the model photosensitizer.  Upon internalization by HepG2 cells, the strongly electron-withdrawing 2,4-dinitrobenzenesulfonyl groups on the PADEE segments were readily cleaved by GSH, during which time the secondary amino groups (pKb = 11.32) were recovered and completely protonated, leading to disassembly of the micelles and rapid release of PhA.  Importantly, the consumption of GSH weakened the intracellular antioxidant capacity, resulting in the synergetic accumulation of reactive oxygen species (ROS) under laser irradn.  As a result, this micellar photosensitization system could overcome the antioxidant capacity of advanced stage tumors through a simultaneous extrinsic and intrinsic strategy, facilitating therapeutic efficiency.  These results demonstrate that the as-designed micelles provide a versatile photosensitization platform for on-demand PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqzpIm2EUek7Vg90H21EOLACvtfcHk0lj2yQLXaKVhWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltFWrt70%253D&md5=0d0d04341038ed6b7c405473ff6d3757</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2FC8BM00094H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8BM00094H%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DGlutathione-induced%2520amino-activatable%2520micellar%2520photosensitization%2520platform%2520for%2520synergistic%2520redox%2520modulation%2520and%2520photodynamic%2520therapy%26jtitle%3DBiomater.%2520Sci.%26date%3D2018%26volume%3D6%26spage%3D1238%26epage%3D1249%26doi%3D10.1039%2FC8BM00094H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy enhances skin cancer chemotherapy effects through autophagy regulation</span>. <i>Photodiagn. Photodyn. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1016/j.pdpdt.2019.08.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.pdpdt.2019.08.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31445100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFejsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2019&pages=159-165&author=L.+Zhangauthor=Z.+Jiauthor=J.+Zhangauthor=S.+Yang&title=Photodynamic+therapy+enhances+skin+cancer+chemotherapy+effects+through+autophagy+regulation&doi=10.1016%2Fj.pdpdt.2019.08.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy enhances skin cancer chemotherapy effects through autophagy regulation</span></div><div class="casAuthors">Zhang, Lili; Ji, Zhoujing; Zhang, Jie; Yang, Shengju</div><div class="citationInfo"><span class="NLM_cas:title">Photodiagnosis and Photodynamic Therapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">159-165</span>CODEN:
                <span class="NLM_cas:coden">PPTHBF</span>;
        ISSN:<span class="NLM_cas:issn">1572-1000</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Non-melanotic cutaneous cancers and melanoma are the main common type skin cancers worldwide.  Despite many therapeutic options, therapeutic efficacy is not satisfied in all patients with advanced skin cancers, esp. in melanoma.  Photodynamic therapy (PDT) is a technol. for skin disease treatment because of its high effectiveness, has no drug resistance and is easy to use compared with traditional therapy.  Our previous study explored that autophagy plays an important role in the formation and development of SCC.  But there was no evidence about the assocn. between PDT with autophagy in skin cancers and the mechanism is also still unclear.  In the study, we want to explore the effects of 5-aminolevulinic acid-PDT (ALA-PDT) on the skin cancers through autophagy regulation.  The result showed that autophagy was regulated by ALA-PDT combined with or without 3-Methyladenine (3-MA) or 5-Fluoracil (5-FU), the proliferation of skin cancer cells A431 and A375 were suppressed while the apoptosis were induced by ALA-PDT and the effects can be enhanced by 3-MA or 5-FU pretreated.  The results suggest that autophagy regulation may be a key point of ALA-PDT therapy; ALA-PDT combined with the chemotherapy of 3-FU or 5-FU may be a new strategy for treatment of skin cancers including non-melanotic cutaneous cancers or melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrShpegp1fRS7Vg90H21EOLACvtfcHk0lhHOUi_DxWwUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFejsrrL&md5=303f42715cb67d29c10c8a1b2a96069b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.pdpdt.2019.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pdpdt.2019.08.023%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DJi%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DS.%26atitle%3DPhotodynamic%2520therapy%2520enhances%2520skin%2520cancer%2520chemotherapy%2520effects%2520through%2520autophagy%2520regulation%26jtitle%3DPhotodiagn.%2520Photodyn.%2520Ther.%26date%3D2019%26volume%3D28%26spage%3D159%26epage%3D165%26doi%3D10.1016%2Fj.pdpdt.2019.08.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Hady, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Hirsch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duggan-Keen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbitt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitchener, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampson, I. N.</span></span> <span> </span><span class="NLM_article-title">Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">196</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=11196160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsl2ksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=192-196&author=E.+S.+Abdel-Hadyauthor=P.+Martin-Hirschauthor=M.+Duggan-Keenauthor=P.+L.+Sternauthor=J.+V.+Mooreauthor=G.+Corbittauthor=H.+C.+Kitchenerauthor=I.+N.+Hampson&title=Immunological+and+viral+factors+associated+with+the+response+of+vulval+intraepithelial+neoplasia+to+photodynamic+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy</span></div><div class="casAuthors">Abdel-Hady, El-Said; Martin-Hirsch, Pierre; Duggan-Keen, Maggie; Stern, Peter L.; Moore, James V.; Corbitt, Gerald; Kitchener, Henry C.; Hampson, Ian N.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">192-196</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Topical 5-aminolevulinic acid-based photodynamic therapy (PDT) has produced complete response rates of >90% for nonmelanoma skin carcinomas, which are mostly human papillomavirus (HPV) neg.  Using a similar treatment protocol, we obsd. a short-term response in only one third (10 of 32) of high-grade vulval intraepithelial neoplasia (VIN 2-3) lesions.  Unifocal lesions were found more responsive than multifocal and pigmented lesions.  Animal model studies have suggested that longterm PDT response involves an immune reaction in which CTLs play a crucial role.  In this study, we have assessed: (a) HPV infection; (b) HLA expression; and (c) immune infiltrating cells in VIN biopsies from responders and nonresponders to det. whether these factors may limit response to topical 5-aminolevulinic acid-based PDT.  Tissues from normal vulva (n = 9), vulval carcinoma (n = 11), and VIN (32 patients from which 19 pre- and 43 post-PDT biopsies were taken) were investigated for immune cell infiltration and HLA class I expression by immunohisto-chem. and HPV infection by PCR.  There was a greater likelihood of HPV positivity assocd. with a lack of response of VIN to PDT (P = 0.002), and VIN nonresponders were more likely to show HLA class I loss compared with responders (P = 0.030).  HLA class I down-regulation was significantly greater in the carcinomas (82%, total loss) than the VIN (28%, 19%, total loss; and 9%, allele loss; P = 0.004).  None of the cases with class I down-regulation responded to PDT, whereas 3 of 6 (50%) of cases that showed total class I loss subsequently developed superficial invasion.  Compared with normal vulval skin, VIN lesions showed increased infiltration by CD4 (T-helper) and CD68 (macrophages) but not CD1a (Langerhans cells) or CD8 (CTLs).  There was, however, a significant increase of CD8 infiltration in posttreatment VIN responders compared with nonresponders (P = 0.0001).  These data clearly support the contention that high-risk HPV infection and lack of cell-mediated immunity may play a role in the obsd. poor response of lower genital lesions to topical PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP9iijMdUEWrVg90H21EOLACvtfcHk0lhHOUi_DxWwUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsl2ksQ%253D%253D&md5=a27a724d502f5450047a664528172803</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Hady%26aufirst%3DE.%2BS.%26aulast%3DMartin-Hirsch%26aufirst%3DP.%26aulast%3DDuggan-Keen%26aufirst%3DM.%26aulast%3DStern%26aufirst%3DP.%2BL.%26aulast%3DMoore%26aufirst%3DJ.%2BV.%26aulast%3DCorbitt%26aufirst%3DG.%26aulast%3DKitchener%26aufirst%3DH.%2BC.%26aulast%3DHampson%26aufirst%3DI.%2BN.%26atitle%3DImmunological%2520and%2520viral%2520factors%2520associated%2520with%2520the%2520response%2520of%2520vulval%2520intraepithelial%2520neoplasia%2520to%2520photodynamic%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D192%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agostinis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cengel, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girotti, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollnick, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juzeniene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korbelik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mroz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piette, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golab, J.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy of cancer: an update</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">250</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.3322/caac.20114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.3322%2Fcaac.20114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=21617154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BC3MnkslajtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=250-281&author=P.+Agostinisauthor=K.+Bergauthor=K.+A.+Cengelauthor=T.+H.+Fosterauthor=A.+W.+Girottiauthor=S.+O.+Gollnickauthor=S.+M.+Hahnauthor=M.+R.+Hamblinauthor=A.+Juzenieneauthor=D.+Kesselauthor=M.+Korbelikauthor=J.+Moanauthor=P.+Mrozauthor=D.+Nowisauthor=J.+Pietteauthor=B.+C.+Wilsonauthor=J.+Golab&title=Photodynamic+therapy+of+cancer%3A+an+update&doi=10.3322%2Fcaac.20114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy of cancer: an update</span></div><div class="casAuthors">Agostinis Patrizia; Berg Kristian; Cengel Keith A; Foster Thomas H; Girotti Albert W; Gollnick Sandra O; Hahn Stephen M; Hamblin Michael R; Juzeniene Asta; Kessel David; Korbelik Mladen; Moan Johan; Mroz Pawel; Nowis Dominika; Piette Jacques; Wilson Brian C; Golab Jakub</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">250-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Photodynamic therapy (PDT) is a clinically approved, minimally invasive therapeutic procedure that can exert a selective cytotoxic activity toward malignant cells.  The procedure involves administration of a photosensitizing agent followed by irradiation at a wavelength corresponding to an absorbance band of the sensitizer.  In the presence of oxygen, a series of events lead to direct tumor cell death, damage to the microvasculature, and induction of a local inflammatory reaction.  Clinical studies revealed that PDT can be curative, particularly in early stage tumors.  It can prolong survival in patients with inoperable cancers and significantly improve quality of life.  Minimal normal tissue toxicity, negligible systemic effects, greatly reduced long-term morbidity, lack of intrinsic or acquired resistance mechanisms, and excellent cosmetic as well as organ function-sparing effects of this treatment make it a valuable therapeutic option for combination treatments.  With a number of recent technological improvements, PDT has the potential to become integrated into the mainstream of cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQZ951D5fAqz-xsqfvU0ziafW6udTcc2eausB9k37D77rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MnkslajtQ%253D%253D&md5=81f4bb716e0dd1967c4819f5593cf109</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3322%2Fcaac.20114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.20114%26sid%3Dliteratum%253Aachs%26aulast%3DAgostinis%26aufirst%3DP.%26aulast%3DBerg%26aufirst%3DK.%26aulast%3DCengel%26aufirst%3DK.%2BA.%26aulast%3DFoster%26aufirst%3DT.%2BH.%26aulast%3DGirotti%26aufirst%3DA.%2BW.%26aulast%3DGollnick%26aufirst%3DS.%2BO.%26aulast%3DHahn%26aufirst%3DS.%2BM.%26aulast%3DHamblin%26aufirst%3DM.%2BR.%26aulast%3DJuzeniene%26aufirst%3DA.%26aulast%3DKessel%26aufirst%3DD.%26aulast%3DKorbelik%26aufirst%3DM.%26aulast%3DMoan%26aufirst%3DJ.%26aulast%3DMroz%26aufirst%3DP.%26aulast%3DNowis%26aufirst%3DD.%26aulast%3DPiette%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DB.%2BC.%26aulast%3DGolab%26aufirst%3DJ.%26atitle%3DPhotodynamic%2520therapy%2520of%2520cancer%253A%2520an%2520update%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2011%26volume%3D61%26spage%3D250%26epage%3D281%26doi%3D10.3322%2Fcaac.20114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brackett, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollnick, S. O.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy enhancement of anti-tumor immunity</span>. <i>Photochem. Photobiol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">652</span>, <span class="refDoi"> DOI: 10.1039/c0pp00354a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2Fc0pp00354a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=21253659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltleitrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=649-652&author=C.+M.+Brackettauthor=S.+O.+Gollnick&title=Photodynamic+therapy+enhancement+of+anti-tumor+immunity&doi=10.1039%2Fc0pp00354a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy enhancement of anti-tumor immunity</span></div><div class="casAuthors">Brackett, Craig M.; Gollnick, Sandra O.</div><div class="citationInfo"><span class="NLM_cas:title">Photochemical & Photobiological Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">649-652</span>CODEN:
                <span class="NLM_cas:coden">PPSHCB</span>;
        ISSN:<span class="NLM_cas:issn">1474-905X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is an FDA-approved modality for the treatment of early-stage disease and palliation of late-stage disease.  Pre-clin. studies using mouse models and clin. studies in patients have demonstrated that PDT is capable of influencing the immune system.  The effect of PDT on the generation of anti-tumor immunity is regimen-dependent and is tightly linked to the degree and nature of inflammation induced by PDT.  However, the precise mechanism underlying PDT-regulated adaptive anti-tumor immunity remains unclear.  This review will focus on the current knowledge of immune regulation by PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkBRXInhovHrVg90H21EOLACvtfcHk0ljValnGt1hmqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltleitrk%253D&md5=c919445b6732b6092abd1f4639c9cc87</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fc0pp00354a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0pp00354a%26sid%3Dliteratum%253Aachs%26aulast%3DBrackett%26aufirst%3DC.%2BM.%26aulast%3DGollnick%26aufirst%3DS.%2BO.%26atitle%3DPhotodynamic%2520therapy%2520enhancement%2520of%2520anti-tumor%2520immunity%26jtitle%3DPhotochem.%2520Photobiol.%2520Sci.%26date%3D2011%26volume%3D10%26spage%3D649%26epage%3D652%26doi%3D10.1039%2Fc0pp00354a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandra, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbara, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patricia, M.</span></span> <span> </span><span class="NLM_article-title">Induction of anti-tumor immunity by photodynamic therapy (PDT)</span>. <i>Proc. SPIE</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6087</i></span>, <span class="NLM_elocation-id">60870E</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1117%2F12.649852" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6087&publication_year=2006&author=O.+G.+Sandraauthor=O.+Barbaraauthor=M.+Patricia&title=Induction+of+anti-tumor+immunity+by+photodynamic+therapy+%28PDT%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1117%2F12.649852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1117%252F12.649852%26sid%3Dliteratum%253Aachs%26aulast%3DSandra%26aufirst%3DO.%2BG.%26aulast%3DBarbara%26aufirst%3DO.%26aulast%3DPatricia%26aufirst%3DM.%26atitle%3DInduction%2520of%2520anti-tumor%2520immunity%2520by%2520photodynamic%2520therapy%2520%2528PDT%2529%26jtitle%3DProc.%2520SPIE%26date%3D2006%26volume%3D6087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mroz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashmi, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lange, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, M. R.</span></span> <span> </span><span class="NLM_article-title">Stimulation of anti-tumor immunity by photodynamic therapy</span>. <i>Expert Rev. Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1586/eci.10.81</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1586%2Feci.10.81" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=21162652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOgtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=75-91&author=P.+Mrozauthor=J.+T.+Hashmiauthor=Y.-Y.+Huangauthor=N.+Langeauthor=M.+R.+Hamblin&title=Stimulation+of+anti-tumor+immunity+by+photodynamic+therapy&doi=10.1586%2Feci.10.81"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of anti-tumor immunity by photodynamic therapy</span></div><div class="casAuthors">Mroz, Pawel; Hashmi, Javad T.; Huang, Ying-Ying; Lange, Norbert; Hamblin, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Clinical Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-91</span>CODEN:
                <span class="NLM_cas:coden">ERCIBU</span>;
        ISSN:<span class="NLM_cas:issn">1744-666X</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Photodynamic therapy (PDT) is a rapidly developing cancer treatment that utilizes the combination of nontoxic dyes and harmless visible light to destroy tumors by generating reactive oxygen species.  PDT produces tumor-cell destruction in the context of acute inflammation that acts as a danger signal' to the innate immune system.  Activation of the innate immune system increases the priming of tumor-specific T lymphocytes that have the ability to recognize and destroy distant tumor cells and, in addn., lead to the development of an immune memory that can combat recurrence of the cancer at a later point in time.  PDT may be also successfully combined with immunomodulating strategies that are capable of overcoming or bypassing the escape mechanisms employed by the progressing tumor to evade immune attack.  This article will cover the role of the immune response in PDT anti-tumor effectiveness.  It will highlight the milestones in the development of PDT-mediated anti-tumor immunity and emphasize the combination strategies that may improve this therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9dXGvT50XiLVg90H21EOLACvtfcHk0ljXnPKKy-Kn8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOgtL3I&md5=1b3666b4db013872441faed6e1056008</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1586%2Feci.10.81&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Feci.10.81%26sid%3Dliteratum%253Aachs%26aulast%3DMroz%26aufirst%3DP.%26aulast%3DHashmi%26aufirst%3DJ.%2BT.%26aulast%3DHuang%26aufirst%3DY.-Y.%26aulast%3DLange%26aufirst%3DN.%26aulast%3DHamblin%26aufirst%3DM.%2BR.%26atitle%3DStimulation%2520of%2520anti-tumor%2520immunity%2520by%2520photodynamic%2520therapy%26jtitle%3DExpert%2520Rev.%2520Clin.%2520Immunol.%26date%3D2011%26volume%3D7%26spage%3D75%26epage%3D91%26doi%3D10.1586%2Feci.10.81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weichselbaum, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W.</span></span> <span> </span><span class="NLM_article-title">Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">12499</span> <span class="refDoi"> DOI: 10.1038/ncomms12499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fncomms12499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=27530650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlyltr7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&author=C.+Heauthor=X.+Duanauthor=N.+Guoauthor=C.+Chanauthor=C.+Poonauthor=R.+R.+Weichselbaumauthor=W.+Lin&title=Core-shell+nanoscale+coordination+polymers+combine+chemotherapy+and+photodynamic+therapy+to+potentiate+checkpoint+blockade+cancer+immunotherapy&doi=10.1038%2Fncomms12499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy</span></div><div class="casAuthors">He, Chunbai; Duan, Xiaopin; Guo, Nining; Chan, Christina; Poon, Christopher; Weichselbaum, Ralph R.; Lin, Wenbin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12499</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Advanced colorectal cancer is one of the deadliest cancers, with a 5-yr survival rate of only 12% for patients with the metastatic disease.  Checkpoint inhibitors, such as the antibodies inhibiting the PD-1/PD-L1 axis, are among the most promising immunotherapies for patients with advanced colon cancer, but their durable response rate remains low.  We herein report the use of immunogenic nanoparticles to augment the antitumor efficacy of PD-L1 antibody-mediated cancer immunotherapy.  Nanoscale coordination polymer (NCP) core-shell nanoparticles carry oxaliplatin in the core and the photosensitizer pyropheophorbide-lipid conjugate (pyrolipid) in the shell (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="aee0edfeeeded7dcc1c2c7dec7ca">[email protected]</a>) for effective chemotherapy and photodynamic therapy (PDT).  Synergy between oxaliplatin and pyrolipid-induced PDT kills tumor cells and provokes an immune response, resulting in calreticulin exposure on the cell surface, antitumor vaccination and an abscopal effect.  When combined with anti-PD-L1 therapy, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="df919c8f9fafa6adb0b3b6afb6bb">[email protected]</a> mediates regression of both light-irradiated primary tumors and non-irradiated distant tumors by inducing a strong tumor-specific immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2l-hIcEiayrVg90H21EOLACvtfcHk0ljXnPKKy-Kn8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlyltr7N&md5=89a6611f1003fc6aa1e3d25ba7ec2cad</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fncomms12499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12499%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DC.%26aulast%3DDuan%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DN.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DPoon%26aufirst%3DC.%26aulast%3DWeichselbaum%26aufirst%3DR.%2BR.%26aulast%3DLin%26aufirst%3DW.%26atitle%3DCore-shell%2520nanoscale%2520coordination%2520polymers%2520combine%2520chemotherapy%2520and%2520photodynamic%2520therapy%2520to%2520potentiate%2520checkpoint%2520blockade%2520cancer%2520immunotherapy%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26doi%3D10.1038%2Fncomms12499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weichselbaum, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W.</span></span> <span> </span><span class="NLM_article-title">Chlorin-based nanoscalemetal–organic framework systemically rejects colorectal cancers via synergistic photodynamic therapy and checkpoint blockade immunotherapy</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">12502</span>– <span class="NLM_lpage">12510</span>, <span class="refDoi"> DOI: 10.1021/jacs.6b06663</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b06663" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVChtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=12502-12510&author=K.+Luauthor=C.+Heauthor=N.+Guoauthor=C.+Chanauthor=K.+Niauthor=R.+R.+Weichselbaumauthor=W.+Lin&title=Chlorin-based+nanoscalemetal%E2%80%93organic+framework+systemically+rejects+colorectal+cancers+via+synergistic+photodynamic+therapy+and+checkpoint+blockade+immunotherapy&doi=10.1021%2Fjacs.6b06663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy</span></div><div class="casAuthors">Lu, Kuangda; He, Chunbai; Guo, Nining; Chan, Christina; Ni, Kaiyuan; Weichselbaum, Ralph R.; Lin, Wenbin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">12502-12510</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) can destroy local tumors and minimize normal tissue damage, but is ineffective at eliminating metastases.  Checkpoint blockade immunotherapy has enjoyed recent success in the clinic, but only elicits limited rates of systemic antitumor response for most cancers due to insufficient activation of the host immune system.  Here we describe a treatment strategy that combines PDT by a new chlorin-based nanoscale metal-org. framework (nMOF), TBC-Hf, and a small-mol. immunotherapy agent that inhibits indoleamine 2,3-dioxygenase (IDO), encapsulated in the nMOF channels to induce systemic antitumor immunity.  The synergistic combination therapy achieved effective local and distant tumor rejection in colorectal cancer models.  We detected increased T cell infiltration in the tumor microenvironment after activation of the immune system with the combination of IDO inhibition by the small-mol. immunotherapy agent and immunogenic cell death induced by PDT.  We also elucidated the underlying immunol. mechanisms and revealed compensatory roles of neutrophils and B cells in presenting tumor-assocd. antigens to T cells in this combination therapy.  We believe that nMOF-enabled PDT has the potential to significantly enhance checkpoint blockade cancer immunotherapy, affording clin. benefits for the treatment of many difficult-to-treat cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_vb_7ukLa7bVg90H21EOLACvtfcHk0liiRB7E0-heYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVChtr%252FM&md5=a5817a195c3cf30ecc53f6fcfd3d5c12</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b06663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b06663%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DN.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DNi%26aufirst%3DK.%26aulast%3DWeichselbaum%26aufirst%3DR.%2BR.%26aulast%3DLin%26aufirst%3DW.%26atitle%3DChlorin-based%2520nanoscalemetal%25E2%2580%2593organic%2520framework%2520systemically%2520rejects%2520colorectal%2520cancers%2520via%2520synergistic%2520photodynamic%2520therapy%2520and%2520checkpoint%2520blockade%2520immunotherapy%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26spage%3D12502%26epage%3D12510%26doi%3D10.1021%2Fjacs.6b06663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krosl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korbelik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krosl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korbelik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, G. J.</span></span> <span> </span><span class="NLM_article-title">Induction of cell infiltration into murine SCCVII tumor by photofrin-based photodynamic therapy</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">555</span>, <span class="refDoi"> DOI: 10.1038/bjc.1995.108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fbjc.1995.108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=7880738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADyaK2MXkvVCku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1995&pages=549-555&author=G.+Kroslauthor=M.+Korbelikauthor=G.+Doughertyauthor=G.+Kroslauthor=M.+Korbelikauthor=G.+J.+Dougherty&title=Induction+of+cell+infiltration+into+murine+SCCVII+tumor+by+photofrin-based+photodynamic+therapy&doi=10.1038%2Fbjc.1995.108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of immune cell infiltration into murine SCCVII tumor by Photofrin-based photodynamic therapy</span></div><div class="casAuthors">Krosl, G.; Korbelik, M.; Dougherty, G J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">549-55</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">Cellular populations in the squamous cell carcinoma SCCVII, growing in C3H/HeN mice given Photofrin, were examd. at various time intervals during the photodynamic light treatment and up to 8 h later.  Cell populations present within excised tumors were identified by monoclonal antibodies directed against cell type-specific membrane markers using a combination of the indirect immunoperoxidase and Wright staining or by flow cytometry.  Photofrin-based photodynamic therapy (PDT) induced dramatic changes in the level of different cellular populations contained in the treated tumor.  The most pronounced was a rapid increase in the content of neutrophils, which increased 200-fold within 5 min after the initiation of light treatment.  This was followed immediately by an increase in the levels of mast cells, while another type of myeloid cells, most likely monocytes, invaded the tumor between 0 and 2 h after PDT.  The examn. of cytolysis of in vitro cultured SCCVII tumor cells mediated by macrophages harvested from the SCCVII tumor revealed a pronounced increase in the tumoricidal activity of tumor-assocd. macrophages isolated at 2 h post PDT.  It seems, therefore, that the PDT-induced acute inflammatory infiltration of myeloid cells into the treated tumor is assocd. with functional activation of immune cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Gxgyf85worVg90H21EOLACvtfcHk0liiRB7E0-heYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkvVCku7o%253D&md5=3cc489013e4ca17d51e85d8243015e5a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1995.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1995.108%26sid%3Dliteratum%253Aachs%26aulast%3DKrosl%26aufirst%3DG.%26aulast%3DKorbelik%26aufirst%3DM.%26aulast%3DDougherty%26aufirst%3DG.%26aulast%3DKrosl%26aufirst%3DG.%26aulast%3DKorbelik%26aufirst%3DM.%26aulast%3DDougherty%26aufirst%3DG.%2BJ.%26atitle%3DInduction%2520of%2520cell%2520infiltration%2520into%2520murine%2520SCCVII%2520tumor%2520by%2520photofrin-based%2520photodynamic%2520therapy%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1995%26volume%3D71%26spage%3D549%26epage%3D555%26doi%3D10.1038%2Fbjc.1995.108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donohoe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senge, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnaut, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes-da-Silva, L. C.</span></span> <span> </span><span class="NLM_article-title">Cell death in photodynamic therapy: From oxidative stress to anti-tumor immunity</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1872</i></span>, <span class="NLM_elocation-id">188308</span> <span class="refDoi"> DOI: 10.1016/j.bbcan.2019.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.bbcan.2019.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31401103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1ygtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1872&publication_year=2019&author=C.+Donohoeauthor=M.+O.+Sengeauthor=L.+G.+Arnautauthor=L.+C.+Gomes-da-Silva&title=Cell+death+in+photodynamic+therapy%3A+From+oxidative+stress+to+anti-tumor+immunity&doi=10.1016%2Fj.bbcan.2019.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Cell death in photodynamic therapy: From oxidative stress to anti-tumor immunity</span></div><div class="casAuthors">Donohoe, Claire; Senge, Mathias O.; Arnaut, Luis G.; Gomes-da-Silva, Ligia C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1872</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">188308</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Photodynamic therapy is a promising approach for cancer treatment that relies on the administration of a photosensitizer followed by tumor illumination.  The generated oxidative stress may activate multiple mechanisms of cell death which are counteracted by cells through adaptive stress responses that target homeostasis rescue.  The present renaissance of PDT was leveraged by the acknowledgment that this therapy has an immediate impact locally, in the illumination vol., but that subsequently it may also elicit immune responses with systemic impact.  The investigation of the mechanisms of cell death under the oxidative stress of PDT is of paramount importance to understand how the immune system is activated and, ultimately, to make PDT a more appealing/relevant therapeutic option.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ2efgcvdQtbVg90H21EOLACvtfcHk0lhGQ2E4Xw_mXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1ygtb7J&md5=8017f572a7c30442026748894e43daff</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2019.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2019.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DDonohoe%26aufirst%3DC.%26aulast%3DSenge%26aufirst%3DM.%2BO.%26aulast%3DArnaut%26aufirst%3DL.%2BG.%26aulast%3DGomes-da-Silva%26aufirst%3DL.%2BC.%26atitle%3DCell%2520death%2520in%2520photodynamic%2520therapy%253A%2520From%2520oxidative%2520stress%2520to%2520anti-tumor%2520immunity%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2019%26volume%3D1872%26doi%3D10.1016%2Fj.bbcan.2019.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, K.</span></span> <span> </span><span class="NLM_article-title">Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy</span>. <i>J. Pharm. Investig.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1007/s40005-017-0377-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1007%2Fs40005-017-0377-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=30680248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1WgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2018&pages=143-151&author=H.+S.+Hwangauthor=H.+Shinauthor=J.+Hanauthor=K.+Na&title=Combination+of+photodynamic+therapy+%28PDT%29+and+anti-tumor+immunity+in+cancer+therapy&doi=10.1007%2Fs40005-017-0377-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy</span></div><div class="casAuthors">Hwang, Hee Sook; Shin, Heejun; Han, Jieun; Na, Kun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Investigation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-151</span>CODEN:
                <span class="NLM_cas:coden">JPIOBH</span>;
        ISSN:<span class="NLM_cas:issn">2093-5552</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Photodynamic therapy (PDT) is performed using a photosensitizer and light of specific wavelength in the presence of oxygen to generate singlet oxygen and reactive oxygen species(ROS) in the cancer cells.  The accumulated photosensitizers in target sites induce ROS generation upon light activation, then the generated cytotoxic reactive oxygen species lead to tumor cell death via apoptosis or necrosis, and damages the target sites which results tumor destruction.  As a consequence, the PDT-mediated cell death is assocd. with anti-tumor immune response.  In this paper, the effects of PDT and immune response on tumors are reviewed.  Activation of an immune response regarding the innate and adaptive immune response, interaction with immune cells and tumor cells that assocd. with antitumor efficacy of PDT are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcNYReTe25rrVg90H21EOLACvtfcHk0lhGQ2E4Xw_mXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1WgtA%253D%253D&md5=3220870ec7b2a50cf6880418b1c2f9bd</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs40005-017-0377-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40005-017-0377-x%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DH.%2BS.%26aulast%3DShin%26aufirst%3DH.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DNa%26aufirst%3DK.%26atitle%3DCombination%2520of%2520photodynamic%2520therapy%2520%2528PDT%2529%2520and%2520anti-tumor%2520immunity%2520in%2520cancer%2520therapy%26jtitle%3DJ.%2520Pharm.%2520Investig.%26date%3D2018%26volume%3D48%26spage%3D143%26epage%3D151%26doi%3D10.1007%2Fs40005-017-0377-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castano, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mroz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, M. R.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy and anti-tumour immunity</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">545</span>, <span class="refDoi"> DOI: 10.1038/nrc1894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fnrc1894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=16794636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtFehu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=535-545&author=A.+P.+Castanoauthor=P.+Mrozauthor=M.+R.+Hamblin&title=Photodynamic+therapy+and+anti-tumour+immunity&doi=10.1038%2Fnrc1894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy and anti-tumour immunity</span></div><div class="casAuthors">Castano, Ana P.; Mroz, Pawel; Hamblin, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">535-545</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Photodynamic therapy (PDT) uses non-toxic photosensitizers and harmless visible light in combination with oxygen to produce cytotoxic reactive oxygen species that kill malignant cells by apoptosis and/or necrosis, shut down the tumor microvasculature and stimulate the host immune system.  In contrast to surgery, radiotherapy and chemotherapy that are mostly immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins, invasion and infiltration of the tumor by leukocytes, and might increase the presentation of tumor-derived antigens to T cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcQPY6qlMQvLVg90H21EOLACvtfcHk0lhGQ2E4Xw_mXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtFehu7k%253D&md5=7b02eb36a28b98d700e9fdebd7e0697f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnrc1894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1894%26sid%3Dliteratum%253Aachs%26aulast%3DCastano%26aufirst%3DA.%2BP.%26aulast%3DMroz%26aufirst%3DP.%26aulast%3DHamblin%26aufirst%3DM.%2BR.%26atitle%3DPhotodynamic%2520therapy%2520and%2520anti-tumour%2520immunity%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D535%26epage%3D545%26doi%3D10.1038%2Fnrc1894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span> <span> </span><span class="NLM_article-title">Targeted nanocarriers based on iodinated-cyanine dyes as immunomodulators for synergistic phototherapy</span>. <i>Nanoscale</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">11008</span>– <span class="NLM_lpage">11025</span>, <span class="refDoi"> DOI: 10.1039/C9NR10674J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2FC9NR10674J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=32301458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BB3cXltlCksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=11008-11025&author=J.+Chiauthor=Q.+Maauthor=Z.+Shenauthor=C.+Maauthor=W.+Zhuauthor=S.+Hanauthor=Y.+Liangauthor=J.+Caoauthor=Y.+Sun&title=Targeted+nanocarriers+based+on+iodinated-cyanine+dyes+as+immunomodulators+for+synergistic+phototherapy&doi=10.1039%2FC9NR10674J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted nanocarriers based on iodinated-cyanine dyes as immunomodulators for synergistic phototherapy</span></div><div class="casAuthors">Chi, Jinnan; Ma, Qingming; Shen, Zijun; Ma, Caiyun; Zhu, Wei; Han, Shangcong; Liang, Yan; Cao, Jie; Sun, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Nanoscale</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11008-11025</span>CODEN:
                <span class="NLM_cas:coden">NANOHL</span>;
        ISSN:<span class="NLM_cas:issn">2040-3372</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT), as one of the most powerful photo-therapeutic strategies for cancer treatment with min. invasiveness, can effectively damage local tumor cells and significantly induce systemic antitumor immunity.  However, current nanotechnol.-assisted PDT-immunomodulators have either poor penetration for deep tumors or low singlet oxygen generation.  Herein, we construct a novel theranostic nanocarrier (HA-PEG-CyI, HPC) by inducing the self-assembly of PEGylated CyI and attaching the ligand HA to its surface.  The prepd. HPC can be used as an ideal PDT-immunomodulator for synergistic cancer therapy.  CyI is an iodinated-cyanine dye with enhanced singlet oxygen generation ability as well as excellent photo-to-photothermal and near-IR fluorescence imaging properties.  Under 808 nm laser irradn., the prepd. HPC can generate both reactive oxygen species (ROS) and elevate temp. which can subsequently result in apoptosis and necrosis at tumor sites.  Moreover, the HPC-induced cell death can generate a series of acute inflammatory reactions, leading to systemic immunity induction and secondary death of tumor cells, which further results in reducing tumor recurrence.  In vitro and in vivo results show that HPC can enhance the tumor targeting efficacy, generate ROS efficiently and exhibit a high temp. response under NIR irradn., which working together can activate immune responses for synergistic phototherapy on tumor cells.  Accordingly, the proposed multi-functional HPC nanocarriers represent an important advance in PDT and can be used as a superior cancer treatment strategy with great promise for clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb3iOCxGbEmbVg90H21EOLACvtfcHk0ljOUmyPtXCtdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXltlCksL8%253D&md5=24d0d33514cd5366a1ad2651a1e287e4</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1039%2FC9NR10674J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9NR10674J%26sid%3Dliteratum%253Aachs%26aulast%3DChi%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DY.%26atitle%3DTargeted%2520nanocarriers%2520based%2520on%2520iodinated-cyanine%2520dyes%2520as%2520immunomodulators%2520for%2520synergistic%2520phototherapy%26jtitle%3DNanoscale%26date%3D2020%26volume%3D12%26spage%3D11008%26epage%3D11025%26doi%3D10.1039%2FC9NR10674J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, C.</span></span> <span> </span><span class="NLM_article-title">Targeted delivery of chlorin e6 via redox sensitive diselenide-containing micelles for improved photodynamic therapy in cluster of differentiation 44-overexpressing breast cancer</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">369</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.3389%2Ffphar.2019.00369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31057402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVGkt7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=369&author=C.+Fengauthor=D.+Zhuauthor=L.+Chenauthor=Y.+Luauthor=J.+Liuauthor=N.+Y.+Kimauthor=S.+Liangauthor=X.+Zhangauthor=Y.+Linauthor=Y.+Maauthor=C.+Dong&title=Targeted+delivery+of+chlorin+e6+via+redox+sensitive+diselenide-containing+micelles+for+improved+photodynamic+therapy+in+cluster+of+differentiation+44-overexpressing+breast+cancer&doi=10.3389%2Ffphar.2019.00369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted delivery of chlorin e6 via redox sensitive diselenide-containing micelles for improved photodynamic therapy in cluster of differentiation 44-overexpressing breast cancer</span></div><div class="casAuthors">Feng, Chan; Zhu, Donglei; Chen, Lv; Lu, Yonglin; Liu, Jie; Kim, Na Yoon; Liang, Shujing; Zhang, Xia; Lin, Yun; Ma, Yabin; Dong, Chunyan</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">369</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The off-target activation of photosensitizers is one of the most well-known obstacles to effective photodynamic therapy (PDT).  The selected activation of photosensitizers in cancer cells is highly desired to overcome this problem.  We developed a strategy that enabled diselenide bonds to link hyaluronic acid (HA) and photosensitizer chlorin e6 (Ce6) to assemble the micelles (HA-sese-Ce6 NPs) that can target cancer and achieve a redox responsive release of drugs to enhance the PDT efficiency in breast cancer.  The HA was used to form a hydrophilic shell that can target cluster of differentiation 44 (CD44) on the cancer cells.  The selenium-contg. core is easily dissembled in a redox environment to release Ce6.  The triggered release of Ce6 in a redox condition and the pos. feedback release by activated Ce6 were obsd. in vitro.  In cytotoxicity assays and in vitro cellular uptake assays, the increased PDT efficiency and targeted internalization of HA-sese-Ce6 NPs in the cells were verified, compared to a free Ce6 treated group.  Similar results were showed in the therapeutic study and in vivo fluorescence imaging in an orthotopic mammary fat pad tumor model.  In addn., a significant inhibition of metastasis was found after the HA-sese-Ce6 NPs treatment.  In general, this study promises an ingenious and easy strategy for improved PDT efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEMwfuniycZbVg90H21EOLACvtfcHk0ljOUmyPtXCtdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVGkt7bI&md5=85798ad15f4f108a71142fed906ca004</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00369%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DN.%2BY.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DC.%26atitle%3DTargeted%2520delivery%2520of%2520chlorin%2520e6%2520via%2520redox%2520sensitive%2520diselenide-containing%2520micelles%2520for%2520improved%2520photodynamic%2520therapy%2520in%2520cluster%2520of%2520differentiation%252044-overexpressing%2520breast%2520cancer%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D369%26doi%3D10.3389%2Ffphar.2019.00369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Tumor-targeting photodynamic therapy based on folate-modified polydopamine nanoparticles</span>. <i>Int. J. Nanomed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">6799</span>– <span class="NLM_lpage">6812</span>, <span class="refDoi"> DOI: 10.2147/IJN.S216194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.2147%2FIJN.S216194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31692522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVCmtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=6799-6812&author=S.+Yanauthor=Q.+Huangauthor=J.+Chenauthor=X.+Songauthor=Z.+Chenauthor=M.+Huangauthor=P.+Xuauthor=J.+Zhang&title=Tumor-targeting+photodynamic+therapy+based+on+folate-modified+polydopamine+nanoparticles&doi=10.2147%2FIJN.S216194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-targeting photodynamic therapy based on folate-modified polydopamine nanoparticles</span></div><div class="casAuthors">Yan, Shufeng; Huang, Qingqing; Chen, Jincan; Song, Xiaorong; Chen, Zhuo; Huang, Mingdong; Xu, Peng; Zhang, Juncheng</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Nanomedicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6799-6812</span>CODEN:
                <span class="NLM_cas:coden">IJNNHQ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2013</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: Photodynamic therapy (PDT), a clin. anticancer therapeutic modality, has a long history in clin. cancer treatments since the 1970s.  However, PDT has not been widely used largely because of metabolic problems and off-target phototoxicities of the current clin. photosensitizers.  Purpose: The objective of the study is to develop a high-efficiency and high-specificity carrier to precisely deliver photosensitizers to tumor sites, aiming at addressing metabolic problems, as well as the systemic damages current clin. photosensitizers are known to cause.  Methods: We synthesized a polydopamine (PDA)-based carrier with the modification of folic acid (FA), which is to target the overexpressed folate receptors on tumor surfaces.  We used this carrier to load a cationic phthalocyanine-type photosensitizer (Pc) and generated a PDA-FA-Pc nanomedicine.  We detd. the antitumor effects and the specificity to tumor cell lines in vitro.  In addn., we established human cancer-xenografted mice models to evaluate the tumor-targeting property and anticancer efficacies in vivo.  Results: Our PDA-FA-Pc nanomedicine demonstrated a high stability in normal physiol. conditions, however, could specifically release photosensitizers in acidic conditions, eg, tumor microenvironment and lysosomes in cancer cells.  Addnl., PDA-FA-Pc nanomedicine demonstrated a much higher cellular uptake and phototoxicity in cancer cell lines than in healthy cell lines.  Moreover, the in vivo imaging data indicated excellent tumor-targeting properties of PDA-FA-Pc nanomedicine in human cancer-xenografted mice.  Lastly, PDAFA- Pc nanomedicine was found to significantly suppress tumor growth within two human cancer-xenografted mice models.  Conclusion: Our current study not only demonstrates PDA-FA-Pc nanomedicine as a highly potent and specific anticancer agent, but also suggests a strategy to address the metabolic and specificity problems of clin. photosensitizers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoua8NhxRFb7Vg90H21EOLACvtfcHk0lhsU5p047J7UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVCmtb%252FI&md5=7e387f3e47386aaa7538f74afb84d1b3</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.2147%2FIJN.S216194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FIJN.S216194%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DTumor-targeting%2520photodynamic%2520therapy%2520based%2520on%2520folate-modified%2520polydopamine%2520nanoparticles%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2019%26volume%3D14%26spage%3D6799%26epage%3D6812%26doi%3D10.2147%2FIJN.S216194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musani, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barqawi, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. K.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy for treatment of solid tumors-potential and technical challenges</span>. <i>Technol. Cancer Res. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1177/153303460800700405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1177%2F153303460800700405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=18642969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSrtbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=309-320&author=Z.+Huangauthor=H.+Xuauthor=A.+D.+Meyersauthor=A.+I.+Musaniauthor=L.+Wangauthor=R.+Taggauthor=A.+B.+Barqawiauthor=Y.+K.+Chen&title=Photodynamic+therapy+for+treatment+of+solid+tumors-potential+and+technical+challenges&doi=10.1177%2F153303460800700405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy for treatment of solid tumors-potential and technical challenges</span></div><div class="casAuthors">Huang, Zheng; Xu, Heping; Meyers, Arlen D.; Musani, Ali I.; Wang, Luowei; Tagg, Randall; Barqawi, Al B.; Chen, Yang K.</div><div class="citationInfo"><span class="NLM_cas:title">Technology in Cancer Research & Treatment</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">309-320</span>CODEN:
                <span class="NLM_cas:coden">TCRTBS</span>;
        ISSN:<span class="NLM_cas:issn">1533-0346</span>.
    
            (<span class="NLM_cas:orgname">Adenine Press</span>)
        </div><div class="casAbstract">A review.  Photodynamic therapy (PDT) involves the administration of photosensitizer followed by local illumination with visible light of specific wavelength(s).  In the presence of oxygen mols., the light illumination of photosensitizer can lead to a series of photochem. reactions and consequently the generation of cytotoxic species.  The quantity and location of PDT-induced cytotoxic species det. the nature and consequence of PDT.  Much progress has been seen in both basic research and clin. application in recent years.  Although the majority of approved PDT clin. protocols have primarily been used for the treatment of superficial lesions of both malignant and non-malignant diseases, intersititial PDT for the ablation of deep-seated solid tumors are now being investigated worldwide.  The complexity of the geometry and non-homogeneity of solid tumor pose a great challenge on the implementation of minimally invasive interstitial PDT and the estn. of PDT dosimetry.  This review will discuss the recent progress and tech. challenges of various forms of interstitial PDT for the treatment of parenchymal and/or stromal tissues of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCQxgNqu8r3LVg90H21EOLACvtfcHk0lhsU5p047J7UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSrtbbO&md5=93dbaba5d27199d7dd69c00326727729</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1177%2F153303460800700405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F153303460800700405%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DMeyers%26aufirst%3DA.%2BD.%26aulast%3DMusani%26aufirst%3DA.%2BI.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DTagg%26aufirst%3DR.%26aulast%3DBarqawi%26aufirst%3DA.%2BB.%26aulast%3DChen%26aufirst%3DY.%2BK.%26atitle%3DPhotodynamic%2520therapy%2520for%2520treatment%2520of%2520solid%2520tumors-potential%2520and%2520technical%2520challenges%26jtitle%3DTechnol.%2520Cancer%2520Res.%2520Treat.%26date%3D2008%26volume%3D7%26spage%3D309%26epage%3D320%26doi%3D10.1177%2F153303460800700405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharman, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Lier, J. E.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapeutics: basic principles and clinical applications</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">517</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(99)01412-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2FS1359-6446%2899%2901412-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10529768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADyaK1MXmvVKhsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=507-517&author=W.+M.+Sharmanauthor=C.+M.+Allenauthor=J.+E.+van+Lier&title=Photodynamic+therapeutics%3A+basic+principles+and+clinical+applications&doi=10.1016%2FS1359-6446%2899%2901412-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapeutics: basic principles and clinical applications</span></div><div class="casAuthors">Sharman, W. M.; Allen, C. M.; van Lier, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">507-517</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 71 refs.  Photodynamic therapy (PDT) is a promising new treatment for cancer that has been recently accepted in the clinic.  PDT involves the localization of a light-sensitive drug (photosensitizer) in the target tissue prior to illumination using an appropriate wavelength.  Cytotoxic agents generated upon illumination trigger a cascade of biochem. responses that inactivate cancer cells either directly or through the induction of vascular stasis.  These treatments are better tolerated as they destroy diseased tissue while leaving normal tissue intact.  The hematoporphyrin deriv., Photofrin, has been approved in a no. of European and Asian countries, as well as in North America.  To enhance the potential of PDT and explore its application for other conditions, second-generation photosensitizers are being rigorously investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH5aWUaH7trLVg90H21EOLACvtfcHk0ljCKTQ9HogY8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvVKhsrY%253D&md5=6bf14daa571a10e3982d773b4a5730d6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2899%2901412-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252899%252901412-9%26sid%3Dliteratum%253Aachs%26aulast%3DSharman%26aufirst%3DW.%2BM.%26aulast%3DAllen%26aufirst%3DC.%2BM.%26aulast%3Dvan%2BLier%26aufirst%3DJ.%2BE.%26atitle%3DPhotodynamic%2520therapeutics%253A%2520basic%2520principles%2520and%2520clinical%2520applications%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D1999%26volume%3D4%26spage%3D507%26epage%3D517%26doi%3D10.1016%2FS1359-6446%2899%2901412-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span> <span> </span><span class="NLM_article-title">Photothermal-pH-hypoxia responsive multifunctional nanoplatform for cancer photo-chemo therapy with negligible skin phototoxicity</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>221</i></span>, <span class="NLM_elocation-id">119422</span> <span class="refDoi"> DOI: 10.1016/j.biomaterials.2019.119422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.biomaterials.2019.119422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31437723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1Shs77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=2019&author=D.+Chenauthor=Y.+Tangauthor=J.+Zhuauthor=J.+Zhangauthor=X.+Songauthor=W.+Wangauthor=J.+Shaoauthor=W.+Huangauthor=P.+Chenauthor=X.+Dong&title=Photothermal-pH-hypoxia+responsive+multifunctional+nanoplatform+for+cancer+photo-chemo+therapy+with+negligible+skin+phototoxicity&doi=10.1016%2Fj.biomaterials.2019.119422"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Photothermal-pH-hypoxia responsive multifunctional nanoplatform for cancer photo-chemo therapy with negligible skin phototoxicity</span></div><div class="casAuthors">Chen, Dapeng; Tang, Yunyun; Zhu, Jiawei; Zhang, Jiaojiao; Song, Xuejiao; Wang, Wenjun; Shao, Jinjun; Huang, Wei; Chen, Peng; Dong, Xiaochen</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119422</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Highly specific and effective cancer phototherapy remains as a great challenge.  Herein, a smart nanoplatform (TENAB NP) sequentially responsive to light, low pH and hypoxia is demonstrated for multi-mode imaging guided synergistic cancer therapy with negligible skin phototoxicity.  Upon 808-nm laser irradn., TENAB NPs can generate hyperthermia to melt the phase change material (PCM-LASA) coat and thereafter release chemo-drug tirapazamine (TPZ).  Meanwhile, under acidic pH, photosensitizer ENAB would turn "off" its charge-transfer state, generating prominent 1O2 for photodynamic therapy (PDT) and heat for photothermal therapy (PTT), resp.  Accompanied with PDT-induced hypoxia, the released TPZ can be activated into its cytotoxic form for tumor cells killing.  Notably, owing to phase change material LASA coat and ENAB's pH sensitivity, TENAB NPs show negligible photosensitization to skin and normal tissues.  As the multi-stimuli responsive mechanism, TENAB NPs demonstrate a promising future in cancer photo-chemo theranostics with excellent skin protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkHU2anngKJbVg90H21EOLACvtfcHk0ljCKTQ9HogY8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1Shs77N&md5=d0441208d1adaff56660c7e82e2318ca</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2019.119422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2019.119422%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DShao%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DDong%26aufirst%3DX.%26atitle%3DPhotothermal-pH-hypoxia%2520responsive%2520multifunctional%2520nanoplatform%2520for%2520cancer%2520photo-chemo%2520therapy%2520with%2520negligible%2520skin%2520phototoxicity%26jtitle%3DBiomaterials%26date%3D2019%26volume%3D221%26doi%3D10.1016%2Fj.biomaterials.2019.119422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span> <span> </span><span class="NLM_article-title">Epidermal growth factor receptor-targeted delivery of a singlet-oxygen sensitizer with thermal controlled release for efficient anticancer therapy</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3703</span>– <span class="NLM_lpage">3710</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.9b00670</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.9b00670" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1ensL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=3703-3710&author=J.+Chenauthor=D.+Liauthor=B.+Huoauthor=F.+Zhangauthor=X.+Zhaoauthor=G.+Yuanauthor=D.+Chenauthor=M.+Songauthor=J.+Xue&title=Epidermal+growth+factor+receptor-targeted+delivery+of+a+singlet-oxygen+sensitizer+with+thermal+controlled+release+for+efficient+anticancer+therapy&doi=10.1021%2Facs.molpharmaceut.9b00670"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Epidermal Growth Factor Receptor-Targeted Delivery of a Singlet-Oxygen Sensitizer with Thermal Controlled Release for Efficient Anticancer Therapy</span></div><div class="casAuthors">Chen, Juanjuan; Li, Dongyao; Huo, Beibei; Zhang, Fengling; Zhao, Xuan; Yuan, Gankun; Chen, Dan; Song, Meiru; Xue, Jinping</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3703-3710</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) utilizing light-induced singlet oxygen has achieved attractive results in anticancer fields; however, its development is hindered by limited light penetration depth, skin phototoxicity, tumor hypoxia, and PDT-induced hypoxia.  Inspired by our previous research work and the limitations of PDT, we introduce a small-mol.-targeted drug erlotinib into the singlet-oxygen chem. source endoperoxide to achieve an EGFR-targeted PDT-mimetic sensitizer (Y3-1) for anticancer therapy.  We demonstrated the erlotinib-based precise delivery of the singlet-oxygen chem. source (in vitro photosensitization) to EFGR-overexpressing tumor cells and tissues.  Moreover, the anticancer assays validated that the enhanced anticancer efficacy (in vitro and in vivo) of Y3-1 was due to reversible singlet-oxygen thermal release.  This study is expected to provide a smart strategy to break through the current roadblock in targeted PDT and achieve a more efficient anticancer therapy model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPKflnIRgCOLVg90H21EOLACvtfcHk0ljCKTQ9HogY8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1ensL3P&md5=c815fd7e4728c647f110585f88ca477c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.9b00670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.9b00670%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DHuo%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DYuan%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DXue%26aufirst%3DJ.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor-targeted%2520delivery%2520of%2520a%2520singlet-oxygen%2520sensitizer%2520with%2520thermal%2520controlled%2520release%2520for%2520efficient%2520anticancer%2520therapy%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2019%26volume%3D16%26spage%3D3703%26epage%3D3710%26doi%3D10.1021%2Facs.molpharmaceut.9b00670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sebak, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomaa, I. E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ElMeshad, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">AbdelKader, M. H.</span></span> <span> </span><span class="NLM_article-title">Targeted photodynamic-induced singlet oxygen production by peptide-conjugated biodegradable nanoparticles for treatment of skin melanoma</span>. <i>Photodiagn. Photodyn. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1016/j.pdpdt.2018.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.pdpdt.2018.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=29885810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht12qtL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=181-189&author=A.+A.+Sebakauthor=I.+E.+O.+Gomaaauthor=A.+N.+ElMeshadauthor=M.+H.+AbdelKader&title=Targeted+photodynamic-induced+singlet+oxygen+production+by+peptide-conjugated+biodegradable+nanoparticles+for+treatment+of+skin+melanoma&doi=10.1016%2Fj.pdpdt.2018.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted photodynamic-induced singlet oxygen production by peptide-conjugated biodegradable nanoparticles for treatment of skin melanoma</span></div><div class="casAuthors">Sebak, Aya Ahmed; Gomaa, Iman Emam Omar; ElMeshad, Aliaa Nabil; AbdelKader, Mahmoud Hashem</div><div class="citationInfo"><span class="NLM_cas:title">Photodiagnosis and Photodynamic Therapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">181-189</span>CODEN:
                <span class="NLM_cas:coden">PPTHBF</span>;
        ISSN:<span class="NLM_cas:issn">1572-1000</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) has been detd. to be a promising treatment modality in the most resistant tumors such as malignant melanoma.  However, the key cytotoxic agent of PDT, -singlet oxygen (1O2) - represents a high risk of photodynamic-assocd. side effects e.g. skin photosensitization.  Recently, controllable photosensitization, where 1O2 is produced on demand, has received increasing attention.  In our study, this could be achieved via loading the photosensitizer (PS) in nanoparticles (NPs) decorated with target-specific moieties characterized by 1O2 quenching abilities to specifically locate the PS in the targeted cells and assure that 1O2 is only produced where desired after cellular processing.  Polymeric and hybrid lipid-polymer NPs were formulated and assayed for their physicochem. properties.  This was followed by conjugation with an active targeting ligand, cRGDyk, cyclic (Arginine-Glycine-Aspartic acid-D-Tyrosine-Lysine) peptide.  Finally, photodynamic potential of the selected formulations was assayed by quantification of 1O2 prodn. and in vitro cytotoxicity.  Three formulations were selected and nominated to be formulations of choice (FOCs); FOC-1 (200 nm, polymeric), FOC-2 (130 nm, polymeric) and FOC-3 (200 nm, hybrid).  Physicochem. properties, most importantly particle size and NPs' compn. have shown to be the major determinants in targeted NPs' 1O2 prodn. and PDT-mediated cytotoxicity of melanoma.  Proper selection of formulations intended for PDT application and target-specific ligands could achieve dual targeting; enhanced accumulation of NPs and protection of 1O2 prodn. elsewhere other than target cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosJHY0KiAwabVg90H21EOLACvtfcHk0lg8nGB_aDOIjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht12qtL7J&md5=e8b949193da756688f1794fa0c395594</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.pdpdt.2018.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pdpdt.2018.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DSebak%26aufirst%3DA.%2BA.%26aulast%3DGomaa%26aufirst%3DI.%2BE.%2BO.%26aulast%3DElMeshad%26aufirst%3DA.%2BN.%26aulast%3DAbdelKader%26aufirst%3DM.%2BH.%26atitle%3DTargeted%2520photodynamic-induced%2520singlet%2520oxygen%2520production%2520by%2520peptide-conjugated%2520biodegradable%2520nanoparticles%2520for%2520treatment%2520of%2520skin%2520melanoma%26jtitle%3DPhotodiagn.%2520Photodyn.%2520Ther.%26date%3D2018%26volume%3D23%26spage%3D181%26epage%3D189%26doi%3D10.1016%2Fj.pdpdt.2018.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lütje, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heskamp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franssen, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frielink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kip, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hekman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fracasso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colombatti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boerman, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotthardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rijpkema, M.</span></span> <span> </span><span class="NLM_article-title">Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2924</span>– <span class="NLM_lpage">2938</span>, <span class="refDoi"> DOI: 10.7150/thno.35274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.7150%2Fthno.35274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31244933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvF2htLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=2924-2938&author=S.+L%C3%BCtjeauthor=S.+Heskampauthor=G.+M.+Franssenauthor=C.+Frielinkauthor=A.+Kipauthor=M.+Hekmanauthor=G.+Fracassoauthor=M.+Colombattiauthor=K.+Herrmannauthor=O.+C.+Boermanauthor=M.+Gotthardtauthor=M.+Rijpkema&title=Development+and+characterization+of+a+theranostic+multimodal+anti-PSMA+targeting+agent+for+imaging%2C+surgical+guidance%2C+and+targeted+photodynamic+therapy+of+PSMA-expressing+tumors&doi=10.7150%2Fthno.35274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors</span></div><div class="casAuthors">Luetje, Susanne; Heskamp, Sandra; Franssen, Gerben M.; Frielink, Cathelijne; Kip, Annemarie; Hekman, Marlene; Fracasso, Giulio; Colombatti, Marco; Herrmann, Ken; Boerman, Otto C.; Gotthardt, Martin; Rijpkema, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2924-2938</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Rationale: Prostate cancer (PCa) recurrences after surgery frequently occur.  To improve the outcome after surgical resection of the tumor, the theranostic multimodal anti-PSMA targeting agent 111In-DTPA-D2B-IRDye700DX was developed and characterized for both pre- and intra-operative tumor localization and eradication of (residual) tumor tissue by PSMA-targeted photodynamic therapy (tPDT), which is a highly selective cancer treatment based on targeting mols. conjugated to photosensitizers that can induce cell destruction upon exposure to near-IR (NIR) light.  Methods: The anti-PSMA monoclonal antibody D2B was conjugated with IRDye700DX and DTPA and subsequently radiolabeled with 111In.  To det. the optimal dose and time point for tPDT, BALB/c nude mice with PSMA-expressing (PSMA+) s.c.  LS174T-PSMA xenografts received the conjugate (24-240 μg/mouse) i.v. (8 MBq/mouse) followed by μSPECT/CT, near-IR fluorescence imaging, and ex vivo biodistribution at 24, 48, 72 and 168 h p.i.  Tumor growth of LS174T-PSMA xenografts and overall survival of mice treated with 1-3 times of NIR light irradn. (50, 100, 150 J/cm2) 24 h after injection of 80 μg of DTPA-D2B-IRDye700DX was compared to control conditions.  Results: Highest specific tumor uptake was obsd. at conjugate doses of 80 μg/mouse.  Biodistribution revealed no significant difference in tumor uptake in mice at 24, 48, 72 and 168 h p.i.  PSMA+ tumors were clearly visualized with both μSPECT/CT and NIR fluorescence imaging.  Overall survival in mice treated with 80 μg of DTPA-D2B-IRDye700DX and 1 x 150 J/cm2 of NIR light at 24 h p.i. was significantly improved compared to the control group receiving neither conjugate nor NIR light (73 days vs. 16 days, resp., p = 0.0453).  Treatment with 3 x 150 J/cm2 resulted in significantly prolonged survival compared to treatment with 3 x 100 J/cm2 (p = 0.0067) and 3 x 50 J/cm2 (p = 0.0338).  Principal conclusions:111In-DTPA-D2B-IRDye700DX can be used for pre- and intra-operative detection of PSMA+ tumors with radionuclide and NIR fluorescence imaging and PSMA-targeted PDT.  PSMA-tPDT using this multimodal agent resulted in significant prolongation of survival and shows great potential for treatment of (metastasized) prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1anzkaLMV1bVg90H21EOLACvtfcHk0lg8nGB_aDOIjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvF2htLnK&md5=a32cea3516fe6c1e6b8ebf7ae932d114</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.7150%2Fthno.35274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.35274%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25BCtje%26aufirst%3DS.%26aulast%3DHeskamp%26aufirst%3DS.%26aulast%3DFranssen%26aufirst%3DG.%2BM.%26aulast%3DFrielink%26aufirst%3DC.%26aulast%3DKip%26aufirst%3DA.%26aulast%3DHekman%26aufirst%3DM.%26aulast%3DFracasso%26aufirst%3DG.%26aulast%3DColombatti%26aufirst%3DM.%26aulast%3DHerrmann%26aufirst%3DK.%26aulast%3DBoerman%26aufirst%3DO.%2BC.%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3DRijpkema%26aufirst%3DM.%26atitle%3DDevelopment%2520and%2520characterization%2520of%2520a%2520theranostic%2520multimodal%2520anti-PSMA%2520targeting%2520agent%2520for%2520imaging%252C%2520surgical%2520guidance%252C%2520and%2520targeted%2520photodynamic%2520therapy%2520of%2520PSMA-expressing%2520tumors%26jtitle%3DTheranostics%26date%3D2019%26volume%3D9%26spage%3D2924%26epage%3D2938%26doi%3D10.7150%2Fthno.35274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, S. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarmento, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, P. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomé, J. P. C.</span></span> <span> </span><span class="NLM_article-title">Photoimmunoconjugates: novel synthetic strategies to target and treat cancer by photodynamic therapy</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2579</span>– <span class="NLM_lpage">2593</span>, <span class="refDoi"> DOI: 10.1039/C8OB02902D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2FC8OB02902D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=30648722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvV2nuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=2579-2593&author=S.+R.+G.+Fernandesauthor=R.+Fernandesauthor=B.+Sarmentoauthor=P.+M.+R.+Pereiraauthor=J.+P.+C.+Tom%C3%A9&title=Photoimmunoconjugates%3A+novel+synthetic+strategies+to+target+and+treat+cancer+by+photodynamic+therapy&doi=10.1039%2FC8OB02902D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Photoimmunoconjugates: novel synthetic strategies to target and treat cancer by photodynamic therapy</span></div><div class="casAuthors">Fernandes, Sara R. G.; Fernandes, Rosa; Sarmento, Bruno; Pereira, Patricia M. R.; Tome, Joao P. C.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2579-2593</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) combines a photosensitizer (PS) with the phys. energy of non-ionizing light to trigger cell death pathways.  PDT has potential as a therapeutic modality to be used in alternative or in combination with other conventional cancer treatment protocols (e.g. surgery, chemotherapy and radiotherapy).  Still, due to the lack of specificity of the current PSs to target the tumor cells, several studies have exploited their conjugation with targeting moieties.  PSs conjugated with antibodies (Abs) or their fragments, able to bind antigens overexpressed in the tumors, have demonstrated potential in PDT of tumors.  This review provides an overview of the most recent advances on photoimmunoconjugates (PICs) for cancer PDT, which involve the first and second-generation PSs conjugated to Abs.  This is an update of our previous review "Antibodies armed with photosensitizers: from chem. synthesis to photobiol. applications", published in 2015 in Org. Biomol. Chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPGEH7r1jTC7Vg90H21EOLACvtfcHk0ljnyHHjwx-mSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvV2nuw%253D%253D&md5=7f9d9256b2b2571966801691e3726aa4</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1039%2FC8OB02902D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8OB02902D%26sid%3Dliteratum%253Aachs%26aulast%3DFernandes%26aufirst%3DS.%2BR.%2BG.%26aulast%3DFernandes%26aufirst%3DR.%26aulast%3DSarmento%26aufirst%3DB.%26aulast%3DPereira%26aufirst%3DP.%2BM.%2BR.%26aulast%3DTom%25C3%25A9%26aufirst%3DJ.%2BP.%2BC.%26atitle%3DPhotoimmunoconjugates%253A%2520novel%2520synthetic%2520strategies%2520to%2520target%2520and%2520treat%2520cancer%2520by%2520photodynamic%2520therapy%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2019%26volume%3D17%26spage%3D2579%26epage%3D2593%26doi%3D10.1039%2FC8OB02902D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Enhancing anti-PD-1/PD-L1 immune checkpoint inhibitory cancer therapy by CD276-targeted photodynamic ablation of tumor cells and tumor vasculature</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.8b00997</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.8b00997" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1aru7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=339-348&author=R.+Baoauthor=Y.+Wangauthor=J.+Laiauthor=H.+Zhuauthor=Y.+Zhaoauthor=S.+Liauthor=N.+Liauthor=J.+Huangauthor=Z.+Yangauthor=F.+Wangauthor=Z.+Liu&title=Enhancing+anti-PD-1%2FPD-L1+immune+checkpoint+inhibitory+cancer+therapy+by+CD276-targeted+photodynamic+ablation+of+tumor+cells+and+tumor+vasculature&doi=10.1021%2Facs.molpharmaceut.8b00997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancing Anti-PD-1/PD-L1 Immune Checkpoint Inhibitory Cancer Therapy by CD276-Targeted Photodynamic Ablation of Tumor Cells and Tumor Vasculature</span></div><div class="casAuthors">Bao, Rui; Wang, Yanpu; Lai, Jianhao; Zhu, Hua; Zhao, Yang; Li, Suping; Li, Nan; Huang, Jing; Yang, Zhi; Wang, Fan; Liu, Zhaofei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">339-348</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antiangiogenic therapies have been demonstrated to improve the efficacy of immune checkpoint inhibition by overcoming the immunosuppressive status of the tumor microenvironment.  However, most of the current antiangiogenic agents cannot discriminate tumor angiogenesis from physiol. angiogenesis.  The aim of this study was to investigate whether a photodynamic therapy (PDT) agent that targets CD276, a receptor overexpressed in various tumor cells and tumor vasculature but with limited expression in normal tissue vasculature, could improve the tumor inhibitory efficacy of a PD-1/PD-L1 blockade.  A CD276-targeting agent (IRD-αCD276/Fab) was synthesized by conjugating the Fab fragment of an anti-CD276 antibody with a photosensitizer IRDye700.  The in vivo tumor-targeting efficacy and therapeutic effects of IRD-αCD276/Fab with or without an anti-PD-1/PD-L1 blockade were tested in s.c. and lung metastatic tumor models.  PDT using IRD-αCD276/Fab significantly suppressed the growth of s.c. 4T1 tumor and inhibited its lung metastasis.  Moreover, it triggered in vivo antitumor immunity by increasing the activation and maturation of dendritic cells.  Tumor PD-L1 levels were also markedly increased after PDT using IRD-αCD276/Fab, as evidenced by noninvasive PD-L1-targeted small-animal PET imaging.  In combination with an anti-PD-1/PD-L1 blockade, IRD-αCD276/Fab PDT markedly suppressed the growth of tumors and prevented their metastasis to the lung by recruiting the tumor infiltration of CD8+ T cells.  Our data provide evidence for the role of CD276-targeted PDT for local immune modulation, and its combination with PD-L1/PD-1 axis inhibition is a promising strategy for eliminating primary tumors as well as disseminated metastases, by generating local and systemic antitumor responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL-WcGbGJzeLVg90H21EOLACvtfcHk0ljnyHHjwx-mSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1aru7%252FP&md5=b1fd4e19b3b92dfde0771382c906bad5</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.8b00997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.8b00997%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DEnhancing%2520anti-PD-1%252FPD-L1%2520immune%2520checkpoint%2520inhibitory%2520cancer%2520therapy%2520by%2520CD276-targeted%2520photodynamic%2520ablation%2520of%2520tumor%2520cells%2520and%2520tumor%2520vasculature%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2019%26volume%3D16%26spage%3D339%26epage%3D348%26doi%3D10.1021%2Facs.molpharmaceut.8b00997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span> <span> </span><span class="NLM_article-title">A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer</span>. <i>Acta Biomater.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">400</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1016/j.actbio.2018.11.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.actbio.2018.11.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=30465921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlensLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2019&pages=400-413&author=W.+Xuauthor=J.+Qianauthor=G.+Houauthor=Y.+Wangauthor=J.+Wangauthor=T.+Sunauthor=L.+Jiauthor=A.+Suoauthor=Y.+Yao&title=A+dual-targeted+hyaluronic+acid-gold+nanorod+platform+with+triple-stimuli+responsiveness+for+photodynamic%2Fphotothermal+therapy+of+breast+cancer&doi=10.1016%2Fj.actbio.2018.11.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer</span></div><div class="casAuthors">Xu, Weijun; Qian, Junmin; Hou, Guanghui; Wang, Yaping; Wang, Jinlei; Sun, Tiantian; Ji, Lijie; Suo, Aili; Yao, Yu</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biomaterialia</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">400-413</span>CODEN:
                <span class="NLM_cas:coden">ABCICB</span>;
        ISSN:<span class="NLM_cas:issn">1742-7061</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Multi-stimuli-responsive theranostic nanoplatform integrating functions of both imaging and multimodal therapeutics holds great promise for improving diagnosis and therapeutic efficacy.  In this study, we reported a pH, glutathione (GSH) and hyaluronidase (HAase) triple-responsive nanoplatform for HER2 and CD44 dual-targeted and fluorescence imaging-guided PDT/PTT dual-therapy against HER2-overexpressed breast cancer.  The nanoplatform was fabricated by functionalizing gold nanorods (GNRs) with hyaluronic acid (HA) bearing pendant hydrazide and thiol groups via Au-S bonds, and subsequently chem. conjugating 5-aminolevulinic acid (ALA), Cy7.5 and anti-HER2 antibody onto HA moiety for PDT, fluorescence imaging and active targeting, resp.  The resulting versatile nanoplatform GNR-HA-ALA/Cy7.5-HER2 had uniform sizes, favorable dispersibility, as well as pH, GSH and HAase triple-responsive drug release manner.  In vitro studies demonstrated that HER2 and CD44 receptor-mediated dual-targeting strategy could significantly enhance the cellular uptake of GNR-HA-ALA/Cy7.5-HER2.  Under near-IR (NIR) irradn., MCF-7 cells could efficiently generate reactive oxygen species (ROS) and heat, and be more efficiently killed by a combination of PDT and PTT as compared with individual therapy.  Pharmacokinetic and biodistribution studies showed that the nanoplatform possessed a circulation half-life of 1.9 h and could be specifically delivered to tumor tissues with an accumulation ratio of 12.8%.  Upon the fluorescence imaging-guided PDT/PTT treatments, the tumors were completely eliminated without obvious side effects.  The results suggest that the GNR-HA-ALA/Cy7.5-HER2 holds great potential for breast cancer therapy.  A combination of photodynamic therapy (PDT) and photothermal therapy (PTT) is emerging as a promising cancer treatment strategy.  However, its therapeutic efficacy is compromised by the nonspecific delivery and unintended release of photo-responsive agents.  Herein, we developed a multifunctional theranostic nanoplatform GNR-HA-ALA/Cy7.5-HER2 with pH, glutathione and hyaluronidase triple-responsive drug release for HER2 and CD44 dual-targeted and fluorescence imaging-guided PDT/PTT therapy against breast cancer.  We demonstrated that HER2 and CD44 receptors-mediated dual-targeting strategy significantly enhanced the cellular uptake of GNR-HA-ALA/Cy7.5-HER2.  We also demonstrated that the combined PDT/PTT treatment had significantly superior antitumor effect than PDT or PTT alone both in vitro and in vivo.  Therefore, GNR-HA-ALA/Cy7.5-HER2 could serve as a promising nanoplatform for HER2-pos. breast cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo79AQM5AedK7Vg90H21EOLACvtfcHk0lgNI84eOQLD2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlensLjJ&md5=5e673e1972962e1e6792f6cd763995b4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.actbio.2018.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.actbio.2018.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DHou%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DSuo%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DY.%26atitle%3DA%2520dual-targeted%2520hyaluronic%2520acid-gold%2520nanorod%2520platform%2520with%2520triple-stimuli%2520responsiveness%2520for%2520photodynamic%252Fphotothermal%2520therapy%2520of%2520breast%2520cancer%26jtitle%3DActa%2520Biomater.%26date%3D2019%26volume%3D83%26spage%3D400%26epage%3D413%26doi%3D10.1016%2Fj.actbio.2018.11.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miley, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ming, X.</span></span> <span> </span><span class="NLM_article-title">P-glycoprotein targeted photodynamic therapy of chemoresistant tumors using recombinant Fab fragment conjugates</span>. <i>Biomater. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">3063</span>– <span class="NLM_lpage">3074</span>, <span class="refDoi"> DOI: 10.1039/C8BM00844B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2FC8BM00844B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=30298866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslejurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=3063-3074&author=C.+Maoauthor=P.+Quauthor=M.+J.+Mileyauthor=Y.+Zhaoauthor=Z.+Liauthor=X.+Ming&title=P-glycoprotein+targeted+photodynamic+therapy+of+chemoresistant+tumors+using+recombinant+Fab+fragment+conjugates&doi=10.1039%2FC8BM00844B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">P-glycoprotein targeted photodynamic therapy of chemoresistant tumors using recombinant Fab fragment conjugates</span></div><div class="casAuthors">Mao, Chengqiong; Qu, Ping; Miley, Michael J.; Zhao, Yan; Li, Zibo; Ming, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3063-3074</span>CODEN:
                <span class="NLM_cas:coden">BSICCH</span>;
        ISSN:<span class="NLM_cas:issn">2047-4849</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">P-glycoprotein (Pgp) has been considered as a major cause of cancer multidrug resistance; however, clin. solns. to overcome this drug resistance do not exist despite the tremendous endeavors.  The lack of cancer specificity is a main reason for clin. failure of conventional approaches.  Targeted photodynamic therapy (PDT) is highly cancer specific by combining antibody targeting and locoregional light irradn.  We aimed to develop Pgp-targeted PDT using antibody-photosensitizer conjugates made of a recombinant Fab fragment.  We prepd. the photosensitizer conjugates by expressing a recombinant Fab fragment and specifically linking IR700-maleimide at the C-terminal of the Fab heavy chain.  In vitro studies showed that the Fab conjugates specifically bind to Pgp.  Their phototoxicity was comparable to full antibody conjugates when assayed with conventional 2-D cell culture, but they outperformed the full antibody conjugates in a 3-D tumor spheroid model.  In a mouse xenograft model of chemoresistant tumors, Fab conjugates showed Pgp specific delivery to chemoresistant tumors.  Upon irradn. with near-IR light, they caused rapid tumor shrinkage and significantly prolonged the survival of tumor-bearing mice.  Compared to the full antibody conjugates, Fab conjugates took a shorter time to reach peak tumor levels and achieved a more homogeneous tumor distribution.  This allows light irradn. to be initiated at a shorter time interval after the conjugate injection, and thus may facilitate clin. translation.  We conclude that our targeted PDT approach provides a highly cancer-specific approach to combat chemoresistant tumors, and that the conjugates made of recombinant antibody fragments are superior to full antibody conjugates for targeted PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrutVSSFUaA7Vg90H21EOLACvtfcHk0lgNI84eOQLD2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslejurzF&md5=b442896e5c25f41c7c3e3dff0d836b95</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1039%2FC8BM00844B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8BM00844B%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DC.%26aulast%3DQu%26aufirst%3DP.%26aulast%3DMiley%26aufirst%3DM.%2BJ.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DMing%26aufirst%3DX.%26atitle%3DP-glycoprotein%2520targeted%2520photodynamic%2520therapy%2520of%2520chemoresistant%2520tumors%2520using%2520recombinant%2520Fab%2520fragment%2520conjugates%26jtitle%3DBiomater.%2520Sci.%26date%3D2018%26volume%3D6%26spage%3D3063%26epage%3D3074%26doi%3D10.1039%2FC8BM00844B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Que, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamburini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldazzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Optical imaging and pH-awakening therapy of deep tissue cancer based on specific upconversion nanophotosensitizers</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>230</i></span>, <span class="NLM_elocation-id">119637</span> <span class="refDoi"> DOI: 10.1016/j.biomaterials.2019.119637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.biomaterials.2019.119637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31776018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1Wrt73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=2020&author=Y.+Fengauthor=H.+Chenauthor=Y.+Wuauthor=I.+Queauthor=F.+Tamburiniauthor=F.+Baldazziauthor=Y.+Changauthor=H.+Zhang&title=Optical+imaging+and+pH-awakening+therapy+of+deep+tissue+cancer+based+on+specific+upconversion+nanophotosensitizers&doi=10.1016%2Fj.biomaterials.2019.119637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Optical imaging and pH-awakening therapy of deep tissue cancer based on specific upconversion nanophotosensitizers</span></div><div class="casAuthors">Feng, Yansong; Chen, Haoran; Wu, Yanni; Que, Ivo; Tamburini, Filippo; Baldazzi, Fabio; Chang, Yulei; Zhang, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">230</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119637</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Side effect is one of the main factors affecting the success of cancer therapies in clinic.  Patients treated with photodynamic therapy (PDT) suffer mainly from the phototoxicity due to the relatively long time blood circulation of the tumor enrichment and they have also to be protected from background light for days after the treatment.  Here we introduce a new design of nanophotosensitizers in which the luminescence upconversion nanoparticles loaded with photosensitizers are self-assembled into a nanoball with the aid of a specific pH-sensitive polymer layer contg. overloaded photosensitizers and quenching mols.  This design makes the therapy function "off/on" possible, i.e. only imaging during the circulation of the nanoballs ascribing to the near-IR (NIR) photon upconversion of the nanoballs and the pH-sensitive shell.  Activation of PDT solely occurs once the nanoballs are taken up by the cancer cells due to the acidic microenvironment.  This design prevents effectively the photodamage of the photosensitizers during enrichment and targeting process of tumor, as validated in vitro and in vivo, which enables imaging-guided PDT treatment of deep-seated tumor in a much more relax and comfortable way for patients.  This patient-friendly nanomaterial construction strategy can also be extended to other therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYtd85be2qo7Vg90H21EOLACvtfcHk0lhyyvls39fkkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1Wrt73J&md5=a7c663cef68a1acb41950de4e8321f19</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2019.119637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2019.119637%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DQue%26aufirst%3DI.%26aulast%3DTamburini%26aufirst%3DF.%26aulast%3DBaldazzi%26aufirst%3DF.%26aulast%3DChang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DOptical%2520imaging%2520and%2520pH-awakening%2520therapy%2520of%2520deep%2520tissue%2520cancer%2520based%2520on%2520specific%2520upconversion%2520nanophotosensitizers%26jtitle%3DBiomaterials%26date%3D2020%26volume%3D230%26doi%3D10.1016%2Fj.biomaterials.2019.119637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B. Z.</span></span> <span> </span><span class="NLM_article-title">Efficient near-infrared photosensitizer with aggregation-induced emission for imaging-guided photodynamic therapy in multiple xenograft tumor models</span>. <i>ACS Nano</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">854</span>– <span class="NLM_lpage">866</span>, <span class="refDoi"> DOI: 10.1021/acsnano.9b07972</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsnano.9b07972" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlOhsbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2020&pages=854-866&author=J.+Daiauthor=Y.+Liauthor=Z.+Longauthor=R.+Jiangauthor=Z.+Zhuangauthor=Z.+Wangauthor=Z.+Zhaoauthor=X.+Louauthor=F.+Xiaauthor=B.+Z.+Tang&title=Efficient+near-infrared+photosensitizer+with+aggregation-induced+emission+for+imaging-guided+photodynamic+therapy+in+multiple+xenograft+tumor+models&doi=10.1021%2Facsnano.9b07972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient Near-Infrared Photosensitizer with Aggregation-Induced Emission for Imaging-Guided Photodynamic Therapy in Multiple Xenograft Tumor Models</span></div><div class="casAuthors">Dai, Jun; Li, Yinghao; Long, Zi; Jiang, Ruming; Zhuang, Zeyan; Wang, Zhiming; Zhao, Zujin; Lou, Xiaoding; Xia, Fan; Tang, Ben Zhong</div><div class="citationInfo"><span class="NLM_cas:title">ACS Nano</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">854-866</span>CODEN:
                <span class="NLM_cas:coden">ANCAC3</span>;
        ISSN:<span class="NLM_cas:issn">1936-0851</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) strategy has been widely used in tumor treatment, and the reagents for reactive oxygen species (ROS) play a crucial role.  Herein, we develop a fluorogen (TTB) contg. an electron-accepting benzo[1,2-b:4,5-b']dithiophene 1,1,5,5-tetraoxide core and electron-donating 4,4'-(2,2-diphenylethene-1,1-diyl)bis(N,N-diphenylaniline) groups for image-guided targeting PDT application.  TTB exhibits a prominent aggregation-induced emission (AIE) property with strong near-IR (NIR) fluorescence in aggregates and is capable of efficiently generating ROS of O2•- and 1O2 under white light irradn.  The nanoparticles (RGD-4R-MPD/TTB NPs) with NIR emission (∼730 nm), high photostability, and low dark cytotoxicity are fabricated by encapsulating TTB within polymeric matrix and then modified with RGD-4R peptide.  They show excellent performance in targeting PDT treatment of PC3, HeLa, and SKOV-3 cancer cells in vitro.  The investigations on pharmacokinetics, biodistribution, and long-term tracing in vivo reveal that RGD-4R-MPD/TTB NPs can selectively accumulate in tumors for real-time, long-term image-guided PDT treatment.  The RGD-4R-MPD/TTB NPs-mediated PDT in multiple xenograft tumor models disclose that the growth of cervical, prostate, and ovarian cancers in mice can be effectively inhibited.  These results demonstrate that the reagents employing NIR fluorogen TTB as a photosensitizer could be promising candidates for in vivo image-guided PDT treatments of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNJFR6wF7lPrVg90H21EOLACvtfcHk0lhyyvls39fkkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlOhsbzN&md5=df9d7e88f8c68b8c9315130900262314</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facsnano.9b07972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsnano.9b07972%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLong%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DR.%26aulast%3DZhuang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DLou%26aufirst%3DX.%26aulast%3DXia%26aufirst%3DF.%26aulast%3DTang%26aufirst%3DB.%2BZ.%26atitle%3DEfficient%2520near-infrared%2520photosensitizer%2520with%2520aggregation-induced%2520emission%2520for%2520imaging-guided%2520photodynamic%2520therapy%2520in%2520multiple%2520xenograft%2520tumor%2520models%26jtitle%3DACS%2520Nano%26date%3D2020%26volume%3D14%26spage%3D854%26epage%3D866%26doi%3D10.1021%2Facsnano.9b07972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haimov-Talmoud, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motiei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovtzer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lellouche, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shefi, O.</span></span> <span> </span><span class="NLM_article-title">Magnetic targeting of mTHPC to improve the selectivity and efficiency of photodynamic therapy</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">45368</span>– <span class="NLM_lpage">45380</span>, <span class="refDoi"> DOI: 10.1021/acsami.9b14060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.9b14060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1WktL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=45368-45380&author=E.+Haimov-Talmoudauthor=Y.+Harelauthor=H.+Schoriauthor=M.+Motieiauthor=A.+Atkinsauthor=R.+Popovtzerauthor=J.-P.+Lelloucheauthor=O.+Shefi&title=Magnetic+targeting+of+mTHPC+to+improve+the+selectivity+and+efficiency+of+photodynamic+therapy&doi=10.1021%2Facsami.9b14060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Magnetic Targeting of mTHPC To Improve the Selectivity and Efficiency of Photodynamic Therapy</span></div><div class="casAuthors">Haimov-Talmoud, Elina; Harel, Yifat; Schori, Hadas; Motiei, Menachem; Atkins, Ayelet; Popovtzer, Rachela; Lellouche, Jean-Paul; Shefi, Orit</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">45368-45380</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is a promising recognized treatment for cancer.  To date, PDT drugs are injected systemically, and the tumor area is irradiated to induce cell death.  Current clin. protocols have several drawbacks, including limited accessibility to solid tumors and insufficient selectivity of drugs.  Herein, we propose an alternative approach to improve PDT effectiveness by magnetic targeting of responsive carriers conjugated to the PDT drug.  We coordinatively attached a meso-tetrahydroxyphenylchlorin (mTHPC) photosensitizer to Ce-doped-γ-Fe2O3 maghemite nanoparticles (MNPs).  These MNPs are superparamagnetic and biocompatible, and the resulting mTHPC-MNPs nanocomposites are stable in aq. suspensions.  MDA-MB231 (human breast cancer) cells incubated with the mTHPC-MNPs showed high uptake and high death rates in cell population after PDT.  The exposure to external magnetic forces during the incubation period directed the nanocomposites to selected sites enhancing drug accumulation that was double that of cells with no magnetic exposure.  Next, breast cancer tumors were induced s.c. in mice and treated magnetically.  In vivo results showed accelerated drug accumulation in tumors of mice injected with mTHPC-MNP nanocomposites, compared to the free drug.  PDT irradn. led to a decrease in tumor size of both groups, whereas treatment with the focused magnetic nanocomposites led to significant tumor regression.  Our results demonstrate a method to improve the current PDT treatments by applying magnetic forces to effectively direct the drug to cancerous tissue.  This approach leads to a highly localized and effective PDT process, opening new directions for clin. PDT protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ2n0x6AyYQ7Vg90H21EOLACvtfcHk0lg4rsGK8lngLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1WktL3P&md5=18f5839fc0f43f88918fa1c223ee961b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Facsami.9b14060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.9b14060%26sid%3Dliteratum%253Aachs%26aulast%3DHaimov-Talmoud%26aufirst%3DE.%26aulast%3DHarel%26aufirst%3DY.%26aulast%3DSchori%26aufirst%3DH.%26aulast%3DMotiei%26aufirst%3DM.%26aulast%3DAtkins%26aufirst%3DA.%26aulast%3DPopovtzer%26aufirst%3DR.%26aulast%3DLellouche%26aufirst%3DJ.-P.%26aulast%3DShefi%26aufirst%3DO.%26atitle%3DMagnetic%2520targeting%2520of%2520mTHPC%2520to%2520improve%2520the%2520selectivity%2520and%2520efficiency%2520of%2520photodynamic%2520therapy%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2019%26volume%3D11%26spage%3D45368%26epage%3D45380%26doi%3D10.1021%2Facsami.9b14060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">GSH-activatable NIR nanoplatform with mitochondria targeting for enhancing tumor-specific therapy</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">44961</span>– <span class="NLM_lpage">44969</span>, <span class="refDoi"> DOI: 10.1021/acsami.9b15996</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.9b15996" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFSqtb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=44961-44969&author=G.+Yangauthor=C.+Chenauthor=Y.+Zhuauthor=Z.+Liuauthor=Y.+Xueauthor=S.+Zhongauthor=C.+Wangauthor=Y.+Gaoauthor=W.+Zhang&title=GSH-activatable+NIR+nanoplatform+with+mitochondria+targeting+for+enhancing+tumor-specific+therapy&doi=10.1021%2Facsami.9b15996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">GSH-Activatable NIR Nanoplatform with Mitochondria Targeting for Enhancing Tumor-Specific Therapy</span></div><div class="casAuthors">Yang, Guoliang; Chen, Chao; Zhu, Yucheng; Liu, Zhiyong; Xue, Yudong; Zhong, Sheng; Wang, Chaochao; Gao, Yun; Zhang, Weian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">44961-44969</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Developing smart photosensitizers that are sensitive to tumor-specific signals for minimal side effects and enhanced antitumor efficacy is a tremendous challenge for tumor phototherapies.  Herein, we construct a nanoplatform with glutathione (GSH)-activatable and mitochondria-targeted pro-photosensitizer encapsulated by ultrasensitive pH-responsive polymer for achieving imaging-guided tumor-specific photodynamic therapy (PDT).  The GSH-activatable pro-photosensitizer, di-cyanine (DCy7), has been synthesized where two cyanine moieties are covalently conjugated by a disulfide bond, and the hydrophobic DCy7 is further encapsulated with an amphiphilic pH-responsive diblock copolymer POEGMA-b-PDPA to form <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="97c7d7d3d4eea0">[email protected]</a> nanoparticles.  Upon endocytosis by cancer cells, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="24746460675d13">[email protected]</a> nanoparticles dissoc. at endosome first and then DCy7 is released to cytoplasm and subsequently activated by the high concn. of GSH, finally targets mitochondria for organelle-targeted PDT.  Moreover, intracellular antioxidant GSH is consumed during the activation procedure that is beneficial to efficient PDT.  These <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="7e2e3e3a3d0749">[email protected]</a> nanoparticles display selective phototoxicity against tumor cells (HepG2 or 4T1 cells) over normal cells (BEAS-2B cells) in vitro, and their GSH-activatable enhanced PDT efficacy is further confirmed in tumor-bearing mice.  Thus, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="15455551566c22">[email protected]</a> nanoparticles allow for accurate and highly efficient PDT with minimal side effects, providing an attractive nanoplatform for organelle-targeted precise PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxtOmP32EZl7Vg90H21EOLACvtfcHk0lg4rsGK8lngLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFSqtb7I&md5=48761279d0600456c7efad8b2657553d</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facsami.9b15996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.9b15996%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DGSH-activatable%2520NIR%2520nanoplatform%2520with%2520mitochondria%2520targeting%2520for%2520enhancing%2520tumor-specific%2520therapy%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2019%26volume%3D11%26spage%3D44961%26epage%3D44969%26doi%3D10.1021%2Facsami.9b15996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">Aptamer/photosensitizer hybridized mesoporous MnO<sub>2</sub> based tumor cell activated ROS regulator for precise photodynamic therapy of breast cancer</span>. <i>Colloid Surf., B</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>184</i></span>, <span class="NLM_elocation-id">110536</span> <span class="refDoi"> DOI: 10.1016/j.colsurfb.2019.110536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.colsurfb.2019.110536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31639567" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2019&author=W.+Liuauthor=K.+Zhangauthor=L.+Zhuangauthor=J.+Liuauthor=W.+Zengauthor=J.+Shiauthor=Z.+Zhang&title=Aptamer%2Fphotosensitizer+hybridized+mesoporous+MnO2+based+tumor+cell+activated+ROS+regulator+for+precise+photodynamic+therapy+of+breast+cancer&doi=10.1016%2Fj.colsurfb.2019.110536"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.colsurfb.2019.110536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.colsurfb.2019.110536%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DZhuang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DW.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DAptamer%252Fphotosensitizer%2520hybridized%2520mesoporous%2520MnO2%2520based%2520tumor%2520cell%2520activated%2520ROS%2520regulator%2520for%2520precise%2520photodynamic%2520therapy%2520of%2520breast%2520cancer%26jtitle%3DColloid%2520Surf.%252C%2520B%26date%3D2019%26volume%3D184%26doi%3D10.1016%2Fj.colsurfb.2019.110536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span> <span> </span><span class="NLM_article-title">Biomacromolecules as carriers in drug delivery and tissue engineering</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2017.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.apsb.2017.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=29872621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BC1MbktlClsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=34-50&author=Y.+Zhangauthor=T.+Sunauthor=C.+Jiang&title=Biomacromolecules+as+carriers+in+drug+delivery+and+tissue+engineering&doi=10.1016%2Fj.apsb.2017.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Biomacromolecules as carriers in drug delivery and tissue engineering</span></div><div class="casAuthors">Zhang Yujie; Sun Tao; Jiang Chen</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-50</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Natural biomacromolecules have attracted increased attention as carriers in biomedicine in recent years because of their inherent biochemical and biophysical properties including renewability, nontoxicity, biocompatibility, biodegradability, long blood circulation time and targeting ability.  Recent advances in our understanding of the biological functions of natural-origin biomacromolecules and the progress in the study of biological drug carriers indicate that such carriers may have advantages over synthetic material-based carriers in terms of half-life, stability, safety and ease of manufacture.  In this review, we give a brief introduction to the biochemical properties of the widely used biomacromolecule-based carriers such as albumin, lipoproteins and polysaccharides.  Then examples from the clinic and in recent laboratory development are summarized.  Finally the current challenges and future prospects of present biological carriers are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5YHmp9KDVO4xhnOQkIHOxfW6udTcc2eaVqeaAwXfasLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbktlClsQ%253D%253D&md5=aacf867bb2d4726a75d4f0dc321f8d66</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2017.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2017.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DC.%26atitle%3DBiomacromolecules%2520as%2520carriers%2520in%2520drug%2520delivery%2520and%2520tissue%2520engineering%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2018%26volume%3D8%26spage%3D34%26epage%3D50%26doi%3D10.1016%2Fj.apsb.2017.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.-w.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span> <span> </span><span class="NLM_article-title">In vitro toxicity of silica nanoparticles in human lung cancer cells</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>217</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">259</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2006.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.taap.2006.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=17112558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12rsbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=2006&pages=252-259&author=W.+Linauthor=Y.-w.+Huangauthor=X.-D.+Zhouauthor=Y.+Ma&title=In+vitro+toxicity+of+silica+nanoparticles+in+human+lung+cancer+cells&doi=10.1016%2Fj.taap.2006.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro toxicity of silica nanoparticles in human lung cancer cells</span></div><div class="casAuthors">Lin, Weisheng; Huang, Yue-wern; Zhou, Xiao-Dong; Ma, Yinfa</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">252-259</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The cytotoxicity of 15-nm and 46-nm silica nanoparticles was investigated by using cryst. silica (Min-U-Sil 5) as a pos. control in cultured human bronchoalveolar carcinoma-derived cells.  Exposure to 15-nm or 46-nm SiO2 nanoparticles for 48 h at dosage levels between 10 and 100 μg/mL decreased cell viability in a dose-dependent manner.  Both SiO2 nanoparticles were more cytotoxic than Min-U-Sil 5; however, the cytotoxicities of 15-nm and 46-nm silica nanoparticles were not significantly different.  The 15-nm SiO2 nanoparticles were used to det. time-dependent cytotoxicity and oxidative stress responses.  Cell viability decreased significantly as a function of both nanoparticle dosage (10-100 μg/mL) and exposure time (24, 48, and 72 h).  Indicators of oxidative stress and cytotoxicity, including total reactive oxygen species (ROS), glutathione, malondialdehyde, and lactate dehydrogenase, were quant. assessed.  Exposure to SiO2 nanoparticles increased ROS levels and reduced glutathione levels.  The increased prodn. of malondialdehyde and lactate dehydrogenase release from the cells indicated lipid peroxidn. and membrane damage.  In summary, exposure to SiO2 nanoparticles results in a dose-dependent cytotoxicity in cultural human bronchoalveolar carcinoma-derived cells that is closely correlated to increased oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYsyZyzK_-RLVg90H21EOLACvtfcHk0lhHJOrX_w4YEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12rsbvN&md5=28bcac4cbb4e09b10be0ec0691560476</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2006.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2006.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DY.-w.%26aulast%3DZhou%26aufirst%3DX.-D.%26aulast%3DMa%26aufirst%3DY.%26atitle%3DIn%2520vitro%2520toxicity%2520of%2520silica%2520nanoparticles%2520in%2520human%2520lung%2520cancer%2520cells%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2006%26volume%3D217%26spage%3D252%26epage%3D259%26doi%3D10.1016%2Fj.taap.2006.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soenen, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera-Gil, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montenegro, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parak, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Smedt, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braeckmans, K.</span></span> <span> </span><span class="NLM_article-title">Cellular toxicity of inorganic nanoparticles: common aspects and guidelines for improved nanotoxicity evaluation</span>. <i>Nano Today</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1016/j.nantod.2011.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.nantod.2011.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOisbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=446-465&author=S.+J.+Soenenauthor=P.+Rivera-Gilauthor=J.-M.+Montenegroauthor=W.+J.+Parakauthor=S.+C.+De+Smedtauthor=K.+Braeckmans&title=Cellular+toxicity+of+inorganic+nanoparticles%3A+common+aspects+and+guidelines+for+improved+nanotoxicity+evaluation&doi=10.1016%2Fj.nantod.2011.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular toxicity of inorganic nanoparticles: common aspects and guidelines for improved nanotoxicity evaluation</span></div><div class="casAuthors">Soenen, Stefaan J.; Rivera-Gil, Pilar; Montenegro, Jose-Maria; Parak, Wolfgang J.; De Smedt, Stefaan C.; Braeckmans, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Nano Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">446-465</span>CODEN:
                <span class="NLM_cas:coden">NTAOCG</span>;
        ISSN:<span class="NLM_cas:issn">1748-0132</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The safe use of inorg. nanoparticles (NPs) in biomedical applications remains an unresolved issue.  The present review presents an overview of the cytotoxic effects of commonly used inorg. NPs: quantum dots, gold and iron oxide nanoparticles.  The main focus is on presenting recent findings and identifying similar cytotoxic effects which appear common to all these NPs.  Next, several considerations are provided for optimizing cell-NP interaction studies which could aid in improving our understanding of NP toxicity.  Finally, several crit. NP parameters are discussed and suggestions are made on how to optimize NP design in view of minimal cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAYPbKrRPDUbVg90H21EOLACvtfcHk0lgN0eS2jYx8Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOisbbN&md5=2eebb978fd2ccd8b5e30df28ffc75222</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.nantod.2011.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nantod.2011.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DSoenen%26aufirst%3DS.%2BJ.%26aulast%3DRivera-Gil%26aufirst%3DP.%26aulast%3DMontenegro%26aufirst%3DJ.-M.%26aulast%3DParak%26aufirst%3DW.%2BJ.%26aulast%3DDe%2BSmedt%26aufirst%3DS.%2BC.%26aulast%3DBraeckmans%26aufirst%3DK.%26atitle%3DCellular%2520toxicity%2520of%2520inorganic%2520nanoparticles%253A%2520common%2520aspects%2520and%2520guidelines%2520for%2520improved%2520nanotoxicity%2520evaluation%26jtitle%3DNano%2520Today%26date%3D2011%26volume%3D6%26spage%3D446%26epage%3D465%26doi%3D10.1016%2Fj.nantod.2011.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fadeel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Bennett, A. E.</span></span> <span> </span><span class="NLM_article-title">Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2009.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.addr.2009.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=19900497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1OntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=362-374&author=B.+Fadeelauthor=A.+E.+Garcia-Bennett&title=Better+safe+than+sorry%3A+understanding+the+toxicological+properties+of+inorganic+nanoparticles+manufactured+for+biomedical+applications&doi=10.1016%2Fj.addr.2009.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications</span></div><div class="casAuthors">Fadeel, Bengt; Garcia-Bennett, Alfonso E.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">362-374</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The development of nanoparticles for biomedical applications including medical imaging and drug delivery is currently undergoing a dramatic expansion.  However, as the range of nanoparticle types and applications increases, it is also clear that the potential toxicities of these novel materials and the properties driving such toxic responses must also be understood.  Indeed, a detailed assessment of the factors that influence the biocompatibility and/or toxicity of nanoparticles is crucial for the safe and sustainable development of the emerging nanotechnologies.  This review summarizes some of the recent developments in the field of nanomedicine with particular emphasis on inorg. nanoparticles for drug delivery.  The synthesis routes, physico-chem. characteristics, and cytotoxic properties of inorg. nanoparticles are thus explored and lessons learned from the toxicol. investigation of three common types of engineered nanomaterials of titania, gold, and mesoporous silica are discussed.  Emphasis is placed on the recognition vs. non-recognition of engineered nanomaterials by the immune system, the primary surveillance system against microorganisms and particles, which, in turn, is intimately linked to the issue of targeted drug delivery using such nanomaterials as carrier systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQmvmGp18nj7Vg90H21EOLACvtfcHk0lgN0eS2jYx8Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1OntL8%253D&md5=ed1227e5710ee4f3301ced737f5c2505</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2009.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2009.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DFadeel%26aufirst%3DB.%26aulast%3DGarcia-Bennett%26aufirst%3DA.%2BE.%26atitle%3DBetter%2520safe%2520than%2520sorry%253A%2520understanding%2520the%2520toxicological%2520properties%2520of%2520inorganic%2520nanoparticles%2520manufactured%2520for%2520biomedical%2520applications%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D362%26epage%3D374%26doi%3D10.1016%2Fj.addr.2009.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elsaesser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, C. V.</span></span> <span> </span><span class="NLM_article-title">Toxicology of nanoparticles</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2011.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.addr.2011.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=21925220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1Glsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=129-137&author=A.+Elsaesserauthor=C.+V.+Howard&title=Toxicology+of+nanoparticles&doi=10.1016%2Fj.addr.2011.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicology of nanoparticles</span></div><div class="casAuthors">Elsaesser, Andreas; Howard, C. Vyvyan</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-137</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  While nanotechnol. and the prodn. of nanoparticles are growing exponentially, research into the toxicol. impact and possible hazard of nanoparticles to human health and the environment is still in its infancy.  This review aims to give a comprehensive summary of what is known today about nanoparticle toxicol., the mechanisms at the cellular level, entry routes into the body and possible impacts to public health.  Proper characterization of the nanomaterial, as well as understanding processes happening on the nanoparticle surface when in contact with living systems, is crucial to understand possible toxicol. effects.  Dose as a key parameter is essential in hazard identification and risk assessment of nanotechnologies.  Understanding nanoparticle pathways and entry routes into the body requires further research in order to inform policy makers and regulatory bodies about the nanotoxicol. potential of certain nanomaterials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDvHJNaMb_n7Vg90H21EOLACvtfcHk0lgN0eS2jYx8Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1Glsrg%253D&md5=452bec5f06d7fe912a8490a58325e69e</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2011.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2011.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DElsaesser%26aufirst%3DA.%26aulast%3DHoward%26aufirst%3DC.%2BV.%26atitle%3DToxicology%2520of%2520nanoparticles%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2012%26volume%3D64%26spage%3D129%26epage%3D137%26doi%3D10.1016%2Fj.addr.2011.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Degradable molybdenum oxide nanosheets with rapid clearance and efficient tumor homing capabilities as a therapeutic nanoplatform</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2122</span>– <span class="NLM_lpage">2126</span>, <span class="refDoi"> DOI: 10.1002/anie.201510597</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1002%2Fanie.201510597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVyqurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=2122-2126&author=G.+Songauthor=J.+Haoauthor=C.+Liangauthor=T.+Liuauthor=M.+Gaoauthor=L.+Chengauthor=J.+Huauthor=Z.+Liu&title=Degradable+molybdenum+oxide+nanosheets+with+rapid+clearance+and+efficient+tumor+homing+capabilities+as+a+therapeutic+nanoplatform&doi=10.1002%2Fanie.201510597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Degradable Molybdenum Oxide Nanosheets with Rapid Clearance and Efficient Tumor Homing Capabilities as a Therapeutic Nanoplatform</span></div><div class="casAuthors">Song, Guosheng; Hao, Jiali; Liang, Chao; Liu, Teng; Gao, Min; Cheng, Liang; Hu, Junqing; Liu, Zhuang</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2122-2126</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Molybdenum oxide (MoOx) nanosheets with high near-IR (NIR) absorbance and pH-dependent oxidative degrdn. properties were synthesized, functionalized with polyethylene glycol (PEG), and then used as a degradable photothermal agent and drug carrier.  The nanosheets, which are relatively stable under acidic pH, could be degraded at physiol. pH.  Therefore, MoOx-PEG distributed in organs upon i.v. injection would be rapidly degraded and excreted without apparent in vivo toxicity.  MoOx-PEG shows efficient accumulation in tumors, the acidic pH of which then leads to longer tumor retention of those nanosheets.  Along with the capability of acting as a photothermal agent for effective tumor ablation, MoOx-PEG can load therapeutic mols. with high efficiencies.  This concept of inorg. theranostic nanoagent should be relatively stable in tumors to allow imaging and treatment, while being readily degradable in normal organs to enable rapid excretion and avoid long-term retention/toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI4GC4aFoDgrVg90H21EOLACvtfcHk0ljMD9xw8fYKvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVyqurfJ&md5=498a6cb3cf94f3a09538e68c46909a95</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fanie.201510597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201510597%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DG.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DDegradable%2520molybdenum%2520oxide%2520nanosheets%2520with%2520rapid%2520clearance%2520and%2520efficient%2520tumor%2520homing%2520capabilities%2520as%2520a%2520therapeutic%2520nanoplatform%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D2122%26epage%3D2126%26doi%3D10.1002%2Fanie.201510597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utsunomiya, A.</span></span> <span> </span><span class="NLM_article-title">Sensitive photodynamic detection of adult T-cell leukemia/lymphoma and specific leukemic cell death induced by photodynamic therapy: current status in hematopoietic malignancies</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">335</span>, <span class="refDoi"> DOI: 10.3390/cancers12020335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.3390%2Fcancers12020335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1KlsrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=335&author=T.+Okaauthor=K.+I.+Matsuokaauthor=A.+Utsunomiya&title=Sensitive+photodynamic+detection+of+adult+T-cell+leukemia%2Flymphoma+and+specific+leukemic+cell+death+induced+by+photodynamic+therapy%3A+current+status+in+hematopoietic+malignancies&doi=10.3390%2Fcancers12020335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitive photodynamic detection of adult T-cell leukemia/lymphoma and specific leukemic cell death induced by photodynamic therapy: current status in hematopoietic malignancies</span></div><div class="casAuthors">Oka, Takashi; Matsuoka, Ken-ichi; Utsunomiya, Atae</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">335</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Adult T-cell leukemia/lymphoma (ATL), an aggressive type of T-cell malignancy, is caused by the human T-cell leukemia virus type I (HTLV-1) infections.  The outcomes, following therapeutic interventions for ATL, have not been satisfactory.  Photodynamic therapy (PDT) exerts selective cytotoxic activity against malignant cells, as it is considered a minimally invasive therapeutic procedure.  In PDT, photosensitizing agent administration is followed by irradn. at an absorbance wavelength of the sensitizer in the presence of oxygen, with ultimate direct tumor cell death, microvasculature injury, and induced local inflammatory reaction.  This review provides an overview of the present status and state-of-the-art ATL treatments.  It also focuses on the photodynamic detection (PDD) of hematopoietic malignancies and the recent progress of 5-Aminolevulinic acid (ALA)-PDT/PDD, which can efficiently induce ATL leukemic cell-specific death with minor influence on normal lymphocytes.  Further consideration of the ALA-PDT/PDD system along with the circulatory system regarding the clin. application in ATL and others will be discussed.  ALA-PDT/PDD can be promising as a novel treatment modality that overcomes unmet medical needs with the optimization of PDT parameters to increase the effectiveness of the tumor-killing activity and enhance the innate and adaptive anti-tumor immune responses by the optimized immunogenic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQZXvTAsjj7rVg90H21EOLACvtfcHk0ljMD9xw8fYKvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1KlsrbE&md5=d1278c2444be8960a7a332a806a61d32</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.3390%2Fcancers12020335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers12020335%26sid%3Dliteratum%253Aachs%26aulast%3DOka%26aufirst%3DT.%26aulast%3DMatsuoka%26aufirst%3DK.%2BI.%26aulast%3DUtsunomiya%26aufirst%3DA.%26atitle%3DSensitive%2520photodynamic%2520detection%2520of%2520adult%2520T-cell%2520leukemia%252Flymphoma%2520and%2520specific%2520leukemic%2520cell%2520death%2520induced%2520by%2520photodynamic%2520therapy%253A%2520current%2520status%2520in%2520hematopoietic%2520malignancies%26jtitle%3DCancers%26date%3D2020%26volume%3D12%26spage%3D335%26doi%3D10.3390%2Fcancers12020335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, T.</span></span> <span> </span><span class="NLM_article-title">Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription</span>. <i>Retrovirology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5</span>, <span class="refDoi"> DOI: 10.1186/s12977-019-0467-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1186%2Fs12977-019-0467-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=30782173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BB3cflt1Kmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=5&author=L.+Xuauthor=X.+Zhangauthor=W.+Chengauthor=Y.+Wangauthor=K.+Yiauthor=Z.+Wangauthor=Y.+Zhangauthor=L.+Shaoauthor=T.+Zhao&title=Hypericin-photodynamic+therapy+inhibits+the+growth+of+adult+T-cell+leukemia+cells+through+induction+of+apoptosis+and+suppression+of+viral+transcription&doi=10.1186%2Fs12977-019-0467-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription</span></div><div class="casAuthors">Xu Lingling; Zhang Xueqing; Cheng Wenzhao; Wang Yong; Yi Kaining; Wang Zhilong; Zhang Yiling; Shao Linxiang; Zhao Tiejun; Cheng Wenzhao</div><div class="citationInfo"><span class="NLM_cas:title">Retrovirology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Adult T-cell leukemia (ATL) is an aggressive neoplasm caused by human T-cell leukemia virus type 1 (HTLV-1).  ATL carries a poor prognosis due to chemotherapy resistance.  Thus, it is urgent to develop new treatment strategies.  Hypericin (HY) is a new-type of photosensitizer in the context of photodynamic therapy (PDT) due to its excellent photosensitizing properties and anti-tumor activities.  RESULTS:  In the present study, we investigated the efficacy of hypericin in ATL cells.  Clinically achievable concentrations of hypericin in association with PDT induced the inhibition of cell proliferation in ATL cell lines with minimal effect on peripheral blood CD4(+) T lymphocytes.  Moreover, hypericin-PDT treatment caused apoptosis and G2/M phase cell cycle arrest in leukemic cells.  Western blot analyses revealed that hypericin-PDT treatment resulted in downregulation of Bcl-2 and enhanced the expression of Bad, cytochrome C, and AIF.  Cleavage of caspases-3/-7/-9/-8, Bid, and PARP was increased in hypericin-PDT-treated ATL cells.  In a luciferase assay, hypericin-PDT treatment was able to activate the promoter activity of Bax and p53, resulting in enhanced expression of Bax and p53 proteins.  Finally, hypericin-PDT treatment suppressed the expression of viral protein HBZ and Tax by blocking the promoter activity via HTLV-1 5'LTR and 3'LTR.  CONCLUSIONS:  Our results revealed that hypericin-PDT is highly effective against ATL cells by induction of apoptosis and suppression of viral transcription.  These studies highlight the promising use of hypericin-PDT as a targeted therapy for ATL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQGm3fFMcHFSEPI-fCgwosgfW6udTcc2eYox_mAD_T5BLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cflt1Kmtw%253D%253D&md5=3838f174c3bc43f60002580c3a3838d0</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1186%2Fs12977-019-0467-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12977-019-0467-0%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYi%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DShao%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DT.%26atitle%3DHypericin-photodynamic%2520therapy%2520inhibits%2520the%2520growth%2520of%2520adult%2520T-cell%2520leukemia%2520cells%2520through%2520induction%2520of%2520apoptosis%2520and%2520suppression%2520of%2520viral%2520transcription%26jtitle%3DRetrovirology%26date%3D2019%26volume%3D16%26spage%3D5%26doi%3D10.1186%2Fs12977-019-0467-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aksakal, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazan, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eçik, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuksel, F.</span></span> <span> </span><span class="NLM_article-title">A novel photosensitizer based on a ruthenium(ii) phenanthroline bis(perylenediimide) dyad: synthesis, generation of singlet oxygen and in vitro photodynamic therapy</span>. <i>New J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">17538</span>– <span class="NLM_lpage">17545</span>, <span class="refDoi"> DOI: 10.1039/C8NJ02944J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2FC8NJ02944J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVSrurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2018&pages=17538-17545&author=N.+E.+Aksakalauthor=H.+H.+Kazanauthor=E.+T.+E%C3%A7ikauthor=F.+Yuksel&title=A+novel+photosensitizer+based+on+a+ruthenium%28ii%29+phenanthroline+bis%28perylenediimide%29+dyad%3A+synthesis%2C+generation+of+singlet+oxygen+and+in+vitro+photodynamic+therapy&doi=10.1039%2FC8NJ02944J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A novel photosensitizer based on a ruthenium(II) phenanthroline bis(perylenediimide) dyad: synthesis, generation of singlet oxygen and in vitro photodynamic therapy</span></div><div class="casAuthors">Aksakal, Nuray Esra; Kazan, Hasan Huseyin; Ecik, Esra Tanriverdi; Yuksel, Fatma</div><div class="citationInfo"><span class="NLM_cas:title">New Journal of Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">17538-17545</span>CODEN:
                <span class="NLM_cas:coden">NJCHE5</span>;
        ISSN:<span class="NLM_cas:issn">1144-0546</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In this study, a novel photosensitizer having two perylenediimide units and a phenanthroline ruthenium(II) coordination moiety (Ru-BP) has been developed for photodynamic therapy (PDT) of cancer cells.  This new compd. was prepd. via reactions of two newly designed mols., namely, 5,6,12,13-tetrakis(4-(tert-butyl)phenoxy)-2-(2,6-diisopropylphenyl)-9-(4-hydroxyphenyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone (P6) and a bis(2,2'-bipyridyl)-(4,7-dichlorophenanthroline)ruthenium(II) complex (7).  The singlet oxygen prodn. of P6 and Ru-BP was investigated by a chem. method using 1,3-diphenylisobenzofurane as a trap mol.  Addnl., photodynamic therapy efficacy of the novel Ru-BP complex and P6 was evaluated in vitro.  Ru-BP significantly decreased the viability of human chronic myeloid leukemia cells under red light but not in the dark, pointing out that the complex, itself, was not cytotoxic and singlet oxygen formation was required for the initiation of cell death mechanisms.  Thus, Ru-BP can be effectively used as a photosensitizer in photodynamic therapy, which makes the novel Ru-BP a promising singlet oxygen generator for further biol. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBfmL5bGTZS7Vg90H21EOLACvtfcHk0lhlZ-glYVWHKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVSrurzL&md5=9946d3c554de2b98946004bfde44fef4</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1039%2FC8NJ02944J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8NJ02944J%26sid%3Dliteratum%253Aachs%26aulast%3DAksakal%26aufirst%3DN.%2BE.%26aulast%3DKazan%26aufirst%3DH.%2BH.%26aulast%3DE%25C3%25A7ik%26aufirst%3DE.%2BT.%26aulast%3DYuksel%26aufirst%3DF.%26atitle%3DA%2520novel%2520photosensitizer%2520based%2520on%2520a%2520ruthenium%2528ii%2529%2520phenanthroline%2520bis%2528perylenediimide%2529%2520dyad%253A%2520synthesis%252C%2520generation%2520of%2520singlet%2520oxygen%2520and%2520in%2520vitro%2520photodynamic%2520therapy%26jtitle%3DNew%2520J.%2520Chem.%26date%3D2018%26volume%3D42%26spage%3D17538%26epage%3D17545%26doi%3D10.1039%2FC8NJ02944J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Păunescu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clavel, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak-Sliwinska, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffioen, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">Improved angiostatic activity of dasatinib by modulation with hydrophobic chains</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1021/ml500496u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500496u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVeitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=313-317&author=E.+P%C4%83unescuauthor=C.+M.+Clavelauthor=P.+Nowak-Sliwinskaauthor=A.+W.+Griffioenauthor=P.+J.+Dyson&title=Improved+angiostatic+activity+of+dasatinib+by+modulation+with+hydrophobic+chains&doi=10.1021%2Fml500496u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Improved Angiostatic Activity of Dasatinib by Modulation with Hydrophobic Chains</span></div><div class="casAuthors">Paunescu, Emilia; Clavel, Catherine M.; Nowak-Sliwinska, Patrycja; Griffioen, Arjan W.; Dyson, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">313-317</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dasatinib is an orally active nonselective tyrosine kinase inhibitor used to treat certain types of adult leukemia.  By inhibiting PDGFR-β and SFKs in both tumor cells and tumor-assocd. endothelial cells, dasatinib inhibits tumor growth and angiogenesis.  Herein, dasatinib derivs. modified with hydrophobic chains were prepd. and evaluated for their in vitro antiproliferative selectivity and their in vivo antiangiogenic activity.  For one of the derivs., modified with a long perfluorinated chain, a significant enhancement in antiangiogenic activity was obsd.  Combined, these results suggest a possible generic route to modulate the angiostatic activity of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryj0ll0VFq-7Vg90H21EOLACvtfcHk0lgfYNe6u7gHcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVeitbg%253D&md5=3841140af5e762094eeba9682c6a3bd7</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fml500496u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500496u%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C4%2583unescu%26aufirst%3DE.%26aulast%3DClavel%26aufirst%3DC.%2BM.%26aulast%3DNowak-Sliwinska%26aufirst%3DP.%26aulast%3DGriffioen%26aufirst%3DA.%2BW.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DImproved%2520angiostatic%2520activity%2520of%2520dasatinib%2520by%2520modulation%2520with%2520hydrophobic%2520chains%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D313%26epage%3D317%26doi%3D10.1021%2Fml500496u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.-P.</span></span> <span> </span><span class="NLM_article-title">A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(ii) phthalocyanine and small molecule target-based anticancer drug erlotinib</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">9570</span>– <span class="NLM_lpage">9572</span>, <span class="refDoi"> DOI: 10.1039/c3cc45487h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2Fc3cc45487h" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=24018863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFWks7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=9570-9572&author=F.-L.+Zhangauthor=Q.+Huangauthor=K.+Zhengauthor=J.+Liauthor=J.-Y.+Liuauthor=J.-P.+Xue&title=A+novel+strategy+for+targeting+photodynamic+therapy.+Molecular+combo+of+photodynamic+agent+zinc%28ii%29+phthalocyanine+and+small+molecule+target-based+anticancer+drug+erlotinib&doi=10.1039%2Fc3cc45487h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(ii) phthalocyanine and small molecule target-based anticancer drug erlotinib</span></div><div class="casAuthors">Zhang, Feng-Ling; Huang, Qi; Zheng, Ke; Li, Jun; Liu, Jian-Yong; Xue, Jin-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">83</span>),
    <span class="NLM_cas:pages">9570-9572</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In this study, two phthalocyanine-erlotinib conjugates linked by an oligoethylene glycol chain have been synthesized and fully characterised.  Having erlotinib as the targeting moiety, the two conjugates exhibited high specific affinity to HepG2 cancer cells and tumor tissues, therefore leading to high photodynamic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXisipQF2XPLVg90H21EOLACvtfcHk0lgfYNe6u7gHcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFWks7nF&md5=7a3c354ed0aa639507e9903c6145e3bf</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1039%2Fc3cc45487h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cc45487h%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DF.-L.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DZheng%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.-Y.%26aulast%3DXue%26aufirst%3DJ.-P.%26atitle%3DA%2520novel%2520strategy%2520for%2520targeting%2520photodynamic%2520therapy.%2520Molecular%2520combo%2520of%2520photodynamic%2520agent%2520zinc%2528ii%2529%2520phthalocyanine%2520and%2520small%2520molecule%2520target-based%2520anticancer%2520drug%2520erlotinib%26jtitle%3DChem.%2520Commun.%26date%3D2013%26volume%3D49%26spage%3D9570%26epage%3D9572%26doi%3D10.1039%2Fc3cc45487h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Würthner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saha-Moller, C. R.</span></span> <span> </span><span class="NLM_article-title">J-aggregates: from serendipitous discovery to supramolecular engineering of functional dye materials</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3376</span>– <span class="NLM_lpage">3410</span>, <span class="refDoi"> DOI: 10.1002/anie.201002307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1002%2Fanie.201002307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=21442690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=3376-3410&author=F.+W%C3%BCrthnerauthor=T.+E.+Kaiserauthor=C.+R.+Saha-Moller&title=J-aggregates%3A+from+serendipitous+discovery+to+supramolecular+engineering+of+functional+dye+materials&doi=10.1002%2Fanie.201002307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">J-Aggregates: From Serendipitous Discovery to Supramolecular Engineering of Functional Dye Materials</span></div><div class="casAuthors">Wuerthner, Frank; Kaiser, Theo E.; Saha-Moeller, Chantu R.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3376-3410</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  J-aggregates are of significant interest for org. materials conceived by supramol. approaches.  Their discovery in the 1930s represents one of the most important milestones in dye chem. as well as the germination of supramol. chem.  The intriguing optical properties of J-aggregates as well as their prospect for applications have motivated scientists to become involved in this field, and numerous contributions have been published.  This Review provides an overview on the J-aggregates of a broad variety of dyes well as their potential applications.  Thus, this Review is intended to be of interest to the supramol., photochem., and materials science communities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFPy6741WWCrVg90H21EOLACvtfcHk0lgfYNe6u7gHcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWmtL0%253D&md5=a4da0f17b4afad13f6aee2509b919f60</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1002%2Fanie.201002307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201002307%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25BCrthner%26aufirst%3DF.%26aulast%3DKaiser%26aufirst%3DT.%2BE.%26aulast%3DSaha-Moller%26aufirst%3DC.%2BR.%26atitle%3DJ-aggregates%253A%2520from%2520serendipitous%2520discovery%2520to%2520supramolecular%2520engineering%2520of%2520functional%2520dye%2520materials%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D3376%26epage%3D3410%26doi%3D10.1002%2Fanie.201002307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walczak, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisfeld, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, J. S.</span></span> <span> </span><span class="NLM_article-title">Exchange narrowing of the J band of molecular dye aggregates</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>128</i></span>, <span class="NLM_elocation-id">044505</span> <span class="refDoi"> DOI: 10.1063/1.2823730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1063%2F1.2823730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=18247967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhslOgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2008&author=P.+B.+Walczakauthor=A.+Eisfeldauthor=J.+S.+Briggs&title=Exchange+narrowing+of+the+J+band+of+molecular+dye+aggregates&doi=10.1063%2F1.2823730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Exchange narrowing of the J band of molecular dye aggregates</span></div><div class="casAuthors">Walczak, P. B.; Eisfeld, A.; Briggs, J. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">044505/1-044505/12</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">The exchange narrowing of the J band of certain dye monomers upon aggregation in soln. was known since the 1930s.  Here, the authors analyze the theor. explanations put forward to account for these narrow absorption bands.  Although the theories range from models of identical monomers interacting with vibrations to the opposite of rigid monomers with statistically distributed electronic site energies, all approaches exhibit exchange narrowing.  However, the origins of the narrowing are different.  A unified theory incorporating the two approaches is presented in which features of both narrowing mechanisms are evident.  (c) 2008 American Institute of Physics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonfiMoW7CsT7Vg90H21EOLACvtfcHk0ljSA1kmVU4kug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhslOgu70%253D&md5=659cea43e0b3d2dfdd612b208af73022</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1063%2F1.2823730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.2823730%26sid%3Dliteratum%253Aachs%26aulast%3DWalczak%26aufirst%3DP.%2BB.%26aulast%3DEisfeld%26aufirst%3DA.%26aulast%3DBriggs%26aufirst%3DJ.%2BS.%26atitle%3DExchange%2520narrowing%2520of%2520the%2520J%2520band%2520of%2520molecular%2520dye%2520aggregates%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D2008%26volume%3D128%26doi%3D10.1063%2F1.2823730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egorov, V. V.</span></span> <span> </span><span class="NLM_article-title">Theory of the J-band: from the Frenkel exciton to charge transfer</span>. <i>Phys. Procedia</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">326</span>, <span class="refDoi"> DOI: 10.1016/j.phpro.2009.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.phpro.2009.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ygsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=223-326&author=V.+V.+Egorov&title=Theory+of+the+J-band%3A+from+the+Frenkel+exciton+to+charge+transfer&doi=10.1016%2Fj.phpro.2009.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Theory of the J-band: from the Frenkel exciton to charge transfer</span></div><div class="casAuthors">Egorov, Vladimir V.</div><div class="citationInfo"><span class="NLM_cas:title">Physics Procedia</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-326</span>CODEN:
                <span class="NLM_cas:coden">PPHRCK</span>;
        ISSN:<span class="NLM_cas:issn">1875-3892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This review concerns the current status of the theory of formation of the so-called J-band, an abnormally narrow, high-intensity, red-shifted optical absorption band arising from the aggregation of polymethine dyes.  Two opposite approaches to explaining the phys. nature of the J-band are given special attention.  In the first of these, the old one based on Frenkel's statistical exciton model, the specific structure of the dye is considered irrelevant, and the J-band is explained by assuming that the quickly moving Frenkel exciton acts to av. out the quasistatic disorder in electronic transition energies of mols. in the linear J-aggregate.  In the second approach, on the contrary, the specific structure of the dye (the existence of a quasilinear polymethine chain) is supposed to be very important.  This new approach is based on a new theory of charge transfer.  The explanation of the J-band here is that an elementary charge transfer along the J-aggregate's chromophore is dynamically pumped by the chaotic reorganization of nuclei in the nearby environment at a resonance between electronic and nuclear movements - when the motion of nuclei being reorganized is only weakly chaotic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFYWNZbefiaLVg90H21EOLACvtfcHk0ljSA1kmVU4kug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ygsr%252FJ&md5=0580bbfc4060ced83f89d9fc53f21663</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.phpro.2009.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phpro.2009.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DEgorov%26aufirst%3DV.%2BV.%26atitle%3DTheory%2520of%2520the%2520J-band%253A%2520from%2520the%2520Frenkel%2520exciton%2520to%2520charge%2520transfer%26jtitle%3DPhys.%2520Procedia%26date%3D2009%26volume%3D2%26spage%3D223%26epage%3D326%26doi%3D10.1016%2Fj.phpro.2009.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scalise, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durantini, E. N.</span></span> <span> </span><span class="NLM_article-title">Synthesis, properties, and photodynamic inactivation of Escherichia coli using a cationic and a noncharged Zn(II) pyridyloxyphthalocyanine derivatives</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">3037</span>– <span class="NLM_lpage">3045</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.01.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.bmc.2005.01.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=15781413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVCgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=3037-3045&author=I.+Scaliseauthor=E.+N.+Durantini&title=Synthesis%2C+properties%2C+and+photodynamic+inactivation+of+Escherichia+coli+using+a+cationic+and+a+noncharged+Zn%28II%29+pyridyloxyphthalocyanine+derivatives&doi=10.1016%2Fj.bmc.2005.01.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, properties, and photodynamic inactivation of Escherichia coli using a cationic and a noncharged Zn(II) pyridyloxyphthalocyanine derivatives</span></div><div class="casAuthors">Scalise, Ines; Durantini, Edgardo N.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3037-3045</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The photodynamic effect of a cationic Zn(II) N-methylpyridyloxyphthalocyanine (ZnPc 2) and a noncharged Zn(II) pyridyloxyphthalocyanine (ZnPc 1) has been compared in both homogeneous media bearing photooxidizable substrates and in vitro using a typical Gram-neg. bacterium Escherichia coli.  Absorption and fluorescence spectroscopic studies were analyzed in different media.  Fluorescence quantum yields (.vphi.F) of 0.23 for ZnPc 1 and 0.22 for ZnPc 2 were calcd. in N,N-dimethylformamide (DMF).  The singlet mol. oxygen, O2(1Δg), prodn. was evaluated using 9,10-dimethylanthracene (DMA) in DMF yielding values of ΦΔ = 0.56 for ZnPc 1 and 0.59 for ZnPc 2.  A faster decompn. of -tryptophan (Trp), which was used as biol. substrate model, was obtained using ZnPc 2 as a sensitizer with respect to ZnPc 1.  In biol. medium, the E. coli cultures were treated with 10 μM of sensitizer for different times at 37 °C in the dark.  Both ZnPcs 1 and 2 are rapidly bound to E. coli cells in 5 min and the amt. of cell-bound sensitizer is not appreciably changed incubating the cultures for longer times.  The recovered ZnPc 2 after one washing step is ∼3 times higher than 1, reaching a value of ∼3 nmol/106 cells.  After irradn. with visible light, a higher photoinactivation of cells was found for ZnPc 2.  Thus, a ∼4.5 log (99.997%) decrease of cell survival was obtained after 30 min of irradn.  On the other hand, a very low photodamage was found for cells treated with ZnPc 1 (∼0.5 log).  Also, these results were established by stopping of growth curves for E. coli.  In the structure of ZnPc 2, the cationic centers are isolated from the phthalocyanine ring by an ether bridge, which also provides a higher mobility of the charges facilitating the interaction with the outer membrane of the Gram-neg. bacteria.  These studies show that cationic ZnPc 2 is an efficient phototherapeutic agent with potential applications in photodynamic inactivation of bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEADh4_wlxLLVg90H21EOLACvtfcHk0liIkemRWRGT-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVCgtrY%253D&md5=b03001c7e0030c7dd01f99c3226fbaa4</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.01.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.01.063%26sid%3Dliteratum%253Aachs%26aulast%3DScalise%26aufirst%3DI.%26aulast%3DDurantini%26aufirst%3DE.%2BN.%26atitle%3DSynthesis%252C%2520properties%252C%2520and%2520photodynamic%2520inactivation%2520of%2520Escherichia%2520coli%2520using%2520a%2520cationic%2520and%2520a%2520noncharged%2520Zn%2528II%2529%2520pyridyloxyphthalocyanine%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D3037%26epage%3D3045%26doi%3D10.1016%2Fj.bmc.2005.01.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savić, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maysinger, D.</span></span> <span> </span><span class="NLM_article-title">Block copolymer micelles as delivery vehicles of hydrophobic drugs: Micelle–cell interactions</span>. <i>J. Drug Target.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1080/10611860600874538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1080%2F10611860600874538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=17092835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1Cqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=343-355&author=R.+Savi%C4%87author=A.+Eisenbergauthor=D.+Maysinger&title=Block+copolymer+micelles+as+delivery+vehicles+of+hydrophobic+drugs%3A+Micelle%E2%80%93cell+interactions&doi=10.1080%2F10611860600874538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Block copolymer micelles as delivery vehicles of hydrophobic drugs: micelle-cell interactions</span></div><div class="casAuthors">Savic, Radoslav; Eisenberg, Adi; Maysinger, Dusica</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">343-355</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  One-third of drugs in development are water insol. and one-half fail in trials because of poor pharmacokinetics.  Block copolymer micelles are nanosized particles that can solubilize hydrophobic drugs and alter their kinetics in vitro and in vivo.  However, block copolymer micelles are not solely passive drug containers that simply solubilize hydrophobic drugs; cells internalize micelles.  To facilitate the development of advanced, controlled, micellar drug delivery vehicles, we have to understand the fate of micelles and micelle-incorporated drugs in cells and in vivo.  With micelle-based drug formulations recently reaching clin. trials, the impetus for answers is ever so strong and detailed studies of interactions of micelles and cells are starting to emerge.  Most notably, the question arises: Is the internalization of block copolymer micelles carrying small mol. wt. drugs an undesired side effect or a useful means of improving the effectiveness of the incorporated drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPBUQGrLWO4bVg90H21EOLACvtfcHk0liIkemRWRGT-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1Cqtrk%253D&md5=8be608c14cc56eec264cc7e5983866c8</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1080%2F10611860600874538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10611860600874538%26sid%3Dliteratum%253Aachs%26aulast%3DSavi%25C4%2587%26aufirst%3DR.%26aulast%3DEisenberg%26aufirst%3DA.%26aulast%3DMaysinger%26aufirst%3DD.%26atitle%3DBlock%2520copolymer%2520micelles%2520as%2520delivery%2520vehicles%2520of%2520hydrophobic%2520drugs%253A%2520Micelle%25E2%2580%2593cell%2520interactions%26jtitle%3DJ.%2520Drug%2520Target.%26date%3D2006%26volume%3D14%26spage%3D343%26epage%3D355%26doi%3D10.1080%2F10611860600874538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Master, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleinick, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A. S.</span></span> <span> </span><span class="NLM_article-title">EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies</span>. <i>Nanomedicine</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">655</span>– <span class="NLM_lpage">664</span>, <span class="refDoi"> DOI: 10.1016/j.nano.2011.09.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.nano.2011.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=22024195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC38XptVKmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=655-664&author=A.+M.+Masterauthor=Y.+Qiauthor=N.+L.+Oleinickauthor=A.+S.+Gupta&title=EGFR-mediated+intracellular+delivery+of+Pc+4+nanoformulation+for+targeted+photodynamic+therapy+of+cancer%3A+in+vitro+studies&doi=10.1016%2Fj.nano.2011.09.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies</span></div><div class="casAuthors">Master, Alyssa M.; Qi, Yizhi; Oleinick, Nancy L.; Sen Gupta, Anirban</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">655-664</span>CODEN:
                <span class="NLM_cas:coden">NANOBF</span>;
        ISSN:<span class="NLM_cas:issn">1549-9634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In photodynamic therapy (PDT), the light activation of a photosensitizer leads to the generation of reactive oxygen species that can trigger various mechanisms of cell death.  Harnessing this process within cancer cells enables minimally invasive yet targeted cancer treatment.  With this rationale, here we demonstrate tumor-targeted delivery of a highly hydrophobic photosensitizer Pc 4 loaded within biocompatible poly(ethylene glycol)-poly(ε-caprolactone) block co-polymer micelles.  The micelles were surface-modified with epidermal growth factor receptor (EGFR)-targeting GE11 peptides for active targeting of EGFR-overexpressing cancer cells, in vitro.  Pc 4-loaded EGFR-targeted micelles were incubated with EGFR-overexpressing A431 epidermoid carcinoma cells for various time periods, to det. Pc 4 uptake by epifluorescence microscopy.  The cells were subsequently photoirradiated, and PDT-induced cell death for various incubation periods was detd. by MTT assay and fluorescence Live/Dead assay.  Our results indicate that active EGFR targeting of the Pc 4-loaded micelles accelerates intracellular uptake of the drug.  Consequently, this enhances the PDT-induced cytotoxicity within shorter time periods.  Photodynamic cancer therapy using Pc 4, a light activated and highly hydrophobic photosensitizer is demonstrated in this paper in vitro.  Pc 4 was delivered in block-copolymer micelles surface-modified with GE11 peptides targeting EGFR-overexpressing cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu13s6lWfL77Vg90H21EOLACvtfcHk0liIkemRWRGT-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptVKmsr4%253D&md5=56fbd1ed49e53da38bec0936ab616351</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.nano.2011.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nano.2011.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DMaster%26aufirst%3DA.%2BM.%26aulast%3DQi%26aufirst%3DY.%26aulast%3DOleinick%26aufirst%3DN.%2BL.%26aulast%3DGupta%26aufirst%3DA.%2BS.%26atitle%3DEGFR-mediated%2520intracellular%2520delivery%2520of%2520Pc%25204%2520nanoformulation%2520for%2520targeted%2520photodynamic%2520therapy%2520of%2520cancer%253A%2520in%2520vitro%2520studies%26jtitle%3DNanomedicine%26date%3D2012%26volume%3D8%26spage%3D655%26epage%3D664%26doi%3D10.1016%2Fj.nano.2011.09.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckett, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blair, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirtakusuma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakjang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enshaei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halsey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vormoor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidenreich, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krippner-Heidenreich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Delft, F. W.</span></span> <span> </span><span class="NLM_article-title">Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>105</i></span>, <span class="NLM_elocation-id">241026</span> <span class="refDoi"> DOI: 10.3324/haematol.2019.241026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.3324%2Fhaematol.2019.241026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2020&author=Y.+Shiauthor=M.+C.+Beckettauthor=H.+J.+Blairauthor=R.+Tirtakusumaauthor=S.+Nakjangauthor=A.+Enshaeiauthor=C.+Halseyauthor=J.+Vormoorauthor=O.+Heidenreichauthor=A.+Krippner-Heidenreichauthor=F.+W.+van+Delft&title=Phase+II-like+murine+trial+identifies+synergy+between+dexamethasone+and+dasatinib+in+T-cell+acute+lymphoblastic+leukemia&doi=10.3324%2Fhaematol.2019.241026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2019.241026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2019.241026%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DY.%26aulast%3DBeckett%26aufirst%3DM.%2BC.%26aulast%3DBlair%26aufirst%3DH.%2BJ.%26aulast%3DTirtakusuma%26aufirst%3DR.%26aulast%3DNakjang%26aufirst%3DS.%26aulast%3DEnshaei%26aufirst%3DA.%26aulast%3DHalsey%26aufirst%3DC.%26aulast%3DVormoor%26aufirst%3DJ.%26aulast%3DHeidenreich%26aufirst%3DO.%26aulast%3DKrippner-Heidenreich%26aufirst%3DA.%26aulast%3Dvan%2BDelft%26aufirst%3DF.%2BW.%26atitle%3DPhase%2520II-like%2520murine%2520trial%2520identifies%2520synergy%2520between%2520dexamethasone%2520and%2520dasatinib%2520in%2520T-cell%2520acute%2520lymphoblastic%2520leukemia%26jtitle%3DHaematologica%26date%3D2020%26volume%3D105%26doi%3D10.3324%2Fhaematol.2019.241026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harr, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caimi, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McColl, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distelhorst, C. W.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1381</span>– <span class="NLM_lpage">1391</span>, <span class="refDoi"> DOI: 10.1038/cdd.2010.25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fcdd.2010.25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=20300113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVantr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1381-1391&author=M.+W.+Harrauthor=P.+F.+Caimiauthor=K.+S.+McCollauthor=F.+Zhongauthor=S.+N.+Patelauthor=P.+M.+Barrauthor=C.+W.+Distelhorst&title=Inhibition+of+Lck+enhances+glucocorticoid+sensitivity+and+apoptosis+in+lymphoid+cell+lines+and+in+chronic+lymphocytic+leukemia&doi=10.1038%2Fcdd.2010.25"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia</span></div><div class="casAuthors">Harr, M. W.; Caimi, P. F.; McColl, K. S.; Zhong, F.; Patel, S. N.; Barr, P. M.; Distelhorst, C. W.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1381-1391</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glucocorticoids are used as part of front-line therapy to treat lymphoid malignancy because of their remarkable ability to induce apoptosis.  Yet, in T cells, glucocorticoid-induced apoptosis is readily inhibited by lymphocyte activation and signaling.  We have previously shown that the Src family kinase, Lck (lymphocyte cell-specific tyrosine kinase), which is predominantly expressed in T cells, interacts with IP3 receptors to facilitate calcium signaling.  Here, we discovered that dexamethasone downregulates Lck, which, in turn, suppresses lymphocyte activation by inhibiting pro-survival calcium oscillations.  Moreover, stable expression of shRNAs that selectively targeted Lck or treatment with the Src inhibitor dasatinib (BMS-354825) enhanced apoptosis induction by dexamethasone.  To investigate the effect of Lck inhibition in a primary leukemia model, we employed chronic lymphocytic leukemia (CLL) cells that aberrantly expressed Lck and were relatively insensitive to dexamethasone.  Lck expression was correlated with resistance to dexamethasone in CLL cells, and its inhibition by dasatinib or other inhibitors markedly enhanced glucocorticoid sensitivity.  Collectively, these data indicate that Lck protects cells from glucocorticoid-induced apoptosis and its inhibition enhances sensitivity to dexamethasone.  Small-mol. inhibitors of Lck, such as dasatinib, may function to reverse glucocorticoid resistance in some lymphoid malignancies.  Cell Death and Differentiation (2010) 17, 1381-1391; doi:10.1038/cdd.2010.25; published online 19 March 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaM1YbNhebrrVg90H21EOLACvtfcHk0liHOorF5S2C6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVantr7O&md5=b27c64888919351e9d70a12cdd555c8f</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2010.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2010.25%26sid%3Dliteratum%253Aachs%26aulast%3DHarr%26aufirst%3DM.%2BW.%26aulast%3DCaimi%26aufirst%3DP.%2BF.%26aulast%3DMcColl%26aufirst%3DK.%2BS.%26aulast%3DZhong%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DS.%2BN.%26aulast%3DBarr%26aufirst%3DP.%2BM.%26aulast%3DDistelhorst%26aufirst%3DC.%2BW.%26atitle%3DInhibition%2520of%2520Lck%2520enhances%2520glucocorticoid%2520sensitivity%2520and%2520apoptosis%2520in%2520lymphoid%2520cell%2520lines%2520and%2520in%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2010%26volume%3D17%26spage%3D1381%26epage%3D1391%26doi%3D10.1038%2Fcdd.2010.25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">The role of porphyrin chemistry in tumor imaging and photodynamic therapy</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.1039/B915149B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2FB915149B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=20694259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFKju7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=340-362&author=M.+Ethirajanauthor=Y.+Chenauthor=P.+Joshiauthor=R.+K.+Pandey&title=The+role+of+porphyrin+chemistry+in+tumor+imaging+and+photodynamic+therapy&doi=10.1039%2FB915149B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">The role of porphyrin chemistry in tumor imaging and photodynamic therapy</span></div><div class="casAuthors">Ethirajan, Manivannan; Chen, Yihui; Joshi, Penny; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">340-362</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  In recent years several review articles and books have been published on the use of porphyrin-based compds. in photodynamic therapy (PDT).  This crit. review is focused on (i) the basic concept of PDT, (ii) advantages of long-wavelength absorbing photosensitizers (PS), (iii) a brief discussion on recent advances in developing PDT agents, and (iv) the various synthetic strategies designed at the Roswell Park Cancer Institute, Buffalo, for developing highly effective long-wavelength PDT agents and their utility in constructing the conjugates with tumor-imaging and therapeutic potential (Theranostics).  The clin. status of certain selected PDT agents is also summarized (205 refs.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwaO6TvgtDibVg90H21EOLACvtfcHk0liZb4vpZlY5Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFKju7bF&md5=b462478255e32db5d073a892c64e2d52</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1039%2FB915149B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB915149B%26sid%3Dliteratum%253Aachs%26aulast%3DEthirajan%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DThe%2520role%2520of%2520porphyrin%2520chemistry%2520in%2520tumor%2520imaging%2520and%2520photodynamic%2520therapy%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2011%26volume%3D40%26spage%3D340%26epage%3D362%26doi%3D10.1039%2FB915149B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J. L.</span></span> <span> </span><span class="NLM_article-title">Intranuclear photosensitizer delivery and photosensitization for enhanced photodynamic therapy with ultralow irradiance</span>. <i>Adv. Funct. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">7318</span>– <span class="NLM_lpage">7327</span>, <span class="refDoi"> DOI: 10.1002/adfm.201402255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1002%2Fadfm.201402255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVChsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=7318-7327&author=L.+M.+Panauthor=J.+A.+Liuauthor=J.+L.+Shi&title=Intranuclear+photosensitizer+delivery+and+photosensitization+for+enhanced+photodynamic+therapy+with+ultralow+irradiance&doi=10.1002%2Fadfm.201402255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Intranuclear Photosensitizer Delivery and Photosensitization for Enhanced Photodynamic Therapy with Ultralow Irradiance</span></div><div class="casAuthors">Pan, Limin; Liu, Jianan; Shi, Jianlin</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Functional Materials</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">7318-7327</span>CODEN:
                <span class="NLM_cas:coden">AFMDC6</span>;
        ISSN:<span class="NLM_cas:issn">1616-301X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is a well-established clin. treatment modality for various diseases.  However, reactive oxygen species (ROS) generated by photosensitizers(PS) under proper irradn. exhibits extremely short life span (<200 ns) and severely limited diffusion distance (20 nm), so the damage of ROS to biomols., esp. DNA, is strongly confined to the immediate vicinity of ROS generation.  In this report, an efficient nuclear-targeted delivery strategy is proposed by using TAT and RGD peptides co-conjugated mesoporous silica nanoparticles (MSNs) as PS carriers.  The conjugation of TAT peptides enable the nuclear penetration of MSNs for efficient accumulation of PS inside nuclei.  The intranuclear-accumulated PS can generate ROS upon irradn. right inside nuclei to destroy DNA instantaneously.  For the purpose of in vivo applications, the co-conjugated RGD peptides endow the nuclear-targeted delivery system with specific binding and recognition to tumor vasculature and tumor cell membranes for significantly enhanced specificity and reduced side effects.  Through i.v. injection of these nanosystems in tumor-bearing mice at a rather low PS dose of 2 mg/kg, tumor growth is efficiently inhibited by an extremely low irradn. dose of 6 J/cm2.  This work presents a new paradigm for specific PDT with high efficacy and low side effects in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTh7ZQ_mWKtLVg90H21EOLACvtfcHk0liZb4vpZlY5Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVChsrbN&md5=80fe232186a32ab441da4478d8513d3a</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1002%2Fadfm.201402255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadfm.201402255%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DL.%2BM.%26aulast%3DLiu%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DJ.%2BL.%26atitle%3DIntranuclear%2520photosensitizer%2520delivery%2520and%2520photosensitization%2520for%2520enhanced%2520photodynamic%2520therapy%2520with%2520ultralow%2520irradiance%26jtitle%3DAdv.%2520Funct.%2520Mater.%26date%3D2014%26volume%3D24%26spage%3D7318%26epage%3D7327%26doi%3D10.1002%2Fadfm.201402255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B.</span></span> <span> </span><span class="NLM_article-title">A near-infrared triggered nanophotosensitizer inducing domino effect on mitochondrial reactive oxygen species burst for cancer therapy</span>. <i>ACS Nano</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">11064</span>– <span class="NLM_lpage">11074</span>, <span class="refDoi"> DOI: 10.1021/acsnano.5b04501</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsnano.5b04501" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Cht77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=11064-11074&author=Z.+Yuauthor=Q.+Sunauthor=W.+Panauthor=N.+Liauthor=B.+Tang&title=A+near-infrared+triggered+nanophotosensitizer+inducing+domino+effect+on+mitochondrial+reactive+oxygen+species+burst+for+cancer+therapy&doi=10.1021%2Facsnano.5b04501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">A Near-Infrared Triggered Nanophotosensitizer Inducing Domino Effect on Mitochondrial Reactive Oxygen Species Burst for Cancer Therapy</span></div><div class="casAuthors">Yu, Zhengze; Sun, Qiaoqiao; Pan, Wei; Li, Na; Tang, Bo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Nano</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">11064-11074</span>CODEN:
                <span class="NLM_cas:coden">ANCAC3</span>;
        ISSN:<span class="NLM_cas:issn">1936-0851</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is a well-established modality for cancer therapy, which locally kills cancer cells when light irradiates a photosensitizer.  However, conventional PDT is often limited by the extremely short lifespan and severely limited diffusion distance of reactive oxygen species (ROS) generated by photosensitizer, as well as the penetration depth of visible light activation.  Here, we develop a near-IR (NIR) triggered nanophotosensitizer based on mitochondria targeted titanium dioxide-coated upconversion nanoparticles for PDT against cancer.  When irradiated by NIR laser, the nanophotosensitizer could produce ROS in mitochondria, which induced the domino effect on ROS burst.  The overproduced ROS accumulated in mitochondria, resulting in mitochondrial collapse and irreversible cell apoptosis.  Confocal fluorescence imaging indicated that the mitochondrial targeting and real-time imaging of ROS burst could be achieved in living cells.  The complete removal of tumor in vivo confirmed the excellent therapeutic effect of the nanophotosensitizer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU_3KP99PxsbVg90H21EOLACvtfcHk0liZb4vpZlY5Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Cht77O&md5=39bb1a41f1e10acb318993d360f8c091</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Facsnano.5b04501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsnano.5b04501%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DB.%26atitle%3DA%2520near-infrared%2520triggered%2520nanophotosensitizer%2520inducing%2520domino%2520effect%2520on%2520mitochondrial%2520reactive%2520oxygen%2520species%2520burst%2520for%2520cancer%2520therapy%26jtitle%3DACS%2520Nano%26date%3D2015%26volume%3D9%26spage%3D11064%26epage%3D11074%26doi%3D10.1021%2Facsnano.5b04501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rajaputra, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nkepang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro biological evaluation of lipophilic cation conjugated photosensitizers for targeting mitochondria</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2012.11.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.bmc.2012.11.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=23245573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVektbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=379-387&author=P.+Rajaputraauthor=G.+Nkepangauthor=R.+Watleyauthor=Y.+You&title=Synthesis+and+in+vitro+biological+evaluation+of+lipophilic+cation+conjugated+photosensitizers+for+targeting+mitochondria&doi=10.1016%2Fj.bmc.2012.11.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro biological evaluation of lipophilic cation conjugated photosensitizers for targeting mitochondria</span></div><div class="casAuthors">Rajaputra, Pallavi; Nkepang, Gregory; Watley, Ryan; You, Youngjae</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">379-387</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mitochondria-specific photosensitizers were designed by taking advantage of the preferential localization of delocalized lipophilic cations (DLCs) in mitochondria.  Three DLC-porphyrin conjugates: CMP-Rh (a core modified porphyrin-rhodamine B cation), CMP-tPP (a core modified porphyrin-mono-triphenyl phosphonium cation), CMP-(tPP)2 (a core modified porphyrin-di-tPP cation) were prepd.  The conjugates were synthesized by conjugating a monohydroxy core modified porphyrin (CMP-OH) to rhodamine B (Rh B), or either one or two tPPs, resp., via a satd. hydrocarbon linker.  Their ability for delivering photosensitizers to mitochondria was evaluated using dual staining fluorescence microscopy.  In addn., to evaluate the efficiency of the conjugates as photosensitizers, their photophys. properties and in vitro biol. activities were studied in comparison to those of CMP-OH.  Fluorescence imaging study suggested that CMP-Rh specifically localized in mitochondria.  On the other hand, CMP-tPP and CMP-(tPP)2 showed less significant mitochondrial localization.  All conjugates were capable of generating singlet oxygen at rates comparable to CMP-OH.  Interestingly, all cationic conjugates showed dramatic increase in cellular uptake and phototoxicity compared to CMP-OH.  This improved photodynamic activity might be primarily due to an enhanced cellular uptake.  Our study suggests that Rh B cationic group is better at least for CMP than tPP as a mitochondrial targeting vector.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq18xy_w0Y0P7Vg90H21EOLACvtfcHk0lgLRh6EyQUH1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVektbrL&md5=d80cc5ae274da98a6b3d514ebba548d3</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.11.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.11.032%26sid%3Dliteratum%253Aachs%26aulast%3DRajaputra%26aufirst%3DP.%26aulast%3DNkepang%26aufirst%3DG.%26aulast%3DWatley%26aufirst%3DR.%26aulast%3DYou%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520biological%2520evaluation%2520of%2520lipophilic%2520cation%2520conjugated%2520photosensitizers%2520for%2520targeting%2520mitochondria%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D379%26epage%3D387%26doi%3D10.1016%2Fj.bmc.2012.11.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H. Y.</span></span> <span> </span><span class="NLM_article-title">Acidity-triggered tumor-targeted chimeric peptide for enhanced intra-nuclear photodynamic therapy</span>. <i>Adv. Funct. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4351</span>– <span class="NLM_lpage">4361</span>, <span class="refDoi"> DOI: 10.1002/adfm.201600170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1002%2Fadfm.201600170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlKmtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4351-4361&author=K.+Hanauthor=W.+Y.+Zhangauthor=J.+Zhangauthor=Q.+Leiauthor=S.+B.+Wangauthor=J.+W.+Liuauthor=X.+Z.+Zhangauthor=H.+Y.+Han&title=Acidity-triggered+tumor-targeted+chimeric+peptide+for+enhanced+intra-nuclear+photodynamic+therapy&doi=10.1002%2Fadfm.201600170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Acidity-Triggered Tumor-Targeted Chimeric Peptide for Enhanced Intra-Nuclear Photodynamic Therapy</span></div><div class="casAuthors">Han, Kai; Zhang, Wei-Yun; Zhang, Jin; Lei, Qi; Wang, Shi-Bo; Liu, Jia-Wei; Zhang, Xian-Zheng; Han, He-You</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Functional Materials</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4351-4361</span>CODEN:
                <span class="NLM_cas:coden">AFMDC6</span>;
        ISSN:<span class="NLM_cas:issn">1616-301X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Photodynamic therapy suffers from poor tumor selectivity and poor therapeutical efficacy.  In this paper, an amphiphilic chimeric peptide is fabricated to realize sequential acidity-responsive tumor-targeted transport of photosensitizer and in situ photodynamic therapy in nuclei.  In vitro studies demonstrate that the acidic tumor microenvironment successfully sheds the mask of cationic nuclear localization sequence (NLS) of the neg. charged chimeric peptide.  This charge reversal remarkably accelerates cellular uptake of chimeric peptide in tumor cells and maximizes the photodynamic therapeutical efficacy in nuclei.  Most importantly, direct disguise of the biofunctional NLS sequence decreases the complexity and increases the performance of the chimeric peptide further by achieving long blood retention time, specific tumor accumulation, minimal side effects, and efficient antitumor therapy in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxlx1_eWP8IbVg90H21EOLACvtfcHk0lgLRh6EyQUH1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlKmtLg%253D&md5=6b2fe87bfdfa6e0e35e85c396262de55</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1002%2Fadfm.201600170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadfm.201600170%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DW.%2BY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLei%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DS.%2BB.%26aulast%3DLiu%26aufirst%3DJ.%2BW.%26aulast%3DZhang%26aufirst%3DX.%2BZ.%26aulast%3DHan%26aufirst%3DH.%2BY.%26atitle%3DAcidity-triggered%2520tumor-targeted%2520chimeric%2520peptide%2520for%2520enhanced%2520intra-nuclear%2520photodynamic%2520therapy%26jtitle%3DAdv.%2520Funct.%2520Mater.%26date%3D2016%26volume%3D26%26spage%3D4351%26epage%3D4361%26doi%3D10.1002%2Fadfm.201600170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sivori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Zotto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mingari, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moretta, L.</span></span> <span> </span><span class="NLM_article-title">Human NK cells: surface receptors, inhibitory checkpoints, and translational applications</span>. <i>Cell Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">430</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1038/s41423-019-0206-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fs41423-019-0206-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=30778167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmt1yksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=430-441&author=S.+Sivoriauthor=P.+Vaccaauthor=G.+Del+Zottoauthor=E.+Munariauthor=M.+C.+Mingariauthor=L.+Moretta&title=Human+NK+cells%3A+surface+receptors%2C+inhibitory+checkpoints%2C+and+translational+applications&doi=10.1038%2Fs41423-019-0206-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Human NK cells: surface receptors, inhibitory checkpoints, and translational applications</span></div><div class="casAuthors">Sivori, Simona; Vacca, Paola; Del Zotto, Genny; Munari, Enrico; Mingari, Maria Cristina; Moretta, Lorenzo</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Immunology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">430-441</span>CODEN:
                <span class="NLM_cas:coden">CMIEAO</span>;
        ISSN:<span class="NLM_cas:issn">1672-7681</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">NK cells play important roles in innate defenses against viruses and in the control of tumor growth and metastasis.  The regulation/induction of NK cell function is mediated by an array of activating or inhibitory surface receptors.  In humans, major activating receptors involved in target cell killing are the natural cytotoxicity receptors (NCRs) and NKG2D.  Activating receptors recognize ligands that are overexpressed or expressed de novo upon cell stress, viral infection, or tumor transformation.  The HLA-class I-specific inhibitory receptors, including KIRs recognizing HLA-class I allotypic determinants and CD94/NKG2A recognizing the class-Ib HLA-E, constitute a fail-safe mechanism to avoid unwanted NK-mediated damage to healthy cells.  Other receptors such as PD-1, primarily expressed by activated T lymphocytes, are important inhibitory checkpoints of immune responses that ensure T-cell tolerance.  PD-1 also may be expressed by NK cells in cancer patients.  Since PD-1 ligand (PD-L1) may be expressed by different tumors, PD-1/PD-L1 interactions inactivate both T and NK cells.  Thus, the reliable evaluation of PD-L1 expression in tumors has become a major issue to select patients who may benefit from therapy with mAbs disrupting PD-1/PD-L1 interactions.  Recently, NKG2A was revealed to be an important checkpoint controlling both NK and T-cell activation.  Since most tumors express HLA-E, mAbs targeting NKG2A has been used alone or in combination with other therapeutic mAbs targeting PD-1 or tumor antigens (e.g., EGFR), with encouraging results.  The translational value of NK cells and their receptors is evidenced by the extraordinary therapeutic success of haploidentical HSCT to cure otherwise fatal high-risk leukemias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsfRZnt4Q5D7Vg90H21EOLACvtfcHk0lhUqr_G7wIemw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmt1yksb0%253D&md5=fa4b68872ff43beeadb177d2efdb19db</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1038%2Fs41423-019-0206-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41423-019-0206-4%26sid%3Dliteratum%253Aachs%26aulast%3DSivori%26aufirst%3DS.%26aulast%3DVacca%26aufirst%3DP.%26aulast%3DDel%2BZotto%26aufirst%3DG.%26aulast%3DMunari%26aufirst%3DE.%26aulast%3DMingari%26aufirst%3DM.%2BC.%26aulast%3DMoretta%26aufirst%3DL.%26atitle%3DHuman%2520NK%2520cells%253A%2520surface%2520receptors%252C%2520inhibitory%2520checkpoints%252C%2520and%2520translational%2520applications%26jtitle%3DCell%2520Mol.%2520Immunol.%26date%3D2019%26volume%3D16%26spage%3D430%26epage%3D441%26doi%3D10.1038%2Fs41423-019-0206-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiossone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumas, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vienne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivier, E.</span></span> <span> </span><span class="NLM_article-title">Natural killer cells and other innate lymphoid cells in cancer</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">688</span>, <span class="refDoi"> DOI: 10.1038/s41577-018-0061-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fs41577-018-0061-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=30209347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslSnu7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=671-688&author=L.+Chiossoneauthor=P.+Y.+Dumasauthor=M.+Vienneauthor=E.+Vivier&title=Natural+killer+cells+and+other+innate+lymphoid+cells+in+cancer&doi=10.1038%2Fs41577-018-0061-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Natural killer cells and other innate lymphoid cells in cancer</span></div><div class="casAuthors">Chiossone, Laura; Dumas, Pierre-Yves; Vienne, Margaux; Vivier, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">671-688</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Immuno-oncol. is an emerging field that has revolutionized cancer treatment.  Most immunomodulatory strategies focus on enhancing T cell responses, but there has been a recent surge of interest in harnessing the relatively underexplored natural killer (NK) cell compartment for therapeutic interventions.  NK cells show cytotoxic activity against diverse tumor cell types, and some of the clin. approaches originally developed to increase T cell cytotoxicity may also activate NK cells.  Moreover, increasing nos. of studies have identified novel methods for increasing NK cell antitumor immunity and expanding NK cell populations ex vivo, thereby paving the way for a new generation of anticancer immunotherapies.  The role of other innate lymphoid cells (group 1 innate lymphoid cell (ILC1), ILC2 and ILC3 subsets) in tumors is also being actively explored.  This Review provides an overview of the field and summarizes current immunotherapeutic approaches for solid tumors and haematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGostky6tNI3Z7Vg90H21EOLACvtfcHk0lgxSaJMv_j_-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslSnu7fP&md5=0f8f392583afdd60e5a607677e8e132c</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fs41577-018-0061-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41577-018-0061-z%26sid%3Dliteratum%253Aachs%26aulast%3DChiossone%26aufirst%3DL.%26aulast%3DDumas%26aufirst%3DP.%2BY.%26aulast%3DVienne%26aufirst%3DM.%26aulast%3DVivier%26aufirst%3DE.%26atitle%3DNatural%2520killer%2520cells%2520and%2520other%2520innate%2520lymphoid%2520cells%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2018%26volume%3D18%26spage%3D671%26epage%3D688%26doi%3D10.1038%2Fs41577-018-0061-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeNardo, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruffell, B.</span></span> <span> </span><span class="NLM_article-title">Macrophages as regulators of tumour immunity and immunotherapy</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">382</span>, <span class="refDoi"> DOI: 10.1038/s41577-019-0127-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fs41577-019-0127-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=30718830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtFKhtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2019&pages=369-382&author=D.+G.+DeNardoauthor=B.+Ruffell&title=Macrophages+as+regulators+of+tumour+immunity+and+immunotherapy&doi=10.1038%2Fs41577-019-0127-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophages as regulators of tumour immunity and immunotherapy</span></div><div class="casAuthors">DeNardo, David G.; Ruffell, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">369-382</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Macrophages are crit. mediators of tissue homeostasis, with tumors distorting this proclivity to stimulate proliferation, angiogenesis and metastasis.  This had led to an interest in targeting macrophages in cancer, and preclin. studies have demonstrated efficacy across therapeutic modalities and tumor types.  Much of the obsd. efficacy can be traced to the suppressive capacity of macrophages, driven by microenvironmental cues such as hypoxia and fibrosis.  As a result, tumor macrophages display an ability to suppress T cell recruitment and function as well as to regulate other aspects of tumor immunity.  With the increasing impact of cancer immunotherapy, macrophage targeting is now being evaluated in this context.  Here, we discuss the results of clin. trials and the future of combinatorial immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBmZbwMl_tu7Vg90H21EOLACvtfcHk0lgxSaJMv_j_-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtFKhtrw%253D&md5=b2c97a2c6e6605d9fa6dae24eed6373f</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1038%2Fs41577-019-0127-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41577-019-0127-6%26sid%3Dliteratum%253Aachs%26aulast%3DDeNardo%26aufirst%3DD.%2BG.%26aulast%3DRuffell%26aufirst%3DB.%26atitle%3DMacrophages%2520as%2520regulators%2520of%2520tumour%2520immunity%2520and%2520immunotherapy%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2019%26volume%3D19%26spage%3D369%26epage%3D382%26doi%3D10.1038%2Fs41577-019-0127-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pluddemann, A.</span></span> <span> </span><span class="NLM_article-title">Tissue macrophages: heterogeneity and functions</span>. <i>BMC Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">53</span>, <span class="refDoi"> DOI: 10.1186/s12915-017-0392-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1186%2Fs12915-017-0392-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=28662662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVeksbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=53&author=S.+Gordonauthor=A.+Pluddemann&title=Tissue+macrophages%3A+heterogeneity+and+functions&doi=10.1186%2Fs12915-017-0392-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue macrophages: heterogeneity and functions</span></div><div class="casAuthors">Gordon, Siamon; Pluddemann, Annette</div><div class="citationInfo"><span class="NLM_cas:title">BMC Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">53/1-53/18</span>CODEN:
                <span class="NLM_cas:coden">BBMIF7</span>;
        ISSN:<span class="NLM_cas:issn">1741-7007</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Macrophages are present in all vertebrate tissues, from mid-gestation throughout life, constituting a widely dispersed organ system.  They promote homeostasis by responding to internal and external changes within the body, not only as phagocytes in defense against microbes and in clearance of dead and senescent cells, but also through trophic, regulatory and repair functions.  In this review, we describe macrophage phenotypic heterogeneity in different tissue environments, drawing particular attention to organ-specific functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz4h1xVWAXr7Vg90H21EOLACvtfcHk0lgxSaJMv_j_-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVeksbvN&md5=c487aabab25a12867528dfa8af142d8f</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1186%2Fs12915-017-0392-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12915-017-0392-4%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DS.%26aulast%3DPluddemann%26aufirst%3DA.%26atitle%3DTissue%2520macrophages%253A%2520heterogeneity%2520and%2520functions%26jtitle%3DBMC%2520Biol.%26date%3D2017%26volume%3D15%26spage%3D53%26doi%3D10.1186%2Fs12915-017-0392-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yunna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengru, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidong, C.</span></span> <span> </span><span class="NLM_article-title">Macrophage M1/M2 polarization</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>877</i></span>, <span class="NLM_elocation-id">173090</span> <span class="refDoi"> DOI: 10.1016/j.ejphar.2020.173090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.ejphar.2020.173090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=32234529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BB383ps1GqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=877&publication_year=2020&author=C.+Yunnaauthor=H.+Mengruauthor=W.+Leiauthor=C.+Weidong&title=Macrophage+M1%2FM2+polarization&doi=10.1016%2Fj.ejphar.2020.173090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage M1/M2 polarization</span></div><div class="casAuthors">Yunna Chen; Mengru Hu; Lei Wang; Weidong Chen</div><div class="citationInfo"><span class="NLM_cas:title">European journal of pharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">877</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">173090</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Macrophages can be affected by a variety of factors to change their phenotype and thus affect their function.  Activated macrophages are usually divided into two categories, M1-like macrophages and M2-like macrophages.  Both M1 macrophages and M2 macrophages are closely related to inflammatory responses, among which M1 macrophages are mainly involved in pro-inflammatory responses and M2 macrophages are mainly involved in anti-inflammatory responses.  Improving the inflammatory environment by modulating the activation state of macrophages is an effective method for the treatment of diseases.  In this review, we analyzed the mechanism of macrophage polarization from the tumor microenvironment, nanocarriers, nuclear receptor PPARγ, phagocytosis, NF-κB signaling pathways, and other pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8pnXsScpYdgHqQV89nF-2fW6udTcc2eYnzFBYBTP03Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB383ps1GqsA%253D%253D&md5=ed4bbcec65aad7affffdc7ce841fdcaf</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2020.173090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2020.173090%26sid%3Dliteratum%253Aachs%26aulast%3DYunna%26aufirst%3DC.%26aulast%3DMengru%26aufirst%3DH.%26aulast%3DLei%26aufirst%3DW.%26aulast%3DWeidong%26aufirst%3DC.%26atitle%3DMacrophage%2520M1%252FM2%2520polarization%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2020%26volume%3D877%26doi%3D10.1016%2Fj.ejphar.2020.173090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Binding site of dasatinib to kinases (pink) and the modifiable functional group (green). (B) Chemical structure of the reference compound <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1</b>–<b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) dasatinib, succinic anhydride, triethylamine, DMF, room temperature (rt), 48 h, and 90%; (b) (i) K<sub>2</sub>CO<sub>3</sub>, 3-nitrophthalphthalonitrile, acetonitrile, and 70 °C and (ii) triethylene glycol, 90 °C, 7 h, and 65%; (c) phthalonitrile, n-pentanol, and 100 °C and (ii) Zn(OAc)<sub>2</sub>, diazabicyclo[5.4.0]undec-7-ene, 130 °C, 7 h, and 12%; (d) <b>1</b>, EDCI, DMAP, DMF, rt, 24 h, and 7%.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. UV/vis absorption spectra of (A) <b>4</b> and (B) <b>5</b> at different concentrations in DMF. The inset shows the linear relationship of absorbance (Q band at 677 and 678 nm, respectively) and concentration (0.5–3.0 and 1.0–6.0 μM, respectively).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <i>In vitro</i> cellular uptake study. The fluorescence intensity profiles and the mean intracellular fluorescence intensities of (A) CEM cells incubated with <b>4</b> and <b>5</b> (both at 1 μM) for 1 h, (B) CEM cells pretreated with free dasatinib (0, 10, 20, 30, and 50 μM) for 1 h, followed by incubation with <b>4</b> (1 μM) for a further 1 h, (C) CEM and HELF cells co-incubated with <b>4</b> (1 μM) in the same cell culture dishes for 1 h, and (D) CEM and HELF cells co-incubated with <b>5</b> (1 μM) in the same cell culture dishes for 1 h. All of the experimental under the same conditions determined by flow cytometry. The compounds were in a culture medium with 0.78% <i>N</i>,<i>N</i>-dimethylacetamide (DMAC), 0.20% 1,2-propylene glycol, and 0.02% Cremophor EL (CEL) (v/v) prior to addition to the cells. Data are expressed as mean values ± standard error of mean (SEM) value of three independent experiments (*<i>p</i> < 0.05, <sup>**</sup><i>p</i> < 0.01, <sup>***</sup><i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <i>In vitro</i> photodynamic activities. (A) Cytotoxicity toward CEM cells by incubation with <b>4</b>, <b>5</b>, dasatinib, and the control for 1 h under light illumination (λ = 670 nm, 4 mW·cm<sup>–2</sup>, 0.48 J·cm<sup>–2</sup>). (B) Cytotoxicity toward CEM cells by incubation with <b>4</b>, <b>5</b>, dasatinib, and the control for 1 h in the absence of irradiation. The compounds were in a culture medium with 0.1% or less mixed organic solvents (78% DMAC, 20% 1,2-propylene glycol, and 2% Cremophor EL) (v/v) prior to addition to the cells. Data are expressed as mean values ± standard error of mean (SEM) value of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Confocal fluorescence images of CEM cells treated with Hoechst 33258, Lyso-Tracker DND-26, and Mito-Tracker Green FM (column 2) and <b>4</b> (column 3); the merged images (column 4) and the fluorescence colocalization of <b>4</b> with trackers traced along the green lines in the merged images (column 5, <i>r</i> = overlap ratio). The scale bar is 10 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <i>In vivo</i> specificity study using nude mice bearing CEM tumors. (A) Three-dimensional fluorescence images based on FMT at 0, 2, 6, and 12 h after administration of <b>4</b> and <b>5</b>. (B) Changes in the mean tumor content of <b>4</b> and <b>5</b> over time were compared. Compounds <b>4</b> and <b>5</b> were present in PBS with 0.78% DMAC, 0.20% 1,2-propylene glycol, and 0.02% Cremophor EL (v/v) prior to injection in the mice. Data are presented as mean ± standard deviation (SD) (<i>n</i> = 3) (*<i>p</i> < 0.05, <sup>**</sup><i>p</i> < 0.01, <sup>***</sup><i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <i>In vivo</i> PDT study of nude mice bearing CEM tumors. (A) Photos of mice at 0, 1, 7, and 16 days post treatment. (B) Pictures of tumors stripped from mice at 16 days after treatment. (C) Tumor volume change curves after PDT treatment. (D) Average tumor weight after PDT treatment. (E) Body weight change curves of mice during 16 days. (F) Hematoxylin and eosin (H&E) staining of tumor tissues. The compounds were in PBS with 0.78% DMAC, 0.20% 1,2-propylene glycol, and 0.02% Cremophor EL (v/v) prior to injection in the mice. Data are presented as mean ± SD (<i>n</i> = 5) (*<i>p</i> < 0.05, <sup>**</sup><i>p</i> < 0.01, <sup>***</sup><i>p</i> < 0.001). The scale bar is 50 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/medium/jm0c01072_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Immunohistochemical staining of tumor tissues sections. (A) Staining of different antibodies in the <b>4</b> group: (a) DAPI (blue), (b) NK1.1 (red), (c) CD19 (cyan), (d) F4–80 (yellow), (e) CD163 (pink), and (f) Ki67 (green). (B) Five antibodies’ expression levels in the four groups: (a) NK1.1, (b) CD19, (c) F4–80, (d) CD163, and (e) Ki67. Data are presented as mean ± SD (<i>n</i> = 3) (*<i>p</i> < 0.05, <sup>**</sup><i>p</i> < 0.01, <sup>***</sup><i>p</i> < 0.001). The scale bar is 100 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01072/20201218/images/large/jm0c01072_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01072&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46366" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46366" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 85 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantarjian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabbour, E. J.</span></span> <span> </span><span class="NLM_article-title">Adult acute lymphoblastic leukemia</span>. <i>Mayo Clin. Proc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">1645</span>– <span class="NLM_lpage">1666</span>, <span class="refDoi"> DOI: 10.1016/j.mayocp.2016.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.mayocp.2016.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=27814839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BC2snjtFCksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2016&pages=1645-1666&author=S.+Paulauthor=H.+Kantarjianauthor=E.+J.+Jabbour&title=Adult+acute+lymphoblastic+leukemia&doi=10.1016%2Fj.mayocp.2016.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Adult Acute Lymphoblastic Leukemia</span></div><div class="casAuthors">Paul Shilpa; Kantarjian Hagop; Jabbour Elias J</div><div class="citationInfo"><span class="NLM_cas:title">Mayo Clinic proceedings</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1645-1666</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Conventional cytotoxic chemotherapy used to treat acute lymphoblastic leukemia (ALL) results in high cure rates in pediatric patients but is suboptimal in the treatment of adult patients.  The 5-year overall survival is approximately 90% in children and 30% to 40% in adults and elderly patients.  Adults with ALL tend to have higher risk factors at diagnosis, more comorbidities, and increasing age that often requires dose reductions.  Major advancements have been made in redefining the pathologic classification of ALL, identifying new cytogenetic-molecular abnormalities, and developing novel targeted agents in order to improve survival.  The addition of new monoclonal antibodies and tyrosine kinase inhibitors to conventional chemotherapy in the frontline setting has resulted in increased rates of complete remission and overall survival.  These new developments are changing the treatment of adult ALL from a "one therapy fits all" approach to individualized treatment based on patient's cytogenetic and molecular profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXUmUA9vzNdb5XHngOXiV_fW6udTcc2ebYNOq5e658u7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snjtFCksw%253D%253D&md5=a98b4dd3e8a8a3f0fb8f4b6bfb9e4d1d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.mayocp.2016.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mayocp.2016.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DS.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DJabbour%26aufirst%3DE.%2BJ.%26atitle%3DAdult%2520acute%2520lymphoblastic%2520leukemia%26jtitle%3DMayo%2520Clin.%2520Proc.%26date%3D2016%26volume%3D91%26spage%3D1645%26epage%3D1666%26doi%3D10.1016%2Fj.mayocp.2016.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Styczynski, J.</span></span> <span> </span><span class="NLM_article-title">A step forward in acute lymphoblastic leukemia</span>. <i>Transl. Pediatr.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=26835266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BC28nmvVegtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2012&pages=68-69&author=J.+Styczynski&title=A+step+forward+in+acute+lymphoblastic+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A step forward in acute lymphoblastic leukemia</span></div><div class="casAuthors">Styczynski Jan</div><div class="citationInfo"><span class="NLM_cas:title">Translational pediatrics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">68-9</span>
        ISSN:<span class="NLM_cas:issn">2224-4344</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAM8q032c8iEPI-fCgwosgfW6udTcc2ebYNOq5e658u7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28nmvVegtw%253D%253D&md5=a6a39e181b33eae4d56d5b1ff55c8231</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStyczynski%26aufirst%3DJ.%26atitle%3DA%2520step%2520forward%2520in%2520acute%2520lymphoblastic%2520leukemia%26jtitle%3DTransl.%2520Pediatr.%26date%3D2012%26volume%3D1%26spage%3D68%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdul-Hay, M.</span></span> <span> </span><span class="NLM_article-title">Acute lymphoblastic leukemia: a comprehensive review and 2017 update</span>. <i>Blood Cancer J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e577</span> <span class="refDoi"> DOI: 10.1038/bcj.2017.53</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fbcj.2017.53" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=28665419" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&author=T.+Terwilligerauthor=M.+Abdul-Hay&title=Acute+lymphoblastic+leukemia%3A+a+comprehensive+review+and+2017+update&doi=10.1038%2Fbcj.2017.53"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fbcj.2017.53&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbcj.2017.53%26sid%3Dliteratum%253Aachs%26aulast%3DTerwilliger%26aufirst%3DT.%26aulast%3DAbdul-Hay%26aufirst%3DM.%26atitle%3DAcute%2520lymphoblastic%2520leukemia%253A%2520a%2520comprehensive%2520review%2520and%25202017%2520update%26jtitle%3DBlood%2520Cancer%2520J.%26date%3D2017%26volume%3D7%26doi%3D10.1038%2Fbcj.2017.53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, D.</span></span> <span> </span><span class="NLM_article-title">Sgc8 aptamer targeted glutathione-responsive nanoassemblies containing Ara-C prodrug for the treatment of acute lymphoblastic leukemia</span>. <i>Nanoscale</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">23000</span>– <span class="NLM_lpage">23012</span>, <span class="refDoi"> DOI: 10.1039/C9NR07391D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2FC9NR07391D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31769777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFamtr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=23000-23012&author=Z.+Fangauthor=X.+Wangauthor=Y.+Sunauthor=R.+Fanauthor=Z.+Liuauthor=R.+Guoauthor=D.+Xie&title=Sgc8+aptamer+targeted+glutathione-responsive+nanoassemblies+containing+Ara-C+prodrug+for+the+treatment+of+acute+lymphoblastic+leukemia&doi=10.1039%2FC9NR07391D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Sgc8 aptamer targeted glutathione-responsive nanoassemblies containing Ara-C prodrug for the treatment of acute lymphoblastic leukemia</span></div><div class="casAuthors">Fang, Zhigang; Wang, Xiaozhen; Sun, Yanling; Fan, Ruifang; Liu, Zhong; Guo, Rui; Xie, Deming</div><div class="citationInfo"><span class="NLM_cas:title">Nanoscale</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">23000-23012</span>CODEN:
                <span class="NLM_cas:coden">NANOHL</span>;
        ISSN:<span class="NLM_cas:issn">2040-3372</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cytarabine (Ara-C) is an essential medicine used in the clin. treatment of acute lymphoblastic leukemia.  However, Ara-C suffers from high hydrophilicity, rapid plasma degrdn. and significant side effects.  Thus, herein, to eliminate the limitations of Ara-C in the treatment of leukemia, Sgc8 aptamer targeting and glutathione (GSH)-responsive polymeric micelles (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="f1a1b2bddc8282dcb08390b1a29692c9dcb3a2b0">[email protected]</a>) were prepd.  The prodrug was synthesized via covalent bond formation between acryloyl chloride-terminal PCL-ss-PCL and Ara-C, and surface decoration with Sgc8-bovine serum albumin (Sgc8-BSA).  The obtained <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="cb9b8887e6b8b8e68ab9aa8b98aca8f3e689988a">[email protected]</a> exhibited good GSH-responsive drug release behavior, obvious targetability and sufficient antitumor effect to acute lymphoblastic leukemia (ALL) cells (CCRF-CEM).  A hemolysis test was further carried out to demonstrate that these polymeric micelles are safe to be administrated i.v.  Compared with free Ara-C, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="3e6e7d72134d4d137f4c5f7e6d595d06137c6d7f">[email protected]</a> significantly enhanced tumor growth inhibition in mice bearing CCRF-CEM xenograft tumors, while causing little side effects, and improved the survival rate of CCRF-CEM tumor-bearing mice in vivo.  Therefore, this new self-assembling small mol. prodrug equipped with Sgc8 targeting function is a potential treatment for the targeted therapy of acute lymphoblastic leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyVcF9FDjaabVg90H21EOLACvtfcHk0lhSbK1-0pGyIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFamtr%252FF&md5=b5b83859897b9ab949c36c5a5eb3ddfb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1039%2FC9NR07391D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9NR07391D%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DXie%26aufirst%3DD.%26atitle%3DSgc8%2520aptamer%2520targeted%2520glutathione-responsive%2520nanoassemblies%2520containing%2520Ara-C%2520prodrug%2520for%2520the%2520treatment%2520of%2520acute%2520lymphoblastic%2520leukemia%26jtitle%3DNanoscale%26date%3D2019%26volume%3D11%26spage%3D23000%26epage%3D23012%26doi%3D10.1039%2FC9NR07391D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogueira, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariotto, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabroff, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfano, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span> <span> </span><span class="NLM_article-title">Cancer treatment and survivorship statistics, 2019</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.3322/caac.21565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.3322%2Fcaac.21565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31184787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BB3M3ltlemug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2019&pages=363-385&author=K.+D.+Millerauthor=L.+Nogueiraauthor=A.+B.+Mariottoauthor=J.+H.+Rowlandauthor=K.+R.+Yabroffauthor=C.+M.+Alfanoauthor=A.+Jemalauthor=J.+L.+Kramerauthor=R.+L.+Siegel&title=Cancer+treatment+and+survivorship+statistics%2C+2019&doi=10.3322%2Fcaac.21565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer treatment and survivorship statistics, 2019</span></div><div class="casAuthors">Miller Kimberly D; Jemal Ahmedin; Siegel Rebecca L; Nogueira Leticia; Yabroff K Robin; Jemal Ahmedin; Mariotto Angela B; Rowland Julia H; Alfano Catherine M; Kramer Joan L</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">363-385</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The number of cancer survivors continues to increase in the United States because of the growth and aging of the population as well as advances in early detection and treatment.  To assist the public health community in better serving these individuals, the American Cancer Society and the National Cancer Institute collaborate every 3 years to estimate cancer prevalence in the United States using incidence and survival data from the Surveillance, Epidemiology, and End Results cancer registries; vital statistics from the Centers for Disease Control and Prevention's National Center for Health Statistics; and population projections from the US Census Bureau.  Current treatment patterns based on information in the National Cancer Data Base are presented for the most prevalent cancer types.  Cancer-related and treatment-related short-term, long-term, and late health effects are also briefly described.  More than 16.9 million Americans (8.1 million males and 8.8 million females) with a history of cancer were alive on January 1, 2019; this number is projected to reach more than 22.1 million by January 1, 2030 based on the growth and aging of the population alone.  The 3 most prevalent cancers in 2019 are prostate (3,650,030), colon and rectum (776,120), and melanoma of the skin (684,470) among males, and breast (3,861,520), uterine corpus (807,860), and colon and rectum (768,650) among females.  More than one-half (56%) of survivors were diagnosed within the past 10 years, and almost two-thirds (64%) are aged 65 years or older.  People with a history of cancer have unique medical and psychosocial needs that require proactive assessment and management by follow-up care providers.  Although there are growing numbers of tools that can assist patients, caregivers, and clinicians in navigating the various phases of cancer survivorship, further evidence-based resources are needed to optimize care.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTqS-tR1uHDx5ggzHGM8X5CfW6udTcc2eaVQgDzjZ6vprntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3ltlemug%253D%253D&md5=3bcced5db38c65d9d98364c3884a21d9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21565%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DNogueira%26aufirst%3DL.%26aulast%3DMariotto%26aufirst%3DA.%2BB.%26aulast%3DRowland%26aufirst%3DJ.%2BH.%26aulast%3DYabroff%26aufirst%3DK.%2BR.%26aulast%3DAlfano%26aufirst%3DC.%2BM.%26aulast%3DJemal%26aufirst%3DA.%26aulast%3DKramer%26aufirst%3DJ.%2BL.%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26atitle%3DCancer%2520treatment%2520and%2520survivorship%2520statistics%252C%25202019%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2019%26volume%3D69%26spage%3D363%26epage%3D385%26doi%3D10.3322%2Fcaac.21565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Portell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Advani, A.</span></span> <span> </span><span class="NLM_article-title">Antibody therapy for acute lymphoblastic leukemia</span>. <i>Curr. Hematol. Malig. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1007/s11899-012-0120-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1007%2Fs11899-012-0120-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=22422550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BC38vntVelsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=153-159&author=C.+Portellauthor=A.+Advani&title=Antibody+therapy+for+acute+lymphoblastic+leukemia&doi=10.1007%2Fs11899-012-0120-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody therapy for acute lymphoblastic leukemia</span></div><div class="casAuthors">Portell Craig A; Advani Anjali S</div><div class="citationInfo"><span class="NLM_cas:title">Current hematologic malignancy reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Advances in chemotherapy administration have made acute lymphoblastic leukemia (ALL) a curable disease; however, most patients will relapse, despite readily attaining a complete remission.  Treatment of relapse has shown dismal results with little advances made in the recent decades.  Antigenic-directed therapy of ALL can complement cytotoxic chemotherapy and has shown encouraging results.  This review will evaluate four antigens in ALL (CD20, CD22, CD52, and CD19) and therapeutic strategies to target them.  We will review the clinical and preclinical data surrounding rituximab, epratuzumab, inotuzumab ozogamicin, alemtuzumab, blinatumomab, and chimeric antigen receptor-modified T-cell therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSTtGK2GWcaaCSm0e6ZOaemfW6udTcc2eZdsbiTzRmMxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vntVelsw%253D%253D&md5=ba20fff753568fe09cea2595c487e75f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs11899-012-0120-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11899-012-0120-7%26sid%3Dliteratum%253Aachs%26aulast%3DPortell%26aufirst%3DC.%26aulast%3DAdvani%26aufirst%3DA.%26atitle%3DAntibody%2520therapy%2520for%2520acute%2520lymphoblastic%2520leukemia%26jtitle%3DCurr.%2520Hematol.%2520Malig.%2520Rep.%26date%3D2012%26volume%3D7%26spage%3D153%26epage%3D159%26doi%3D10.1007%2Fs11899-012-0120-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bassan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelzer, D.</span></span> <span> </span><span class="NLM_article-title">Modern therapy of acute lymphoblastic leukemia</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">543</span>, <span class="refDoi"> DOI: 10.1200/JCO.2010.30.1382</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1200%2FJCO.2010.30.1382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=21220592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BC3M7ns1yjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=532-543&author=R.+Bassanauthor=D.+Hoelzer&title=Modern+therapy+of+acute+lymphoblastic+leukemia&doi=10.1200%2FJCO.2010.30.1382"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Modern therapy of acute lymphoblastic leukemia</span></div><div class="casAuthors">Bassan Renato; Hoelzer Dieter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">532-43</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although acute lymphoblastic leukemia is curable in one third of adult patients, results vary greatly on account of different clinical, immunologic, and cytogenetic/genetic characteristics.  These data, along with the kinetics of response to early treatment, help establish the individual risk class with considerable accuracy, and support risk-specific treatments that should warrant optimal results with as little as possible nonrelapse mortality.  Modern first-line therapy consists of standard- and high-dose chemotherapy (increasingly inspired to pediatric principles), hematopoietic stem-cell transplantation, and new targeted therapy, all integrated with the analysis of prognostic factors and the study of subclinical residual disease for key therapeutic decisions.  These changes are improving long-term outcome, which in ongoing studies is expected close to 50% or greater.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQfM1v72oaeokh5eUSa2oe_fW6udTcc2eZdsbiTzRmMxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7ns1yjtw%253D%253D&md5=bd8d0b0bb14736761fce9dff233bc53b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1200%2FJCO.2010.30.1382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2010.30.1382%26sid%3Dliteratum%253Aachs%26aulast%3DBassan%26aufirst%3DR.%26aulast%3DHoelzer%26aufirst%3DD.%26atitle%3DModern%2520therapy%2520of%2520acute%2520lymphoblastic%2520leukemia%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26spage%3D532%26epage%3D543%26doi%3D10.1200%2FJCO.2010.30.1382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moisoiu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodorescu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tranca, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pop, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iluta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blag, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Man, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constantinescu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rus, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buse, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fetica, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selicean, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berindan-Neagoe, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrushev, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bumbea, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanase, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zdrenghea, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomuleasa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanian Soc Bone Marrow, T.</span></span> <span> </span><span class="NLM_article-title">Approach to the adult acute lymphoblastic leukemia patient</span>. <i>J. Clin. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1175</span>, <span class="refDoi"> DOI: 10.3390/jcm8081175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.3390%2Fjcm8081175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslWktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=1175&author=V.+Sasauthor=V.+Moisoiuauthor=P.+Teodorescuauthor=S.+Trancaauthor=L.+Popauthor=S.+Ilutaauthor=S.+Pascaauthor=C.+Blagauthor=S.+Manauthor=A.+Romanauthor=C.+Constantinescuauthor=I.+Rusauthor=M.+Buseauthor=B.+Feticaauthor=M.+Marianauthor=C.+Seliceanauthor=I.+Berindan-Neagoeauthor=B.+Petrushevauthor=H.+Bumbeaauthor=A.+Tanaseauthor=M.+Zdrengheaauthor=S.+Fujiauthor=S.+Kitanoauthor=C.+Tomuleasaauthor=T.+Romanian+Soc+Bone+Marrow&title=Approach+to+the+adult+acute+lymphoblastic+leukemia+patient&doi=10.3390%2Fjcm8081175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Approach to the adult acute lymphoblastic leukemia patient</span></div><div class="casAuthors">Sas, Valentina; Moisoiu, Vlad; Teodorescu, Patric; Tranca, Sebastian; Pop, Laura; Iluta, Sabina; Pasca, Sergiu; Blag, Cristina; Man, Sorin; Roman, Andrei; Constantinescu, Catalin; Rus, Ioana; Buse, Mihail; Fetica, Bogdan; Marian, Mirela; Selicean, Cristina; Berindan-Neagoe, Ioana; Petrushev, Bobe; Bumbea, Horia; Tanase, Alina; Zdrenghea, Mihnea; Fuji, Shigeo; Kitano, Shigehisa; Tomuleasa, Ciprian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1175</span>CODEN:
                <span class="NLM_cas:coden">JCMOHK</span>;
        ISSN:<span class="NLM_cas:issn">2077-0383</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">During recent decades, understanding of the mol. mechanisms of acute lymphoblastic leukemia (ALL) has improved considerably, resulting in better risk stratification of patients and increased survival rates.  Age, white blood cell count (WBC), and specific genetic abnormalities are the most important factors that define risk groups for ALL.  State-of-the-art diagnosis of ALL requires cytol. and cytogenetical analyses, as well as flow cytometry and high-throughput sequencing assays.  An important aspect in the diagnostic characterization of patients with ALL is the identification of the Philadelphia (Ph) chromosome, which warrants the addn. of tyrosine kinase inhibitors (TKI) to the chemotherapy backbone.  Data that support the benefit of hematopoietic stem cell transplantation (HSCT) in high risk patient subsets or in late relapse patients are still questioned and have yet to be detd. conclusive.  This article presents the newly published data in ALL workup and treatment, putting it into perspective for the attending physician in hematol. and oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCcEc_msdOsrVg90H21EOLACvtfcHk0lihKcgFjYDmVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslWktrc%253D&md5=d98a8643ee472bf667c5e53994aef82c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3390%2Fjcm8081175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcm8081175%26sid%3Dliteratum%253Aachs%26aulast%3DSas%26aufirst%3DV.%26aulast%3DMoisoiu%26aufirst%3DV.%26aulast%3DTeodorescu%26aufirst%3DP.%26aulast%3DTranca%26aufirst%3DS.%26aulast%3DPop%26aufirst%3DL.%26aulast%3DIluta%26aufirst%3DS.%26aulast%3DPasca%26aufirst%3DS.%26aulast%3DBlag%26aufirst%3DC.%26aulast%3DMan%26aufirst%3DS.%26aulast%3DRoman%26aufirst%3DA.%26aulast%3DConstantinescu%26aufirst%3DC.%26aulast%3DRus%26aufirst%3DI.%26aulast%3DBuse%26aufirst%3DM.%26aulast%3DFetica%26aufirst%3DB.%26aulast%3DMarian%26aufirst%3DM.%26aulast%3DSelicean%26aufirst%3DC.%26aulast%3DBerindan-Neagoe%26aufirst%3DI.%26aulast%3DPetrushev%26aufirst%3DB.%26aulast%3DBumbea%26aufirst%3DH.%26aulast%3DTanase%26aufirst%3DA.%26aulast%3DZdrenghea%26aufirst%3DM.%26aulast%3DFuji%26aufirst%3DS.%26aulast%3DKitano%26aufirst%3DS.%26aulast%3DTomuleasa%26aufirst%3DC.%26aulast%3DRomanian%2BSoc%2BBone%2BMarrow%26aufirst%3DT.%26atitle%3DApproach%2520to%2520the%2520adult%2520acute%2520lymphoblastic%2520leukemia%2520patient%26jtitle%3DJ.%2520Clin.%2520Med.%26date%3D2019%26volume%3D8%26spage%3D1175%26doi%3D10.3390%2Fjcm8081175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldoss, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, A. S.</span></span> <span> </span><span class="NLM_article-title">Advances in adult acute lymphoblastic leukemia therapy</span>. <i>Leuk. Lymphoma</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1050</span>, <span class="refDoi"> DOI: 10.1080/10428194.2017.1354372</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1080%2F10428194.2017.1354372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=28745565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BC1cfhtlarsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2018&pages=1033-1050&author=I.+Aldossauthor=A.+S.+Stein&title=Advances+in+adult+acute+lymphoblastic+leukemia+therapy&doi=10.1080%2F10428194.2017.1354372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in adult acute lymphoblastic leukemia therapy</span></div><div class="casAuthors">Aldoss Ibrahim; Stein Anthony S</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & lymphoma</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1033-1050</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Progress in adult acute lymphoblastic leukemia (ALL) treatment has been met with challenge until recently.  A steady improvement in outcomes is being witnessed among adults with ALL, and it will be enhanced further with early referral of newly diagnosed ALL patients to specialized centers, enrolling more ALL adults in clinical trials, adopting pediatric-inspired ALL regimens in younger adults, tailoring treatments according to minimal residual disease response and disease genetics, incorporating novel therapies and tyrosine kinase inhibitors in frontline regimens, early referral to transplant when indicated, expanding the donor pool, and developing more effective salvage therapies for relapsed/refractory ALL.  In this review, we will discuss the most significant advances in treating adult ALL observed in the last five years that have the potential to enhance adult ALL treatment and outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQwlCI9LSUG9acY7HFp97qMfW6udTcc2eYTahryl7behrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfhtlarsw%253D%253D&md5=2ea6b5c9cd6a23361de30459af3c01ce</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1080%2F10428194.2017.1354372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10428194.2017.1354372%26sid%3Dliteratum%253Aachs%26aulast%3DAldoss%26aufirst%3DI.%26aulast%3DStein%26aufirst%3DA.%2BS.%26atitle%3DAdvances%2520in%2520adult%2520acute%2520lymphoblastic%2520leukemia%2520therapy%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2018%26volume%3D59%26spage%3D1033%26epage%3D1050%26doi%3D10.1080%2F10428194.2017.1354372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Araujo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logothetis, C.</span></span> <span> </span><span class="NLM_article-title">Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumors</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">500</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2010.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.ctrv.2010.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=20226597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWqsrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2010&pages=492-500&author=J.+Araujoauthor=C.+Logothetis&title=Dasatinib%3A+a+potent+SRC+inhibitor+in+clinical+development+for+the+treatment+of+solid+tumors&doi=10.1016%2Fj.ctrv.2010.02.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors</span></div><div class="casAuthors">Araujo, John; Logothetis, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">492-500</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  SRC is a tyrosine kinase that plays a role in oncogenic, invasive and bone-metastatic processes.  It has therefore been prioritized as a candidate therapeutic target in patients with solid tumors.  Several SRC inhibitors are now in development, of which dasatinib has been most explored.  Preclin. studies in a wide variety of solid tumor cell lines, including prostate, breast and glioma, have shown that that dasatinib acts as a cytostatic agent, inhibiting the processes of cell proliferation, invasion and metastasis.  Dasatinib also inhibits the activity of osteoclasts, which have a major role in the development of metastatic bone lesions.  Dasatinib has additive or synergistic activity in combination with a no. of other agents, including cytotoxic agents and targeted therapies, providing a rationale for combination treatment in a clin. setting.  Emerging clin. data with dasatinib support exptl. observations, with preliminary phase 1 and 2 data demonstrating activity, both as a single agent and as combination therapy, in a range of solid tumors.  Future clin. trials will further assess the clin. value of SRC inhibition with dasatinib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDmKVikY4klbVg90H21EOLACvtfcHk0lihKcgFjYDmVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWqsrrK&md5=b3ab6c318777b619d8b8ba72d0817ac6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2010.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2010.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DAraujo%26aufirst%3DJ.%26aulast%3DLogothetis%26aufirst%3DC.%26atitle%3DDasatinib%253A%2520a%2520potent%2520SRC%2520inhibitor%2520in%2520clinical%2520development%2520for%2520the%2520treatment%2520of%2520solid%2520tumors%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2010%26volume%3D36%26spage%3D492%26epage%3D500%26doi%3D10.1016%2Fj.ctrv.2010.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malkan, U. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etgul, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aydin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haznedaroglu, I. C.</span></span> <span> </span><span class="NLM_article-title">Reply: management of De Novo CML and imatinib-induced acute rhabdomyolysis with the second-generation TKI, dasatinib</span>. <i>Ann. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">336</span>, <span class="refDoi"> DOI: 10.1177/1060028016629981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1177%2F1060028016629981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=26861992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ajsbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2016&pages=336&author=U.+Y.+Malkanauthor=G.+Gunesauthor=S.+Etgulauthor=T.+Aslanauthor=S.+Aydinauthor=I.+C.+Haznedaroglu&title=Reply%3A+management+of+De+Novo+CML+and+imatinib-induced+acute+rhabdomyolysis+with+the+second-generation+TKI%2C+dasatinib&doi=10.1177%2F1060028016629981"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Reply: management of de novo CML and imatinib-induced acute rhabdomyolysis with the second-generation TKI, dasatinib</span></div><div class="casAuthors">Malkan, Umit Y.; Gunes, Gursel; Etgul, Sezgin; Aslan, Tuncay; Aydin, Seda; Haznedaroglu, Ibrahim C.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Pharmacotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">336</span>CODEN:
                <span class="NLM_cas:coden">APHRER</span>;
        ISSN:<span class="NLM_cas:issn">1542-6270</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A polemic in response to Torres et al is given.  In this article the author discusses about the management of de novo CML and imatinib-induced acute rhabdomyolysis with the second-generation TKI, dasatinib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1T4q8KroUr7Vg90H21EOLACvtfcHk0lhxSiSt_7rnXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ajsbzL&md5=3f2cc0e16cbad7f174f2437822caa985</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1177%2F1060028016629981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1060028016629981%26sid%3Dliteratum%253Aachs%26aulast%3DMalkan%26aufirst%3DU.%2BY.%26aulast%3DGunes%26aufirst%3DG.%26aulast%3DEtgul%26aufirst%3DS.%26aulast%3DAslan%26aufirst%3DT.%26aulast%3DAydin%26aufirst%3DS.%26aulast%3DHaznedaroglu%26aufirst%3DI.%2BC.%26atitle%3DReply%253A%2520management%2520of%2520De%2520Novo%2520CML%2520and%2520imatinib-induced%2520acute%2520rhabdomyolysis%2520with%2520the%2520second-generation%2520TKI%252C%2520dasatinib%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2016%26volume%3D50%26spage%3D336%26doi%3D10.1177%2F1060028016629981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kostos, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burbury, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prince, H. M.</span></span> <span> </span><span class="NLM_article-title">Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: case report</span>. <i>Platelets</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">811</span>, <span class="refDoi"> DOI: 10.3109/09537104.2015.1049138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.3109%2F09537104.2015.1049138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=26029798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCqtbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=809-811&author=L.+Kostosauthor=K.+Burburyauthor=G.+Srivastavaauthor=H.+M.+Prince&title=Gastrointestinal+bleeding+in+a+chronic+myeloid+leukaemia+patient+precipitated+by+dasatinib-induced+platelet+dysfunction%3A+case+report&doi=10.3109%2F09537104.2015.1049138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case report</span></div><div class="casAuthors">Kostos, Louise; Burbury, Kate; Srivastava, Gaurav; Prince, H. Miles</div><div class="citationInfo"><span class="NLM_cas:title">Platelets</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">809-811</span>CODEN:
                <span class="NLM_cas:coden">PLTEEF</span>;
        ISSN:<span class="NLM_cas:issn">0953-7104</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Bleeding in patients with chronic myeloid leukemia (CML) receiving the second-line tyrosine kinase inhibitor (TKI) dasatinib is a well-documented side effect, occurring in up to 24% of patients.  In most cases, it is attributed directly to a secondary grade 3 or 4 thrombocytopaenia.  Platelet dysfunction pptd. by dasatinib has been demonstrated in multiple in vitro and in vivo studies; however, there is currently no correlative data that definitively assocs. this with clin. significant bleeding.  In this case, we report a patient with chronic-phase CML receiving dasatinib who developed significant gastrointestinal bleeding secondary to angiodysplasia in the absence of a severe thrombocytopaenia or coagulopathy.  Platelet function testing on the PFA-100 assay and formal platelet aggregometry demonstrated impaired platelet aggregation, however, upon cessation of dasatinib, platelet function normalized and the bleeding resolved without further intervention.  This case demonstrates that dasatinib-induced platelet dysfunction can cause clin. significant bleeding and highlights the need for physicians to be aware of this adverse effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU_gh5qaGv87Vg90H21EOLACvtfcHk0lhxSiSt_7rnXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCqtbrN&md5=ad86acef8c9ea09db1ccc6eee13f1747</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3109%2F09537104.2015.1049138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F09537104.2015.1049138%26sid%3Dliteratum%253Aachs%26aulast%3DKostos%26aufirst%3DL.%26aulast%3DBurbury%26aufirst%3DK.%26aulast%3DSrivastava%26aufirst%3DG.%26aulast%3DPrince%26aufirst%3DH.%2BM.%26atitle%3DGastrointestinal%2520bleeding%2520in%2520a%2520chronic%2520myeloid%2520leukaemia%2520patient%2520precipitated%2520by%2520dasatinib-induced%2520platelet%2520dysfunction%253A%2520case%2520report%26jtitle%3DPlatelets%26date%3D2015%26volume%3D26%26spage%3D809%26epage%3D811%26doi%3D10.3109%2F09537104.2015.1049138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aleshin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, R. S.</span></span> <span> </span><span class="NLM_article-title">SRC: a century of science brought to the clinic</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1593/neo.10328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1593%2Fneo.10328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=20689754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVClsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=599-607&author=A.+Aleshinauthor=R.+S.+Finn&title=SRC%3A+a+century+of+science+brought+to+the+clinic&doi=10.1593%2Fneo.10328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">SRC: a century of science brought to the clinic</span></div><div class="casAuthors">Aleshin, Alexey; Finn, Richard S.</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (Ann Arbor, MI, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">599-607</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Neoplasia Press Inc.</span>)
        </div><div class="casAbstract">A review.  The SRC family kinases are the largest family of nonreceptor tyrosine kinases and one of the best-studied targets for cancer therapy.  SRC, arguably the oldest oncogene, has been implicated in pathways regulating proliferation, angiogenesis, invasion and metastasis, and bone metab.  More recently, researchers have proposed that the transforming ability of SRC is linked to its ability to activate key signaling mols. in these pathways, rather than through direct activity.  It has been hypothesized that blocking SRC activation may inhibit these pathways, resulting in antitumor activity.  However, successfully targeting SRC in a clin. setting remains a challenge, and SRC inhibitors have only recently begun to move through clin. development.  Preclin. studies have identified specific mol. "subgroups" and histologies that may be more sensitive to SRC inhibition.  In addn., other studies have demonstrated synergistic interactions between SRC inhibitors and other targeted therapies and cytotoxics.  In this review, we summarize SRC biol. and how it has been applied to the clin. development of SRC inhibitors.  The status of SRC inhibitors, including dasatinib, saracatinib, and bosutinib, which are in phase 1, 2, and 3 trials, is highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_g3wyg6sIcLVg90H21EOLACvtfcHk0li_xKrOibeocA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVClsrs%253D&md5=4eaa783194fb3abb0a8234f4e16d5af4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1593%2Fneo.10328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.10328%26sid%3Dliteratum%253Aachs%26aulast%3DAleshin%26aufirst%3DA.%26aulast%3DFinn%26aufirst%3DR.%2BS.%26atitle%3DSRC%253A%2520a%2520century%2520of%2520science%2520brought%2520to%2520the%2520clinic%26jtitle%3DNeoplasia%26date%3D2010%26volume%3D12%26spage%3D599%26epage%3D607%26doi%3D10.1593%2Fneo.10328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakadiya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanjiv, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. C.</span></span> <span> </span><span class="NLM_article-title">Multidrug-resistant cells overexpressing P-glycoprotein are susceptible to DNA crosslinking agents due to attenuated Src/nuclear EGFR cascade-activated DNA repair activity</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1144</span>– <span class="NLM_lpage">1154</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fonc.2012.133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=22525278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFajsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=1144-1154&author=P.+C.+Leeauthor=H.+J.+Leeauthor=R.+Kakadiyaauthor=K.+Sanjivauthor=T.+L.+Suauthor=T.+C.+Lee&title=Multidrug-resistant+cells+overexpressing+P-glycoprotein+are+susceptible+to+DNA+crosslinking+agents+due+to+attenuated+Src%2Fnuclear+EGFR+cascade-activated+DNA+repair+activity&doi=10.1038%2Fonc.2012.133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug-resistant cells overexpressing P-glycoprotein are susceptible to DNA crosslinking agents due to attenuated Src/nuclear EGFR cascade-activated DNA repair activity</span></div><div class="casAuthors">Lee, P.-C.; Lee, H.-J.; Kakadiya, R.; Sanjiv, K.; Su, T.-L.; Lee, T.-C.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1144-1154</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We synthesized several novel bifunctional alkylating derivs. of 3a-aza-cyclopenta[a]indene (BO-1012, BO-1005, BO-1099 and BO-1101) that are potent DNA interstrand crosslinking agents.  In in vitro cytotoxicity assay, these compds. were more cytotoxic to multidrug-resistant (MDR) cells, such as KBvin10, KBtax50 and CEM/VBL, than their parental cells.  Using a xenograft model, BO-1012, at a dose of 5 mg/kg, partially suppressed the growth of parental KB cells but completely suppressed the growth of KBvin10 cells in nude mice.  In exploring the possible mechanism, we found that DNA double-strand break (DSB) repair activity in MDR cells, KBvin10 and CEM/VBL, was significantly reduced compared with their parental cells, KB and CEM.  Reduced DSB repair activity in KBvin10 cells was likely due to a defect in nuclear translocation of DNA-dependent protein kinase (DNA-PK), a component of the non-homologous end-joining repair machinery.  Furthermore, BO-1012-induced DNA-PK translocation from the cytosol into the nucleus in KB cells is assocd. with the activation of the Src/nuclear epidermal growth factor receptor (EGFR) cascade, which is defective in MDR cells.  As knockdown of P-glycoprotein (P-gp) by siRNA reactivated the Src/nuclear EGFR cascade, DNA-PK translocation and DNA repair activity in MDR cells, overexpression of P-gp attenuates the activity of DNA DSB repair through suppression of Src/nuclear EGFR cascade.  Therefore, DNA interstrand crosslinking agents may have potential therapeutic use against P-gp-overexpressing MDR cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYHDTx6Q_Eq7Vg90H21EOLACvtfcHk0li_xKrOibeocA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFajsbc%253D&md5=428754f87994cad5091302c41436604c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.133%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DP.%2BC.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DKakadiya%26aufirst%3DR.%26aulast%3DSanjiv%26aufirst%3DK.%26aulast%3DSu%26aufirst%3DT.%2BL.%26aulast%3DLee%26aufirst%3DT.%2BC.%26atitle%3DMultidrug-resistant%2520cells%2520overexpressing%2520P-glycoprotein%2520are%2520susceptible%2520to%2520DNA%2520crosslinking%2520agents%2520due%2520to%2520attenuated%2520Src%252Fnuclear%2520EGFR%2520cascade-activated%2520DNA%2520repair%2520activity%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D1144%26epage%3D1154%26doi%3D10.1038%2Fonc.2012.133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yeatman, T. J.</span></span> <span> </span><span class="NLM_article-title">A renaissance for SRC</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">470</span>– <span class="NLM_lpage">480</span>, <span class="refDoi"> DOI: 10.1038/nrc1366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fnrc1366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=15170449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVaisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=470-480&author=T.+J.+Yeatman&title=A+renaissance+for+SRC&doi=10.1038%2Fnrc1366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A renaissance for SRC</span></div><div class="casAuthors">Yeatman, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">470-480</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  The c-SRC non-receptor tyrosine kinase is overexpressed and activated in a large no. of human malignancies and has been linked to the development of cancer and progression to distant metastases.  These observations have led to the recent targeting of c-SRC for the development of anticancer therapeutics, which show promise as a new avenue for cancer treatment.  Despite this, however, the precise functions of c-SRC in cancer remain unclear.  In addn. to increasing cell proliferation, a key role of c-SRC in cancer seems to be to promote invasion and motility, functions that might contribute to tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCGFL31NDP4LVg90H21EOLACvtfcHk0liYWdWMjWIAjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVaisbo%253D&md5=e14e862826b2881721d0f6bb14356650</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrc1366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1366%26sid%3Dliteratum%253Aachs%26aulast%3DYeatman%26aufirst%3DT.%2BJ.%26atitle%3DA%2520renaissance%2520for%2520SRC%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D470%26epage%3D480%26doi%3D10.1038%2Fnrc1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serafin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuzzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minuzzo, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinazza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolozzi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bresolin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porcu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frasson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Indraccolo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Accordi, B.</span></span> <span> </span><span class="NLM_article-title">Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">2750</span>– <span class="NLM_lpage">2761</span>, <span class="refDoi"> DOI: 10.1182/blood-2017-05-784603</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1182%2Fblood-2017-05-784603" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=29101238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Cjur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2017&pages=2750-2761&author=V.+Serafinauthor=G.+Capuzzoauthor=G.+Milaniauthor=S.+A.+Minuzzoauthor=M.+Pinazzaauthor=R.+Bortolozziauthor=S.+Bresolinauthor=E.+Porcuauthor=C.+Frassonauthor=S.+Indraccoloauthor=G.+Bassoauthor=B.+Accordi&title=Glucocorticoid+resistance+is+reverted+by+LCK+inhibition+in+pediatric+T-cell+acute+lymphoblastic+leukemia&doi=10.1182%2Fblood-2017-05-784603"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia</span></div><div class="casAuthors">Serafin, Valentina; Capuzzo, Giorgia; Milani, Gloria; Minuzzo, Sonia Anna; Pinazza, Marica; Bortolozzi, Roberta; Bresolin, Silvia; Porcu, Elena; Frasson, Chiara; Indraccolo, Stefano; Basso, Giuseppe; Accordi, Benedetta</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2750-2761</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">1528-0020</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Pediatric T-acute lymphoblastic leukemia (T-ALL) patients often display resistance to glucocorticoid (GC) treatment.  These patients, classified as prednisone poor responders (PPR), have poorer outcome than do the other pediatric T-ALL patients receiving a high-risk adapted therapy.  Because glucocorticoids are administered to ALL patients during all the different phases of therapy, GC resistance represents an important challenge to improving the outcome for these patients.  Mechanisms underlying resistance are not yet fully unraveled; thus our research focused on the identification of deregulated signaling pathways to point out new targeted approaches.  We first identified, by reverse-phase protein arrays, the lymphocyte cell-specific protein-tyrosine kinase (LCK) as aberrantly activated in PPR patients.  We showed that LCK inhibitors, such as dasatinib, bosutinib, nintedanib, and WH-4-023, are able to induce cell death in GC-resistant T-ALL cells, and remarkably, cotreatment with dexamethasone is able to reverse GC resistance, even at therapeutic drug concns.  This was confirmed by specific LCK gene silencing and ex vivo combined treatment of cells from PPR patient-derived xenografts.  Moreover, we obsd. that LCK hyperactivation in PPR patients upregulates the calcineurin/nuclear factor of activated T cells signaling triggering to interleukin-4 (IL-4) overexpression.  GC-sensitive cells cultured with IL-4 display an increased resistance to dexamethasone, whereas the inhibition of IL-4 signaling could increase GC-induced apoptosis in resistant cells.  Treatment with dexamethasone and dasatinib also impaired engraftment of leukemia cells in vivo.  Our results suggest a quickly actionable approach to supporting conventional therapies and overcoming GC resistance in pediatric T-ALL patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQm_rduInbzLVg90H21EOLACvtfcHk0liYWdWMjWIAjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Cjur%252FL&md5=9103800c495bccdd2bac3a7f4496babb</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1182%2Fblood-2017-05-784603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2017-05-784603%26sid%3Dliteratum%253Aachs%26aulast%3DSerafin%26aufirst%3DV.%26aulast%3DCapuzzo%26aufirst%3DG.%26aulast%3DMilani%26aufirst%3DG.%26aulast%3DMinuzzo%26aufirst%3DS.%2BA.%26aulast%3DPinazza%26aufirst%3DM.%26aulast%3DBortolozzi%26aufirst%3DR.%26aulast%3DBresolin%26aufirst%3DS.%26aulast%3DPorcu%26aufirst%3DE.%26aulast%3DFrasson%26aufirst%3DC.%26aulast%3DIndraccolo%26aufirst%3DS.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DAccordi%26aufirst%3DB.%26atitle%3DGlucocorticoid%2520resistance%2520is%2520reverted%2520by%2520LCK%2520inhibition%2520in%2520pediatric%2520T-cell%2520acute%2520lymphoblastic%2520leukemia%26jtitle%3DBlood%26date%3D2017%26volume%3D130%26spage%3D2750%26epage%3D2761%26doi%3D10.1182%2Fblood-2017-05-784603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joosten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seitz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sommerfeld, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenze, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hummel, M.</span></span> <span> </span><span class="NLM_article-title">Histone acetylation and DNA demethylation of T cells result in an anaplastic large cell lymphoma-like phenotype</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.3324/haematol.2011.054619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.3324%2Fhaematol.2011.054619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=22899583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFalurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2013&pages=247-254&author=M.+Joostenauthor=V.+Seitzauthor=K.+Zimmermannauthor=A.+Sommerfeldauthor=E.+Bergauthor=D.+Lenzeauthor=U.+Leserauthor=H.+Steinauthor=M.+Hummel&title=Histone+acetylation+and+DNA+demethylation+of+T+cells+result+in+an+anaplastic+large+cell+lymphoma-like+phenotype&doi=10.3324%2Fhaematol.2011.054619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Histone acetylation and DNA demethylation of T cells result in an anaplastic large cell lymphoma-like phenotype</span></div><div class="casAuthors">Joosten, Maria; Seitz, Volkhard; Zimmermann, Karin; Sommerfeld, Anke; Berg, Erika; Lenze, Dido; Leser, Ulf; Stein, Harald; Hummel, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Haematologica</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-254</span>CODEN:
                <span class="NLM_cas:coden">HAEMAX</span>;
        ISSN:<span class="NLM_cas:issn">0390-6078</span>.
    
            (<span class="NLM_cas:orgname">Ferrata Storti Foundation</span>)
        </div><div class="casAbstract">A characteristic feature of anaplastic large cell lymphoma is the significant repression of the T-cell expression program despite its T-cell origin.  The reasons for this down-regulation of T-cell phenotype are still unknown.  To elucidate whether epigenetic mechanisms are responsible for the loss of the T-cell phenotype, we treated anaplastic large cell lymphoma and T-cell lymphoma/leukemia cell lines (n=4, each) with epigenetic modifiers to evoke DNA demethylation and histone acetylation.  Global gene expression data from treated and untreated cell lines were generated and selected, and differentially expressed genes were evaluated by real-time reverse transcriptase polymerase chain reaction and western blot anal.  Addnl., histone H3 lysine 27 trimethylation was analyzed by chromatin immunopptn.  Combined DNA demethylation and histone acetylation of anaplastic large cell lymphoma cells was not able to reconstitute their T-cell phenotype.  Instead, the same treatment induced in T cells: (i) an up-regulation of anaplastic large cell lymphoma-characteristic genes (e.g. ID2, LGALS1, c-JUN), and (ii) an almost complete extinction of their T-cell phenotype including CD3, LCK and ZAP70.  In addn., suppressive trimethylation of histone H3 lysine 27 of important T-cell transcription factor genes (GATA3, LEF1, TCF1) was present in anaplastic large cell lymphoma cells, which is in line with their absence in primary tumor specimens as demonstrated by immunohistochem.  Our data suggest that epigenetically activated suppressors (e.g. ID2) contribute to the down-regulation of the T-cell expression program in anaplastic large cell lymphoma, which is maintained by trimethylation of histone H3 lysine 27.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppnc9xmdJRt7Vg90H21EOLACvtfcHk0liYWdWMjWIAjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFalurjO&md5=7c7245e4c005d3797afb6528fe3da541</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2011.054619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2011.054619%26sid%3Dliteratum%253Aachs%26aulast%3DJoosten%26aufirst%3DM.%26aulast%3DSeitz%26aufirst%3DV.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DSommerfeld%26aufirst%3DA.%26aulast%3DBerg%26aufirst%3DE.%26aulast%3DLenze%26aufirst%3DD.%26aulast%3DLeser%26aufirst%3DU.%26aulast%3DStein%26aufirst%3DH.%26aulast%3DHummel%26aufirst%3DM.%26atitle%3DHistone%2520acetylation%2520and%2520DNA%2520demethylation%2520of%2520T%2520cells%2520result%2520in%2520an%2520anaplastic%2520large%2520cell%2520lymphoma-like%2520phenotype%26jtitle%3DHaematologica%26date%3D2013%26volume%3D98%26spage%3D247%26epage%3D254%26doi%3D10.3324%2Fhaematol.2011.054619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laukkanen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gronroos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polonen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuusanmaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehtonen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ossenkoppele, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gjertsen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oystein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinaniemi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohi, O.</span></span> <span> </span><span class="NLM_article-title">In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL</span>. <i>Blood Cancer J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e604</span> <span class="refDoi"> DOI: 10.1038/bcj.2017.87</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fbcj.2017.87" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=28885610" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&author=S.+Laukkanenauthor=T.+Gronroosauthor=P.+Polonenauthor=H.+Kuusanmakiauthor=J.+Mehtonenauthor=J.+Cloosauthor=G.+Ossenkoppeleauthor=B.+Gjertsenauthor=B.+Oysteinauthor=C.+Heckmanauthor=M.+Heinaniemiauthor=M.+Kontroauthor=O.+Lohi&title=In+silico+and+preclinical+drug+screening+identifies+dasatinib+as+a+targeted+therapy+for+T-ALL&doi=10.1038%2Fbcj.2017.87"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fbcj.2017.87&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbcj.2017.87%26sid%3Dliteratum%253Aachs%26aulast%3DLaukkanen%26aufirst%3DS.%26aulast%3DGronroos%26aufirst%3DT.%26aulast%3DPolonen%26aufirst%3DP.%26aulast%3DKuusanmaki%26aufirst%3DH.%26aulast%3DMehtonen%26aufirst%3DJ.%26aulast%3DCloos%26aufirst%3DJ.%26aulast%3DOssenkoppele%26aufirst%3DG.%26aulast%3DGjertsen%26aufirst%3DB.%26aulast%3DOystein%26aufirst%3DB.%26aulast%3DHeckman%26aufirst%3DC.%26aulast%3DHeinaniemi%26aufirst%3DM.%26aulast%3DKontro%26aufirst%3DM.%26aulast%3DLohi%26aufirst%3DO.%26atitle%3DIn%2520silico%2520and%2520preclinical%2520drug%2520screening%2520identifies%2520dasatinib%2520as%2520a%2520targeted%2520therapy%2520for%2520T-ALL%26jtitle%3DBlood%2520Cancer%2520J.%26date%3D2017%26volume%3D7%26doi%3D10.1038%2Fbcj.2017.87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.-l.</span></span> <span> </span><span class="NLM_article-title">Transferrin-conjugated polymeric nanomedicine to enhance the anticancer efficacy of edelfosine in acute myeloid leukemia</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2016.05.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.biopha.2016.05.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=27470549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFWhs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2016&pages=51-57&author=Y.+Sunauthor=Z.-l.+Sun&title=Transferrin-conjugated+polymeric+nanomedicine+to+enhance+the+anticancer+efficacy+of+edelfosine+in+acute+myeloid+leukemia&doi=10.1016%2Fj.biopha.2016.05.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Transferrin-conjugated polymeric nanomedicine to enhance the anticancer efficacy of edelfosine in acute myeloid leukemia</span></div><div class="casAuthors">Sun, Yu; Sun, Zhong-liang</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51-57</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In this study, transferrin (Tf)-conjugated polyethylene glycol (PEG)-poly-L-lysine (PLL)-poly(lactic-co-glycolic acid) (PLGA) (PEG-PLL-PLGA)-based micellar formulations were successfully prepd. for the delivery of edelfosine (EDS) in leukemia treatment.  The micelles were nanosized and presented spherical shaped particles.  Our in vitro data suggest that the nanoformulations maintain the biol. activity of drugs for longer periods and lead to a continuous release of active drug.  The enhanced cellular uptake of EDS-TM resulted in significantly higher cytotoxic effect in K562 leukemia cells.  Cell cycle anal. further demonstrated the significantly higher G2/M phase arrest of cancer cells.  Immunoblot anal. clearly revealed the potential of EDS-TM in inducing apoptosis of cancer cells which could improve the anticancer efficacy in leukemia.  Importantly, EDS-M and EDS-TM significantly prolonged the circulation profile of EDS throughout until 24 h, indicating the potential of targeted nanoparticulate delivery system.  The prolonged blood circulation potential of micellar formulations might improve the therapeutic potential of drug by increasing its bioavailability in the serum.  It would be worthwhile evaluating the effects of the EDS-loaded micelles on cancer cells in vivo for clin. application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw1fDFGnJBdLVg90H21EOLACvtfcHk0lizL3rPdEHmFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFWhs7bF&md5=76bbe948d59d94198eb6436273290c7a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2016.05.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2016.05.046%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DZ.-l.%26atitle%3DTransferrin-conjugated%2520polymeric%2520nanomedicine%2520to%2520enhance%2520the%2520anticancer%2520efficacy%2520of%2520edelfosine%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2016%26volume%3D83%26spage%3D51%26epage%3D57%26doi%3D10.1016%2Fj.biopha.2016.05.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hareedy, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Desoky, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woillard, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thabet, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picard, N.</span></span> <span> </span><span class="NLM_article-title">Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients</span>. <i>Pharmacogenomics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1119</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.2217/PGS.15.62</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.2217%2FPGS.15.62" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=26237184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVyktLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=1119-1133&author=M.+S.+Hareedyauthor=E.+S.+El+Desokyauthor=J.-B.+Woillardauthor=R.+H.+Thabetauthor=A.+M.+Aliauthor=P.+Marquetauthor=N.+Picard&title=Genetic+variants+in+6-mercaptopurine+pathway+as+potential+factors+of+hematological+toxicity+in+acute+lymphoblastic+leukemia+patients&doi=10.2217%2FPGS.15.62"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients</span></div><div class="casAuthors">Hareedy, Mohammad Salem; El Desoky, Ehab S.; Woillard, Jean-Baptiste; Thabet, Romany Helmy; Ali, Amany Mohamad; Marquet, Pierre; Picard, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacogenomics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1119-1134</span>CODEN:
                <span class="NLM_cas:coden">PARMFL</span>;
        ISSN:<span class="NLM_cas:issn">1462-2416</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">Aim: We investigated the assocns. between variants in genes coding for enzymes and transporters related to the 6-mercaptopurine pathway and clin. outcomes in pediatric patients with acute lymphoblastic leukemia.  Materials & methods: Statistical assocn. between gender, age and genotypes of selected SNPs, and the risks of hematol. toxicity and relapse were investigated using a Cox proportional hazard model in 70 acute lymphoblastic leukemia patients from upper Egypt.  Results: We found significant assocns. between ITPA, IMPDH1, SLC29A1, SLC28A2, SLC28A3 and ABCC4 SNPs and one or more of the hematol. toxicity manifestations (neutropenia, agranulocytosis and leukopenia); age was significantly related to relapse.  Conclusion: Genetic polymorphisms in enzymes and transporters involved in the 6-mercaptopurine pathway should be considered during its use to avoid hematol. toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobHqyGQGUh57Vg90H21EOLACvtfcHk0lizL3rPdEHmFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVyktLfK&md5=8b50f25467fdde6ab239e58e04042dc4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2217%2FPGS.15.62&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252FPGS.15.62%26sid%3Dliteratum%253Aachs%26aulast%3DHareedy%26aufirst%3DM.%2BS.%26aulast%3DEl%2BDesoky%26aufirst%3DE.%2BS.%26aulast%3DWoillard%26aufirst%3DJ.-B.%26aulast%3DThabet%26aufirst%3DR.%2BH.%26aulast%3DAli%26aufirst%3DA.%2BM.%26aulast%3DMarquet%26aufirst%3DP.%26aulast%3DPicard%26aufirst%3DN.%26atitle%3DGenetic%2520variants%2520in%25206-mercaptopurine%2520pathway%2520as%2520potential%2520factors%2520of%2520hematological%2520toxicity%2520in%2520acute%2520lymphoblastic%2520leukemia%2520patients%26jtitle%3DPharmacogenomics%26date%3D2015%26volume%3D16%26spage%3D1119%26epage%3D1133%26doi%3D10.2217%2FPGS.15.62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span> <span> </span><span class="NLM_article-title">Glutathione-sensitive hyaluronic acid-mercaptopurine prodrug linked via carbonyl vinyl sulfide: a robust and CD44-targeted nanomedicine for leukemia</span>. <i>Biomacromolecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3207</span>– <span class="NLM_lpage">3214</span>, <span class="refDoi"> DOI: 10.1021/acs.biomac.7b00846</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biomac.7b00846" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKqtrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=3207-3214&author=J.+Qiuauthor=R.+Chengauthor=J.+Zhangauthor=H.+Sunauthor=C.+Dengauthor=F.+Mengauthor=Z.+Zhong&title=Glutathione-sensitive+hyaluronic+acid-mercaptopurine+prodrug+linked+via+carbonyl+vinyl+sulfide%3A+a+robust+and+CD44-targeted+nanomedicine+for+leukemia&doi=10.1021%2Facs.biomac.7b00846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Glutathione-Sensitive Hyaluronic Acid-Mercaptopurine Prodrug Linked via Carbonyl Vinyl Sulfide: A Robust and CD44-Targeted Nanomedicine for Leukemia</span></div><div class="casAuthors">Qiu, Jie; Cheng, Ru; Zhang, Jian; Sun, Huanli; Deng, Chao; Meng, Fenghua; Zhong, Zhiyuan</div><div class="citationInfo"><span class="NLM_cas:title">Biomacromolecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3207-3214</span>CODEN:
                <span class="NLM_cas:coden">BOMAF6</span>;
        ISSN:<span class="NLM_cas:issn">1525-7797</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">6-Mercaptopurine (6-MP) is an essential medicine used for treating leukemia in the clinics. 6-MP suffers, however, from poor water soly., low bioavailability and significant side effects.  Here, we designed CD44-targeted glutathione-sensitive hyaluronic acid-mercaptopurine prodrug (HA-GS-MP) linked via carbonyl vinyl sulfide for safer and enhanced treatment of acute myeloid leukemia (AML).  HA-GS-MP obtained with 50 kDa HA and 6-MP conjugation content of 6.9 wt.% showed excellent water soly. with a hydrodynamic size of ca. 15 nm.  Intriguingly, HA-GS-MP was extremely stable, without any drug leakage, under physiol. environment while rapidly released 6-MP in response to 10 mM glutathione.  HA-GS-MP exhibited obvious targetability and markedly enhanced antitumor effect to OCI/AML-2 human acute myeloid leukemia cells (IC50 = 16.9 μg 6-MP equiv./mL).  The pharmacokinetic studies displayed that Cy5-labeled HA-GS-MP had a long circulation time in mice (elimination half-life = 4.37 h).  The in vivo fluorescence images demonstrated strong and persistent accumulation of Cy5-labeled HA-GS-MP from 4 to 48 h post injection in the s.c. OCI/AML-2 tumor in nude mice.  Notably, HA-GS-MP while causing little side effects induced significantly enhanced growth inhibition of OCI/AML-2 tumor and better survival rate of OCI/AML-2 tumor-bearing mice as compared to free 6-MP.  Carbonyl vinyl sulfide-linked hyaluronic acid-mercaptopurine prodrug has appeared to be a simple and smart nanomedicine for targeted treatment of acute myeloid leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr56vga8jmGMbVg90H21EOLACvtfcHk0lizL3rPdEHmFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKqtrrE&md5=7071ab8485a4099be3bc670516c65679</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.biomac.7b00846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biomac.7b00846%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DC.%26aulast%3DMeng%26aufirst%3DF.%26aulast%3DZhong%26aufirst%3DZ.%26atitle%3DGlutathione-sensitive%2520hyaluronic%2520acid-mercaptopurine%2520prodrug%2520linked%2520via%2520carbonyl%2520vinyl%2520sulfide%253A%2520a%2520robust%2520and%2520CD44-targeted%2520nanomedicine%2520for%2520leukemia%26jtitle%3DBiomacromolecules%26date%3D2017%26volume%3D18%26spage%3D3207%26epage%3D3214%26doi%3D10.1021%2Facs.biomac.7b00846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Celli, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, B. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizvi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samkoe, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogue, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, T.</span></span> <span> </span><span class="NLM_article-title">Imaging and photodynamic therapy: mechanisms, monitoring, and optimization</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">2795</span>– <span class="NLM_lpage">2838</span>, <span class="refDoi"> DOI: 10.1021/cr900300p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr900300p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVeqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2010&pages=2795-2838&author=J.+P.+Celliauthor=B.+Q.+Springauthor=I.+Rizviauthor=C.+L.+Evansauthor=K.+S.+Samkoeauthor=S.+Vermaauthor=B.+W.+Pogueauthor=T.+Hasan&title=Imaging+and+photodynamic+therapy%3A+mechanisms%2C+monitoring%2C+and+optimization&doi=10.1021%2Fcr900300p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization</span></div><div class="casAuthors">Celli, Jonathan P.; Spring, Bryan Q.; Rizvi, Imran; Evans, Conor L.; Samkoe, Kimberley S.; Verma, Sarika; Pogue, Brian W.; Hasan, Tayyaba</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2795-2838</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI9HITC5FGibVg90H21EOLACvtfcHk0lho6kYmgQxnUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVeqt7o%253D&md5=43f42186964bfb1227739a8acaf82077</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcr900300p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900300p%26sid%3Dliteratum%253Aachs%26aulast%3DCelli%26aufirst%3DJ.%2BP.%26aulast%3DSpring%26aufirst%3DB.%2BQ.%26aulast%3DRizvi%26aufirst%3DI.%26aulast%3DEvans%26aufirst%3DC.%2BL.%26aulast%3DSamkoe%26aufirst%3DK.%2BS.%26aulast%3DVerma%26aufirst%3DS.%26aulast%3DPogue%26aufirst%3DB.%2BW.%26aulast%3DHasan%26aufirst%3DT.%26atitle%3DImaging%2520and%2520photodynamic%2520therapy%253A%2520mechanisms%252C%2520monitoring%252C%2520and%2520optimization%26jtitle%3DChem.%2520Rev.%26date%3D2010%26volume%3D110%26spage%3D2795%26epage%3D2838%26doi%3D10.1021%2Fcr900300p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovell, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T. W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, G.</span></span> <span> </span><span class="NLM_article-title">Activatable photosensitizers for imaging and therapy</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">2839</span>– <span class="NLM_lpage">2857</span>, <span class="refDoi"> DOI: 10.1021/cr900236h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr900236h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Sgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2010&pages=2839-2857&author=J.+F.+Lovellauthor=T.+W.+B.+Liuauthor=J.+Chenauthor=G.+Zheng&title=Activatable+photosensitizers+for+imaging+and+therapy&doi=10.1021%2Fcr900236h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Activatable Photosensitizers for Imaging and Therapy</span></div><div class="casAuthors">Lovell, Jonathan F.; Liu, Tracy W. B.; Chen, Juan; Zheng, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2839-2857</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG5g8oYD9QXLVg90H21EOLACvtfcHk0lho6kYmgQxnUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Sgu7k%253D&md5=c6bd3c7a45733ed230b04715a9477d39</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcr900236h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900236h%26sid%3Dliteratum%253Aachs%26aulast%3DLovell%26aufirst%3DJ.%2BF.%26aulast%3DLiu%26aufirst%3DT.%2BW.%2BB.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DG.%26atitle%3DActivatable%2520photosensitizers%2520for%2520imaging%2520and%2520therapy%26jtitle%3DChem.%2520Rev.%26date%3D2010%26volume%3D110%26spage%3D2839%26epage%3D2857%26doi%3D10.1021%2Fcr900236h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Acetal-linked hyperbranched polyphosphoester nanocarriers loaded with chlorin e6 for pH-activatable photodynamic therapy</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">21198</span>– <span class="NLM_lpage">21205</span>, <span class="refDoi"> DOI: 10.1021/acsami.8b06758</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.8b06758" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFeht7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=21198-21205&author=F.+Liauthor=C.+Chenauthor=X.+Yangauthor=X.+Heauthor=Z.+Zhaoauthor=J.+Liauthor=Y.+Yuauthor=X.+Yangauthor=J.+Wang&title=Acetal-linked+hyperbranched+polyphosphoester+nanocarriers+loaded+with+chlorin+e6+for+pH-activatable+photodynamic+therapy&doi=10.1021%2Facsami.8b06758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Acetal-Linked Hyperbranched Polyphosphoester Nanocarriers Loaded with Chlorin e6 for pH-Activatable Photodynamic Therapy</span></div><div class="casAuthors">Li, Feng; Chen, Chao; Yang, Xixi; He, Xinyu; Zhao, Zhangyan; Li, Jie; Yu, Yue; Yang, Xianzhu; Wang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">21198-21205</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nanocarrier-mediated photodynamic therapy (PDT), which involves the systemic delivery of photosensitizers (PSs) into tumor tissue and tumor cells, has emerged as an attractive treatment for cancer.  However, insufficient PS release limits intracellular cytotoxic reactive oxygen species (ROS) generation, which has become a major obstacle to improving the PDT therapeutic efficacy.  Herein, a novel hyperbranched polyphosphoester (hbPPE) contg. numerous acetal bonds (S-hbPPE/Ce6) was explored as a chlorin e6 (Ce6) nanocarrier for PDT.  S-hbPPE/Ce6 with a branched topol. structure efficiently encapsulated Ce6 and then significantly enhanced its internalization by tumor cells.  Subsequently, the endo-/lysosomal acid microenvironment rapidly cleaved the acetal linkage of S-hbPPE and destroyed the nanostructure of S-hbPPE/Ce6, resulting in increased Ce6 release and obviously elevated the intracellular ROS generation under illumination.  Therefore, treatment with S-hbPPE/Ce6 noticeably enhanced the PDT therapeutic efficacy, indicating that such a pH-sensitive hbPPE nanocarrier has great potential to improve the PDT therapeutic efficacy for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYhWUzofBaALVg90H21EOLACvtfcHk0lho6kYmgQxnUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFeht7vN&md5=1cfd6a4f36e821adc13b3837453fd86a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facsami.8b06758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.8b06758%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DAcetal-linked%2520hyperbranched%2520polyphosphoester%2520nanocarriers%2520loaded%2520with%2520chlorin%2520e6%2520for%2520pH-activatable%2520photodynamic%2520therapy%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2018%26volume%3D10%26spage%3D21198%26epage%3D21205%26doi%3D10.1021%2Facsami.8b06758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">6597</span>– <span class="NLM_lpage">6626</span>, <span class="refDoi"> DOI: 10.1039/C6CS00271D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2FC6CS00271D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=27722328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1ajsb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=6597-6626&author=Z.+Zhouauthor=J.+Songauthor=L.+Nieauthor=X.+Chen&title=Reactive+oxygen+species+generating+systems+meeting+challenges+of+photodynamic+cancer+therapy&doi=10.1039%2FC6CS00271D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy</span></div><div class="casAuthors">Zhou, Zijian; Song, Jibin; Nie, Liming; Chen, Xiaoyuan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6597-6626</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The reactive oxygen species (ROS)-mediated mechanism is the major cause underlying the efficacy of photodynamic therapy (PDT).  The PDT procedure is based on the cascade of synergistic effects between light, a photosensitizer (PS) and oxygen, which greatly favors the spatiotemporal control of the treatment.  This procedure has also evoked several unresolved challenges at different levels including (i) the limited penetration depth of light, which restricts traditional PDT to superficial tumors; (ii) oxygen reliance does not allow PDT treatment of hypoxic tumors; (iii) light can complicate the phototherapeutic outcomes because of the concurrent heat generation; (iv) specific delivery of PSs to sub-cellular organelles for exerting effective toxicity remains an issue; and (v) side effects from undesirable white-light activation and self-catalyzation of traditional PSs.  Recent advances in nanotechnol. and nanomedicine have provided new opportunities to develop ROS-generating systems through photodynamic or non-photodynamic procedures while tackling the challenges of the current PDT approaches.  In this review, we summarize the current status and discuss the possible opportunities for ROS generation for cancer therapy.  We hope this review will spur pre-clin. research and clin. practice for ROS-mediated tumor treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1GpQ6JDijQLVg90H21EOLACvtfcHk0lg2Lmfxfnu7Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1ajsb7J&md5=f20c76915d97a39cd9630934701291bb</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2FC6CS00271D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6CS00271D%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DNie%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DReactive%2520oxygen%2520species%2520generating%2520systems%2520meeting%2520challenges%2520of%2520photodynamic%2520cancer%2520therapy%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2016%26volume%3D45%26spage%3D6597%26epage%3D6626%26doi%3D10.1039%2FC6CS00271D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Glutathione-induced amino-activatable micellar photosensitization platform for synergistic redox modulation and photodynamic therapy</span>. <i>Biomater. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1238</span>– <span class="NLM_lpage">1249</span>, <span class="refDoi"> DOI: 10.1039/C8BM00094H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2FC8BM00094H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=29589866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltFWrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=1238-1249&author=R.+Guoauthor=G.+Yangauthor=Z.+Fengauthor=Y.+Zhuauthor=P.+Yangauthor=H.+Songauthor=W.+Wangauthor=P.+Huangauthor=J.+Zhang&title=Glutathione-induced+amino-activatable+micellar+photosensitization+platform+for+synergistic+redox+modulation+and+photodynamic+therapy&doi=10.1039%2FC8BM00094H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Glutathione-induced amino-activatable micellar photosensitization platform for synergistic redox modulation and photodynamic therapy</span></div><div class="casAuthors">Guo, Ruiwei; Yang, Guang; Feng, Zujian; Zhu, Yujie; Yang, Pengxiang; Song, Huijuan; Wang, Weiwei; Huang, Pingsheng; Zhang, Jianhua</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1238-1249</span>CODEN:
                <span class="NLM_cas:coden">BSICCH</span>;
        ISSN:<span class="NLM_cas:issn">2047-4849</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In recent years, photodynamic therapy (PDT) was considered to be a promising cancer treatment modality, however, the therapeutic efficiency was often attenuated by the intrinsic antioxidant defense systems.  Herein, a kind of novel glutathione-induced amino-activatable micelle was designed, which was expected to weaken the antioxidant capacity and in the meantime release the photosensitizer by the exhaustion of intracellular glutathione (GSH).  The amphiphilic poly(ethylene glycol)-(2-((2,4-dinitro-N-(ethyl) phenyl)sulfonamido) Et methacrylate) copolymers were synthesized and assembled into a core-shell nano structure in aq. media.  The nano structure demonstrated high sensitivity and selectivity to bio-thiols in vitro and in vivo.  Subsequently, pheophorbide a (PhA) was encapsulated as the model photosensitizer.  Upon internalization by HepG2 cells, the strongly electron-withdrawing 2,4-dinitrobenzenesulfonyl groups on the PADEE segments were readily cleaved by GSH, during which time the secondary amino groups (pKb = 11.32) were recovered and completely protonated, leading to disassembly of the micelles and rapid release of PhA.  Importantly, the consumption of GSH weakened the intracellular antioxidant capacity, resulting in the synergetic accumulation of reactive oxygen species (ROS) under laser irradn.  As a result, this micellar photosensitization system could overcome the antioxidant capacity of advanced stage tumors through a simultaneous extrinsic and intrinsic strategy, facilitating therapeutic efficiency.  These results demonstrate that the as-designed micelles provide a versatile photosensitization platform for on-demand PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqzpIm2EUek7Vg90H21EOLACvtfcHk0lg2Lmfxfnu7Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltFWrt70%253D&md5=0d0d04341038ed6b7c405473ff6d3757</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2FC8BM00094H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8BM00094H%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DGlutathione-induced%2520amino-activatable%2520micellar%2520photosensitization%2520platform%2520for%2520synergistic%2520redox%2520modulation%2520and%2520photodynamic%2520therapy%26jtitle%3DBiomater.%2520Sci.%26date%3D2018%26volume%3D6%26spage%3D1238%26epage%3D1249%26doi%3D10.1039%2FC8BM00094H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy enhances skin cancer chemotherapy effects through autophagy regulation</span>. <i>Photodiagn. Photodyn. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1016/j.pdpdt.2019.08.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.pdpdt.2019.08.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31445100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFejsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2019&pages=159-165&author=L.+Zhangauthor=Z.+Jiauthor=J.+Zhangauthor=S.+Yang&title=Photodynamic+therapy+enhances+skin+cancer+chemotherapy+effects+through+autophagy+regulation&doi=10.1016%2Fj.pdpdt.2019.08.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy enhances skin cancer chemotherapy effects through autophagy regulation</span></div><div class="casAuthors">Zhang, Lili; Ji, Zhoujing; Zhang, Jie; Yang, Shengju</div><div class="citationInfo"><span class="NLM_cas:title">Photodiagnosis and Photodynamic Therapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">159-165</span>CODEN:
                <span class="NLM_cas:coden">PPTHBF</span>;
        ISSN:<span class="NLM_cas:issn">1572-1000</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Non-melanotic cutaneous cancers and melanoma are the main common type skin cancers worldwide.  Despite many therapeutic options, therapeutic efficacy is not satisfied in all patients with advanced skin cancers, esp. in melanoma.  Photodynamic therapy (PDT) is a technol. for skin disease treatment because of its high effectiveness, has no drug resistance and is easy to use compared with traditional therapy.  Our previous study explored that autophagy plays an important role in the formation and development of SCC.  But there was no evidence about the assocn. between PDT with autophagy in skin cancers and the mechanism is also still unclear.  In the study, we want to explore the effects of 5-aminolevulinic acid-PDT (ALA-PDT) on the skin cancers through autophagy regulation.  The result showed that autophagy was regulated by ALA-PDT combined with or without 3-Methyladenine (3-MA) or 5-Fluoracil (5-FU), the proliferation of skin cancer cells A431 and A375 were suppressed while the apoptosis were induced by ALA-PDT and the effects can be enhanced by 3-MA or 5-FU pretreated.  The results suggest that autophagy regulation may be a key point of ALA-PDT therapy; ALA-PDT combined with the chemotherapy of 3-FU or 5-FU may be a new strategy for treatment of skin cancers including non-melanotic cutaneous cancers or melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrShpegp1fRS7Vg90H21EOLACvtfcHk0lg2Lmfxfnu7Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFejsrrL&md5=303f42715cb67d29c10c8a1b2a96069b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.pdpdt.2019.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pdpdt.2019.08.023%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DJi%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DS.%26atitle%3DPhotodynamic%2520therapy%2520enhances%2520skin%2520cancer%2520chemotherapy%2520effects%2520through%2520autophagy%2520regulation%26jtitle%3DPhotodiagn.%2520Photodyn.%2520Ther.%26date%3D2019%26volume%3D28%26spage%3D159%26epage%3D165%26doi%3D10.1016%2Fj.pdpdt.2019.08.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Hady, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Hirsch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duggan-Keen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbitt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitchener, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampson, I. N.</span></span> <span> </span><span class="NLM_article-title">Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">196</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=11196160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsl2ksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=192-196&author=E.+S.+Abdel-Hadyauthor=P.+Martin-Hirschauthor=M.+Duggan-Keenauthor=P.+L.+Sternauthor=J.+V.+Mooreauthor=G.+Corbittauthor=H.+C.+Kitchenerauthor=I.+N.+Hampson&title=Immunological+and+viral+factors+associated+with+the+response+of+vulval+intraepithelial+neoplasia+to+photodynamic+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy</span></div><div class="casAuthors">Abdel-Hady, El-Said; Martin-Hirsch, Pierre; Duggan-Keen, Maggie; Stern, Peter L.; Moore, James V.; Corbitt, Gerald; Kitchener, Henry C.; Hampson, Ian N.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">192-196</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Topical 5-aminolevulinic acid-based photodynamic therapy (PDT) has produced complete response rates of >90% for nonmelanoma skin carcinomas, which are mostly human papillomavirus (HPV) neg.  Using a similar treatment protocol, we obsd. a short-term response in only one third (10 of 32) of high-grade vulval intraepithelial neoplasia (VIN 2-3) lesions.  Unifocal lesions were found more responsive than multifocal and pigmented lesions.  Animal model studies have suggested that longterm PDT response involves an immune reaction in which CTLs play a crucial role.  In this study, we have assessed: (a) HPV infection; (b) HLA expression; and (c) immune infiltrating cells in VIN biopsies from responders and nonresponders to det. whether these factors may limit response to topical 5-aminolevulinic acid-based PDT.  Tissues from normal vulva (n = 9), vulval carcinoma (n = 11), and VIN (32 patients from which 19 pre- and 43 post-PDT biopsies were taken) were investigated for immune cell infiltration and HLA class I expression by immunohisto-chem. and HPV infection by PCR.  There was a greater likelihood of HPV positivity assocd. with a lack of response of VIN to PDT (P = 0.002), and VIN nonresponders were more likely to show HLA class I loss compared with responders (P = 0.030).  HLA class I down-regulation was significantly greater in the carcinomas (82%, total loss) than the VIN (28%, 19%, total loss; and 9%, allele loss; P = 0.004).  None of the cases with class I down-regulation responded to PDT, whereas 3 of 6 (50%) of cases that showed total class I loss subsequently developed superficial invasion.  Compared with normal vulval skin, VIN lesions showed increased infiltration by CD4 (T-helper) and CD68 (macrophages) but not CD1a (Langerhans cells) or CD8 (CTLs).  There was, however, a significant increase of CD8 infiltration in posttreatment VIN responders compared with nonresponders (P = 0.0001).  These data clearly support the contention that high-risk HPV infection and lack of cell-mediated immunity may play a role in the obsd. poor response of lower genital lesions to topical PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP9iijMdUEWrVg90H21EOLACvtfcHk0li_9DgM4l7_NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsl2ksQ%253D%253D&md5=a27a724d502f5450047a664528172803</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Hady%26aufirst%3DE.%2BS.%26aulast%3DMartin-Hirsch%26aufirst%3DP.%26aulast%3DDuggan-Keen%26aufirst%3DM.%26aulast%3DStern%26aufirst%3DP.%2BL.%26aulast%3DMoore%26aufirst%3DJ.%2BV.%26aulast%3DCorbitt%26aufirst%3DG.%26aulast%3DKitchener%26aufirst%3DH.%2BC.%26aulast%3DHampson%26aufirst%3DI.%2BN.%26atitle%3DImmunological%2520and%2520viral%2520factors%2520associated%2520with%2520the%2520response%2520of%2520vulval%2520intraepithelial%2520neoplasia%2520to%2520photodynamic%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D192%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agostinis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cengel, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girotti, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollnick, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juzeniene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korbelik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mroz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piette, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golab, J.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy of cancer: an update</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">250</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.3322/caac.20114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.3322%2Fcaac.20114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=21617154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BC3MnkslajtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=250-281&author=P.+Agostinisauthor=K.+Bergauthor=K.+A.+Cengelauthor=T.+H.+Fosterauthor=A.+W.+Girottiauthor=S.+O.+Gollnickauthor=S.+M.+Hahnauthor=M.+R.+Hamblinauthor=A.+Juzenieneauthor=D.+Kesselauthor=M.+Korbelikauthor=J.+Moanauthor=P.+Mrozauthor=D.+Nowisauthor=J.+Pietteauthor=B.+C.+Wilsonauthor=J.+Golab&title=Photodynamic+therapy+of+cancer%3A+an+update&doi=10.3322%2Fcaac.20114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy of cancer: an update</span></div><div class="casAuthors">Agostinis Patrizia; Berg Kristian; Cengel Keith A; Foster Thomas H; Girotti Albert W; Gollnick Sandra O; Hahn Stephen M; Hamblin Michael R; Juzeniene Asta; Kessel David; Korbelik Mladen; Moan Johan; Mroz Pawel; Nowis Dominika; Piette Jacques; Wilson Brian C; Golab Jakub</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">250-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Photodynamic therapy (PDT) is a clinically approved, minimally invasive therapeutic procedure that can exert a selective cytotoxic activity toward malignant cells.  The procedure involves administration of a photosensitizing agent followed by irradiation at a wavelength corresponding to an absorbance band of the sensitizer.  In the presence of oxygen, a series of events lead to direct tumor cell death, damage to the microvasculature, and induction of a local inflammatory reaction.  Clinical studies revealed that PDT can be curative, particularly in early stage tumors.  It can prolong survival in patients with inoperable cancers and significantly improve quality of life.  Minimal normal tissue toxicity, negligible systemic effects, greatly reduced long-term morbidity, lack of intrinsic or acquired resistance mechanisms, and excellent cosmetic as well as organ function-sparing effects of this treatment make it a valuable therapeutic option for combination treatments.  With a number of recent technological improvements, PDT has the potential to become integrated into the mainstream of cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQZ951D5fAqz-xsqfvU0ziafW6udTcc2eYanQwSCwntubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MnkslajtQ%253D%253D&md5=81f4bb716e0dd1967c4819f5593cf109</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3322%2Fcaac.20114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.20114%26sid%3Dliteratum%253Aachs%26aulast%3DAgostinis%26aufirst%3DP.%26aulast%3DBerg%26aufirst%3DK.%26aulast%3DCengel%26aufirst%3DK.%2BA.%26aulast%3DFoster%26aufirst%3DT.%2BH.%26aulast%3DGirotti%26aufirst%3DA.%2BW.%26aulast%3DGollnick%26aufirst%3DS.%2BO.%26aulast%3DHahn%26aufirst%3DS.%2BM.%26aulast%3DHamblin%26aufirst%3DM.%2BR.%26aulast%3DJuzeniene%26aufirst%3DA.%26aulast%3DKessel%26aufirst%3DD.%26aulast%3DKorbelik%26aufirst%3DM.%26aulast%3DMoan%26aufirst%3DJ.%26aulast%3DMroz%26aufirst%3DP.%26aulast%3DNowis%26aufirst%3DD.%26aulast%3DPiette%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DB.%2BC.%26aulast%3DGolab%26aufirst%3DJ.%26atitle%3DPhotodynamic%2520therapy%2520of%2520cancer%253A%2520an%2520update%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2011%26volume%3D61%26spage%3D250%26epage%3D281%26doi%3D10.3322%2Fcaac.20114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brackett, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollnick, S. O.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy enhancement of anti-tumor immunity</span>. <i>Photochem. Photobiol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">652</span>, <span class="refDoi"> DOI: 10.1039/c0pp00354a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2Fc0pp00354a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=21253659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltleitrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=649-652&author=C.+M.+Brackettauthor=S.+O.+Gollnick&title=Photodynamic+therapy+enhancement+of+anti-tumor+immunity&doi=10.1039%2Fc0pp00354a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy enhancement of anti-tumor immunity</span></div><div class="casAuthors">Brackett, Craig M.; Gollnick, Sandra O.</div><div class="citationInfo"><span class="NLM_cas:title">Photochemical & Photobiological Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">649-652</span>CODEN:
                <span class="NLM_cas:coden">PPSHCB</span>;
        ISSN:<span class="NLM_cas:issn">1474-905X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is an FDA-approved modality for the treatment of early-stage disease and palliation of late-stage disease.  Pre-clin. studies using mouse models and clin. studies in patients have demonstrated that PDT is capable of influencing the immune system.  The effect of PDT on the generation of anti-tumor immunity is regimen-dependent and is tightly linked to the degree and nature of inflammation induced by PDT.  However, the precise mechanism underlying PDT-regulated adaptive anti-tumor immunity remains unclear.  This review will focus on the current knowledge of immune regulation by PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkBRXInhovHrVg90H21EOLACvtfcHk0li_9DgM4l7_NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltleitrk%253D&md5=c919445b6732b6092abd1f4639c9cc87</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fc0pp00354a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0pp00354a%26sid%3Dliteratum%253Aachs%26aulast%3DBrackett%26aufirst%3DC.%2BM.%26aulast%3DGollnick%26aufirst%3DS.%2BO.%26atitle%3DPhotodynamic%2520therapy%2520enhancement%2520of%2520anti-tumor%2520immunity%26jtitle%3DPhotochem.%2520Photobiol.%2520Sci.%26date%3D2011%26volume%3D10%26spage%3D649%26epage%3D652%26doi%3D10.1039%2Fc0pp00354a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandra, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbara, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patricia, M.</span></span> <span> </span><span class="NLM_article-title">Induction of anti-tumor immunity by photodynamic therapy (PDT)</span>. <i>Proc. SPIE</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6087</i></span>, <span class="NLM_elocation-id">60870E</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1117%2F12.649852" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6087&publication_year=2006&author=O.+G.+Sandraauthor=O.+Barbaraauthor=M.+Patricia&title=Induction+of+anti-tumor+immunity+by+photodynamic+therapy+%28PDT%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1117%2F12.649852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1117%252F12.649852%26sid%3Dliteratum%253Aachs%26aulast%3DSandra%26aufirst%3DO.%2BG.%26aulast%3DBarbara%26aufirst%3DO.%26aulast%3DPatricia%26aufirst%3DM.%26atitle%3DInduction%2520of%2520anti-tumor%2520immunity%2520by%2520photodynamic%2520therapy%2520%2528PDT%2529%26jtitle%3DProc.%2520SPIE%26date%3D2006%26volume%3D6087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mroz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashmi, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lange, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, M. R.</span></span> <span> </span><span class="NLM_article-title">Stimulation of anti-tumor immunity by photodynamic therapy</span>. <i>Expert Rev. Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1586/eci.10.81</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1586%2Feci.10.81" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=21162652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOgtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=75-91&author=P.+Mrozauthor=J.+T.+Hashmiauthor=Y.-Y.+Huangauthor=N.+Langeauthor=M.+R.+Hamblin&title=Stimulation+of+anti-tumor+immunity+by+photodynamic+therapy&doi=10.1586%2Feci.10.81"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of anti-tumor immunity by photodynamic therapy</span></div><div class="casAuthors">Mroz, Pawel; Hashmi, Javad T.; Huang, Ying-Ying; Lange, Norbert; Hamblin, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Clinical Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-91</span>CODEN:
                <span class="NLM_cas:coden">ERCIBU</span>;
        ISSN:<span class="NLM_cas:issn">1744-666X</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Photodynamic therapy (PDT) is a rapidly developing cancer treatment that utilizes the combination of nontoxic dyes and harmless visible light to destroy tumors by generating reactive oxygen species.  PDT produces tumor-cell destruction in the context of acute inflammation that acts as a danger signal' to the innate immune system.  Activation of the innate immune system increases the priming of tumor-specific T lymphocytes that have the ability to recognize and destroy distant tumor cells and, in addn., lead to the development of an immune memory that can combat recurrence of the cancer at a later point in time.  PDT may be also successfully combined with immunomodulating strategies that are capable of overcoming or bypassing the escape mechanisms employed by the progressing tumor to evade immune attack.  This article will cover the role of the immune response in PDT anti-tumor effectiveness.  It will highlight the milestones in the development of PDT-mediated anti-tumor immunity and emphasize the combination strategies that may improve this therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9dXGvT50XiLVg90H21EOLACvtfcHk0lj8DLnzNbzDLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOgtL3I&md5=1b3666b4db013872441faed6e1056008</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1586%2Feci.10.81&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Feci.10.81%26sid%3Dliteratum%253Aachs%26aulast%3DMroz%26aufirst%3DP.%26aulast%3DHashmi%26aufirst%3DJ.%2BT.%26aulast%3DHuang%26aufirst%3DY.-Y.%26aulast%3DLange%26aufirst%3DN.%26aulast%3DHamblin%26aufirst%3DM.%2BR.%26atitle%3DStimulation%2520of%2520anti-tumor%2520immunity%2520by%2520photodynamic%2520therapy%26jtitle%3DExpert%2520Rev.%2520Clin.%2520Immunol.%26date%3D2011%26volume%3D7%26spage%3D75%26epage%3D91%26doi%3D10.1586%2Feci.10.81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weichselbaum, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W.</span></span> <span> </span><span class="NLM_article-title">Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">12499</span> <span class="refDoi"> DOI: 10.1038/ncomms12499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fncomms12499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=27530650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlyltr7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&author=C.+Heauthor=X.+Duanauthor=N.+Guoauthor=C.+Chanauthor=C.+Poonauthor=R.+R.+Weichselbaumauthor=W.+Lin&title=Core-shell+nanoscale+coordination+polymers+combine+chemotherapy+and+photodynamic+therapy+to+potentiate+checkpoint+blockade+cancer+immunotherapy&doi=10.1038%2Fncomms12499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy</span></div><div class="casAuthors">He, Chunbai; Duan, Xiaopin; Guo, Nining; Chan, Christina; Poon, Christopher; Weichselbaum, Ralph R.; Lin, Wenbin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12499</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Advanced colorectal cancer is one of the deadliest cancers, with a 5-yr survival rate of only 12% for patients with the metastatic disease.  Checkpoint inhibitors, such as the antibodies inhibiting the PD-1/PD-L1 axis, are among the most promising immunotherapies for patients with advanced colon cancer, but their durable response rate remains low.  We herein report the use of immunogenic nanoparticles to augment the antitumor efficacy of PD-L1 antibody-mediated cancer immunotherapy.  Nanoscale coordination polymer (NCP) core-shell nanoparticles carry oxaliplatin in the core and the photosensitizer pyropheophorbide-lipid conjugate (pyrolipid) in the shell (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="216f6271615158534e4d48514845">[email protected]</a>) for effective chemotherapy and photodynamic therapy (PDT).  Synergy between oxaliplatin and pyrolipid-induced PDT kills tumor cells and provokes an immune response, resulting in calreticulin exposure on the cell surface, antitumor vaccination and an abscopal effect.  When combined with anti-PD-L1 therapy, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="e8a6abb8a898919a87848198818c">[email protected]</a> mediates regression of both light-irradiated primary tumors and non-irradiated distant tumors by inducing a strong tumor-specific immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2l-hIcEiayrVg90H21EOLACvtfcHk0lj8DLnzNbzDLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlyltr7N&md5=89a6611f1003fc6aa1e3d25ba7ec2cad</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fncomms12499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12499%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DC.%26aulast%3DDuan%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DN.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DPoon%26aufirst%3DC.%26aulast%3DWeichselbaum%26aufirst%3DR.%2BR.%26aulast%3DLin%26aufirst%3DW.%26atitle%3DCore-shell%2520nanoscale%2520coordination%2520polymers%2520combine%2520chemotherapy%2520and%2520photodynamic%2520therapy%2520to%2520potentiate%2520checkpoint%2520blockade%2520cancer%2520immunotherapy%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26doi%3D10.1038%2Fncomms12499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weichselbaum, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W.</span></span> <span> </span><span class="NLM_article-title">Chlorin-based nanoscalemetal–organic framework systemically rejects colorectal cancers via synergistic photodynamic therapy and checkpoint blockade immunotherapy</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">12502</span>– <span class="NLM_lpage">12510</span>, <span class="refDoi"> DOI: 10.1021/jacs.6b06663</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b06663" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVChtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=12502-12510&author=K.+Luauthor=C.+Heauthor=N.+Guoauthor=C.+Chanauthor=K.+Niauthor=R.+R.+Weichselbaumauthor=W.+Lin&title=Chlorin-based+nanoscalemetal%E2%80%93organic+framework+systemically+rejects+colorectal+cancers+via+synergistic+photodynamic+therapy+and+checkpoint+blockade+immunotherapy&doi=10.1021%2Fjacs.6b06663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy</span></div><div class="casAuthors">Lu, Kuangda; He, Chunbai; Guo, Nining; Chan, Christina; Ni, Kaiyuan; Weichselbaum, Ralph R.; Lin, Wenbin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">12502-12510</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) can destroy local tumors and minimize normal tissue damage, but is ineffective at eliminating metastases.  Checkpoint blockade immunotherapy has enjoyed recent success in the clinic, but only elicits limited rates of systemic antitumor response for most cancers due to insufficient activation of the host immune system.  Here we describe a treatment strategy that combines PDT by a new chlorin-based nanoscale metal-org. framework (nMOF), TBC-Hf, and a small-mol. immunotherapy agent that inhibits indoleamine 2,3-dioxygenase (IDO), encapsulated in the nMOF channels to induce systemic antitumor immunity.  The synergistic combination therapy achieved effective local and distant tumor rejection in colorectal cancer models.  We detected increased T cell infiltration in the tumor microenvironment after activation of the immune system with the combination of IDO inhibition by the small-mol. immunotherapy agent and immunogenic cell death induced by PDT.  We also elucidated the underlying immunol. mechanisms and revealed compensatory roles of neutrophils and B cells in presenting tumor-assocd. antigens to T cells in this combination therapy.  We believe that nMOF-enabled PDT has the potential to significantly enhance checkpoint blockade cancer immunotherapy, affording clin. benefits for the treatment of many difficult-to-treat cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_vb_7ukLa7bVg90H21EOLACvtfcHk0lj8DLnzNbzDLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVChtr%252FM&md5=a5817a195c3cf30ecc53f6fcfd3d5c12</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b06663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b06663%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DN.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DNi%26aufirst%3DK.%26aulast%3DWeichselbaum%26aufirst%3DR.%2BR.%26aulast%3DLin%26aufirst%3DW.%26atitle%3DChlorin-based%2520nanoscalemetal%25E2%2580%2593organic%2520framework%2520systemically%2520rejects%2520colorectal%2520cancers%2520via%2520synergistic%2520photodynamic%2520therapy%2520and%2520checkpoint%2520blockade%2520immunotherapy%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26spage%3D12502%26epage%3D12510%26doi%3D10.1021%2Fjacs.6b06663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krosl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korbelik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krosl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korbelik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, G. J.</span></span> <span> </span><span class="NLM_article-title">Induction of cell infiltration into murine SCCVII tumor by photofrin-based photodynamic therapy</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">555</span>, <span class="refDoi"> DOI: 10.1038/bjc.1995.108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fbjc.1995.108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=7880738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADyaK2MXkvVCku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1995&pages=549-555&author=G.+Kroslauthor=M.+Korbelikauthor=G.+Doughertyauthor=G.+Kroslauthor=M.+Korbelikauthor=G.+J.+Dougherty&title=Induction+of+cell+infiltration+into+murine+SCCVII+tumor+by+photofrin-based+photodynamic+therapy&doi=10.1038%2Fbjc.1995.108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of immune cell infiltration into murine SCCVII tumor by Photofrin-based photodynamic therapy</span></div><div class="casAuthors">Krosl, G.; Korbelik, M.; Dougherty, G J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">549-55</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">Cellular populations in the squamous cell carcinoma SCCVII, growing in C3H/HeN mice given Photofrin, were examd. at various time intervals during the photodynamic light treatment and up to 8 h later.  Cell populations present within excised tumors were identified by monoclonal antibodies directed against cell type-specific membrane markers using a combination of the indirect immunoperoxidase and Wright staining or by flow cytometry.  Photofrin-based photodynamic therapy (PDT) induced dramatic changes in the level of different cellular populations contained in the treated tumor.  The most pronounced was a rapid increase in the content of neutrophils, which increased 200-fold within 5 min after the initiation of light treatment.  This was followed immediately by an increase in the levels of mast cells, while another type of myeloid cells, most likely monocytes, invaded the tumor between 0 and 2 h after PDT.  The examn. of cytolysis of in vitro cultured SCCVII tumor cells mediated by macrophages harvested from the SCCVII tumor revealed a pronounced increase in the tumoricidal activity of tumor-assocd. macrophages isolated at 2 h post PDT.  It seems, therefore, that the PDT-induced acute inflammatory infiltration of myeloid cells into the treated tumor is assocd. with functional activation of immune cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Gxgyf85worVg90H21EOLACvtfcHk0ljFuvoUaYpAww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkvVCku7o%253D&md5=3cc489013e4ca17d51e85d8243015e5a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1995.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1995.108%26sid%3Dliteratum%253Aachs%26aulast%3DKrosl%26aufirst%3DG.%26aulast%3DKorbelik%26aufirst%3DM.%26aulast%3DDougherty%26aufirst%3DG.%26aulast%3DKrosl%26aufirst%3DG.%26aulast%3DKorbelik%26aufirst%3DM.%26aulast%3DDougherty%26aufirst%3DG.%2BJ.%26atitle%3DInduction%2520of%2520cell%2520infiltration%2520into%2520murine%2520SCCVII%2520tumor%2520by%2520photofrin-based%2520photodynamic%2520therapy%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1995%26volume%3D71%26spage%3D549%26epage%3D555%26doi%3D10.1038%2Fbjc.1995.108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donohoe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senge, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnaut, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes-da-Silva, L. C.</span></span> <span> </span><span class="NLM_article-title">Cell death in photodynamic therapy: From oxidative stress to anti-tumor immunity</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1872</i></span>, <span class="NLM_elocation-id">188308</span> <span class="refDoi"> DOI: 10.1016/j.bbcan.2019.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.bbcan.2019.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31401103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1ygtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1872&publication_year=2019&author=C.+Donohoeauthor=M.+O.+Sengeauthor=L.+G.+Arnautauthor=L.+C.+Gomes-da-Silva&title=Cell+death+in+photodynamic+therapy%3A+From+oxidative+stress+to+anti-tumor+immunity&doi=10.1016%2Fj.bbcan.2019.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Cell death in photodynamic therapy: From oxidative stress to anti-tumor immunity</span></div><div class="casAuthors">Donohoe, Claire; Senge, Mathias O.; Arnaut, Luis G.; Gomes-da-Silva, Ligia C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1872</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">188308</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Photodynamic therapy is a promising approach for cancer treatment that relies on the administration of a photosensitizer followed by tumor illumination.  The generated oxidative stress may activate multiple mechanisms of cell death which are counteracted by cells through adaptive stress responses that target homeostasis rescue.  The present renaissance of PDT was leveraged by the acknowledgment that this therapy has an immediate impact locally, in the illumination vol., but that subsequently it may also elicit immune responses with systemic impact.  The investigation of the mechanisms of cell death under the oxidative stress of PDT is of paramount importance to understand how the immune system is activated and, ultimately, to make PDT a more appealing/relevant therapeutic option.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ2efgcvdQtbVg90H21EOLACvtfcHk0ljFuvoUaYpAww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1ygtb7J&md5=8017f572a7c30442026748894e43daff</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2019.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2019.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DDonohoe%26aufirst%3DC.%26aulast%3DSenge%26aufirst%3DM.%2BO.%26aulast%3DArnaut%26aufirst%3DL.%2BG.%26aulast%3DGomes-da-Silva%26aufirst%3DL.%2BC.%26atitle%3DCell%2520death%2520in%2520photodynamic%2520therapy%253A%2520From%2520oxidative%2520stress%2520to%2520anti-tumor%2520immunity%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2019%26volume%3D1872%26doi%3D10.1016%2Fj.bbcan.2019.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, K.</span></span> <span> </span><span class="NLM_article-title">Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy</span>. <i>J. Pharm. Investig.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1007/s40005-017-0377-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1007%2Fs40005-017-0377-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=30680248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1WgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2018&pages=143-151&author=H.+S.+Hwangauthor=H.+Shinauthor=J.+Hanauthor=K.+Na&title=Combination+of+photodynamic+therapy+%28PDT%29+and+anti-tumor+immunity+in+cancer+therapy&doi=10.1007%2Fs40005-017-0377-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy</span></div><div class="casAuthors">Hwang, Hee Sook; Shin, Heejun; Han, Jieun; Na, Kun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Investigation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-151</span>CODEN:
                <span class="NLM_cas:coden">JPIOBH</span>;
        ISSN:<span class="NLM_cas:issn">2093-5552</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Photodynamic therapy (PDT) is performed using a photosensitizer and light of specific wavelength in the presence of oxygen to generate singlet oxygen and reactive oxygen species(ROS) in the cancer cells.  The accumulated photosensitizers in target sites induce ROS generation upon light activation, then the generated cytotoxic reactive oxygen species lead to tumor cell death via apoptosis or necrosis, and damages the target sites which results tumor destruction.  As a consequence, the PDT-mediated cell death is assocd. with anti-tumor immune response.  In this paper, the effects of PDT and immune response on tumors are reviewed.  Activation of an immune response regarding the innate and adaptive immune response, interaction with immune cells and tumor cells that assocd. with antitumor efficacy of PDT are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcNYReTe25rrVg90H21EOLACvtfcHk0ljFuvoUaYpAww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1WgtA%253D%253D&md5=3220870ec7b2a50cf6880418b1c2f9bd</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs40005-017-0377-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40005-017-0377-x%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DH.%2BS.%26aulast%3DShin%26aufirst%3DH.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DNa%26aufirst%3DK.%26atitle%3DCombination%2520of%2520photodynamic%2520therapy%2520%2528PDT%2529%2520and%2520anti-tumor%2520immunity%2520in%2520cancer%2520therapy%26jtitle%3DJ.%2520Pharm.%2520Investig.%26date%3D2018%26volume%3D48%26spage%3D143%26epage%3D151%26doi%3D10.1007%2Fs40005-017-0377-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castano, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mroz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, M. R.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy and anti-tumour immunity</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">545</span>, <span class="refDoi"> DOI: 10.1038/nrc1894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fnrc1894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=16794636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtFehu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=535-545&author=A.+P.+Castanoauthor=P.+Mrozauthor=M.+R.+Hamblin&title=Photodynamic+therapy+and+anti-tumour+immunity&doi=10.1038%2Fnrc1894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy and anti-tumour immunity</span></div><div class="casAuthors">Castano, Ana P.; Mroz, Pawel; Hamblin, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">535-545</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Photodynamic therapy (PDT) uses non-toxic photosensitizers and harmless visible light in combination with oxygen to produce cytotoxic reactive oxygen species that kill malignant cells by apoptosis and/or necrosis, shut down the tumor microvasculature and stimulate the host immune system.  In contrast to surgery, radiotherapy and chemotherapy that are mostly immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins, invasion and infiltration of the tumor by leukocytes, and might increase the presentation of tumor-derived antigens to T cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcQPY6qlMQvLVg90H21EOLACvtfcHk0lhdDeu3JN08BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtFehu7k%253D&md5=7b02eb36a28b98d700e9fdebd7e0697f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnrc1894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1894%26sid%3Dliteratum%253Aachs%26aulast%3DCastano%26aufirst%3DA.%2BP.%26aulast%3DMroz%26aufirst%3DP.%26aulast%3DHamblin%26aufirst%3DM.%2BR.%26atitle%3DPhotodynamic%2520therapy%2520and%2520anti-tumour%2520immunity%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D535%26epage%3D545%26doi%3D10.1038%2Fnrc1894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span> <span> </span><span class="NLM_article-title">Targeted nanocarriers based on iodinated-cyanine dyes as immunomodulators for synergistic phototherapy</span>. <i>Nanoscale</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">11008</span>– <span class="NLM_lpage">11025</span>, <span class="refDoi"> DOI: 10.1039/C9NR10674J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2FC9NR10674J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=32301458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BB3cXltlCksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=11008-11025&author=J.+Chiauthor=Q.+Maauthor=Z.+Shenauthor=C.+Maauthor=W.+Zhuauthor=S.+Hanauthor=Y.+Liangauthor=J.+Caoauthor=Y.+Sun&title=Targeted+nanocarriers+based+on+iodinated-cyanine+dyes+as+immunomodulators+for+synergistic+phototherapy&doi=10.1039%2FC9NR10674J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted nanocarriers based on iodinated-cyanine dyes as immunomodulators for synergistic phototherapy</span></div><div class="casAuthors">Chi, Jinnan; Ma, Qingming; Shen, Zijun; Ma, Caiyun; Zhu, Wei; Han, Shangcong; Liang, Yan; Cao, Jie; Sun, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Nanoscale</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11008-11025</span>CODEN:
                <span class="NLM_cas:coden">NANOHL</span>;
        ISSN:<span class="NLM_cas:issn">2040-3372</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT), as one of the most powerful photo-therapeutic strategies for cancer treatment with min. invasiveness, can effectively damage local tumor cells and significantly induce systemic antitumor immunity.  However, current nanotechnol.-assisted PDT-immunomodulators have either poor penetration for deep tumors or low singlet oxygen generation.  Herein, we construct a novel theranostic nanocarrier (HA-PEG-CyI, HPC) by inducing the self-assembly of PEGylated CyI and attaching the ligand HA to its surface.  The prepd. HPC can be used as an ideal PDT-immunomodulator for synergistic cancer therapy.  CyI is an iodinated-cyanine dye with enhanced singlet oxygen generation ability as well as excellent photo-to-photothermal and near-IR fluorescence imaging properties.  Under 808 nm laser irradn., the prepd. HPC can generate both reactive oxygen species (ROS) and elevate temp. which can subsequently result in apoptosis and necrosis at tumor sites.  Moreover, the HPC-induced cell death can generate a series of acute inflammatory reactions, leading to systemic immunity induction and secondary death of tumor cells, which further results in reducing tumor recurrence.  In vitro and in vivo results show that HPC can enhance the tumor targeting efficacy, generate ROS efficiently and exhibit a high temp. response under NIR irradn., which working together can activate immune responses for synergistic phototherapy on tumor cells.  Accordingly, the proposed multi-functional HPC nanocarriers represent an important advance in PDT and can be used as a superior cancer treatment strategy with great promise for clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb3iOCxGbEmbVg90H21EOLACvtfcHk0lhdDeu3JN08BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXltlCksL8%253D&md5=24d0d33514cd5366a1ad2651a1e287e4</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1039%2FC9NR10674J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9NR10674J%26sid%3Dliteratum%253Aachs%26aulast%3DChi%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DY.%26atitle%3DTargeted%2520nanocarriers%2520based%2520on%2520iodinated-cyanine%2520dyes%2520as%2520immunomodulators%2520for%2520synergistic%2520phototherapy%26jtitle%3DNanoscale%26date%3D2020%26volume%3D12%26spage%3D11008%26epage%3D11025%26doi%3D10.1039%2FC9NR10674J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, C.</span></span> <span> </span><span class="NLM_article-title">Targeted delivery of chlorin e6 via redox sensitive diselenide-containing micelles for improved photodynamic therapy in cluster of differentiation 44-overexpressing breast cancer</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">369</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.3389%2Ffphar.2019.00369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31057402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVGkt7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=369&author=C.+Fengauthor=D.+Zhuauthor=L.+Chenauthor=Y.+Luauthor=J.+Liuauthor=N.+Y.+Kimauthor=S.+Liangauthor=X.+Zhangauthor=Y.+Linauthor=Y.+Maauthor=C.+Dong&title=Targeted+delivery+of+chlorin+e6+via+redox+sensitive+diselenide-containing+micelles+for+improved+photodynamic+therapy+in+cluster+of+differentiation+44-overexpressing+breast+cancer&doi=10.3389%2Ffphar.2019.00369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted delivery of chlorin e6 via redox sensitive diselenide-containing micelles for improved photodynamic therapy in cluster of differentiation 44-overexpressing breast cancer</span></div><div class="casAuthors">Feng, Chan; Zhu, Donglei; Chen, Lv; Lu, Yonglin; Liu, Jie; Kim, Na Yoon; Liang, Shujing; Zhang, Xia; Lin, Yun; Ma, Yabin; Dong, Chunyan</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">369</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The off-target activation of photosensitizers is one of the most well-known obstacles to effective photodynamic therapy (PDT).  The selected activation of photosensitizers in cancer cells is highly desired to overcome this problem.  We developed a strategy that enabled diselenide bonds to link hyaluronic acid (HA) and photosensitizer chlorin e6 (Ce6) to assemble the micelles (HA-sese-Ce6 NPs) that can target cancer and achieve a redox responsive release of drugs to enhance the PDT efficiency in breast cancer.  The HA was used to form a hydrophilic shell that can target cluster of differentiation 44 (CD44) on the cancer cells.  The selenium-contg. core is easily dissembled in a redox environment to release Ce6.  The triggered release of Ce6 in a redox condition and the pos. feedback release by activated Ce6 were obsd. in vitro.  In cytotoxicity assays and in vitro cellular uptake assays, the increased PDT efficiency and targeted internalization of HA-sese-Ce6 NPs in the cells were verified, compared to a free Ce6 treated group.  Similar results were showed in the therapeutic study and in vivo fluorescence imaging in an orthotopic mammary fat pad tumor model.  In addn., a significant inhibition of metastasis was found after the HA-sese-Ce6 NPs treatment.  In general, this study promises an ingenious and easy strategy for improved PDT efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEMwfuniycZbVg90H21EOLACvtfcHk0lhdDeu3JN08BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVGkt7bI&md5=85798ad15f4f108a71142fed906ca004</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00369%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DN.%2BY.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DC.%26atitle%3DTargeted%2520delivery%2520of%2520chlorin%2520e6%2520via%2520redox%2520sensitive%2520diselenide-containing%2520micelles%2520for%2520improved%2520photodynamic%2520therapy%2520in%2520cluster%2520of%2520differentiation%252044-overexpressing%2520breast%2520cancer%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D369%26doi%3D10.3389%2Ffphar.2019.00369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Tumor-targeting photodynamic therapy based on folate-modified polydopamine nanoparticles</span>. <i>Int. J. Nanomed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">6799</span>– <span class="NLM_lpage">6812</span>, <span class="refDoi"> DOI: 10.2147/IJN.S216194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.2147%2FIJN.S216194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31692522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVCmtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=6799-6812&author=S.+Yanauthor=Q.+Huangauthor=J.+Chenauthor=X.+Songauthor=Z.+Chenauthor=M.+Huangauthor=P.+Xuauthor=J.+Zhang&title=Tumor-targeting+photodynamic+therapy+based+on+folate-modified+polydopamine+nanoparticles&doi=10.2147%2FIJN.S216194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-targeting photodynamic therapy based on folate-modified polydopamine nanoparticles</span></div><div class="casAuthors">Yan, Shufeng; Huang, Qingqing; Chen, Jincan; Song, Xiaorong; Chen, Zhuo; Huang, Mingdong; Xu, Peng; Zhang, Juncheng</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Nanomedicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6799-6812</span>CODEN:
                <span class="NLM_cas:coden">IJNNHQ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2013</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: Photodynamic therapy (PDT), a clin. anticancer therapeutic modality, has a long history in clin. cancer treatments since the 1970s.  However, PDT has not been widely used largely because of metabolic problems and off-target phototoxicities of the current clin. photosensitizers.  Purpose: The objective of the study is to develop a high-efficiency and high-specificity carrier to precisely deliver photosensitizers to tumor sites, aiming at addressing metabolic problems, as well as the systemic damages current clin. photosensitizers are known to cause.  Methods: We synthesized a polydopamine (PDA)-based carrier with the modification of folic acid (FA), which is to target the overexpressed folate receptors on tumor surfaces.  We used this carrier to load a cationic phthalocyanine-type photosensitizer (Pc) and generated a PDA-FA-Pc nanomedicine.  We detd. the antitumor effects and the specificity to tumor cell lines in vitro.  In addn., we established human cancer-xenografted mice models to evaluate the tumor-targeting property and anticancer efficacies in vivo.  Results: Our PDA-FA-Pc nanomedicine demonstrated a high stability in normal physiol. conditions, however, could specifically release photosensitizers in acidic conditions, eg, tumor microenvironment and lysosomes in cancer cells.  Addnl., PDA-FA-Pc nanomedicine demonstrated a much higher cellular uptake and phototoxicity in cancer cell lines than in healthy cell lines.  Moreover, the in vivo imaging data indicated excellent tumor-targeting properties of PDA-FA-Pc nanomedicine in human cancer-xenografted mice.  Lastly, PDAFA- Pc nanomedicine was found to significantly suppress tumor growth within two human cancer-xenografted mice models.  Conclusion: Our current study not only demonstrates PDA-FA-Pc nanomedicine as a highly potent and specific anticancer agent, but also suggests a strategy to address the metabolic and specificity problems of clin. photosensitizers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoua8NhxRFb7Vg90H21EOLACvtfcHk0ljBXRskhe41BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVCmtb%252FI&md5=7e387f3e47386aaa7538f74afb84d1b3</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.2147%2FIJN.S216194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FIJN.S216194%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DTumor-targeting%2520photodynamic%2520therapy%2520based%2520on%2520folate-modified%2520polydopamine%2520nanoparticles%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2019%26volume%3D14%26spage%3D6799%26epage%3D6812%26doi%3D10.2147%2FIJN.S216194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musani, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barqawi, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. K.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy for treatment of solid tumors-potential and technical challenges</span>. <i>Technol. Cancer Res. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1177/153303460800700405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1177%2F153303460800700405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=18642969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSrtbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=309-320&author=Z.+Huangauthor=H.+Xuauthor=A.+D.+Meyersauthor=A.+I.+Musaniauthor=L.+Wangauthor=R.+Taggauthor=A.+B.+Barqawiauthor=Y.+K.+Chen&title=Photodynamic+therapy+for+treatment+of+solid+tumors-potential+and+technical+challenges&doi=10.1177%2F153303460800700405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy for treatment of solid tumors-potential and technical challenges</span></div><div class="casAuthors">Huang, Zheng; Xu, Heping; Meyers, Arlen D.; Musani, Ali I.; Wang, Luowei; Tagg, Randall; Barqawi, Al B.; Chen, Yang K.</div><div class="citationInfo"><span class="NLM_cas:title">Technology in Cancer Research & Treatment</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">309-320</span>CODEN:
                <span class="NLM_cas:coden">TCRTBS</span>;
        ISSN:<span class="NLM_cas:issn">1533-0346</span>.
    
            (<span class="NLM_cas:orgname">Adenine Press</span>)
        </div><div class="casAbstract">A review.  Photodynamic therapy (PDT) involves the administration of photosensitizer followed by local illumination with visible light of specific wavelength(s).  In the presence of oxygen mols., the light illumination of photosensitizer can lead to a series of photochem. reactions and consequently the generation of cytotoxic species.  The quantity and location of PDT-induced cytotoxic species det. the nature and consequence of PDT.  Much progress has been seen in both basic research and clin. application in recent years.  Although the majority of approved PDT clin. protocols have primarily been used for the treatment of superficial lesions of both malignant and non-malignant diseases, intersititial PDT for the ablation of deep-seated solid tumors are now being investigated worldwide.  The complexity of the geometry and non-homogeneity of solid tumor pose a great challenge on the implementation of minimally invasive interstitial PDT and the estn. of PDT dosimetry.  This review will discuss the recent progress and tech. challenges of various forms of interstitial PDT for the treatment of parenchymal and/or stromal tissues of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCQxgNqu8r3LVg90H21EOLACvtfcHk0ljBXRskhe41BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSrtbbO&md5=93dbaba5d27199d7dd69c00326727729</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1177%2F153303460800700405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F153303460800700405%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DMeyers%26aufirst%3DA.%2BD.%26aulast%3DMusani%26aufirst%3DA.%2BI.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DTagg%26aufirst%3DR.%26aulast%3DBarqawi%26aufirst%3DA.%2BB.%26aulast%3DChen%26aufirst%3DY.%2BK.%26atitle%3DPhotodynamic%2520therapy%2520for%2520treatment%2520of%2520solid%2520tumors-potential%2520and%2520technical%2520challenges%26jtitle%3DTechnol.%2520Cancer%2520Res.%2520Treat.%26date%3D2008%26volume%3D7%26spage%3D309%26epage%3D320%26doi%3D10.1177%2F153303460800700405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharman, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Lier, J. E.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapeutics: basic principles and clinical applications</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">517</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(99)01412-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2FS1359-6446%2899%2901412-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10529768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADyaK1MXmvVKhsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=507-517&author=W.+M.+Sharmanauthor=C.+M.+Allenauthor=J.+E.+van+Lier&title=Photodynamic+therapeutics%3A+basic+principles+and+clinical+applications&doi=10.1016%2FS1359-6446%2899%2901412-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapeutics: basic principles and clinical applications</span></div><div class="casAuthors">Sharman, W. M.; Allen, C. M.; van Lier, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">507-517</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 71 refs.  Photodynamic therapy (PDT) is a promising new treatment for cancer that has been recently accepted in the clinic.  PDT involves the localization of a light-sensitive drug (photosensitizer) in the target tissue prior to illumination using an appropriate wavelength.  Cytotoxic agents generated upon illumination trigger a cascade of biochem. responses that inactivate cancer cells either directly or through the induction of vascular stasis.  These treatments are better tolerated as they destroy diseased tissue while leaving normal tissue intact.  The hematoporphyrin deriv., Photofrin, has been approved in a no. of European and Asian countries, as well as in North America.  To enhance the potential of PDT and explore its application for other conditions, second-generation photosensitizers are being rigorously investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH5aWUaH7trLVg90H21EOLACvtfcHk0ljBXRskhe41BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvVKhsrY%253D&md5=6bf14daa571a10e3982d773b4a5730d6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2899%2901412-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252899%252901412-9%26sid%3Dliteratum%253Aachs%26aulast%3DSharman%26aufirst%3DW.%2BM.%26aulast%3DAllen%26aufirst%3DC.%2BM.%26aulast%3Dvan%2BLier%26aufirst%3DJ.%2BE.%26atitle%3DPhotodynamic%2520therapeutics%253A%2520basic%2520principles%2520and%2520clinical%2520applications%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D1999%26volume%3D4%26spage%3D507%26epage%3D517%26doi%3D10.1016%2FS1359-6446%2899%2901412-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span> <span> </span><span class="NLM_article-title">Photothermal-pH-hypoxia responsive multifunctional nanoplatform for cancer photo-chemo therapy with negligible skin phototoxicity</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>221</i></span>, <span class="NLM_elocation-id">119422</span> <span class="refDoi"> DOI: 10.1016/j.biomaterials.2019.119422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.biomaterials.2019.119422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31437723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1Shs77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=2019&author=D.+Chenauthor=Y.+Tangauthor=J.+Zhuauthor=J.+Zhangauthor=X.+Songauthor=W.+Wangauthor=J.+Shaoauthor=W.+Huangauthor=P.+Chenauthor=X.+Dong&title=Photothermal-pH-hypoxia+responsive+multifunctional+nanoplatform+for+cancer+photo-chemo+therapy+with+negligible+skin+phototoxicity&doi=10.1016%2Fj.biomaterials.2019.119422"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Photothermal-pH-hypoxia responsive multifunctional nanoplatform for cancer photo-chemo therapy with negligible skin phototoxicity</span></div><div class="casAuthors">Chen, Dapeng; Tang, Yunyun; Zhu, Jiawei; Zhang, Jiaojiao; Song, Xuejiao; Wang, Wenjun; Shao, Jinjun; Huang, Wei; Chen, Peng; Dong, Xiaochen</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119422</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Highly specific and effective cancer phototherapy remains as a great challenge.  Herein, a smart nanoplatform (TENAB NP) sequentially responsive to light, low pH and hypoxia is demonstrated for multi-mode imaging guided synergistic cancer therapy with negligible skin phototoxicity.  Upon 808-nm laser irradn., TENAB NPs can generate hyperthermia to melt the phase change material (PCM-LASA) coat and thereafter release chemo-drug tirapazamine (TPZ).  Meanwhile, under acidic pH, photosensitizer ENAB would turn "off" its charge-transfer state, generating prominent 1O2 for photodynamic therapy (PDT) and heat for photothermal therapy (PTT), resp.  Accompanied with PDT-induced hypoxia, the released TPZ can be activated into its cytotoxic form for tumor cells killing.  Notably, owing to phase change material LASA coat and ENAB's pH sensitivity, TENAB NPs show negligible photosensitization to skin and normal tissues.  As the multi-stimuli responsive mechanism, TENAB NPs demonstrate a promising future in cancer photo-chemo theranostics with excellent skin protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkHU2anngKJbVg90H21EOLACvtfcHk0lgtcy3HIgV8lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1Shs77N&md5=d0441208d1adaff56660c7e82e2318ca</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2019.119422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2019.119422%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DShao%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DDong%26aufirst%3DX.%26atitle%3DPhotothermal-pH-hypoxia%2520responsive%2520multifunctional%2520nanoplatform%2520for%2520cancer%2520photo-chemo%2520therapy%2520with%2520negligible%2520skin%2520phototoxicity%26jtitle%3DBiomaterials%26date%3D2019%26volume%3D221%26doi%3D10.1016%2Fj.biomaterials.2019.119422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span> <span> </span><span class="NLM_article-title">Epidermal growth factor receptor-targeted delivery of a singlet-oxygen sensitizer with thermal controlled release for efficient anticancer therapy</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3703</span>– <span class="NLM_lpage">3710</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.9b00670</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.9b00670" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1ensL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=3703-3710&author=J.+Chenauthor=D.+Liauthor=B.+Huoauthor=F.+Zhangauthor=X.+Zhaoauthor=G.+Yuanauthor=D.+Chenauthor=M.+Songauthor=J.+Xue&title=Epidermal+growth+factor+receptor-targeted+delivery+of+a+singlet-oxygen+sensitizer+with+thermal+controlled+release+for+efficient+anticancer+therapy&doi=10.1021%2Facs.molpharmaceut.9b00670"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Epidermal Growth Factor Receptor-Targeted Delivery of a Singlet-Oxygen Sensitizer with Thermal Controlled Release for Efficient Anticancer Therapy</span></div><div class="casAuthors">Chen, Juanjuan; Li, Dongyao; Huo, Beibei; Zhang, Fengling; Zhao, Xuan; Yuan, Gankun; Chen, Dan; Song, Meiru; Xue, Jinping</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3703-3710</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) utilizing light-induced singlet oxygen has achieved attractive results in anticancer fields; however, its development is hindered by limited light penetration depth, skin phototoxicity, tumor hypoxia, and PDT-induced hypoxia.  Inspired by our previous research work and the limitations of PDT, we introduce a small-mol.-targeted drug erlotinib into the singlet-oxygen chem. source endoperoxide to achieve an EGFR-targeted PDT-mimetic sensitizer (Y3-1) for anticancer therapy.  We demonstrated the erlotinib-based precise delivery of the singlet-oxygen chem. source (in vitro photosensitization) to EFGR-overexpressing tumor cells and tissues.  Moreover, the anticancer assays validated that the enhanced anticancer efficacy (in vitro and in vivo) of Y3-1 was due to reversible singlet-oxygen thermal release.  This study is expected to provide a smart strategy to break through the current roadblock in targeted PDT and achieve a more efficient anticancer therapy model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPKflnIRgCOLVg90H21EOLACvtfcHk0lgtcy3HIgV8lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1ensL3P&md5=c815fd7e4728c647f110585f88ca477c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.9b00670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.9b00670%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DHuo%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DYuan%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DXue%26aufirst%3DJ.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor-targeted%2520delivery%2520of%2520a%2520singlet-oxygen%2520sensitizer%2520with%2520thermal%2520controlled%2520release%2520for%2520efficient%2520anticancer%2520therapy%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2019%26volume%3D16%26spage%3D3703%26epage%3D3710%26doi%3D10.1021%2Facs.molpharmaceut.9b00670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sebak, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomaa, I. E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ElMeshad, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">AbdelKader, M. H.</span></span> <span> </span><span class="NLM_article-title">Targeted photodynamic-induced singlet oxygen production by peptide-conjugated biodegradable nanoparticles for treatment of skin melanoma</span>. <i>Photodiagn. Photodyn. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1016/j.pdpdt.2018.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.pdpdt.2018.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=29885810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht12qtL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=181-189&author=A.+A.+Sebakauthor=I.+E.+O.+Gomaaauthor=A.+N.+ElMeshadauthor=M.+H.+AbdelKader&title=Targeted+photodynamic-induced+singlet+oxygen+production+by+peptide-conjugated+biodegradable+nanoparticles+for+treatment+of+skin+melanoma&doi=10.1016%2Fj.pdpdt.2018.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted photodynamic-induced singlet oxygen production by peptide-conjugated biodegradable nanoparticles for treatment of skin melanoma</span></div><div class="casAuthors">Sebak, Aya Ahmed; Gomaa, Iman Emam Omar; ElMeshad, Aliaa Nabil; AbdelKader, Mahmoud Hashem</div><div class="citationInfo"><span class="NLM_cas:title">Photodiagnosis and Photodynamic Therapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">181-189</span>CODEN:
                <span class="NLM_cas:coden">PPTHBF</span>;
        ISSN:<span class="NLM_cas:issn">1572-1000</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) has been detd. to be a promising treatment modality in the most resistant tumors such as malignant melanoma.  However, the key cytotoxic agent of PDT, -singlet oxygen (1O2) - represents a high risk of photodynamic-assocd. side effects e.g. skin photosensitization.  Recently, controllable photosensitization, where 1O2 is produced on demand, has received increasing attention.  In our study, this could be achieved via loading the photosensitizer (PS) in nanoparticles (NPs) decorated with target-specific moieties characterized by 1O2 quenching abilities to specifically locate the PS in the targeted cells and assure that 1O2 is only produced where desired after cellular processing.  Polymeric and hybrid lipid-polymer NPs were formulated and assayed for their physicochem. properties.  This was followed by conjugation with an active targeting ligand, cRGDyk, cyclic (Arginine-Glycine-Aspartic acid-D-Tyrosine-Lysine) peptide.  Finally, photodynamic potential of the selected formulations was assayed by quantification of 1O2 prodn. and in vitro cytotoxicity.  Three formulations were selected and nominated to be formulations of choice (FOCs); FOC-1 (200 nm, polymeric), FOC-2 (130 nm, polymeric) and FOC-3 (200 nm, hybrid).  Physicochem. properties, most importantly particle size and NPs' compn. have shown to be the major determinants in targeted NPs' 1O2 prodn. and PDT-mediated cytotoxicity of melanoma.  Proper selection of formulations intended for PDT application and target-specific ligands could achieve dual targeting; enhanced accumulation of NPs and protection of 1O2 prodn. elsewhere other than target cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosJHY0KiAwabVg90H21EOLACvtfcHk0lgtcy3HIgV8lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht12qtL7J&md5=e8b949193da756688f1794fa0c395594</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.pdpdt.2018.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pdpdt.2018.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DSebak%26aufirst%3DA.%2BA.%26aulast%3DGomaa%26aufirst%3DI.%2BE.%2BO.%26aulast%3DElMeshad%26aufirst%3DA.%2BN.%26aulast%3DAbdelKader%26aufirst%3DM.%2BH.%26atitle%3DTargeted%2520photodynamic-induced%2520singlet%2520oxygen%2520production%2520by%2520peptide-conjugated%2520biodegradable%2520nanoparticles%2520for%2520treatment%2520of%2520skin%2520melanoma%26jtitle%3DPhotodiagn.%2520Photodyn.%2520Ther.%26date%3D2018%26volume%3D23%26spage%3D181%26epage%3D189%26doi%3D10.1016%2Fj.pdpdt.2018.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lütje, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heskamp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franssen, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frielink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kip, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hekman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fracasso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colombatti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boerman, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotthardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rijpkema, M.</span></span> <span> </span><span class="NLM_article-title">Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2924</span>– <span class="NLM_lpage">2938</span>, <span class="refDoi"> DOI: 10.7150/thno.35274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.7150%2Fthno.35274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31244933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvF2htLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=2924-2938&author=S.+L%C3%BCtjeauthor=S.+Heskampauthor=G.+M.+Franssenauthor=C.+Frielinkauthor=A.+Kipauthor=M.+Hekmanauthor=G.+Fracassoauthor=M.+Colombattiauthor=K.+Herrmannauthor=O.+C.+Boermanauthor=M.+Gotthardtauthor=M.+Rijpkema&title=Development+and+characterization+of+a+theranostic+multimodal+anti-PSMA+targeting+agent+for+imaging%2C+surgical+guidance%2C+and+targeted+photodynamic+therapy+of+PSMA-expressing+tumors&doi=10.7150%2Fthno.35274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors</span></div><div class="casAuthors">Luetje, Susanne; Heskamp, Sandra; Franssen, Gerben M.; Frielink, Cathelijne; Kip, Annemarie; Hekman, Marlene; Fracasso, Giulio; Colombatti, Marco; Herrmann, Ken; Boerman, Otto C.; Gotthardt, Martin; Rijpkema, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2924-2938</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Rationale: Prostate cancer (PCa) recurrences after surgery frequently occur.  To improve the outcome after surgical resection of the tumor, the theranostic multimodal anti-PSMA targeting agent 111In-DTPA-D2B-IRDye700DX was developed and characterized for both pre- and intra-operative tumor localization and eradication of (residual) tumor tissue by PSMA-targeted photodynamic therapy (tPDT), which is a highly selective cancer treatment based on targeting mols. conjugated to photosensitizers that can induce cell destruction upon exposure to near-IR (NIR) light.  Methods: The anti-PSMA monoclonal antibody D2B was conjugated with IRDye700DX and DTPA and subsequently radiolabeled with 111In.  To det. the optimal dose and time point for tPDT, BALB/c nude mice with PSMA-expressing (PSMA+) s.c.  LS174T-PSMA xenografts received the conjugate (24-240 μg/mouse) i.v. (8 MBq/mouse) followed by μSPECT/CT, near-IR fluorescence imaging, and ex vivo biodistribution at 24, 48, 72 and 168 h p.i.  Tumor growth of LS174T-PSMA xenografts and overall survival of mice treated with 1-3 times of NIR light irradn. (50, 100, 150 J/cm2) 24 h after injection of 80 μg of DTPA-D2B-IRDye700DX was compared to control conditions.  Results: Highest specific tumor uptake was obsd. at conjugate doses of 80 μg/mouse.  Biodistribution revealed no significant difference in tumor uptake in mice at 24, 48, 72 and 168 h p.i.  PSMA+ tumors were clearly visualized with both μSPECT/CT and NIR fluorescence imaging.  Overall survival in mice treated with 80 μg of DTPA-D2B-IRDye700DX and 1 x 150 J/cm2 of NIR light at 24 h p.i. was significantly improved compared to the control group receiving neither conjugate nor NIR light (73 days vs. 16 days, resp., p = 0.0453).  Treatment with 3 x 150 J/cm2 resulted in significantly prolonged survival compared to treatment with 3 x 100 J/cm2 (p = 0.0067) and 3 x 50 J/cm2 (p = 0.0338).  Principal conclusions:111In-DTPA-D2B-IRDye700DX can be used for pre- and intra-operative detection of PSMA+ tumors with radionuclide and NIR fluorescence imaging and PSMA-targeted PDT.  PSMA-tPDT using this multimodal agent resulted in significant prolongation of survival and shows great potential for treatment of (metastasized) prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1anzkaLMV1bVg90H21EOLACvtfcHk0lhpENrOYlkIvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvF2htLnK&md5=a32cea3516fe6c1e6b8ebf7ae932d114</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.7150%2Fthno.35274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.35274%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25BCtje%26aufirst%3DS.%26aulast%3DHeskamp%26aufirst%3DS.%26aulast%3DFranssen%26aufirst%3DG.%2BM.%26aulast%3DFrielink%26aufirst%3DC.%26aulast%3DKip%26aufirst%3DA.%26aulast%3DHekman%26aufirst%3DM.%26aulast%3DFracasso%26aufirst%3DG.%26aulast%3DColombatti%26aufirst%3DM.%26aulast%3DHerrmann%26aufirst%3DK.%26aulast%3DBoerman%26aufirst%3DO.%2BC.%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3DRijpkema%26aufirst%3DM.%26atitle%3DDevelopment%2520and%2520characterization%2520of%2520a%2520theranostic%2520multimodal%2520anti-PSMA%2520targeting%2520agent%2520for%2520imaging%252C%2520surgical%2520guidance%252C%2520and%2520targeted%2520photodynamic%2520therapy%2520of%2520PSMA-expressing%2520tumors%26jtitle%3DTheranostics%26date%3D2019%26volume%3D9%26spage%3D2924%26epage%3D2938%26doi%3D10.7150%2Fthno.35274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, S. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarmento, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, P. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomé, J. P. C.</span></span> <span> </span><span class="NLM_article-title">Photoimmunoconjugates: novel synthetic strategies to target and treat cancer by photodynamic therapy</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2579</span>– <span class="NLM_lpage">2593</span>, <span class="refDoi"> DOI: 10.1039/C8OB02902D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2FC8OB02902D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=30648722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvV2nuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=2579-2593&author=S.+R.+G.+Fernandesauthor=R.+Fernandesauthor=B.+Sarmentoauthor=P.+M.+R.+Pereiraauthor=J.+P.+C.+Tom%C3%A9&title=Photoimmunoconjugates%3A+novel+synthetic+strategies+to+target+and+treat+cancer+by+photodynamic+therapy&doi=10.1039%2FC8OB02902D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Photoimmunoconjugates: novel synthetic strategies to target and treat cancer by photodynamic therapy</span></div><div class="casAuthors">Fernandes, Sara R. G.; Fernandes, Rosa; Sarmento, Bruno; Pereira, Patricia M. R.; Tome, Joao P. C.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2579-2593</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) combines a photosensitizer (PS) with the phys. energy of non-ionizing light to trigger cell death pathways.  PDT has potential as a therapeutic modality to be used in alternative or in combination with other conventional cancer treatment protocols (e.g. surgery, chemotherapy and radiotherapy).  Still, due to the lack of specificity of the current PSs to target the tumor cells, several studies have exploited their conjugation with targeting moieties.  PSs conjugated with antibodies (Abs) or their fragments, able to bind antigens overexpressed in the tumors, have demonstrated potential in PDT of tumors.  This review provides an overview of the most recent advances on photoimmunoconjugates (PICs) for cancer PDT, which involve the first and second-generation PSs conjugated to Abs.  This is an update of our previous review "Antibodies armed with photosensitizers: from chem. synthesis to photobiol. applications", published in 2015 in Org. Biomol. Chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPGEH7r1jTC7Vg90H21EOLACvtfcHk0lhpENrOYlkIvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvV2nuw%253D%253D&md5=7f9d9256b2b2571966801691e3726aa4</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1039%2FC8OB02902D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8OB02902D%26sid%3Dliteratum%253Aachs%26aulast%3DFernandes%26aufirst%3DS.%2BR.%2BG.%26aulast%3DFernandes%26aufirst%3DR.%26aulast%3DSarmento%26aufirst%3DB.%26aulast%3DPereira%26aufirst%3DP.%2BM.%2BR.%26aulast%3DTom%25C3%25A9%26aufirst%3DJ.%2BP.%2BC.%26atitle%3DPhotoimmunoconjugates%253A%2520novel%2520synthetic%2520strategies%2520to%2520target%2520and%2520treat%2520cancer%2520by%2520photodynamic%2520therapy%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2019%26volume%3D17%26spage%3D2579%26epage%3D2593%26doi%3D10.1039%2FC8OB02902D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Enhancing anti-PD-1/PD-L1 immune checkpoint inhibitory cancer therapy by CD276-targeted photodynamic ablation of tumor cells and tumor vasculature</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.8b00997</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.8b00997" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1aru7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=339-348&author=R.+Baoauthor=Y.+Wangauthor=J.+Laiauthor=H.+Zhuauthor=Y.+Zhaoauthor=S.+Liauthor=N.+Liauthor=J.+Huangauthor=Z.+Yangauthor=F.+Wangauthor=Z.+Liu&title=Enhancing+anti-PD-1%2FPD-L1+immune+checkpoint+inhibitory+cancer+therapy+by+CD276-targeted+photodynamic+ablation+of+tumor+cells+and+tumor+vasculature&doi=10.1021%2Facs.molpharmaceut.8b00997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancing Anti-PD-1/PD-L1 Immune Checkpoint Inhibitory Cancer Therapy by CD276-Targeted Photodynamic Ablation of Tumor Cells and Tumor Vasculature</span></div><div class="casAuthors">Bao, Rui; Wang, Yanpu; Lai, Jianhao; Zhu, Hua; Zhao, Yang; Li, Suping; Li, Nan; Huang, Jing; Yang, Zhi; Wang, Fan; Liu, Zhaofei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">339-348</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antiangiogenic therapies have been demonstrated to improve the efficacy of immune checkpoint inhibition by overcoming the immunosuppressive status of the tumor microenvironment.  However, most of the current antiangiogenic agents cannot discriminate tumor angiogenesis from physiol. angiogenesis.  The aim of this study was to investigate whether a photodynamic therapy (PDT) agent that targets CD276, a receptor overexpressed in various tumor cells and tumor vasculature but with limited expression in normal tissue vasculature, could improve the tumor inhibitory efficacy of a PD-1/PD-L1 blockade.  A CD276-targeting agent (IRD-αCD276/Fab) was synthesized by conjugating the Fab fragment of an anti-CD276 antibody with a photosensitizer IRDye700.  The in vivo tumor-targeting efficacy and therapeutic effects of IRD-αCD276/Fab with or without an anti-PD-1/PD-L1 blockade were tested in s.c. and lung metastatic tumor models.  PDT using IRD-αCD276/Fab significantly suppressed the growth of s.c. 4T1 tumor and inhibited its lung metastasis.  Moreover, it triggered in vivo antitumor immunity by increasing the activation and maturation of dendritic cells.  Tumor PD-L1 levels were also markedly increased after PDT using IRD-αCD276/Fab, as evidenced by noninvasive PD-L1-targeted small-animal PET imaging.  In combination with an anti-PD-1/PD-L1 blockade, IRD-αCD276/Fab PDT markedly suppressed the growth of tumors and prevented their metastasis to the lung by recruiting the tumor infiltration of CD8+ T cells.  Our data provide evidence for the role of CD276-targeted PDT for local immune modulation, and its combination with PD-L1/PD-1 axis inhibition is a promising strategy for eliminating primary tumors as well as disseminated metastases, by generating local and systemic antitumor responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL-WcGbGJzeLVg90H21EOLACvtfcHk0lhpENrOYlkIvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1aru7%252FP&md5=b1fd4e19b3b92dfde0771382c906bad5</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.8b00997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.8b00997%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DEnhancing%2520anti-PD-1%252FPD-L1%2520immune%2520checkpoint%2520inhibitory%2520cancer%2520therapy%2520by%2520CD276-targeted%2520photodynamic%2520ablation%2520of%2520tumor%2520cells%2520and%2520tumor%2520vasculature%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2019%26volume%3D16%26spage%3D339%26epage%3D348%26doi%3D10.1021%2Facs.molpharmaceut.8b00997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span> <span> </span><span class="NLM_article-title">A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer</span>. <i>Acta Biomater.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">400</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1016/j.actbio.2018.11.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.actbio.2018.11.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=30465921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlensLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2019&pages=400-413&author=W.+Xuauthor=J.+Qianauthor=G.+Houauthor=Y.+Wangauthor=J.+Wangauthor=T.+Sunauthor=L.+Jiauthor=A.+Suoauthor=Y.+Yao&title=A+dual-targeted+hyaluronic+acid-gold+nanorod+platform+with+triple-stimuli+responsiveness+for+photodynamic%2Fphotothermal+therapy+of+breast+cancer&doi=10.1016%2Fj.actbio.2018.11.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer</span></div><div class="casAuthors">Xu, Weijun; Qian, Junmin; Hou, Guanghui; Wang, Yaping; Wang, Jinlei; Sun, Tiantian; Ji, Lijie; Suo, Aili; Yao, Yu</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biomaterialia</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">400-413</span>CODEN:
                <span class="NLM_cas:coden">ABCICB</span>;
        ISSN:<span class="NLM_cas:issn">1742-7061</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Multi-stimuli-responsive theranostic nanoplatform integrating functions of both imaging and multimodal therapeutics holds great promise for improving diagnosis and therapeutic efficacy.  In this study, we reported a pH, glutathione (GSH) and hyaluronidase (HAase) triple-responsive nanoplatform for HER2 and CD44 dual-targeted and fluorescence imaging-guided PDT/PTT dual-therapy against HER2-overexpressed breast cancer.  The nanoplatform was fabricated by functionalizing gold nanorods (GNRs) with hyaluronic acid (HA) bearing pendant hydrazide and thiol groups via Au-S bonds, and subsequently chem. conjugating 5-aminolevulinic acid (ALA), Cy7.5 and anti-HER2 antibody onto HA moiety for PDT, fluorescence imaging and active targeting, resp.  The resulting versatile nanoplatform GNR-HA-ALA/Cy7.5-HER2 had uniform sizes, favorable dispersibility, as well as pH, GSH and HAase triple-responsive drug release manner.  In vitro studies demonstrated that HER2 and CD44 receptor-mediated dual-targeting strategy could significantly enhance the cellular uptake of GNR-HA-ALA/Cy7.5-HER2.  Under near-IR (NIR) irradn., MCF-7 cells could efficiently generate reactive oxygen species (ROS) and heat, and be more efficiently killed by a combination of PDT and PTT as compared with individual therapy.  Pharmacokinetic and biodistribution studies showed that the nanoplatform possessed a circulation half-life of 1.9 h and could be specifically delivered to tumor tissues with an accumulation ratio of 12.8%.  Upon the fluorescence imaging-guided PDT/PTT treatments, the tumors were completely eliminated without obvious side effects.  The results suggest that the GNR-HA-ALA/Cy7.5-HER2 holds great potential for breast cancer therapy.  A combination of photodynamic therapy (PDT) and photothermal therapy (PTT) is emerging as a promising cancer treatment strategy.  However, its therapeutic efficacy is compromised by the nonspecific delivery and unintended release of photo-responsive agents.  Herein, we developed a multifunctional theranostic nanoplatform GNR-HA-ALA/Cy7.5-HER2 with pH, glutathione and hyaluronidase triple-responsive drug release for HER2 and CD44 dual-targeted and fluorescence imaging-guided PDT/PTT therapy against breast cancer.  We demonstrated that HER2 and CD44 receptors-mediated dual-targeting strategy significantly enhanced the cellular uptake of GNR-HA-ALA/Cy7.5-HER2.  We also demonstrated that the combined PDT/PTT treatment had significantly superior antitumor effect than PDT or PTT alone both in vitro and in vivo.  Therefore, GNR-HA-ALA/Cy7.5-HER2 could serve as a promising nanoplatform for HER2-pos. breast cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo79AQM5AedK7Vg90H21EOLACvtfcHk0lhxUDVxxpdzsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlensLjJ&md5=5e673e1972962e1e6792f6cd763995b4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.actbio.2018.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.actbio.2018.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DHou%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DSuo%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DY.%26atitle%3DA%2520dual-targeted%2520hyaluronic%2520acid-gold%2520nanorod%2520platform%2520with%2520triple-stimuli%2520responsiveness%2520for%2520photodynamic%252Fphotothermal%2520therapy%2520of%2520breast%2520cancer%26jtitle%3DActa%2520Biomater.%26date%3D2019%26volume%3D83%26spage%3D400%26epage%3D413%26doi%3D10.1016%2Fj.actbio.2018.11.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miley, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ming, X.</span></span> <span> </span><span class="NLM_article-title">P-glycoprotein targeted photodynamic therapy of chemoresistant tumors using recombinant Fab fragment conjugates</span>. <i>Biomater. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">3063</span>– <span class="NLM_lpage">3074</span>, <span class="refDoi"> DOI: 10.1039/C8BM00844B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2FC8BM00844B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=30298866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslejurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=3063-3074&author=C.+Maoauthor=P.+Quauthor=M.+J.+Mileyauthor=Y.+Zhaoauthor=Z.+Liauthor=X.+Ming&title=P-glycoprotein+targeted+photodynamic+therapy+of+chemoresistant+tumors+using+recombinant+Fab+fragment+conjugates&doi=10.1039%2FC8BM00844B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">P-glycoprotein targeted photodynamic therapy of chemoresistant tumors using recombinant Fab fragment conjugates</span></div><div class="casAuthors">Mao, Chengqiong; Qu, Ping; Miley, Michael J.; Zhao, Yan; Li, Zibo; Ming, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3063-3074</span>CODEN:
                <span class="NLM_cas:coden">BSICCH</span>;
        ISSN:<span class="NLM_cas:issn">2047-4849</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">P-glycoprotein (Pgp) has been considered as a major cause of cancer multidrug resistance; however, clin. solns. to overcome this drug resistance do not exist despite the tremendous endeavors.  The lack of cancer specificity is a main reason for clin. failure of conventional approaches.  Targeted photodynamic therapy (PDT) is highly cancer specific by combining antibody targeting and locoregional light irradn.  We aimed to develop Pgp-targeted PDT using antibody-photosensitizer conjugates made of a recombinant Fab fragment.  We prepd. the photosensitizer conjugates by expressing a recombinant Fab fragment and specifically linking IR700-maleimide at the C-terminal of the Fab heavy chain.  In vitro studies showed that the Fab conjugates specifically bind to Pgp.  Their phototoxicity was comparable to full antibody conjugates when assayed with conventional 2-D cell culture, but they outperformed the full antibody conjugates in a 3-D tumor spheroid model.  In a mouse xenograft model of chemoresistant tumors, Fab conjugates showed Pgp specific delivery to chemoresistant tumors.  Upon irradn. with near-IR light, they caused rapid tumor shrinkage and significantly prolonged the survival of tumor-bearing mice.  Compared to the full antibody conjugates, Fab conjugates took a shorter time to reach peak tumor levels and achieved a more homogeneous tumor distribution.  This allows light irradn. to be initiated at a shorter time interval after the conjugate injection, and thus may facilitate clin. translation.  We conclude that our targeted PDT approach provides a highly cancer-specific approach to combat chemoresistant tumors, and that the conjugates made of recombinant antibody fragments are superior to full antibody conjugates for targeted PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrutVSSFUaA7Vg90H21EOLACvtfcHk0lhxUDVxxpdzsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslejurzF&md5=b442896e5c25f41c7c3e3dff0d836b95</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1039%2FC8BM00844B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8BM00844B%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DC.%26aulast%3DQu%26aufirst%3DP.%26aulast%3DMiley%26aufirst%3DM.%2BJ.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DMing%26aufirst%3DX.%26atitle%3DP-glycoprotein%2520targeted%2520photodynamic%2520therapy%2520of%2520chemoresistant%2520tumors%2520using%2520recombinant%2520Fab%2520fragment%2520conjugates%26jtitle%3DBiomater.%2520Sci.%26date%3D2018%26volume%3D6%26spage%3D3063%26epage%3D3074%26doi%3D10.1039%2FC8BM00844B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Que, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamburini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldazzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Optical imaging and pH-awakening therapy of deep tissue cancer based on specific upconversion nanophotosensitizers</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>230</i></span>, <span class="NLM_elocation-id">119637</span> <span class="refDoi"> DOI: 10.1016/j.biomaterials.2019.119637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.biomaterials.2019.119637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31776018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1Wrt73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=2020&author=Y.+Fengauthor=H.+Chenauthor=Y.+Wuauthor=I.+Queauthor=F.+Tamburiniauthor=F.+Baldazziauthor=Y.+Changauthor=H.+Zhang&title=Optical+imaging+and+pH-awakening+therapy+of+deep+tissue+cancer+based+on+specific+upconversion+nanophotosensitizers&doi=10.1016%2Fj.biomaterials.2019.119637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Optical imaging and pH-awakening therapy of deep tissue cancer based on specific upconversion nanophotosensitizers</span></div><div class="casAuthors">Feng, Yansong; Chen, Haoran; Wu, Yanni; Que, Ivo; Tamburini, Filippo; Baldazzi, Fabio; Chang, Yulei; Zhang, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">230</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119637</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Side effect is one of the main factors affecting the success of cancer therapies in clinic.  Patients treated with photodynamic therapy (PDT) suffer mainly from the phototoxicity due to the relatively long time blood circulation of the tumor enrichment and they have also to be protected from background light for days after the treatment.  Here we introduce a new design of nanophotosensitizers in which the luminescence upconversion nanoparticles loaded with photosensitizers are self-assembled into a nanoball with the aid of a specific pH-sensitive polymer layer contg. overloaded photosensitizers and quenching mols.  This design makes the therapy function "off/on" possible, i.e. only imaging during the circulation of the nanoballs ascribing to the near-IR (NIR) photon upconversion of the nanoballs and the pH-sensitive shell.  Activation of PDT solely occurs once the nanoballs are taken up by the cancer cells due to the acidic microenvironment.  This design prevents effectively the photodamage of the photosensitizers during enrichment and targeting process of tumor, as validated in vitro and in vivo, which enables imaging-guided PDT treatment of deep-seated tumor in a much more relax and comfortable way for patients.  This patient-friendly nanomaterial construction strategy can also be extended to other therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYtd85be2qo7Vg90H21EOLACvtfcHk0ljcasjnzcsH8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1Wrt73J&md5=a7c663cef68a1acb41950de4e8321f19</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2019.119637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2019.119637%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DQue%26aufirst%3DI.%26aulast%3DTamburini%26aufirst%3DF.%26aulast%3DBaldazzi%26aufirst%3DF.%26aulast%3DChang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DOptical%2520imaging%2520and%2520pH-awakening%2520therapy%2520of%2520deep%2520tissue%2520cancer%2520based%2520on%2520specific%2520upconversion%2520nanophotosensitizers%26jtitle%3DBiomaterials%26date%3D2020%26volume%3D230%26doi%3D10.1016%2Fj.biomaterials.2019.119637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B. Z.</span></span> <span> </span><span class="NLM_article-title">Efficient near-infrared photosensitizer with aggregation-induced emission for imaging-guided photodynamic therapy in multiple xenograft tumor models</span>. <i>ACS Nano</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">854</span>– <span class="NLM_lpage">866</span>, <span class="refDoi"> DOI: 10.1021/acsnano.9b07972</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsnano.9b07972" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlOhsbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2020&pages=854-866&author=J.+Daiauthor=Y.+Liauthor=Z.+Longauthor=R.+Jiangauthor=Z.+Zhuangauthor=Z.+Wangauthor=Z.+Zhaoauthor=X.+Louauthor=F.+Xiaauthor=B.+Z.+Tang&title=Efficient+near-infrared+photosensitizer+with+aggregation-induced+emission+for+imaging-guided+photodynamic+therapy+in+multiple+xenograft+tumor+models&doi=10.1021%2Facsnano.9b07972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient Near-Infrared Photosensitizer with Aggregation-Induced Emission for Imaging-Guided Photodynamic Therapy in Multiple Xenograft Tumor Models</span></div><div class="casAuthors">Dai, Jun; Li, Yinghao; Long, Zi; Jiang, Ruming; Zhuang, Zeyan; Wang, Zhiming; Zhao, Zujin; Lou, Xiaoding; Xia, Fan; Tang, Ben Zhong</div><div class="citationInfo"><span class="NLM_cas:title">ACS Nano</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">854-866</span>CODEN:
                <span class="NLM_cas:coden">ANCAC3</span>;
        ISSN:<span class="NLM_cas:issn">1936-0851</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) strategy has been widely used in tumor treatment, and the reagents for reactive oxygen species (ROS) play a crucial role.  Herein, we develop a fluorogen (TTB) contg. an electron-accepting benzo[1,2-b:4,5-b']dithiophene 1,1,5,5-tetraoxide core and electron-donating 4,4'-(2,2-diphenylethene-1,1-diyl)bis(N,N-diphenylaniline) groups for image-guided targeting PDT application.  TTB exhibits a prominent aggregation-induced emission (AIE) property with strong near-IR (NIR) fluorescence in aggregates and is capable of efficiently generating ROS of O2•- and 1O2 under white light irradn.  The nanoparticles (RGD-4R-MPD/TTB NPs) with NIR emission (∼730 nm), high photostability, and low dark cytotoxicity are fabricated by encapsulating TTB within polymeric matrix and then modified with RGD-4R peptide.  They show excellent performance in targeting PDT treatment of PC3, HeLa, and SKOV-3 cancer cells in vitro.  The investigations on pharmacokinetics, biodistribution, and long-term tracing in vivo reveal that RGD-4R-MPD/TTB NPs can selectively accumulate in tumors for real-time, long-term image-guided PDT treatment.  The RGD-4R-MPD/TTB NPs-mediated PDT in multiple xenograft tumor models disclose that the growth of cervical, prostate, and ovarian cancers in mice can be effectively inhibited.  These results demonstrate that the reagents employing NIR fluorogen TTB as a photosensitizer could be promising candidates for in vivo image-guided PDT treatments of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNJFR6wF7lPrVg90H21EOLACvtfcHk0ljcasjnzcsH8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlOhsbzN&md5=df9d7e88f8c68b8c9315130900262314</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facsnano.9b07972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsnano.9b07972%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLong%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DR.%26aulast%3DZhuang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DLou%26aufirst%3DX.%26aulast%3DXia%26aufirst%3DF.%26aulast%3DTang%26aufirst%3DB.%2BZ.%26atitle%3DEfficient%2520near-infrared%2520photosensitizer%2520with%2520aggregation-induced%2520emission%2520for%2520imaging-guided%2520photodynamic%2520therapy%2520in%2520multiple%2520xenograft%2520tumor%2520models%26jtitle%3DACS%2520Nano%26date%3D2020%26volume%3D14%26spage%3D854%26epage%3D866%26doi%3D10.1021%2Facsnano.9b07972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haimov-Talmoud, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motiei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovtzer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lellouche, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shefi, O.</span></span> <span> </span><span class="NLM_article-title">Magnetic targeting of mTHPC to improve the selectivity and efficiency of photodynamic therapy</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">45368</span>– <span class="NLM_lpage">45380</span>, <span class="refDoi"> DOI: 10.1021/acsami.9b14060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.9b14060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1WktL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=45368-45380&author=E.+Haimov-Talmoudauthor=Y.+Harelauthor=H.+Schoriauthor=M.+Motieiauthor=A.+Atkinsauthor=R.+Popovtzerauthor=J.-P.+Lelloucheauthor=O.+Shefi&title=Magnetic+targeting+of+mTHPC+to+improve+the+selectivity+and+efficiency+of+photodynamic+therapy&doi=10.1021%2Facsami.9b14060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Magnetic Targeting of mTHPC To Improve the Selectivity and Efficiency of Photodynamic Therapy</span></div><div class="casAuthors">Haimov-Talmoud, Elina; Harel, Yifat; Schori, Hadas; Motiei, Menachem; Atkins, Ayelet; Popovtzer, Rachela; Lellouche, Jean-Paul; Shefi, Orit</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">45368-45380</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is a promising recognized treatment for cancer.  To date, PDT drugs are injected systemically, and the tumor area is irradiated to induce cell death.  Current clin. protocols have several drawbacks, including limited accessibility to solid tumors and insufficient selectivity of drugs.  Herein, we propose an alternative approach to improve PDT effectiveness by magnetic targeting of responsive carriers conjugated to the PDT drug.  We coordinatively attached a meso-tetrahydroxyphenylchlorin (mTHPC) photosensitizer to Ce-doped-γ-Fe2O3 maghemite nanoparticles (MNPs).  These MNPs are superparamagnetic and biocompatible, and the resulting mTHPC-MNPs nanocomposites are stable in aq. suspensions.  MDA-MB231 (human breast cancer) cells incubated with the mTHPC-MNPs showed high uptake and high death rates in cell population after PDT.  The exposure to external magnetic forces during the incubation period directed the nanocomposites to selected sites enhancing drug accumulation that was double that of cells with no magnetic exposure.  Next, breast cancer tumors were induced s.c. in mice and treated magnetically.  In vivo results showed accelerated drug accumulation in tumors of mice injected with mTHPC-MNP nanocomposites, compared to the free drug.  PDT irradn. led to a decrease in tumor size of both groups, whereas treatment with the focused magnetic nanocomposites led to significant tumor regression.  Our results demonstrate a method to improve the current PDT treatments by applying magnetic forces to effectively direct the drug to cancerous tissue.  This approach leads to a highly localized and effective PDT process, opening new directions for clin. PDT protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ2n0x6AyYQ7Vg90H21EOLACvtfcHk0ljcasjnzcsH8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1WktL3P&md5=18f5839fc0f43f88918fa1c223ee961b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Facsami.9b14060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.9b14060%26sid%3Dliteratum%253Aachs%26aulast%3DHaimov-Talmoud%26aufirst%3DE.%26aulast%3DHarel%26aufirst%3DY.%26aulast%3DSchori%26aufirst%3DH.%26aulast%3DMotiei%26aufirst%3DM.%26aulast%3DAtkins%26aufirst%3DA.%26aulast%3DPopovtzer%26aufirst%3DR.%26aulast%3DLellouche%26aufirst%3DJ.-P.%26aulast%3DShefi%26aufirst%3DO.%26atitle%3DMagnetic%2520targeting%2520of%2520mTHPC%2520to%2520improve%2520the%2520selectivity%2520and%2520efficiency%2520of%2520photodynamic%2520therapy%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2019%26volume%3D11%26spage%3D45368%26epage%3D45380%26doi%3D10.1021%2Facsami.9b14060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">GSH-activatable NIR nanoplatform with mitochondria targeting for enhancing tumor-specific therapy</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">44961</span>– <span class="NLM_lpage">44969</span>, <span class="refDoi"> DOI: 10.1021/acsami.9b15996</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.9b15996" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFSqtb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=44961-44969&author=G.+Yangauthor=C.+Chenauthor=Y.+Zhuauthor=Z.+Liuauthor=Y.+Xueauthor=S.+Zhongauthor=C.+Wangauthor=Y.+Gaoauthor=W.+Zhang&title=GSH-activatable+NIR+nanoplatform+with+mitochondria+targeting+for+enhancing+tumor-specific+therapy&doi=10.1021%2Facsami.9b15996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">GSH-Activatable NIR Nanoplatform with Mitochondria Targeting for Enhancing Tumor-Specific Therapy</span></div><div class="casAuthors">Yang, Guoliang; Chen, Chao; Zhu, Yucheng; Liu, Zhiyong; Xue, Yudong; Zhong, Sheng; Wang, Chaochao; Gao, Yun; Zhang, Weian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">44961-44969</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Developing smart photosensitizers that are sensitive to tumor-specific signals for minimal side effects and enhanced antitumor efficacy is a tremendous challenge for tumor phototherapies.  Herein, we construct a nanoplatform with glutathione (GSH)-activatable and mitochondria-targeted pro-photosensitizer encapsulated by ultrasensitive pH-responsive polymer for achieving imaging-guided tumor-specific photodynamic therapy (PDT).  The GSH-activatable pro-photosensitizer, di-cyanine (DCy7), has been synthesized where two cyanine moieties are covalently conjugated by a disulfide bond, and the hydrophobic DCy7 is further encapsulated with an amphiphilic pH-responsive diblock copolymer POEGMA-b-PDPA to form <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="b9e9f9fdfac08e">[email protected]</a> nanoparticles.  Upon endocytosis by cancer cells, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="0e5e4e4a4d7739">[email protected]</a> nanoparticles dissoc. at endosome first and then DCy7 is released to cytoplasm and subsequently activated by the high concn. of GSH, finally targets mitochondria for organelle-targeted PDT.  Moreover, intracellular antioxidant GSH is consumed during the activation procedure that is beneficial to efficient PDT.  These <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="1f4f5f5b5c6628">[email protected]</a> nanoparticles display selective phototoxicity against tumor cells (HepG2 or 4T1 cells) over normal cells (BEAS-2B cells) in vitro, and their GSH-activatable enhanced PDT efficacy is further confirmed in tumor-bearing mice.  Thus, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="34647470774d03">[email protected]</a> nanoparticles allow for accurate and highly efficient PDT with minimal side effects, providing an attractive nanoplatform for organelle-targeted precise PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxtOmP32EZl7Vg90H21EOLACvtfcHk0lhoFcV-kJHHVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFSqtb7I&md5=48761279d0600456c7efad8b2657553d</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facsami.9b15996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.9b15996%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DGSH-activatable%2520NIR%2520nanoplatform%2520with%2520mitochondria%2520targeting%2520for%2520enhancing%2520tumor-specific%2520therapy%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2019%26volume%3D11%26spage%3D44961%26epage%3D44969%26doi%3D10.1021%2Facsami.9b15996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">Aptamer/photosensitizer hybridized mesoporous MnO<sub>2</sub> based tumor cell activated ROS regulator for precise photodynamic therapy of breast cancer</span>. <i>Colloid Surf., B</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>184</i></span>, <span class="NLM_elocation-id">110536</span> <span class="refDoi"> DOI: 10.1016/j.colsurfb.2019.110536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.colsurfb.2019.110536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=31639567" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2019&author=W.+Liuauthor=K.+Zhangauthor=L.+Zhuangauthor=J.+Liuauthor=W.+Zengauthor=J.+Shiauthor=Z.+Zhang&title=Aptamer%2Fphotosensitizer+hybridized+mesoporous+MnO2+based+tumor+cell+activated+ROS+regulator+for+precise+photodynamic+therapy+of+breast+cancer&doi=10.1016%2Fj.colsurfb.2019.110536"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.colsurfb.2019.110536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.colsurfb.2019.110536%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DZhuang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DW.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DAptamer%252Fphotosensitizer%2520hybridized%2520mesoporous%2520MnO2%2520based%2520tumor%2520cell%2520activated%2520ROS%2520regulator%2520for%2520precise%2520photodynamic%2520therapy%2520of%2520breast%2520cancer%26jtitle%3DColloid%2520Surf.%252C%2520B%26date%3D2019%26volume%3D184%26doi%3D10.1016%2Fj.colsurfb.2019.110536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span> <span> </span><span class="NLM_article-title">Biomacromolecules as carriers in drug delivery and tissue engineering</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2017.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.apsb.2017.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=29872621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BC1MbktlClsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=34-50&author=Y.+Zhangauthor=T.+Sunauthor=C.+Jiang&title=Biomacromolecules+as+carriers+in+drug+delivery+and+tissue+engineering&doi=10.1016%2Fj.apsb.2017.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Biomacromolecules as carriers in drug delivery and tissue engineering</span></div><div class="casAuthors">Zhang Yujie; Sun Tao; Jiang Chen</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-50</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Natural biomacromolecules have attracted increased attention as carriers in biomedicine in recent years because of their inherent biochemical and biophysical properties including renewability, nontoxicity, biocompatibility, biodegradability, long blood circulation time and targeting ability.  Recent advances in our understanding of the biological functions of natural-origin biomacromolecules and the progress in the study of biological drug carriers indicate that such carriers may have advantages over synthetic material-based carriers in terms of half-life, stability, safety and ease of manufacture.  In this review, we give a brief introduction to the biochemical properties of the widely used biomacromolecule-based carriers such as albumin, lipoproteins and polysaccharides.  Then examples from the clinic and in recent laboratory development are summarized.  Finally the current challenges and future prospects of present biological carriers are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5YHmp9KDVO4xhnOQkIHOxfW6udTcc2ebmKzR74a9Ewbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbktlClsQ%253D%253D&md5=aacf867bb2d4726a75d4f0dc321f8d66</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2017.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2017.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DC.%26atitle%3DBiomacromolecules%2520as%2520carriers%2520in%2520drug%2520delivery%2520and%2520tissue%2520engineering%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2018%26volume%3D8%26spage%3D34%26epage%3D50%26doi%3D10.1016%2Fj.apsb.2017.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.-w.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span> <span> </span><span class="NLM_article-title">In vitro toxicity of silica nanoparticles in human lung cancer cells</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>217</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">259</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2006.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.taap.2006.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=17112558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12rsbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=2006&pages=252-259&author=W.+Linauthor=Y.-w.+Huangauthor=X.-D.+Zhouauthor=Y.+Ma&title=In+vitro+toxicity+of+silica+nanoparticles+in+human+lung+cancer+cells&doi=10.1016%2Fj.taap.2006.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro toxicity of silica nanoparticles in human lung cancer cells</span></div><div class="casAuthors">Lin, Weisheng; Huang, Yue-wern; Zhou, Xiao-Dong; Ma, Yinfa</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">252-259</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The cytotoxicity of 15-nm and 46-nm silica nanoparticles was investigated by using cryst. silica (Min-U-Sil 5) as a pos. control in cultured human bronchoalveolar carcinoma-derived cells.  Exposure to 15-nm or 46-nm SiO2 nanoparticles for 48 h at dosage levels between 10 and 100 μg/mL decreased cell viability in a dose-dependent manner.  Both SiO2 nanoparticles were more cytotoxic than Min-U-Sil 5; however, the cytotoxicities of 15-nm and 46-nm silica nanoparticles were not significantly different.  The 15-nm SiO2 nanoparticles were used to det. time-dependent cytotoxicity and oxidative stress responses.  Cell viability decreased significantly as a function of both nanoparticle dosage (10-100 μg/mL) and exposure time (24, 48, and 72 h).  Indicators of oxidative stress and cytotoxicity, including total reactive oxygen species (ROS), glutathione, malondialdehyde, and lactate dehydrogenase, were quant. assessed.  Exposure to SiO2 nanoparticles increased ROS levels and reduced glutathione levels.  The increased prodn. of malondialdehyde and lactate dehydrogenase release from the cells indicated lipid peroxidn. and membrane damage.  In summary, exposure to SiO2 nanoparticles results in a dose-dependent cytotoxicity in cultural human bronchoalveolar carcinoma-derived cells that is closely correlated to increased oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYsyZyzK_-RLVg90H21EOLACvtfcHk0li-_2o-myrMbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12rsbvN&md5=28bcac4cbb4e09b10be0ec0691560476</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2006.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2006.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DY.-w.%26aulast%3DZhou%26aufirst%3DX.-D.%26aulast%3DMa%26aufirst%3DY.%26atitle%3DIn%2520vitro%2520toxicity%2520of%2520silica%2520nanoparticles%2520in%2520human%2520lung%2520cancer%2520cells%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2006%26volume%3D217%26spage%3D252%26epage%3D259%26doi%3D10.1016%2Fj.taap.2006.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soenen, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera-Gil, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montenegro, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parak, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Smedt, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braeckmans, K.</span></span> <span> </span><span class="NLM_article-title">Cellular toxicity of inorganic nanoparticles: common aspects and guidelines for improved nanotoxicity evaluation</span>. <i>Nano Today</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1016/j.nantod.2011.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.nantod.2011.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOisbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=446-465&author=S.+J.+Soenenauthor=P.+Rivera-Gilauthor=J.-M.+Montenegroauthor=W.+J.+Parakauthor=S.+C.+De+Smedtauthor=K.+Braeckmans&title=Cellular+toxicity+of+inorganic+nanoparticles%3A+common+aspects+and+guidelines+for+improved+nanotoxicity+evaluation&doi=10.1016%2Fj.nantod.2011.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular toxicity of inorganic nanoparticles: common aspects and guidelines for improved nanotoxicity evaluation</span></div><div class="casAuthors">Soenen, Stefaan J.; Rivera-Gil, Pilar; Montenegro, Jose-Maria; Parak, Wolfgang J.; De Smedt, Stefaan C.; Braeckmans, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Nano Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">446-465</span>CODEN:
                <span class="NLM_cas:coden">NTAOCG</span>;
        ISSN:<span class="NLM_cas:issn">1748-0132</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The safe use of inorg. nanoparticles (NPs) in biomedical applications remains an unresolved issue.  The present review presents an overview of the cytotoxic effects of commonly used inorg. NPs: quantum dots, gold and iron oxide nanoparticles.  The main focus is on presenting recent findings and identifying similar cytotoxic effects which appear common to all these NPs.  Next, several considerations are provided for optimizing cell-NP interaction studies which could aid in improving our understanding of NP toxicity.  Finally, several crit. NP parameters are discussed and suggestions are made on how to optimize NP design in view of minimal cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAYPbKrRPDUbVg90H21EOLACvtfcHk0li-_2o-myrMbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOisbbN&md5=2eebb978fd2ccd8b5e30df28ffc75222</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.nantod.2011.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nantod.2011.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DSoenen%26aufirst%3DS.%2BJ.%26aulast%3DRivera-Gil%26aufirst%3DP.%26aulast%3DMontenegro%26aufirst%3DJ.-M.%26aulast%3DParak%26aufirst%3DW.%2BJ.%26aulast%3DDe%2BSmedt%26aufirst%3DS.%2BC.%26aulast%3DBraeckmans%26aufirst%3DK.%26atitle%3DCellular%2520toxicity%2520of%2520inorganic%2520nanoparticles%253A%2520common%2520aspects%2520and%2520guidelines%2520for%2520improved%2520nanotoxicity%2520evaluation%26jtitle%3DNano%2520Today%26date%3D2011%26volume%3D6%26spage%3D446%26epage%3D465%26doi%3D10.1016%2Fj.nantod.2011.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fadeel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Bennett, A. E.</span></span> <span> </span><span class="NLM_article-title">Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2009.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.addr.2009.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=19900497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1OntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=362-374&author=B.+Fadeelauthor=A.+E.+Garcia-Bennett&title=Better+safe+than+sorry%3A+understanding+the+toxicological+properties+of+inorganic+nanoparticles+manufactured+for+biomedical+applications&doi=10.1016%2Fj.addr.2009.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications</span></div><div class="casAuthors">Fadeel, Bengt; Garcia-Bennett, Alfonso E.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">362-374</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The development of nanoparticles for biomedical applications including medical imaging and drug delivery is currently undergoing a dramatic expansion.  However, as the range of nanoparticle types and applications increases, it is also clear that the potential toxicities of these novel materials and the properties driving such toxic responses must also be understood.  Indeed, a detailed assessment of the factors that influence the biocompatibility and/or toxicity of nanoparticles is crucial for the safe and sustainable development of the emerging nanotechnologies.  This review summarizes some of the recent developments in the field of nanomedicine with particular emphasis on inorg. nanoparticles for drug delivery.  The synthesis routes, physico-chem. characteristics, and cytotoxic properties of inorg. nanoparticles are thus explored and lessons learned from the toxicol. investigation of three common types of engineered nanomaterials of titania, gold, and mesoporous silica are discussed.  Emphasis is placed on the recognition vs. non-recognition of engineered nanomaterials by the immune system, the primary surveillance system against microorganisms and particles, which, in turn, is intimately linked to the issue of targeted drug delivery using such nanomaterials as carrier systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQmvmGp18nj7Vg90H21EOLACvtfcHk0li-_2o-myrMbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1OntL8%253D&md5=ed1227e5710ee4f3301ced737f5c2505</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2009.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2009.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DFadeel%26aufirst%3DB.%26aulast%3DGarcia-Bennett%26aufirst%3DA.%2BE.%26atitle%3DBetter%2520safe%2520than%2520sorry%253A%2520understanding%2520the%2520toxicological%2520properties%2520of%2520inorganic%2520nanoparticles%2520manufactured%2520for%2520biomedical%2520applications%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D362%26epage%3D374%26doi%3D10.1016%2Fj.addr.2009.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elsaesser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, C. V.</span></span> <span> </span><span class="NLM_article-title">Toxicology of nanoparticles</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2011.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.addr.2011.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=21925220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1Glsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=129-137&author=A.+Elsaesserauthor=C.+V.+Howard&title=Toxicology+of+nanoparticles&doi=10.1016%2Fj.addr.2011.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicology of nanoparticles</span></div><div class="casAuthors">Elsaesser, Andreas; Howard, C. Vyvyan</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-137</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  While nanotechnol. and the prodn. of nanoparticles are growing exponentially, research into the toxicol. impact and possible hazard of nanoparticles to human health and the environment is still in its infancy.  This review aims to give a comprehensive summary of what is known today about nanoparticle toxicol., the mechanisms at the cellular level, entry routes into the body and possible impacts to public health.  Proper characterization of the nanomaterial, as well as understanding processes happening on the nanoparticle surface when in contact with living systems, is crucial to understand possible toxicol. effects.  Dose as a key parameter is essential in hazard identification and risk assessment of nanotechnologies.  Understanding nanoparticle pathways and entry routes into the body requires further research in order to inform policy makers and regulatory bodies about the nanotoxicol. potential of certain nanomaterials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDvHJNaMb_n7Vg90H21EOLACvtfcHk0litSHEo4Ifsew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1Glsrg%253D&md5=452bec5f06d7fe912a8490a58325e69e</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2011.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2011.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DElsaesser%26aufirst%3DA.%26aulast%3DHoward%26aufirst%3DC.%2BV.%26atitle%3DToxicology%2520of%2520nanoparticles%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2012%26volume%3D64%26spage%3D129%26epage%3D137%26doi%3D10.1016%2Fj.addr.2011.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Degradable molybdenum oxide nanosheets with rapid clearance and efficient tumor homing capabilities as a therapeutic nanoplatform</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2122</span>– <span class="NLM_lpage">2126</span>, <span class="refDoi"> DOI: 10.1002/anie.201510597</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1002%2Fanie.201510597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVyqurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=2122-2126&author=G.+Songauthor=J.+Haoauthor=C.+Liangauthor=T.+Liuauthor=M.+Gaoauthor=L.+Chengauthor=J.+Huauthor=Z.+Liu&title=Degradable+molybdenum+oxide+nanosheets+with+rapid+clearance+and+efficient+tumor+homing+capabilities+as+a+therapeutic+nanoplatform&doi=10.1002%2Fanie.201510597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Degradable Molybdenum Oxide Nanosheets with Rapid Clearance and Efficient Tumor Homing Capabilities as a Therapeutic Nanoplatform</span></div><div class="casAuthors">Song, Guosheng; Hao, Jiali; Liang, Chao; Liu, Teng; Gao, Min; Cheng, Liang; Hu, Junqing; Liu, Zhuang</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2122-2126</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Molybdenum oxide (MoOx) nanosheets with high near-IR (NIR) absorbance and pH-dependent oxidative degrdn. properties were synthesized, functionalized with polyethylene glycol (PEG), and then used as a degradable photothermal agent and drug carrier.  The nanosheets, which are relatively stable under acidic pH, could be degraded at physiol. pH.  Therefore, MoOx-PEG distributed in organs upon i.v. injection would be rapidly degraded and excreted without apparent in vivo toxicity.  MoOx-PEG shows efficient accumulation in tumors, the acidic pH of which then leads to longer tumor retention of those nanosheets.  Along with the capability of acting as a photothermal agent for effective tumor ablation, MoOx-PEG can load therapeutic mols. with high efficiencies.  This concept of inorg. theranostic nanoagent should be relatively stable in tumors to allow imaging and treatment, while being readily degradable in normal organs to enable rapid excretion and avoid long-term retention/toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI4GC4aFoDgrVg90H21EOLACvtfcHk0litSHEo4Ifsew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVyqurfJ&md5=498a6cb3cf94f3a09538e68c46909a95</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fanie.201510597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201510597%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DG.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DDegradable%2520molybdenum%2520oxide%2520nanosheets%2520with%2520rapid%2520clearance%2520and%2520efficient%2520tumor%2520homing%2520capabilities%2520as%2520a%2520therapeutic%2520nanoplatform%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D2122%26epage%3D2126%26doi%3D10.1002%2Fanie.201510597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utsunomiya, A.</span></span> <span> </span><span class="NLM_article-title">Sensitive photodynamic detection of adult T-cell leukemia/lymphoma and specific leukemic cell death induced by photodynamic therapy: current status in hematopoietic malignancies</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">335</span>, <span class="refDoi"> DOI: 10.3390/cancers12020335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.3390%2Fcancers12020335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1KlsrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=335&author=T.+Okaauthor=K.+I.+Matsuokaauthor=A.+Utsunomiya&title=Sensitive+photodynamic+detection+of+adult+T-cell+leukemia%2Flymphoma+and+specific+leukemic+cell+death+induced+by+photodynamic+therapy%3A+current+status+in+hematopoietic+malignancies&doi=10.3390%2Fcancers12020335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitive photodynamic detection of adult T-cell leukemia/lymphoma and specific leukemic cell death induced by photodynamic therapy: current status in hematopoietic malignancies</span></div><div class="casAuthors">Oka, Takashi; Matsuoka, Ken-ichi; Utsunomiya, Atae</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">335</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Adult T-cell leukemia/lymphoma (ATL), an aggressive type of T-cell malignancy, is caused by the human T-cell leukemia virus type I (HTLV-1) infections.  The outcomes, following therapeutic interventions for ATL, have not been satisfactory.  Photodynamic therapy (PDT) exerts selective cytotoxic activity against malignant cells, as it is considered a minimally invasive therapeutic procedure.  In PDT, photosensitizing agent administration is followed by irradn. at an absorbance wavelength of the sensitizer in the presence of oxygen, with ultimate direct tumor cell death, microvasculature injury, and induced local inflammatory reaction.  This review provides an overview of the present status and state-of-the-art ATL treatments.  It also focuses on the photodynamic detection (PDD) of hematopoietic malignancies and the recent progress of 5-Aminolevulinic acid (ALA)-PDT/PDD, which can efficiently induce ATL leukemic cell-specific death with minor influence on normal lymphocytes.  Further consideration of the ALA-PDT/PDD system along with the circulatory system regarding the clin. application in ATL and others will be discussed.  ALA-PDT/PDD can be promising as a novel treatment modality that overcomes unmet medical needs with the optimization of PDT parameters to increase the effectiveness of the tumor-killing activity and enhance the innate and adaptive anti-tumor immune responses by the optimized immunogenic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQZXvTAsjj7rVg90H21EOLACvtfcHk0litSHEo4Ifsew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1KlsrbE&md5=d1278c2444be8960a7a332a806a61d32</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.3390%2Fcancers12020335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers12020335%26sid%3Dliteratum%253Aachs%26aulast%3DOka%26aufirst%3DT.%26aulast%3DMatsuoka%26aufirst%3DK.%2BI.%26aulast%3DUtsunomiya%26aufirst%3DA.%26atitle%3DSensitive%2520photodynamic%2520detection%2520of%2520adult%2520T-cell%2520leukemia%252Flymphoma%2520and%2520specific%2520leukemic%2520cell%2520death%2520induced%2520by%2520photodynamic%2520therapy%253A%2520current%2520status%2520in%2520hematopoietic%2520malignancies%26jtitle%3DCancers%26date%3D2020%26volume%3D12%26spage%3D335%26doi%3D10.3390%2Fcancers12020335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, T.</span></span> <span> </span><span class="NLM_article-title">Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription</span>. <i>Retrovirology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5</span>, <span class="refDoi"> DOI: 10.1186/s12977-019-0467-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1186%2Fs12977-019-0467-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=30782173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BB3cflt1Kmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=5&author=L.+Xuauthor=X.+Zhangauthor=W.+Chengauthor=Y.+Wangauthor=K.+Yiauthor=Z.+Wangauthor=Y.+Zhangauthor=L.+Shaoauthor=T.+Zhao&title=Hypericin-photodynamic+therapy+inhibits+the+growth+of+adult+T-cell+leukemia+cells+through+induction+of+apoptosis+and+suppression+of+viral+transcription&doi=10.1186%2Fs12977-019-0467-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription</span></div><div class="casAuthors">Xu Lingling; Zhang Xueqing; Cheng Wenzhao; Wang Yong; Yi Kaining; Wang Zhilong; Zhang Yiling; Shao Linxiang; Zhao Tiejun; Cheng Wenzhao</div><div class="citationInfo"><span class="NLM_cas:title">Retrovirology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Adult T-cell leukemia (ATL) is an aggressive neoplasm caused by human T-cell leukemia virus type 1 (HTLV-1).  ATL carries a poor prognosis due to chemotherapy resistance.  Thus, it is urgent to develop new treatment strategies.  Hypericin (HY) is a new-type of photosensitizer in the context of photodynamic therapy (PDT) due to its excellent photosensitizing properties and anti-tumor activities.  RESULTS:  In the present study, we investigated the efficacy of hypericin in ATL cells.  Clinically achievable concentrations of hypericin in association with PDT induced the inhibition of cell proliferation in ATL cell lines with minimal effect on peripheral blood CD4(+) T lymphocytes.  Moreover, hypericin-PDT treatment caused apoptosis and G2/M phase cell cycle arrest in leukemic cells.  Western blot analyses revealed that hypericin-PDT treatment resulted in downregulation of Bcl-2 and enhanced the expression of Bad, cytochrome C, and AIF.  Cleavage of caspases-3/-7/-9/-8, Bid, and PARP was increased in hypericin-PDT-treated ATL cells.  In a luciferase assay, hypericin-PDT treatment was able to activate the promoter activity of Bax and p53, resulting in enhanced expression of Bax and p53 proteins.  Finally, hypericin-PDT treatment suppressed the expression of viral protein HBZ and Tax by blocking the promoter activity via HTLV-1 5'LTR and 3'LTR.  CONCLUSIONS:  Our results revealed that hypericin-PDT is highly effective against ATL cells by induction of apoptosis and suppression of viral transcription.  These studies highlight the promising use of hypericin-PDT as a targeted therapy for ATL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQGm3fFMcHFSEPI-fCgwosgfW6udTcc2ebJ57qsAkI5Urntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cflt1Kmtw%253D%253D&md5=3838f174c3bc43f60002580c3a3838d0</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1186%2Fs12977-019-0467-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12977-019-0467-0%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYi%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DShao%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DT.%26atitle%3DHypericin-photodynamic%2520therapy%2520inhibits%2520the%2520growth%2520of%2520adult%2520T-cell%2520leukemia%2520cells%2520through%2520induction%2520of%2520apoptosis%2520and%2520suppression%2520of%2520viral%2520transcription%26jtitle%3DRetrovirology%26date%3D2019%26volume%3D16%26spage%3D5%26doi%3D10.1186%2Fs12977-019-0467-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aksakal, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazan, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eçik, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuksel, F.</span></span> <span> </span><span class="NLM_article-title">A novel photosensitizer based on a ruthenium(ii) phenanthroline bis(perylenediimide) dyad: synthesis, generation of singlet oxygen and in vitro photodynamic therapy</span>. <i>New J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">17538</span>– <span class="NLM_lpage">17545</span>, <span class="refDoi"> DOI: 10.1039/C8NJ02944J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2FC8NJ02944J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVSrurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2018&pages=17538-17545&author=N.+E.+Aksakalauthor=H.+H.+Kazanauthor=E.+T.+E%C3%A7ikauthor=F.+Yuksel&title=A+novel+photosensitizer+based+on+a+ruthenium%28ii%29+phenanthroline+bis%28perylenediimide%29+dyad%3A+synthesis%2C+generation+of+singlet+oxygen+and+in+vitro+photodynamic+therapy&doi=10.1039%2FC8NJ02944J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A novel photosensitizer based on a ruthenium(II) phenanthroline bis(perylenediimide) dyad: synthesis, generation of singlet oxygen and in vitro photodynamic therapy</span></div><div class="casAuthors">Aksakal, Nuray Esra; Kazan, Hasan Huseyin; Ecik, Esra Tanriverdi; Yuksel, Fatma</div><div class="citationInfo"><span class="NLM_cas:title">New Journal of Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">17538-17545</span>CODEN:
                <span class="NLM_cas:coden">NJCHE5</span>;
        ISSN:<span class="NLM_cas:issn">1144-0546</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In this study, a novel photosensitizer having two perylenediimide units and a phenanthroline ruthenium(II) coordination moiety (Ru-BP) has been developed for photodynamic therapy (PDT) of cancer cells.  This new compd. was prepd. via reactions of two newly designed mols., namely, 5,6,12,13-tetrakis(4-(tert-butyl)phenoxy)-2-(2,6-diisopropylphenyl)-9-(4-hydroxyphenyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone (P6) and a bis(2,2'-bipyridyl)-(4,7-dichlorophenanthroline)ruthenium(II) complex (7).  The singlet oxygen prodn. of P6 and Ru-BP was investigated by a chem. method using 1,3-diphenylisobenzofurane as a trap mol.  Addnl., photodynamic therapy efficacy of the novel Ru-BP complex and P6 was evaluated in vitro.  Ru-BP significantly decreased the viability of human chronic myeloid leukemia cells under red light but not in the dark, pointing out that the complex, itself, was not cytotoxic and singlet oxygen formation was required for the initiation of cell death mechanisms.  Thus, Ru-BP can be effectively used as a photosensitizer in photodynamic therapy, which makes the novel Ru-BP a promising singlet oxygen generator for further biol. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBfmL5bGTZS7Vg90H21EOLACvtfcHk0lj87dnOmQp-Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVSrurzL&md5=9946d3c554de2b98946004bfde44fef4</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1039%2FC8NJ02944J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8NJ02944J%26sid%3Dliteratum%253Aachs%26aulast%3DAksakal%26aufirst%3DN.%2BE.%26aulast%3DKazan%26aufirst%3DH.%2BH.%26aulast%3DE%25C3%25A7ik%26aufirst%3DE.%2BT.%26aulast%3DYuksel%26aufirst%3DF.%26atitle%3DA%2520novel%2520photosensitizer%2520based%2520on%2520a%2520ruthenium%2528ii%2529%2520phenanthroline%2520bis%2528perylenediimide%2529%2520dyad%253A%2520synthesis%252C%2520generation%2520of%2520singlet%2520oxygen%2520and%2520in%2520vitro%2520photodynamic%2520therapy%26jtitle%3DNew%2520J.%2520Chem.%26date%3D2018%26volume%3D42%26spage%3D17538%26epage%3D17545%26doi%3D10.1039%2FC8NJ02944J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Păunescu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clavel, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak-Sliwinska, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffioen, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">Improved angiostatic activity of dasatinib by modulation with hydrophobic chains</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1021/ml500496u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500496u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVeitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=313-317&author=E.+P%C4%83unescuauthor=C.+M.+Clavelauthor=P.+Nowak-Sliwinskaauthor=A.+W.+Griffioenauthor=P.+J.+Dyson&title=Improved+angiostatic+activity+of+dasatinib+by+modulation+with+hydrophobic+chains&doi=10.1021%2Fml500496u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Improved Angiostatic Activity of Dasatinib by Modulation with Hydrophobic Chains</span></div><div class="casAuthors">Paunescu, Emilia; Clavel, Catherine M.; Nowak-Sliwinska, Patrycja; Griffioen, Arjan W.; Dyson, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">313-317</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dasatinib is an orally active nonselective tyrosine kinase inhibitor used to treat certain types of adult leukemia.  By inhibiting PDGFR-β and SFKs in both tumor cells and tumor-assocd. endothelial cells, dasatinib inhibits tumor growth and angiogenesis.  Herein, dasatinib derivs. modified with hydrophobic chains were prepd. and evaluated for their in vitro antiproliferative selectivity and their in vivo antiangiogenic activity.  For one of the derivs., modified with a long perfluorinated chain, a significant enhancement in antiangiogenic activity was obsd.  Combined, these results suggest a possible generic route to modulate the angiostatic activity of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryj0ll0VFq-7Vg90H21EOLACvtfcHk0liusQ5kc-r-Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVeitbg%253D&md5=3841140af5e762094eeba9682c6a3bd7</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fml500496u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500496u%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C4%2583unescu%26aufirst%3DE.%26aulast%3DClavel%26aufirst%3DC.%2BM.%26aulast%3DNowak-Sliwinska%26aufirst%3DP.%26aulast%3DGriffioen%26aufirst%3DA.%2BW.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DImproved%2520angiostatic%2520activity%2520of%2520dasatinib%2520by%2520modulation%2520with%2520hydrophobic%2520chains%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D313%26epage%3D317%26doi%3D10.1021%2Fml500496u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.-P.</span></span> <span> </span><span class="NLM_article-title">A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(ii) phthalocyanine and small molecule target-based anticancer drug erlotinib</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">9570</span>– <span class="NLM_lpage">9572</span>, <span class="refDoi"> DOI: 10.1039/c3cc45487h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2Fc3cc45487h" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=24018863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFWks7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=9570-9572&author=F.-L.+Zhangauthor=Q.+Huangauthor=K.+Zhengauthor=J.+Liauthor=J.-Y.+Liuauthor=J.-P.+Xue&title=A+novel+strategy+for+targeting+photodynamic+therapy.+Molecular+combo+of+photodynamic+agent+zinc%28ii%29+phthalocyanine+and+small+molecule+target-based+anticancer+drug+erlotinib&doi=10.1039%2Fc3cc45487h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(ii) phthalocyanine and small molecule target-based anticancer drug erlotinib</span></div><div class="casAuthors">Zhang, Feng-Ling; Huang, Qi; Zheng, Ke; Li, Jun; Liu, Jian-Yong; Xue, Jin-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">83</span>),
    <span class="NLM_cas:pages">9570-9572</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In this study, two phthalocyanine-erlotinib conjugates linked by an oligoethylene glycol chain have been synthesized and fully characterised.  Having erlotinib as the targeting moiety, the two conjugates exhibited high specific affinity to HepG2 cancer cells and tumor tissues, therefore leading to high photodynamic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXisipQF2XPLVg90H21EOLACvtfcHk0liusQ5kc-r-Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFWks7nF&md5=7a3c354ed0aa639507e9903c6145e3bf</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1039%2Fc3cc45487h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cc45487h%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DF.-L.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DZheng%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.-Y.%26aulast%3DXue%26aufirst%3DJ.-P.%26atitle%3DA%2520novel%2520strategy%2520for%2520targeting%2520photodynamic%2520therapy.%2520Molecular%2520combo%2520of%2520photodynamic%2520agent%2520zinc%2528ii%2529%2520phthalocyanine%2520and%2520small%2520molecule%2520target-based%2520anticancer%2520drug%2520erlotinib%26jtitle%3DChem.%2520Commun.%26date%3D2013%26volume%3D49%26spage%3D9570%26epage%3D9572%26doi%3D10.1039%2Fc3cc45487h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Würthner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saha-Moller, C. R.</span></span> <span> </span><span class="NLM_article-title">J-aggregates: from serendipitous discovery to supramolecular engineering of functional dye materials</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3376</span>– <span class="NLM_lpage">3410</span>, <span class="refDoi"> DOI: 10.1002/anie.201002307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1002%2Fanie.201002307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=21442690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=3376-3410&author=F.+W%C3%BCrthnerauthor=T.+E.+Kaiserauthor=C.+R.+Saha-Moller&title=J-aggregates%3A+from+serendipitous+discovery+to+supramolecular+engineering+of+functional+dye+materials&doi=10.1002%2Fanie.201002307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">J-Aggregates: From Serendipitous Discovery to Supramolecular Engineering of Functional Dye Materials</span></div><div class="casAuthors">Wuerthner, Frank; Kaiser, Theo E.; Saha-Moeller, Chantu R.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3376-3410</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  J-aggregates are of significant interest for org. materials conceived by supramol. approaches.  Their discovery in the 1930s represents one of the most important milestones in dye chem. as well as the germination of supramol. chem.  The intriguing optical properties of J-aggregates as well as their prospect for applications have motivated scientists to become involved in this field, and numerous contributions have been published.  This Review provides an overview on the J-aggregates of a broad variety of dyes well as their potential applications.  Thus, this Review is intended to be of interest to the supramol., photochem., and materials science communities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFPy6741WWCrVg90H21EOLACvtfcHk0liusQ5kc-r-Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWmtL0%253D&md5=a4da0f17b4afad13f6aee2509b919f60</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1002%2Fanie.201002307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201002307%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25BCrthner%26aufirst%3DF.%26aulast%3DKaiser%26aufirst%3DT.%2BE.%26aulast%3DSaha-Moller%26aufirst%3DC.%2BR.%26atitle%3DJ-aggregates%253A%2520from%2520serendipitous%2520discovery%2520to%2520supramolecular%2520engineering%2520of%2520functional%2520dye%2520materials%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D3376%26epage%3D3410%26doi%3D10.1002%2Fanie.201002307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walczak, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisfeld, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, J. S.</span></span> <span> </span><span class="NLM_article-title">Exchange narrowing of the J band of molecular dye aggregates</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>128</i></span>, <span class="NLM_elocation-id">044505</span> <span class="refDoi"> DOI: 10.1063/1.2823730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1063%2F1.2823730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=18247967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhslOgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2008&author=P.+B.+Walczakauthor=A.+Eisfeldauthor=J.+S.+Briggs&title=Exchange+narrowing+of+the+J+band+of+molecular+dye+aggregates&doi=10.1063%2F1.2823730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Exchange narrowing of the J band of molecular dye aggregates</span></div><div class="casAuthors">Walczak, P. B.; Eisfeld, A.; Briggs, J. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">044505/1-044505/12</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">The exchange narrowing of the J band of certain dye monomers upon aggregation in soln. was known since the 1930s.  Here, the authors analyze the theor. explanations put forward to account for these narrow absorption bands.  Although the theories range from models of identical monomers interacting with vibrations to the opposite of rigid monomers with statistically distributed electronic site energies, all approaches exhibit exchange narrowing.  However, the origins of the narrowing are different.  A unified theory incorporating the two approaches is presented in which features of both narrowing mechanisms are evident.  (c) 2008 American Institute of Physics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonfiMoW7CsT7Vg90H21EOLACvtfcHk0liyGvtAPrvaAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhslOgu70%253D&md5=659cea43e0b3d2dfdd612b208af73022</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1063%2F1.2823730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.2823730%26sid%3Dliteratum%253Aachs%26aulast%3DWalczak%26aufirst%3DP.%2BB.%26aulast%3DEisfeld%26aufirst%3DA.%26aulast%3DBriggs%26aufirst%3DJ.%2BS.%26atitle%3DExchange%2520narrowing%2520of%2520the%2520J%2520band%2520of%2520molecular%2520dye%2520aggregates%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D2008%26volume%3D128%26doi%3D10.1063%2F1.2823730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egorov, V. V.</span></span> <span> </span><span class="NLM_article-title">Theory of the J-band: from the Frenkel exciton to charge transfer</span>. <i>Phys. Procedia</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">326</span>, <span class="refDoi"> DOI: 10.1016/j.phpro.2009.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.phpro.2009.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ygsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=223-326&author=V.+V.+Egorov&title=Theory+of+the+J-band%3A+from+the+Frenkel+exciton+to+charge+transfer&doi=10.1016%2Fj.phpro.2009.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Theory of the J-band: from the Frenkel exciton to charge transfer</span></div><div class="casAuthors">Egorov, Vladimir V.</div><div class="citationInfo"><span class="NLM_cas:title">Physics Procedia</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-326</span>CODEN:
                <span class="NLM_cas:coden">PPHRCK</span>;
        ISSN:<span class="NLM_cas:issn">1875-3892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This review concerns the current status of the theory of formation of the so-called J-band, an abnormally narrow, high-intensity, red-shifted optical absorption band arising from the aggregation of polymethine dyes.  Two opposite approaches to explaining the phys. nature of the J-band are given special attention.  In the first of these, the old one based on Frenkel's statistical exciton model, the specific structure of the dye is considered irrelevant, and the J-band is explained by assuming that the quickly moving Frenkel exciton acts to av. out the quasistatic disorder in electronic transition energies of mols. in the linear J-aggregate.  In the second approach, on the contrary, the specific structure of the dye (the existence of a quasilinear polymethine chain) is supposed to be very important.  This new approach is based on a new theory of charge transfer.  The explanation of the J-band here is that an elementary charge transfer along the J-aggregate's chromophore is dynamically pumped by the chaotic reorganization of nuclei in the nearby environment at a resonance between electronic and nuclear movements - when the motion of nuclei being reorganized is only weakly chaotic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFYWNZbefiaLVg90H21EOLACvtfcHk0liyGvtAPrvaAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ygsr%252FJ&md5=0580bbfc4060ced83f89d9fc53f21663</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.phpro.2009.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phpro.2009.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DEgorov%26aufirst%3DV.%2BV.%26atitle%3DTheory%2520of%2520the%2520J-band%253A%2520from%2520the%2520Frenkel%2520exciton%2520to%2520charge%2520transfer%26jtitle%3DPhys.%2520Procedia%26date%3D2009%26volume%3D2%26spage%3D223%26epage%3D326%26doi%3D10.1016%2Fj.phpro.2009.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scalise, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durantini, E. N.</span></span> <span> </span><span class="NLM_article-title">Synthesis, properties, and photodynamic inactivation of Escherichia coli using a cationic and a noncharged Zn(II) pyridyloxyphthalocyanine derivatives</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">3037</span>– <span class="NLM_lpage">3045</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.01.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.bmc.2005.01.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=15781413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVCgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=3037-3045&author=I.+Scaliseauthor=E.+N.+Durantini&title=Synthesis%2C+properties%2C+and+photodynamic+inactivation+of+Escherichia+coli+using+a+cationic+and+a+noncharged+Zn%28II%29+pyridyloxyphthalocyanine+derivatives&doi=10.1016%2Fj.bmc.2005.01.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, properties, and photodynamic inactivation of Escherichia coli using a cationic and a noncharged Zn(II) pyridyloxyphthalocyanine derivatives</span></div><div class="casAuthors">Scalise, Ines; Durantini, Edgardo N.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3037-3045</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The photodynamic effect of a cationic Zn(II) N-methylpyridyloxyphthalocyanine (ZnPc 2) and a noncharged Zn(II) pyridyloxyphthalocyanine (ZnPc 1) has been compared in both homogeneous media bearing photooxidizable substrates and in vitro using a typical Gram-neg. bacterium Escherichia coli.  Absorption and fluorescence spectroscopic studies were analyzed in different media.  Fluorescence quantum yields (.vphi.F) of 0.23 for ZnPc 1 and 0.22 for ZnPc 2 were calcd. in N,N-dimethylformamide (DMF).  The singlet mol. oxygen, O2(1Δg), prodn. was evaluated using 9,10-dimethylanthracene (DMA) in DMF yielding values of ΦΔ = 0.56 for ZnPc 1 and 0.59 for ZnPc 2.  A faster decompn. of -tryptophan (Trp), which was used as biol. substrate model, was obtained using ZnPc 2 as a sensitizer with respect to ZnPc 1.  In biol. medium, the E. coli cultures were treated with 10 μM of sensitizer for different times at 37 °C in the dark.  Both ZnPcs 1 and 2 are rapidly bound to E. coli cells in 5 min and the amt. of cell-bound sensitizer is not appreciably changed incubating the cultures for longer times.  The recovered ZnPc 2 after one washing step is ∼3 times higher than 1, reaching a value of ∼3 nmol/106 cells.  After irradn. with visible light, a higher photoinactivation of cells was found for ZnPc 2.  Thus, a ∼4.5 log (99.997%) decrease of cell survival was obtained after 30 min of irradn.  On the other hand, a very low photodamage was found for cells treated with ZnPc 1 (∼0.5 log).  Also, these results were established by stopping of growth curves for E. coli.  In the structure of ZnPc 2, the cationic centers are isolated from the phthalocyanine ring by an ether bridge, which also provides a higher mobility of the charges facilitating the interaction with the outer membrane of the Gram-neg. bacteria.  These studies show that cationic ZnPc 2 is an efficient phototherapeutic agent with potential applications in photodynamic inactivation of bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEADh4_wlxLLVg90H21EOLACvtfcHk0lgeNGRkyHleaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVCgtrY%253D&md5=b03001c7e0030c7dd01f99c3226fbaa4</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.01.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.01.063%26sid%3Dliteratum%253Aachs%26aulast%3DScalise%26aufirst%3DI.%26aulast%3DDurantini%26aufirst%3DE.%2BN.%26atitle%3DSynthesis%252C%2520properties%252C%2520and%2520photodynamic%2520inactivation%2520of%2520Escherichia%2520coli%2520using%2520a%2520cationic%2520and%2520a%2520noncharged%2520Zn%2528II%2529%2520pyridyloxyphthalocyanine%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D3037%26epage%3D3045%26doi%3D10.1016%2Fj.bmc.2005.01.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savić, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maysinger, D.</span></span> <span> </span><span class="NLM_article-title">Block copolymer micelles as delivery vehicles of hydrophobic drugs: Micelle–cell interactions</span>. <i>J. Drug Target.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1080/10611860600874538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1080%2F10611860600874538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=17092835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1Cqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=343-355&author=R.+Savi%C4%87author=A.+Eisenbergauthor=D.+Maysinger&title=Block+copolymer+micelles+as+delivery+vehicles+of+hydrophobic+drugs%3A+Micelle%E2%80%93cell+interactions&doi=10.1080%2F10611860600874538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Block copolymer micelles as delivery vehicles of hydrophobic drugs: micelle-cell interactions</span></div><div class="casAuthors">Savic, Radoslav; Eisenberg, Adi; Maysinger, Dusica</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">343-355</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  One-third of drugs in development are water insol. and one-half fail in trials because of poor pharmacokinetics.  Block copolymer micelles are nanosized particles that can solubilize hydrophobic drugs and alter their kinetics in vitro and in vivo.  However, block copolymer micelles are not solely passive drug containers that simply solubilize hydrophobic drugs; cells internalize micelles.  To facilitate the development of advanced, controlled, micellar drug delivery vehicles, we have to understand the fate of micelles and micelle-incorporated drugs in cells and in vivo.  With micelle-based drug formulations recently reaching clin. trials, the impetus for answers is ever so strong and detailed studies of interactions of micelles and cells are starting to emerge.  Most notably, the question arises: Is the internalization of block copolymer micelles carrying small mol. wt. drugs an undesired side effect or a useful means of improving the effectiveness of the incorporated drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPBUQGrLWO4bVg90H21EOLACvtfcHk0lgeNGRkyHleaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1Cqtrk%253D&md5=8be608c14cc56eec264cc7e5983866c8</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1080%2F10611860600874538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10611860600874538%26sid%3Dliteratum%253Aachs%26aulast%3DSavi%25C4%2587%26aufirst%3DR.%26aulast%3DEisenberg%26aufirst%3DA.%26aulast%3DMaysinger%26aufirst%3DD.%26atitle%3DBlock%2520copolymer%2520micelles%2520as%2520delivery%2520vehicles%2520of%2520hydrophobic%2520drugs%253A%2520Micelle%25E2%2580%2593cell%2520interactions%26jtitle%3DJ.%2520Drug%2520Target.%26date%3D2006%26volume%3D14%26spage%3D343%26epage%3D355%26doi%3D10.1080%2F10611860600874538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Master, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleinick, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A. S.</span></span> <span> </span><span class="NLM_article-title">EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies</span>. <i>Nanomedicine</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">655</span>– <span class="NLM_lpage">664</span>, <span class="refDoi"> DOI: 10.1016/j.nano.2011.09.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.nano.2011.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=22024195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC38XptVKmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=655-664&author=A.+M.+Masterauthor=Y.+Qiauthor=N.+L.+Oleinickauthor=A.+S.+Gupta&title=EGFR-mediated+intracellular+delivery+of+Pc+4+nanoformulation+for+targeted+photodynamic+therapy+of+cancer%3A+in+vitro+studies&doi=10.1016%2Fj.nano.2011.09.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies</span></div><div class="casAuthors">Master, Alyssa M.; Qi, Yizhi; Oleinick, Nancy L.; Sen Gupta, Anirban</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">655-664</span>CODEN:
                <span class="NLM_cas:coden">NANOBF</span>;
        ISSN:<span class="NLM_cas:issn">1549-9634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In photodynamic therapy (PDT), the light activation of a photosensitizer leads to the generation of reactive oxygen species that can trigger various mechanisms of cell death.  Harnessing this process within cancer cells enables minimally invasive yet targeted cancer treatment.  With this rationale, here we demonstrate tumor-targeted delivery of a highly hydrophobic photosensitizer Pc 4 loaded within biocompatible poly(ethylene glycol)-poly(ε-caprolactone) block co-polymer micelles.  The micelles were surface-modified with epidermal growth factor receptor (EGFR)-targeting GE11 peptides for active targeting of EGFR-overexpressing cancer cells, in vitro.  Pc 4-loaded EGFR-targeted micelles were incubated with EGFR-overexpressing A431 epidermoid carcinoma cells for various time periods, to det. Pc 4 uptake by epifluorescence microscopy.  The cells were subsequently photoirradiated, and PDT-induced cell death for various incubation periods was detd. by MTT assay and fluorescence Live/Dead assay.  Our results indicate that active EGFR targeting of the Pc 4-loaded micelles accelerates intracellular uptake of the drug.  Consequently, this enhances the PDT-induced cytotoxicity within shorter time periods.  Photodynamic cancer therapy using Pc 4, a light activated and highly hydrophobic photosensitizer is demonstrated in this paper in vitro.  Pc 4 was delivered in block-copolymer micelles surface-modified with GE11 peptides targeting EGFR-overexpressing cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu13s6lWfL77Vg90H21EOLACvtfcHk0ljwvNs8c4BKkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptVKmsr4%253D&md5=56fbd1ed49e53da38bec0936ab616351</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.nano.2011.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nano.2011.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DMaster%26aufirst%3DA.%2BM.%26aulast%3DQi%26aufirst%3DY.%26aulast%3DOleinick%26aufirst%3DN.%2BL.%26aulast%3DGupta%26aufirst%3DA.%2BS.%26atitle%3DEGFR-mediated%2520intracellular%2520delivery%2520of%2520Pc%25204%2520nanoformulation%2520for%2520targeted%2520photodynamic%2520therapy%2520of%2520cancer%253A%2520in%2520vitro%2520studies%26jtitle%3DNanomedicine%26date%3D2012%26volume%3D8%26spage%3D655%26epage%3D664%26doi%3D10.1016%2Fj.nano.2011.09.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckett, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blair, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirtakusuma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakjang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enshaei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halsey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vormoor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidenreich, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krippner-Heidenreich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Delft, F. W.</span></span> <span> </span><span class="NLM_article-title">Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>105</i></span>, <span class="NLM_elocation-id">241026</span> <span class="refDoi"> DOI: 10.3324/haematol.2019.241026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.3324%2Fhaematol.2019.241026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2020&author=Y.+Shiauthor=M.+C.+Beckettauthor=H.+J.+Blairauthor=R.+Tirtakusumaauthor=S.+Nakjangauthor=A.+Enshaeiauthor=C.+Halseyauthor=J.+Vormoorauthor=O.+Heidenreichauthor=A.+Krippner-Heidenreichauthor=F.+W.+van+Delft&title=Phase+II-like+murine+trial+identifies+synergy+between+dexamethasone+and+dasatinib+in+T-cell+acute+lymphoblastic+leukemia&doi=10.3324%2Fhaematol.2019.241026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2019.241026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2019.241026%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DY.%26aulast%3DBeckett%26aufirst%3DM.%2BC.%26aulast%3DBlair%26aufirst%3DH.%2BJ.%26aulast%3DTirtakusuma%26aufirst%3DR.%26aulast%3DNakjang%26aufirst%3DS.%26aulast%3DEnshaei%26aufirst%3DA.%26aulast%3DHalsey%26aufirst%3DC.%26aulast%3DVormoor%26aufirst%3DJ.%26aulast%3DHeidenreich%26aufirst%3DO.%26aulast%3DKrippner-Heidenreich%26aufirst%3DA.%26aulast%3Dvan%2BDelft%26aufirst%3DF.%2BW.%26atitle%3DPhase%2520II-like%2520murine%2520trial%2520identifies%2520synergy%2520between%2520dexamethasone%2520and%2520dasatinib%2520in%2520T-cell%2520acute%2520lymphoblastic%2520leukemia%26jtitle%3DHaematologica%26date%3D2020%26volume%3D105%26doi%3D10.3324%2Fhaematol.2019.241026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harr, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caimi, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McColl, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distelhorst, C. W.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1381</span>– <span class="NLM_lpage">1391</span>, <span class="refDoi"> DOI: 10.1038/cdd.2010.25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fcdd.2010.25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=20300113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVantr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1381-1391&author=M.+W.+Harrauthor=P.+F.+Caimiauthor=K.+S.+McCollauthor=F.+Zhongauthor=S.+N.+Patelauthor=P.+M.+Barrauthor=C.+W.+Distelhorst&title=Inhibition+of+Lck+enhances+glucocorticoid+sensitivity+and+apoptosis+in+lymphoid+cell+lines+and+in+chronic+lymphocytic+leukemia&doi=10.1038%2Fcdd.2010.25"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia</span></div><div class="casAuthors">Harr, M. W.; Caimi, P. F.; McColl, K. S.; Zhong, F.; Patel, S. N.; Barr, P. M.; Distelhorst, C. W.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1381-1391</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glucocorticoids are used as part of front-line therapy to treat lymphoid malignancy because of their remarkable ability to induce apoptosis.  Yet, in T cells, glucocorticoid-induced apoptosis is readily inhibited by lymphocyte activation and signaling.  We have previously shown that the Src family kinase, Lck (lymphocyte cell-specific tyrosine kinase), which is predominantly expressed in T cells, interacts with IP3 receptors to facilitate calcium signaling.  Here, we discovered that dexamethasone downregulates Lck, which, in turn, suppresses lymphocyte activation by inhibiting pro-survival calcium oscillations.  Moreover, stable expression of shRNAs that selectively targeted Lck or treatment with the Src inhibitor dasatinib (BMS-354825) enhanced apoptosis induction by dexamethasone.  To investigate the effect of Lck inhibition in a primary leukemia model, we employed chronic lymphocytic leukemia (CLL) cells that aberrantly expressed Lck and were relatively insensitive to dexamethasone.  Lck expression was correlated with resistance to dexamethasone in CLL cells, and its inhibition by dasatinib or other inhibitors markedly enhanced glucocorticoid sensitivity.  Collectively, these data indicate that Lck protects cells from glucocorticoid-induced apoptosis and its inhibition enhances sensitivity to dexamethasone.  Small-mol. inhibitors of Lck, such as dasatinib, may function to reverse glucocorticoid resistance in some lymphoid malignancies.  Cell Death and Differentiation (2010) 17, 1381-1391; doi:10.1038/cdd.2010.25; published online 19 March 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaM1YbNhebrrVg90H21EOLACvtfcHk0ljwvNs8c4BKkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVantr7O&md5=b27c64888919351e9d70a12cdd555c8f</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2010.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2010.25%26sid%3Dliteratum%253Aachs%26aulast%3DHarr%26aufirst%3DM.%2BW.%26aulast%3DCaimi%26aufirst%3DP.%2BF.%26aulast%3DMcColl%26aufirst%3DK.%2BS.%26aulast%3DZhong%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DS.%2BN.%26aulast%3DBarr%26aufirst%3DP.%2BM.%26aulast%3DDistelhorst%26aufirst%3DC.%2BW.%26atitle%3DInhibition%2520of%2520Lck%2520enhances%2520glucocorticoid%2520sensitivity%2520and%2520apoptosis%2520in%2520lymphoid%2520cell%2520lines%2520and%2520in%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2010%26volume%3D17%26spage%3D1381%26epage%3D1391%26doi%3D10.1038%2Fcdd.2010.25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">The role of porphyrin chemistry in tumor imaging and photodynamic therapy</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.1039/B915149B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1039%2FB915149B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=20694259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFKju7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=340-362&author=M.+Ethirajanauthor=Y.+Chenauthor=P.+Joshiauthor=R.+K.+Pandey&title=The+role+of+porphyrin+chemistry+in+tumor+imaging+and+photodynamic+therapy&doi=10.1039%2FB915149B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">The role of porphyrin chemistry in tumor imaging and photodynamic therapy</span></div><div class="casAuthors">Ethirajan, Manivannan; Chen, Yihui; Joshi, Penny; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">340-362</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  In recent years several review articles and books have been published on the use of porphyrin-based compds. in photodynamic therapy (PDT).  This crit. review is focused on (i) the basic concept of PDT, (ii) advantages of long-wavelength absorbing photosensitizers (PS), (iii) a brief discussion on recent advances in developing PDT agents, and (iv) the various synthetic strategies designed at the Roswell Park Cancer Institute, Buffalo, for developing highly effective long-wavelength PDT agents and their utility in constructing the conjugates with tumor-imaging and therapeutic potential (Theranostics).  The clin. status of certain selected PDT agents is also summarized (205 refs.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwaO6TvgtDibVg90H21EOLACvtfcHk0liOof8KB7Mzwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFKju7bF&md5=b462478255e32db5d073a892c64e2d52</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1039%2FB915149B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB915149B%26sid%3Dliteratum%253Aachs%26aulast%3DEthirajan%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DThe%2520role%2520of%2520porphyrin%2520chemistry%2520in%2520tumor%2520imaging%2520and%2520photodynamic%2520therapy%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2011%26volume%3D40%26spage%3D340%26epage%3D362%26doi%3D10.1039%2FB915149B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J. L.</span></span> <span> </span><span class="NLM_article-title">Intranuclear photosensitizer delivery and photosensitization for enhanced photodynamic therapy with ultralow irradiance</span>. <i>Adv. Funct. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">7318</span>– <span class="NLM_lpage">7327</span>, <span class="refDoi"> DOI: 10.1002/adfm.201402255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1002%2Fadfm.201402255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVChsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=7318-7327&author=L.+M.+Panauthor=J.+A.+Liuauthor=J.+L.+Shi&title=Intranuclear+photosensitizer+delivery+and+photosensitization+for+enhanced+photodynamic+therapy+with+ultralow+irradiance&doi=10.1002%2Fadfm.201402255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Intranuclear Photosensitizer Delivery and Photosensitization for Enhanced Photodynamic Therapy with Ultralow Irradiance</span></div><div class="casAuthors">Pan, Limin; Liu, Jianan; Shi, Jianlin</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Functional Materials</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">7318-7327</span>CODEN:
                <span class="NLM_cas:coden">AFMDC6</span>;
        ISSN:<span class="NLM_cas:issn">1616-301X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is a well-established clin. treatment modality for various diseases.  However, reactive oxygen species (ROS) generated by photosensitizers(PS) under proper irradn. exhibits extremely short life span (<200 ns) and severely limited diffusion distance (20 nm), so the damage of ROS to biomols., esp. DNA, is strongly confined to the immediate vicinity of ROS generation.  In this report, an efficient nuclear-targeted delivery strategy is proposed by using TAT and RGD peptides co-conjugated mesoporous silica nanoparticles (MSNs) as PS carriers.  The conjugation of TAT peptides enable the nuclear penetration of MSNs for efficient accumulation of PS inside nuclei.  The intranuclear-accumulated PS can generate ROS upon irradn. right inside nuclei to destroy DNA instantaneously.  For the purpose of in vivo applications, the co-conjugated RGD peptides endow the nuclear-targeted delivery system with specific binding and recognition to tumor vasculature and tumor cell membranes for significantly enhanced specificity and reduced side effects.  Through i.v. injection of these nanosystems in tumor-bearing mice at a rather low PS dose of 2 mg/kg, tumor growth is efficiently inhibited by an extremely low irradn. dose of 6 J/cm2.  This work presents a new paradigm for specific PDT with high efficacy and low side effects in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTh7ZQ_mWKtLVg90H21EOLACvtfcHk0liOof8KB7Mzwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVChsrbN&md5=80fe232186a32ab441da4478d8513d3a</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1002%2Fadfm.201402255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadfm.201402255%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DL.%2BM.%26aulast%3DLiu%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DJ.%2BL.%26atitle%3DIntranuclear%2520photosensitizer%2520delivery%2520and%2520photosensitization%2520for%2520enhanced%2520photodynamic%2520therapy%2520with%2520ultralow%2520irradiance%26jtitle%3DAdv.%2520Funct.%2520Mater.%26date%3D2014%26volume%3D24%26spage%3D7318%26epage%3D7327%26doi%3D10.1002%2Fadfm.201402255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B.</span></span> <span> </span><span class="NLM_article-title">A near-infrared triggered nanophotosensitizer inducing domino effect on mitochondrial reactive oxygen species burst for cancer therapy</span>. <i>ACS Nano</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">11064</span>– <span class="NLM_lpage">11074</span>, <span class="refDoi"> DOI: 10.1021/acsnano.5b04501</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsnano.5b04501" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Cht77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=11064-11074&author=Z.+Yuauthor=Q.+Sunauthor=W.+Panauthor=N.+Liauthor=B.+Tang&title=A+near-infrared+triggered+nanophotosensitizer+inducing+domino+effect+on+mitochondrial+reactive+oxygen+species+burst+for+cancer+therapy&doi=10.1021%2Facsnano.5b04501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">A Near-Infrared Triggered Nanophotosensitizer Inducing Domino Effect on Mitochondrial Reactive Oxygen Species Burst for Cancer Therapy</span></div><div class="casAuthors">Yu, Zhengze; Sun, Qiaoqiao; Pan, Wei; Li, Na; Tang, Bo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Nano</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">11064-11074</span>CODEN:
                <span class="NLM_cas:coden">ANCAC3</span>;
        ISSN:<span class="NLM_cas:issn">1936-0851</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is a well-established modality for cancer therapy, which locally kills cancer cells when light irradiates a photosensitizer.  However, conventional PDT is often limited by the extremely short lifespan and severely limited diffusion distance of reactive oxygen species (ROS) generated by photosensitizer, as well as the penetration depth of visible light activation.  Here, we develop a near-IR (NIR) triggered nanophotosensitizer based on mitochondria targeted titanium dioxide-coated upconversion nanoparticles for PDT against cancer.  When irradiated by NIR laser, the nanophotosensitizer could produce ROS in mitochondria, which induced the domino effect on ROS burst.  The overproduced ROS accumulated in mitochondria, resulting in mitochondrial collapse and irreversible cell apoptosis.  Confocal fluorescence imaging indicated that the mitochondrial targeting and real-time imaging of ROS burst could be achieved in living cells.  The complete removal of tumor in vivo confirmed the excellent therapeutic effect of the nanophotosensitizer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU_3KP99PxsbVg90H21EOLACvtfcHk0liMwK8ldIotFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Cht77O&md5=39bb1a41f1e10acb318993d360f8c091</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Facsnano.5b04501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsnano.5b04501%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DB.%26atitle%3DA%2520near-infrared%2520triggered%2520nanophotosensitizer%2520inducing%2520domino%2520effect%2520on%2520mitochondrial%2520reactive%2520oxygen%2520species%2520burst%2520for%2520cancer%2520therapy%26jtitle%3DACS%2520Nano%26date%3D2015%26volume%3D9%26spage%3D11064%26epage%3D11074%26doi%3D10.1021%2Facsnano.5b04501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rajaputra, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nkepang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro biological evaluation of lipophilic cation conjugated photosensitizers for targeting mitochondria</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2012.11.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.bmc.2012.11.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=23245573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVektbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=379-387&author=P.+Rajaputraauthor=G.+Nkepangauthor=R.+Watleyauthor=Y.+You&title=Synthesis+and+in+vitro+biological+evaluation+of+lipophilic+cation+conjugated+photosensitizers+for+targeting+mitochondria&doi=10.1016%2Fj.bmc.2012.11.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro biological evaluation of lipophilic cation conjugated photosensitizers for targeting mitochondria</span></div><div class="casAuthors">Rajaputra, Pallavi; Nkepang, Gregory; Watley, Ryan; You, Youngjae</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">379-387</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mitochondria-specific photosensitizers were designed by taking advantage of the preferential localization of delocalized lipophilic cations (DLCs) in mitochondria.  Three DLC-porphyrin conjugates: CMP-Rh (a core modified porphyrin-rhodamine B cation), CMP-tPP (a core modified porphyrin-mono-triphenyl phosphonium cation), CMP-(tPP)2 (a core modified porphyrin-di-tPP cation) were prepd.  The conjugates were synthesized by conjugating a monohydroxy core modified porphyrin (CMP-OH) to rhodamine B (Rh B), or either one or two tPPs, resp., via a satd. hydrocarbon linker.  Their ability for delivering photosensitizers to mitochondria was evaluated using dual staining fluorescence microscopy.  In addn., to evaluate the efficiency of the conjugates as photosensitizers, their photophys. properties and in vitro biol. activities were studied in comparison to those of CMP-OH.  Fluorescence imaging study suggested that CMP-Rh specifically localized in mitochondria.  On the other hand, CMP-tPP and CMP-(tPP)2 showed less significant mitochondrial localization.  All conjugates were capable of generating singlet oxygen at rates comparable to CMP-OH.  Interestingly, all cationic conjugates showed dramatic increase in cellular uptake and phototoxicity compared to CMP-OH.  This improved photodynamic activity might be primarily due to an enhanced cellular uptake.  Our study suggests that Rh B cationic group is better at least for CMP than tPP as a mitochondrial targeting vector.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq18xy_w0Y0P7Vg90H21EOLACvtfcHk0liMwK8ldIotFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVektbrL&md5=d80cc5ae274da98a6b3d514ebba548d3</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.11.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.11.032%26sid%3Dliteratum%253Aachs%26aulast%3DRajaputra%26aufirst%3DP.%26aulast%3DNkepang%26aufirst%3DG.%26aulast%3DWatley%26aufirst%3DR.%26aulast%3DYou%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520biological%2520evaluation%2520of%2520lipophilic%2520cation%2520conjugated%2520photosensitizers%2520for%2520targeting%2520mitochondria%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D379%26epage%3D387%26doi%3D10.1016%2Fj.bmc.2012.11.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H. Y.</span></span> <span> </span><span class="NLM_article-title">Acidity-triggered tumor-targeted chimeric peptide for enhanced intra-nuclear photodynamic therapy</span>. <i>Adv. Funct. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4351</span>– <span class="NLM_lpage">4361</span>, <span class="refDoi"> DOI: 10.1002/adfm.201600170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1002%2Fadfm.201600170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlKmtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4351-4361&author=K.+Hanauthor=W.+Y.+Zhangauthor=J.+Zhangauthor=Q.+Leiauthor=S.+B.+Wangauthor=J.+W.+Liuauthor=X.+Z.+Zhangauthor=H.+Y.+Han&title=Acidity-triggered+tumor-targeted+chimeric+peptide+for+enhanced+intra-nuclear+photodynamic+therapy&doi=10.1002%2Fadfm.201600170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Acidity-Triggered Tumor-Targeted Chimeric Peptide for Enhanced Intra-Nuclear Photodynamic Therapy</span></div><div class="casAuthors">Han, Kai; Zhang, Wei-Yun; Zhang, Jin; Lei, Qi; Wang, Shi-Bo; Liu, Jia-Wei; Zhang, Xian-Zheng; Han, He-You</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Functional Materials</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4351-4361</span>CODEN:
                <span class="NLM_cas:coden">AFMDC6</span>;
        ISSN:<span class="NLM_cas:issn">1616-301X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Photodynamic therapy suffers from poor tumor selectivity and poor therapeutical efficacy.  In this paper, an amphiphilic chimeric peptide is fabricated to realize sequential acidity-responsive tumor-targeted transport of photosensitizer and in situ photodynamic therapy in nuclei.  In vitro studies demonstrate that the acidic tumor microenvironment successfully sheds the mask of cationic nuclear localization sequence (NLS) of the neg. charged chimeric peptide.  This charge reversal remarkably accelerates cellular uptake of chimeric peptide in tumor cells and maximizes the photodynamic therapeutical efficacy in nuclei.  Most importantly, direct disguise of the biofunctional NLS sequence decreases the complexity and increases the performance of the chimeric peptide further by achieving long blood retention time, specific tumor accumulation, minimal side effects, and efficient antitumor therapy in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxlx1_eWP8IbVg90H21EOLACvtfcHk0liMwK8ldIotFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlKmtLg%253D&md5=6b2fe87bfdfa6e0e35e85c396262de55</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1002%2Fadfm.201600170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadfm.201600170%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DW.%2BY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLei%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DS.%2BB.%26aulast%3DLiu%26aufirst%3DJ.%2BW.%26aulast%3DZhang%26aufirst%3DX.%2BZ.%26aulast%3DHan%26aufirst%3DH.%2BY.%26atitle%3DAcidity-triggered%2520tumor-targeted%2520chimeric%2520peptide%2520for%2520enhanced%2520intra-nuclear%2520photodynamic%2520therapy%26jtitle%3DAdv.%2520Funct.%2520Mater.%26date%3D2016%26volume%3D26%26spage%3D4351%26epage%3D4361%26doi%3D10.1002%2Fadfm.201600170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sivori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Zotto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mingari, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moretta, L.</span></span> <span> </span><span class="NLM_article-title">Human NK cells: surface receptors, inhibitory checkpoints, and translational applications</span>. <i>Cell Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">430</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1038/s41423-019-0206-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fs41423-019-0206-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=30778167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmt1yksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=430-441&author=S.+Sivoriauthor=P.+Vaccaauthor=G.+Del+Zottoauthor=E.+Munariauthor=M.+C.+Mingariauthor=L.+Moretta&title=Human+NK+cells%3A+surface+receptors%2C+inhibitory+checkpoints%2C+and+translational+applications&doi=10.1038%2Fs41423-019-0206-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Human NK cells: surface receptors, inhibitory checkpoints, and translational applications</span></div><div class="casAuthors">Sivori, Simona; Vacca, Paola; Del Zotto, Genny; Munari, Enrico; Mingari, Maria Cristina; Moretta, Lorenzo</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Immunology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">430-441</span>CODEN:
                <span class="NLM_cas:coden">CMIEAO</span>;
        ISSN:<span class="NLM_cas:issn">1672-7681</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">NK cells play important roles in innate defenses against viruses and in the control of tumor growth and metastasis.  The regulation/induction of NK cell function is mediated by an array of activating or inhibitory surface receptors.  In humans, major activating receptors involved in target cell killing are the natural cytotoxicity receptors (NCRs) and NKG2D.  Activating receptors recognize ligands that are overexpressed or expressed de novo upon cell stress, viral infection, or tumor transformation.  The HLA-class I-specific inhibitory receptors, including KIRs recognizing HLA-class I allotypic determinants and CD94/NKG2A recognizing the class-Ib HLA-E, constitute a fail-safe mechanism to avoid unwanted NK-mediated damage to healthy cells.  Other receptors such as PD-1, primarily expressed by activated T lymphocytes, are important inhibitory checkpoints of immune responses that ensure T-cell tolerance.  PD-1 also may be expressed by NK cells in cancer patients.  Since PD-1 ligand (PD-L1) may be expressed by different tumors, PD-1/PD-L1 interactions inactivate both T and NK cells.  Thus, the reliable evaluation of PD-L1 expression in tumors has become a major issue to select patients who may benefit from therapy with mAbs disrupting PD-1/PD-L1 interactions.  Recently, NKG2A was revealed to be an important checkpoint controlling both NK and T-cell activation.  Since most tumors express HLA-E, mAbs targeting NKG2A has been used alone or in combination with other therapeutic mAbs targeting PD-1 or tumor antigens (e.g., EGFR), with encouraging results.  The translational value of NK cells and their receptors is evidenced by the extraordinary therapeutic success of haploidentical HSCT to cure otherwise fatal high-risk leukemias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsfRZnt4Q5D7Vg90H21EOLACvtfcHk0lj2GccAYOSs9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmt1yksb0%253D&md5=fa4b68872ff43beeadb177d2efdb19db</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1038%2Fs41423-019-0206-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41423-019-0206-4%26sid%3Dliteratum%253Aachs%26aulast%3DSivori%26aufirst%3DS.%26aulast%3DVacca%26aufirst%3DP.%26aulast%3DDel%2BZotto%26aufirst%3DG.%26aulast%3DMunari%26aufirst%3DE.%26aulast%3DMingari%26aufirst%3DM.%2BC.%26aulast%3DMoretta%26aufirst%3DL.%26atitle%3DHuman%2520NK%2520cells%253A%2520surface%2520receptors%252C%2520inhibitory%2520checkpoints%252C%2520and%2520translational%2520applications%26jtitle%3DCell%2520Mol.%2520Immunol.%26date%3D2019%26volume%3D16%26spage%3D430%26epage%3D441%26doi%3D10.1038%2Fs41423-019-0206-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiossone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumas, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vienne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivier, E.</span></span> <span> </span><span class="NLM_article-title">Natural killer cells and other innate lymphoid cells in cancer</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">688</span>, <span class="refDoi"> DOI: 10.1038/s41577-018-0061-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fs41577-018-0061-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=30209347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslSnu7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=671-688&author=L.+Chiossoneauthor=P.+Y.+Dumasauthor=M.+Vienneauthor=E.+Vivier&title=Natural+killer+cells+and+other+innate+lymphoid+cells+in+cancer&doi=10.1038%2Fs41577-018-0061-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Natural killer cells and other innate lymphoid cells in cancer</span></div><div class="casAuthors">Chiossone, Laura; Dumas, Pierre-Yves; Vienne, Margaux; Vivier, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">671-688</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Immuno-oncol. is an emerging field that has revolutionized cancer treatment.  Most immunomodulatory strategies focus on enhancing T cell responses, but there has been a recent surge of interest in harnessing the relatively underexplored natural killer (NK) cell compartment for therapeutic interventions.  NK cells show cytotoxic activity against diverse tumor cell types, and some of the clin. approaches originally developed to increase T cell cytotoxicity may also activate NK cells.  Moreover, increasing nos. of studies have identified novel methods for increasing NK cell antitumor immunity and expanding NK cell populations ex vivo, thereby paving the way for a new generation of anticancer immunotherapies.  The role of other innate lymphoid cells (group 1 innate lymphoid cell (ILC1), ILC2 and ILC3 subsets) in tumors is also being actively explored.  This Review provides an overview of the field and summarizes current immunotherapeutic approaches for solid tumors and haematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGostky6tNI3Z7Vg90H21EOLACvtfcHk0lj2GccAYOSs9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslSnu7fP&md5=0f8f392583afdd60e5a607677e8e132c</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fs41577-018-0061-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41577-018-0061-z%26sid%3Dliteratum%253Aachs%26aulast%3DChiossone%26aufirst%3DL.%26aulast%3DDumas%26aufirst%3DP.%2BY.%26aulast%3DVienne%26aufirst%3DM.%26aulast%3DVivier%26aufirst%3DE.%26atitle%3DNatural%2520killer%2520cells%2520and%2520other%2520innate%2520lymphoid%2520cells%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2018%26volume%3D18%26spage%3D671%26epage%3D688%26doi%3D10.1038%2Fs41577-018-0061-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeNardo, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruffell, B.</span></span> <span> </span><span class="NLM_article-title">Macrophages as regulators of tumour immunity and immunotherapy</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">382</span>, <span class="refDoi"> DOI: 10.1038/s41577-019-0127-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1038%2Fs41577-019-0127-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=30718830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtFKhtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2019&pages=369-382&author=D.+G.+DeNardoauthor=B.+Ruffell&title=Macrophages+as+regulators+of+tumour+immunity+and+immunotherapy&doi=10.1038%2Fs41577-019-0127-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophages as regulators of tumour immunity and immunotherapy</span></div><div class="casAuthors">DeNardo, David G.; Ruffell, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">369-382</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Macrophages are crit. mediators of tissue homeostasis, with tumors distorting this proclivity to stimulate proliferation, angiogenesis and metastasis.  This had led to an interest in targeting macrophages in cancer, and preclin. studies have demonstrated efficacy across therapeutic modalities and tumor types.  Much of the obsd. efficacy can be traced to the suppressive capacity of macrophages, driven by microenvironmental cues such as hypoxia and fibrosis.  As a result, tumor macrophages display an ability to suppress T cell recruitment and function as well as to regulate other aspects of tumor immunity.  With the increasing impact of cancer immunotherapy, macrophage targeting is now being evaluated in this context.  Here, we discuss the results of clin. trials and the future of combinatorial immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBmZbwMl_tu7Vg90H21EOLACvtfcHk0lj2GccAYOSs9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtFKhtrw%253D&md5=b2c97a2c6e6605d9fa6dae24eed6373f</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1038%2Fs41577-019-0127-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41577-019-0127-6%26sid%3Dliteratum%253Aachs%26aulast%3DDeNardo%26aufirst%3DD.%2BG.%26aulast%3DRuffell%26aufirst%3DB.%26atitle%3DMacrophages%2520as%2520regulators%2520of%2520tumour%2520immunity%2520and%2520immunotherapy%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2019%26volume%3D19%26spage%3D369%26epage%3D382%26doi%3D10.1038%2Fs41577-019-0127-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pluddemann, A.</span></span> <span> </span><span class="NLM_article-title">Tissue macrophages: heterogeneity and functions</span>. <i>BMC Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">53</span>, <span class="refDoi"> DOI: 10.1186/s12915-017-0392-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1186%2Fs12915-017-0392-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=28662662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVeksbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=53&author=S.+Gordonauthor=A.+Pluddemann&title=Tissue+macrophages%3A+heterogeneity+and+functions&doi=10.1186%2Fs12915-017-0392-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue macrophages: heterogeneity and functions</span></div><div class="casAuthors">Gordon, Siamon; Pluddemann, Annette</div><div class="citationInfo"><span class="NLM_cas:title">BMC Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">53/1-53/18</span>CODEN:
                <span class="NLM_cas:coden">BBMIF7</span>;
        ISSN:<span class="NLM_cas:issn">1741-7007</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Macrophages are present in all vertebrate tissues, from mid-gestation throughout life, constituting a widely dispersed organ system.  They promote homeostasis by responding to internal and external changes within the body, not only as phagocytes in defense against microbes and in clearance of dead and senescent cells, but also through trophic, regulatory and repair functions.  In this review, we describe macrophage phenotypic heterogeneity in different tissue environments, drawing particular attention to organ-specific functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz4h1xVWAXr7Vg90H21EOLACvtfcHk0ljFD7MSWiuYxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVeksbvN&md5=c487aabab25a12867528dfa8af142d8f</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1186%2Fs12915-017-0392-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12915-017-0392-4%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DS.%26aulast%3DPluddemann%26aufirst%3DA.%26atitle%3DTissue%2520macrophages%253A%2520heterogeneity%2520and%2520functions%26jtitle%3DBMC%2520Biol.%26date%3D2017%26volume%3D15%26spage%3D53%26doi%3D10.1186%2Fs12915-017-0392-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yunna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengru, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidong, C.</span></span> <span> </span><span class="NLM_article-title">Macrophage M1/M2 polarization</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>877</i></span>, <span class="NLM_elocation-id">173090</span> <span class="refDoi"> DOI: 10.1016/j.ejphar.2020.173090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=10.1016%2Fj.ejphar.2020.173090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=32234529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;key=1%3ACAS%3A280%3ADC%252BB383ps1GqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=877&publication_year=2020&author=C.+Yunnaauthor=H.+Mengruauthor=W.+Leiauthor=C.+Weidong&title=Macrophage+M1%2FM2+polarization&doi=10.1016%2Fj.ejphar.2020.173090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage M1/M2 polarization</span></div><div class="casAuthors">Yunna Chen; Mengru Hu; Lei Wang; Weidong Chen</div><div class="citationInfo"><span class="NLM_cas:title">European journal of pharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">877</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">173090</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Macrophages can be affected by a variety of factors to change their phenotype and thus affect their function.  Activated macrophages are usually divided into two categories, M1-like macrophages and M2-like macrophages.  Both M1 macrophages and M2 macrophages are closely related to inflammatory responses, among which M1 macrophages are mainly involved in pro-inflammatory responses and M2 macrophages are mainly involved in anti-inflammatory responses.  Improving the inflammatory environment by modulating the activation state of macrophages is an effective method for the treatment of diseases.  In this review, we analyzed the mechanism of macrophage polarization from the tumor microenvironment, nanocarriers, nuclear receptor PPARγ, phagocytosis, NF-κB signaling pathways, and other pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8pnXsScpYdgHqQV89nF-2fW6udTcc2eblXaEeYGKlhbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB383ps1GqsA%253D%253D&md5=ed4bbcec65aad7affffdc7ce841fdcaf</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2020.173090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2020.173090%26sid%3Dliteratum%253Aachs%26aulast%3DYunna%26aufirst%3DC.%26aulast%3DMengru%26aufirst%3DH.%26aulast%3DLei%26aufirst%3DW.%26aulast%3DWeidong%26aufirst%3DC.%26atitle%3DMacrophage%2520M1%252FM2%2520polarization%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2020%26volume%3D877%26doi%3D10.1016%2Fj.ejphar.2020.173090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i33"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01072">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_38240"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01072?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01072</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Electronic absorption spectra of <b>4</b> and <b>5</b> in PBS or RPMI-1640 medium; fluorescence spectra of <b>4</b> and <b>5</b> in DMF; absorbance spectra of DPBF at 415 nm; cytotoxicity of dasatinib toward CEM cells at high concentrations; cytotoxicity of compounds toward HELF cells with/without light illumination; subcellular localization of <b>5</b>; H&E staining of different organs in the four groups; staining of different antibodies in <b>5</b>, dasatinib, and control groups; and <sup>1</sup>H NMR, <sup>13</sup>C NMR, and HRMS of all new compounds and HPLC of compounds <b>3</b>, <b>4</b>, and <b>5</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01072/suppl_file/jm0c01072_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01072/suppl_file/jm0c01072_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01072/suppl_file/jm0c01072_si_001.pdf">jm0c01072_si_001.pdf (2.35 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01072/suppl_file/jm0c01072_si_003.csv">jm0c01072_si_003.csv (0.96 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01072&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-24%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01072%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01072" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                11MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ac0d618bc24bf","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
